FUNCTIONAL NEUROANATOMY OF THE NITRIC OXIDE SYSTEM
FUNCTIONAL NEUROANATOMY OF THE NITRIC OXIDE SYSTEM
This Page Intentionally Left Blank
H A N D B O O K OF CHEMICAL NEUROANATOMY Series Editors: A. Bj6rklund and T. H6kfelt
Volume 17
FUNCTIONAL NEUROANATOMY OF THE NITRIC OXIDE SYSTEM Editors:
H.W.M. STEINBUSCH and J. DE VENTE European Graduate School of Neuroscience (EURON), Department of Psychiatry and Neuropsychology, Maastricht University, PO Box 616, 6200 MD Maastricht, The Netherlands
S.R. VINCENT Graduate Program in Neuroscience, University of British Columbia, Kinsman Laboratory of Neurological Research, Department of Psychiatry, Vancouver, BC V6T 1Z3, Canada
2000
ELSEVIER Amsterdam-
Lausanne - New York-
Oxford-
Shannon - Singapore - Tokyo
ELSEVIER SCIENCE B.V. Sara Burgerhartstraat 25 P.O. Box 211, 1000 AE Amsterdam, The Netherlands
© 2000 Elsevier Science B.V. All rights reserved.
This work is protected under copyright by Elsevier Science, and the following terms and conditions apply to its use: Photocopying Single photocopies of single chapters may be made for personal use as allowed by national copyright laws. Permission of the Publisher and payment of a fee is required for all other photocopying, including multiple or systematic copying, copying for advertising or promotional purposes, resale, and all forms of document delivery. Special rates are available for educational institutions that wish to make photocopies for non-profit educational classroom use. Permissions may be sought directly from Elsevier Science Rights & Permissions Department, PO Box 800, Oxford OX5 1DX, UK; phone: (+44) 1865 843830, fax: (+44) 1865 853333, e-mail:
[email protected]. You may also contact Rights & Permissions directly through Elsevier's home page (http://www.elsevier.nl), selecting first 'Customer Support', then 'General Information', then 'Permissions Query Form'. In the USA, users may clear permissions and make payments through the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, USA; phone: (978) 7508400, fax: (978) 7504744, and in the UK through the Copyright Licensing Agency Rapid Clearance Service (CLARCS), 90 Tottenham Court Road, London W1P 0LP, UK; phone: (+44) 171 631 5555; fax: (+44) 171 631 5500. Other countries may have a local reprographic rights agency for payments. Derivative Works Tables of contents may be reproduced for internal circulation, but permission of Elsevier Science is required for external resale or distribution of such material. Permission of the Publisher is required for all other derivative works, including compilations and translations. Electronic Storage or Usage Permission of the Publisher is required to store or use electronically any material contained in this work, including any chapter or part of a chapter. Except as outlined above, no part of this work may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the Publisher. Address permissions requests to: Elsevier Science Rights & Permissions Department, at the mail, fax and e-mail addresses noted above. Notice No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. First edition 2000 Library of Congress Cataloging in Publication Data Functional neuroanatomy of the nitric oxide system / editors, H.W.M. Steinbusch... [et al.].- 1st ed. p. ; cm - (Handbook of chemical neuroanatomy ; v. 17) Includes index. ISBN 0-444-50285-8 (alk. paper) 1. Nitric oxide. 2. Neurochemistry. 3. Neuroanatomy. I. Steinbusch, Hendrik Wilhelm Maria, 1950- II. Series. [DNLM: 1. Nitric-Oxide Synthase-physiology. 2. Nervous System Physiology. 3. Nitric Oxide-physiology. 4. Signal Transduction. QV 126 F979 2000] QP535.N1 F86 2000 612.8'042-dc21 00-028784
I S B N 0-444-50285-8 (volume) ISBN: 0-444-90340-2 (series) The paper used in this publication meets the requirements of A N S I / N I S O Z39.48-1992 (Permanence of Paper). Printed in The Netherlands
List of Contributors J. AIJON Dpto. Biologfa Celular y Patologfa Universidad de Salamanca Avda. Alfonso X el Sabio 1 37007 Salamanca Spain
T.EC. BATTEN Institute of Cardiovascular Research University of Leeds The Worsley Building Leeds LS2 9JT UK
J.R. ALONSO Dpto. Biologfa Celular y Patologfa Universidad de Salamanca Avda. Alfonso X el Sabio 1 37007 Salamanca Spain
J.G. BRINON Dpto. Biolog/a Celular y Patologfa Universidad de Salamanca Avda. Alfonso X el Sabio 1 37007 Salamanca Spain
S. AMIR Center for Studies in Behavioral Neurobiology Concordia University 1455 de Maisonneuve Boulevard West Montreal, PQ H3G 1M8 Canada
M.S. DAVIDOFF Institute of Anatomy University of Hamburg Martinistr. 52 D-20246 Hamburg Germany
C.R. ANDERSON Department of Anatomy and Cell Biology University of Melbourne Parkville, VIC 3052 Australia R. ARI~VALO Dpto. Biologfa Celular y Patologfa Universidad de Salamanca Avda. Alfonso X el Sabio 1 37007 Salamanca Spain L. ATKINSON School of Biomedical Sciences University of Leeds The Worsley Building Leeds LS 2 9NQ UK
J. DEUCHARS School of Biomedical Sciences University of Leeds The Worsley Building Leeds LS 2 9 NQ UK J. DE VENTE European Graduate School of Neuroscience (EURON) Department of Psychiatry and Neuropsychology Maastricht University PO Box 616 6200 MD Maastricht The Netherlands
W.D. ELDRED Department of Biology Laboratory of Visual Neurobiology Boston University 5 Cummington Street Boston, MA 02215 USA J.B. FURNESS Department of Anatomy and Cell Biology University of Melbourne Parkville, VIC 3052 Australia L.J. IGNARRO Department of Molecular and Medical Pharmacology UCLA School of Medicine CHS 23-120, Box 951785 Los Angeles, CA 90095-1735 USA A. JACOBS Department of Molecular and Medical Pharmacology UCLA School of Medicine CHS 23-120, Box 951785 Los Angeles, CA 90095-1735 USA R. MIDDENDORFF Institute of Anatomy University of Hamburg Martinistr. 52 D-20246 Hamburg Germany A. PORTEROS Dpto. Biologfa Celular y Patologfa Universidad de Salamanca Avda. Alfonso X el Sabio 1 37007 Salamanca Spain
vi
N.L. SCHOLZ Northwest Fisheries Science Center Seattle, WA 98112 USA H.W.M. STEINBUSCH European Graduate School of Neuroscience (EURON) Department of Psychiatry and Neuropsychology Maastricht University PO Box 616 6200 MD Maastricht The Netherlands J.W. TRUMAN Department of Zoology University of Washington Box 351800 Seattle, WA 98195-1800 USA S.R. VINCENT Graduate Program in Neuroscience Kinsmen Laboratory of Neurological Research Department of Psychiatry University of British Columbia Vancouver, BC V6T 1Z3 Canada E. WERUAGA Dpto. Biolog/a Celular y Patologfa Universidad de Salamanca Avda. Alfonso X el Sabio 1 37007 Salamanca Spain B. WOODSIDE Center for Studies in BehaVioral Neurobiology Concordia University 1455 de Maisonneuve Boulevard West Montreal, PQ H3G 1M8 Canada
W. WU Department of Anatomy University of Hong Kong Faculty of Medicine 5 Sassoon Road Hong Kong People's Republic of China
H.M. YOUNG Department of Anatomy and Cell Biology University of Melbourne Parkville, VIC 3052 Australia
vii
This Page Intentionally Left Blank
Preface This volume concerns the neuronal isoform of nitric oxide synthase (nNOS, bNOS or NOS I). Only in the first chapter, the endothelial isoform and the inducible form are briefly mentioned in an attempt to provide a more complete picture. In agreement with the goal of the Handbook Series, the focus of this volume is on the localization of NOS in the nervous system where today extensive information is present from studies on the brain, spinal cord and peripheral nervous system. This is to a considerable extent a consequence of the important discovery that NADPH-diaphorase activity is a part of NOS, which made it possible to use an earlier established histochemical staining method to visualize NOS systems. With this method brilliant staining patterns can be achieved in an easy and relatively cheap way. There are, however, certain caveats in the use of this NADPH-diaphorase method, which are discussed in more or less detail in several chapters of this volume. Nevertheless, this enzyme histochemical staining method remains a valuable and preferred tool for many researchers involved in NOS neuroanatomy. We have tried to bring together a number of reviews on different aspects of NOS, ranging from detailed descriptions of the nNOS distribution to analysis of NO signaling with the aim to provide a first major reference guide to the localization of NOS in different species. In addition we wanted to present an overview of the co-localization of other (co)transmitters with NOS. A more functional approach to NO can be achieved by the combined visualization of the localization of NOS and activated soluble guanylyl cyclase as a target for NO. Although many more direct effects of NO on a number of molecular targets, e.g. ion channels and NMDA receptors, have been reported in the literature, it remains to be demonstrated that these effects are relevant to the physiological function of NO in the nervous system. NOS is present in virtually every area throughout the central and peripheral nervous system. Over the last decade NO has emerged as an important regulator of many brain processes, and its physico-chemical properties and synthetic and release characteristics make NO an unconventional messenger molecule. It is synthesized upon demand and can diffuse over considerable distances in spite of its short half-life. The fact that NO is a free radical makes it potentially harmful to the living organism. Therefore, the expression of the genes for the different NOS isoforms as well as the metabolism of NO in the nervous system have to be rigidly controlled. This potential neurotoxic role may have been accentuated in the first decade of NO research at the expense of its physiological signaling function. It is our hope that this volume will help to further stimulate research on NO as a messenger molecule in the nervous system, which is one of the aims with the publication of this volume of the Handbook Series. We would like to express our gratitude to the authors of this volume who have taken the time and made the effort to produce such excellent chapters, as well as to the highly competent and cooperative staff at Elsevier. Maastricht, Vancouver, Lund and Stockholm, January 2000 HARRY W.M. STEINBUSCH ANDERS BJORKLUND
JAN DE VENTE
STEVEN R. VINCENT TOMAS HOKFELT ix
This Page Intentionally Left Blank
Contents List of Contributors Preface
v
ix
NITRIC OXIDE SYNTHASE AND THE PRODUCTION OF NITRIC O X I D E L.J. IGNARRO AND A. JACOBS 1. 2. 3. 4. 5. II.
1 3 6 10 11
HISTOCHEMISTRY OF NITRIC OXIDE SYNTHASE IN THE CENTRAL NERVOUS SYSTEM- S.R. VINCENT 1. 2.
3. 4. 5. 6. III.
Introduction and historical perspectives NO synthase isoforms Protein structure of NO synthase isoforms Neuronal NO synthase References
Introduction Localization of nitric oxide synthase in the brain 2.1. The olfactory bulb 2.2. The cerebral cortex 2.3. The hippocampal formation 2.4. The basal forebrain 2.5. The basal ganglia 2.6. The thalamus 2.7. The superior colliculus 2.8. The auditory system 2.9. The hypothalamus 2.10. Circumventricular organs 2.11. The mesopontine tegmentum 2.12. The cerebellum 2.13. The medulla 2.14. The spinal cord Arginine metabolism in the brain Heme oxygenase Conclusions References
19 21 21 22 24 26 27 28 29 31 31 33 33 36 36 37 38 39 39 39
COMPARATIVE AND DEVELOPMENTAL NEUROANATOMICAL ASPECTS OF THE NO SYSTEM- J.R. ALONSO, g. ARI~VALO, E. WERUAGA, A. PORTEROS, J.G. BgIlqON AND J. AIJON 1. 2.
Introduction Methods to localize nitric oxide and nitric oxide synthases in brain tissue 2.1. Histological detection of NADPH-diaphorase/nitric oxide synthase
51 52 52 xi
3.
4.
5. 6. IV.
53 53 54 54 54 55 55 55 59 63 67 71 76 87 87 89 91 92 94 101
NITRIC OXIDE IN THE RETINA - W.D. ELDRED 1. 2.
3. 4.
5.
xii
2.1.1. NADPH-diaphorase histochemistry 2.1.2. Immunohistochemistry 2.1.3. In situ hybridization 2.2. Biochemical detection of nitric oxide synthase, nitric oxide production, and nitric oxide proper Results 3.1. Fish 3.1.1. Cyclostomes 3.1.2. Teleosts 3.2. Amphibians 3.3. Reptiles 3.4. Birds 3.5. Mammals 3.6. General pattern of NADPH-diaphorase expression during rat brain development Discussion 4.1. Methodological aspects 4.2. Interspecies differences in the NADPH-diaphorase distribution pattern 4.3. Implications of the NADPH-diaphorase expression during the developmental processes 4.4. NADPH-diaphorase/nitric oxide synthase distribution pattern and nitric oxide functional implications Abbreviations References
Introduction Localization of nitric oxide synthase in the retina 2.1. Methodological considerations 2.1.1. NADPH-diaphorase histochemistry 2.1.2. NOS immunocytochemistry 2.2. Isoforms of NOS in the retina 2.3. Anatomical localizations of NOS 2.3.1. Mammals 2.3.2. Lower vertebrates 2.4. Regional distribution of NOS 2.5. Efferents Development of NOS in the retina and central visual targets Biochemistry and molecular biology of NOS in the retina 4.1. NOS 4.2. Photoreceptors Function of NO in specific retinal cell types 5.1. Photoreceptors 5.2. Horizontal cells 5.3. Bipolar cells 5.4. Amacrine cells 5.5. Ganglion cells
111 111 112 112 113 113 114 114 117 120 122 122 125 125 126 128 128 129 131 131 132
6. Release of NO in the retina 7. Modulation of transmitter release by NO 8. The cGMP signal transduction pathway in retina and its modulation by NO 9. Future areas of investigation 10. Abbreviations 11. Acknowledgements 12. References V.
I32 133 133 138
I39 140 I40
NITRIC OXIDE SIGNALING IN THE HYPOTHALAMUS - B. WOODSIDE AND S, AMIR Introduction 147 NOS in the hypothalamus 147 Co-localization 149 Regulation 151 Functional considerations 157 5.1. Stress axis 157 5.2. Magnocellular neurosecretory system 159 5.2.1. Modulation of vasopressin and oxytocin release 159 5.2.2. Drinking 161 5.2.3. Reproductive behavior 161 5.3. The reproductive axis 161 5.3. I . Modulation of luteinizing hormone-releasing hormone secre161 tion 5.3.2. Modulation of prolactin release 163 5.3.3. Sexual behavior 163 5.4. Somatostatin release 163 5.5. Circadian regulation 1 64 5.6. Autonomic regulation 164 5.7. Plasticity 165 6. Conclusions 166 7. Acknowledgements 167 8. References 167
1. 2. 3. 4. 5.
VI.
NITRIC OXIDE SYSTEMS IN THE MEDULLA OBLONGATA AND THEIR INVOLVEMENT IN AUTONOMIC CONTROL - T.F.C. BATTEN, L. ATKINSON AND J. DEUCHARS 1. Introduction 2. Methods 3. Results and discussion 3.1. Anatomy of NOS in the medulla oblongata 3. I . 1. Description of the location and morphological characteristics of NOS-IR neurones in the rat medulla oblongata 3.1.2. Relative distribution of NOS-IR and NADPH-diaphorase activity 3.1.3. Co-localisation of NOS-IR or NADPH-diaphorase activity with other neuronal phenotypes in the medulla oblongata
177 177 180 180 180 187 188 ...
Xlll
3.2.
,
5. 6.
Role of nitric oxide in medullary pathways involved in autonomic functions 3.2.1. NO in the control of the cardiovascular system 3.2.2. NO in neuronal circuitry underlying control of the oesophagus 3.2.3. NO in CNS control of the stomach and large intestine 3.2.4. NO in central respiratory control 3.2.5. NO in pathways coordinating autonomic and nociceptive responses Abbreviations Acknowledgements References
199 199 204 204 205 206 207 208 208
VII. NITRIC OXIDE IN THE PERIPHERAL AUTONOMIC NERVOUS SYSTEMH.M. YOUNG, C.R. ANDERSON AND J.B. FURNESS Introduction 1.1. Brief history of the identification of NO as a peripheral neurotransmitter 1.2. General properties of NO-mediated neurotransmission 1.3. Scope of this review 2. NO in autonomic ganglia 2.1. Nitric oxide and sympathetic pre- and postganglionic neurones 2.1.1. Presence of NOS in sympathetic pre- and postganglionic neurones 2.1.2. Functionally identified subclasses of sympathetic preganglionic NOS neurones 2.1.3. Presence of NOS in parasympathetic pre- and postganglionic neurones 2.2. Nitric oxide and ganglionic transmission 3. Role of NO in the neural control of the vasculature and the heart 3.1. Role of neurally derived NO in the control of the vasculature 3.1.1. Autonomic vasodilator neurones 3.1.2. Sensory vasodilation 3.1.3. Role of neurally released NO in regulation of blood vessels summary 3.2. Role of neurally derived NO in the control of the heart 4. Role of NO in the neural control of the gastrointestinal tract 4.1. Introduction 4.2. NO is a neurotransmitter of enteric inhibitory motor neurones 4.3. Role of NO in co-transmission from enteric inhibitory motor neurones 4.4. Axo-axonal interactions involving NO 4.5. NOS interneurones within the intestine 4.6. NOS in nerve fibres innervating oesophageal motor endplates 4.7. NOS innervation of the mucosa in the stomach 4.8. NOS in intestinofugal neurones 4.9. NOS in the biliary system and pancreas 5. Role of NO in the neural control of the trachea and lower airways 5.1. Types of neurones innervating the trachea and lower airways xiv
215 215 216 216 217 217 217 219 221 223 224 224 224 228 228 229 232 232 232 233 237 237 238 238 238 239 240 240
5.2.
Pharmacology of transmission and source of NOS neurones in the trachea Role of NO in the neural control of salivary glands and other secretory tissues 6.1. Salivary glands 6.1.1. Types of neurones innervating the salivary glands 6.1.2. Role of NO in vasodilation and secretion in the salivary glands 6.2. Sweat glands 6.3. The nasal mucosa 7. Role of NO in the innervation of the adrenal medulla 7.1. Presence of NOS in neurones in the adrenal medulla 7.2. Role of neurally derived NO in the adrenal medulla 8. Overview of peripheral autonomic NO neurones 9. Acknowledgements 10. References .
241 242 242 242 242 244 244 245 245 246 248 249 249
VIII. THE NITRIC OXIDE SYSTEM IN THE UROGENITAL TRACTM.S. DAVIDOFF AND R. MIDDENDORFF 1.
2.
3. 4. IX.
The urinary tract 1.1. The upper urinary tract 1.1.1. The kidney 1.1.2. The renal pelvis 1.1.3. The ureter 1.2. The lower urinary tract 1.2.1. The urinary bladder 1.2.2. The urethra The genital tract 2.1. The male reproductive organs 2.1.1. The testis 2.1.2. The spermatozoa 2.1.3. The epididymis 2.1.4. The vas deferens 2.1.5. The seminal vesicle 2.1.6. The prostate 2.1.7. The penis 2.2. The female genital tract 2.2.1. The ovary 2.2.2. The Fallopian tube 2.2.3. The uterus 2.2.4. The vagina 2.2.5. The placenta and umbilical artery Acknowledgements References
267 267 267 277 277 279 279 281 282 282 282 286 288 290 290 291 291 292 292 294 294 297 297 301 301
RESPONSE OF NITRIC OXIDE SYNTHASE TO NEURONAL INJURY - W. WU 1. 2.
Introduction Injury-induced expression of NOS
315 316 XV
2.1.
Up-regulation of NOS expression in injured neurons 317 2.1.1. Up-regulation of NOS expression in the neurohypophyseal systern 317 2.1.2. Up-regulation of NOS expression in the nuclei of cranial nerves 317 2.1.3. Up-regulation of NOS expression in the spinal cord 317 2.1.4. Up-regulation of NOS expression in the peripheral nerve and ganglia 319 321 2.2. De novo expression of NOS in injured neurons 2.2.1. De novo expression of NOS in the cerebral cortex 321 2.2.2. De novo expression of NOS in the cerebellar cortex 321 2.2.3. De novo expression of NOS in the nuclei of cranial nerves 321 2.2.4. De novo expression of NOS in spinal motoneurons 324 2.2.5. De novo expression of NOS in nuclei associated with the long descending and ascending pathways 324 325 2.3. Time course of NOS expression in injured neurons 2.3.1. Time course of NOS expression is different in different populations of neurons 325 2.3.2. Time course of NOS expression can be different in the same population of neurons following different types of injuries 326 3. Co-expression of NOS with other injury-relevant components 326 4. Age-related expression of NOS in injured neurons 328 5. Species-related expression of NOS in injured neurons 329 6. Ultrastructure of injury-induced NOS-positive neurons 330 7. Regulation of NOS expression in injured neurons 334 7.1. Regulation of injury-induced NOS by the length of the remaining proximal axons following axotomy 334 7.2. Regulation of injury-induced NOS by peripheral nerve (PN) graft transplantation 336 7.3. Regulation of injury-induced NOS by neurotrophic factors 338 8. Mechanisms of NOS expression in injured neurons 338 8.1. Expression of injury-induced NOS in neurons is a general response to injury 339 8.2. Expression of injury-induced NOS results from the interruption of axonal transport 340 8.3. Expression of injury-induced NOS results from stimulation of NMDA receptors 340 8.4. Expression of injury-induced NOS results from deprivation of neurotrophic factors 341 Potential roles of NOS expression in neuronal degeneration and regeneration 341 342 9.1. Potential role of NOS in neuronal degeneration 342 9.1.1. Involvement of NOS in neural degeneration 343 9.1.2. Potential mechanisms of NO/NOS-mediated neurotoxicity 9.1.3. Evidence suggesting that NO/NOS is not involved in degener344 ative processes after neuronal injury 345 9.2. Potential role of NOS in neuronal regeneration 346 10. Summary 346 11. Acknowledgements 347 12. References ,
xvi
Xo
NITRIC OXIDE-cGMP SIGNALING IN THE RAT BRAIN - J. DE VENTE AND H.W.M. STEINBUSCH 1. 2. 3. 4. 5.
Introduction 355 Soluble guanylyl cyclase 356 Phosphodiesterase activity and the termination of the NO-cGMP signal 357 cGMP immunocytochemistry 358 Immunocytochemical localization of NOS and NO-mediated cGMP synthesis 359 5.1. A note on the use of brain slices 359 5.2. A note on the use of phosphodiesterase inhibitors in in vitro studies 360 5.3. NOS activity in brain slices 361 5.4. Localization of NO-mediated cGMP accumulation in brain slices 362 5.4.1. Telencephalon 362 5.4.2. Diencephalon 365 5.4.3. Mesencephalon 367 5.4.4. Cerebellum 367 5.4.5. Pons and medulla oblongata 372 5.5. Colocalization of cGMP and NOS 378 6. Localization of cGMP in the cerebellum 384 7. NO-cGMP signaling in other vertebrates 389 8. NO-cGMP signaling in the rat brain during development 390 9. Colocalization of cGMP with neurotransmitter systems in the rat brain 395 10. Abbreviations 405 11. Acknowledgements 405 12. References 406
XI.
INVERTEBRATE MODELS FOR STUDYING NO-MEDIATED SIGNALINGN. SCHOLZ AND J.W. TRUMAN 1. 2. 3.
4. 5.
6. 7. 8. 9.
Introduction Components of the NO signaling pathway in invertebrates Developmental roles of NO/cGMP signaling for invertebrates 3.1. NO signaling and proliferation control 3.2. NO sensitivity during neuronal development 3.3. Functional significance of NO/cGMP signaling The role of NO in feeding behavior The role of NO in regulating rhythmic motor networks 5.1. The gastropod feeding circuit 5.2. The crustacean stomatogastric ganglion 5.3. The crustacean cardiac network NO and nociception NO as a potential blood-borne neurohormone Acknowledgements References
Subject Index
417 418 419 419 420 427 428 429 429 430 433 435 436 438 438 443
xvii
CHAPTER I
Nitric oxide synthase and the production of nitric oxide L.J. IGNARRO AND A. JACOBS
1. INTRODUCTION AND HISTORICAL PERSPECTIVES Not too long ago, nitric oxide (NO) was viewed by many as a noxious component of polluted air over industrial cities or as a gas that could be purchased in gas cylinders for the purpose of conducting chemical experiments. The possible biological importance of NO emerged in the 1970s, when a variety of studies from different laboratories revealed that nitroso compounds and related chemical species that were suspected of decomposition or conversion to NO could stimulate the production of cyclic GMP in mammalian tissues by activating the cytosolic isoform of guanylate cyclase (DeRubertis and Craven, 1976; Arnold et al., 1977; Katsuki and Murad, 1977; Katsuki et al., 1977; Miki et al., 1977: Schultz et al., 1977; B6hme et al., 1978; Craven and DeRubertis, 1978; Murad et al., 1978; Axelsson et al., 1979; Craven et al., 1979; Kukovetz et al., 1979; Ignarro, 1989). The well known chemical effects of some of these nitro compounds, such as nitroprusside and nitroglycerin, led us to suspect that their conversion to NO might account for the mechanism of vasodilation elicited by nitroprusside, and organic nitrate esters and organic nitrite esters. Accordingly, NO was tested and found to be a potent vascular smooth muscle relaxant which caused vasorelaxation via the second messenger actions of cyclic GMP (Gruetter et al., 1979, 1980, 1981; Napoli et al., 1980). These observations were confirmed and extended by several laboratories (Ignarro et al., 1981, 1984; Axelsson et al., 1982; Keith et al., 1982; Axelsson and Andersson, 1983; Galvas and DiSalvo, 1983; Horowitz et al., 1983; Ignarro and Kadowitz, 1985; Ignarro, 1989). The discovery that NO itself is a potent relaxant helped to explain the many earlier observations that diverse nitro and nitroso compounds caused both vasorelaxation and tissue accumulation of cyclic GME The clinical awareness that certain nitrovasodilators also interfered with platelet aggregation led us to ascertain whether NO and cyclic GMP were responsible for such anti-platelet actions. NO and a series of S-nitrosothiols, which are used as NO donor agents, were found to inhibit human platelet aggregation and by mechanisms involving the second messenger actions of cyclic GMP (Mellion et al., 1981, 1983). Inhibition of platelet aggregation occurred regardless of the agent used to promote aggregation, including ADP, collagen, thrombin, or thromboxane analogs. It is of historic interest, perhaps, that the first two pharmacological actions described for NO were vasorelaxation and inhibition of platelet aggregation, now appreciated to be the two most important actions of endothelium-derived relaxing factor (EDRF). In the process of elucidating the mechanism by which nitroglycerin causes vascular smooth muscle relaxation, we found that sulfhydryl (-SH) containing compounds or thiols Handbook of Chemical Neuroanatom~; Vol. 17: Functional Neuroanatomv of the Nitric Oxide System H.W.M. Steinbusch, J. De Vente and S.R. Vincent, editors (~ 2000 Elsevier Science B.V. All rights reserved.
Ch. I
L.J. Ignarro and A. Jacobs
(cysteine, dithiothreitol) were required for the activation of cytosolic guanylate cyclase by nitroglycerin, other organic nitrate esters and some organic nitrite esters (Ignarro and Gruetter, 1980; Ignarro et al., 1980a,b). The reason for this thiol requirement was the liberation of NO from intermediate S-nitrosothiols formed, as a result of a chemical reaction between the nitrovasodilator and thiol (Ignarro et al., 1981). These studies constituted the first demonstration of the pharmacological actions of S-nitrosothiols and their characteristic property as NO donor agents. Two of these S-nitrosothiols have become widely used NO donor agents, namely S-nitroso-N-acetylpenicillamine (SNAP) and S-nitrosoglutathione (GSNO). The extraordinary high potency of nitroglycerin as a vasodilator and the finding that NO is responsible for its pharmacological effects suggested that mammals might possess an endogenous nitroglycerin, another NO donor species, or NO itself. This hypothesis was confirmed when the EDRF, discovered in 1980 (Furchgott and Zawadzki, 1980), was identified as NO in 1986-1987 (Ignarro et al., 1986a, 1987a,b, Palmer et al., 1987). This observation provided explanations for previous findings that EDRF activates guanylate cyclase (Frrstermann et al., 1986; Ignarro et al., 1986b) and inhibits platelet aggregation (Azuma et al., 1986). Subsequent experiments revealed the mechanism by which EDRF inhibits platelet aggregation and adhesion compared with the anti-platelet effect of prostacyclin (Radomski et al., 1987). Most of the early biological research on NO focused on its effects on vascular smooth muscle, platelets and cytosolic guanylate cyclase, whereas little or no attention was given to the possible influence of NO on neuronal cell function or as a neurotransmitter. Early studies revealed that certain regions of the brain were rich in cyclic GMP and cytosolic guanylate cyclase (Garthwaite, 1990). Not only NO (Miki et al., 1977) but also an unidentified low molecular weight factor from rat forebrain (Deguchi, 1977) were shown to activate guanylate cyclase, and enzyme activation was inhibited by hemoglobin. This soluble endogenous activator of guanylate cyclase was later identified as arginine (Deguchi and Yoshioka, 1982), although we had observed that arginine alone could not directly activate purified preparations of guanylate cyclase (unpublished observations). In retrospect, these original observations made by the Deguchi laboratory were well ahead of their time. We now understand that in crude soluble fractions from certain brain regions, arginine serves as the substrate for neuronal NO synthase to generate NO, which was likely responsible for the activation of guanylate cyclase in the experiments of Deguchi. This interpretation also explains the earlier finding by Ferrendelli (Ferrendelli et al., 1974) that glutamate caused a calcium-dependent stimulation of cyclic GMP accumulation in cerebellar slices. Now the stage was set for the pioneer studies of Garthwaite in 1988 that NMDA stimulated cyclic GMP accumulation in rat cerebellar cells (Garthwaite et al., 1988). This response to NMDA was associated with the release of an EDRF-like factor, which in turn acted on distinct target cells to elevate cyclic GMP levels. The EDRF-like factor was quickly shown to be NO (Moncada et al., 1991 ). Following the important observation that vascular endothelial cells could synthesize NO and citrulline from arginine by a process requiring NADPH (see Moncada et al., 1991), similar observations were made in brain tissue and the arginine-to-NO pathway was identified and elucidated as the NO synthase enzymatic pathway (Bredt and Snyder, 1989, 1990; Bredt et al., 1990). These pioneering studies showing the calcium- and calmodulin-dependent catalytic activity of NO synthase were performed with enzyme purified from rat cerebellum. The enzyme was termed neuronal NO synthase (nNOS). The discovery and characterization of the other two isoforms of NOS came later. Soon after the identification of nNOS in the brain~ many investigators began to elucidate the possible physiological and pathophysiological roles of endogenous NO in the brain. Since cellular and subcellular localizations of neurotransmitters
Neuronal NO synthase
Ch. I
often help to suggest and clarify biological function, antibodies to nNOS were developed and the tissue distribution and localization of nNOS in brain neurons as well as in peripheral neurons were demonstrated (Bredt and Snyder, 1994). Unfortunately, specific definitive roles for nNOS or NO in the brain are not well established and this is an area of extensive investigation (Bredt and Snyder, 1994). NO has been implicated in long-term potentiation in the hippocampus where it may function as a retrograde messenger in memory and learning processes. Direct evidence for specific neurotransmitter actions of NO derives from research conducted in the peripheral nervous system. In the central nervous system, although NO appears to function in synaptic transmission, the neuronal release of excess quantities of NO is associated with neurotoxicity. For example, excess glutamate release stimulates NMDA receptors and consequent NO production, which mediates the focal schemia of vascular stroke (Choi, 1988) and perhaps other CNS disorders (Bredt and Snyder, 1994). In the peripheral nervous system, NO appears to function as a neurotransmitter mediating vascular and nonvascular smooth muscle relaxation. These tissues are innervated by nonadrenergic-noncholinergic (NANC) neurons, nNOS containing neurons exist in the myenteric (Auerbach's) plexus of the gastrointestinal tract (Bredt et al., 1990; Dawson et al., 1991) and neuronal stimulation causes NO release and nonvascular smooth muscle relaxation (Bult et al., 1990; Boeckxstaens et al., 1991; Desai et al., 1991 ; Tottrup et al., 1991) associated with inhibition of peristalsis. NANC neurons exist also in the outer adventitial layers of large blood vessels, and in arteries within erectile tissue (Burnett et al., 1992). Functional, constitutive nNOS was recovered from rabbit corpus cavernosum (Bush et al., 1992a) and later localized to neurons innervating the erectile tissue (Burnett et al., 1992). In the erectile tissue (corpus cavernosum) of the penis, NO is the NANC neurotransmitter that mediates penile erection by provoking both vascular and nonvascular smooth muscle relaxation, thereby allowing the trabecular and sinusoidal vascular beds to become engorged with blood (Ignarro et al., 1990; Bush et al., 1992a,b,c; Rajfer et al., 1992; Trigo-Rocha et al., 1993).
2. NO SYNTHASE ISOFORMS After the discovery of the nNOS isoform, the inducible isoform of NOS (iNOS) was found. Early studies by Hibbs and colleagues revealed that activated rodent macrophages killed target tumor cells by arginine-dependent mechanisms, and could be inhibited by chemical analogs of arginine such as NG-methylarginine (Hibbs et al., 1987a). Other studies showed that murine macrophages activated by lipopolysaccharide or other agents could produce nitrite and nitrate, and that these latter products might be responsible for the resulting target cell cytotoxicity (Stuehr and Marietta, 1985, 1987a,b; Iyengar et al., 1987; Miwa et al., 1987). Also, arginine was identified as the precursor for nitrite and nitrate in these latter studies (Iyengar et al., 1987). None of these investigators suggested that NO was actually generated first, as the intermediate product of arginine conversion, and subsequently oxidized to nitrite and nitrate, as is now known to occur. Indeed, the first proposed enzymatic pathway for this conversion of arginine to nitrite was via arginine deiminase, which produces citrulline plus ammonia, followed by oxidation of ammonia to nitrite (Hibbs et al., 1987b). The first clue that the conversion of arginine to nitrite and nitrate might involve the intermediate formation of NO came from experiments conducted with activated rat neutrophils, which generated a vascular smooth muscle relaxing factor with the properties of NO (Rimele et al., 1988; Sturm et al., 1988). The definitive observations that arginine can be converted to NO plus
Ch. I
L.J. Ignarro and A. Jacobs
citrulline came from experiments utilizing vascular endothelial cells (Palmer et al., 1988). It turns out, however, that the endothelial cells contain a constitutive isoform of NOS, whereas the activated macrophages and neutrophils contain a distinct inducible isoform of NOS. Research conducted in other laboratories in the early 1980s revealed that the production of nitrate in mammals could occur by pathways that were independent of intestinal microbial metabolism, and present endogenously in the animal (Green et al., 1981). Administration of lipopolysaccharide to rats led to increased urinary output of nitrate (Wagner et al., 1983). The mechanism of this effect was not understood until Stuehr and Marletta (1985) showed that lipopolysaccharide stimulated nitrate production in mice, and that this effect was probably mediated by macrophages, as lipopolysaccharide-activated macrophages were capable of generating nitrite and nitrate. Additional experiments showed that both nitrite and nitrate were derived from a common precursor, arginine (Iyengar et al., 1987). Therefore, research from several independent laboratories showed that lipopolysaccharide-treated animals and lipopolysaccharide-activated macrophages and other cell types could synthesize nitrite and nitrate from arginine. Following the demonstration that NO could be synthesized from arginine by vascular endothelial cells (Palmer et al., 1988), it became apparent that NO was likely an intermediate in the production of nitrite and nitrate from arginine by activated macrophages. These findings led to subsequent studies confirming that activated macrophages synthesized NO from arginine and that the NO was subsequently oxidized to nitrite and nitrate (Hibbs et al., 1988; Marletta et al., 1988; Stuehr et al., 1989). After the initial discovery and purification of nNOS (Bredt and Snyder, 1994), the inducible iNOS and endothelial NOS (eNOS) isoforms were characterized (F6rstermann et al., 1994; Griffith and Stuehr, 1995). Two distinct nomenclatures have been used to designate the three isoforms of NOS. One nomenclature refers to the NOS isoforms according to principal tissue distribution and the inducibility of one isoform, and these isoforms are designated as nNOS, eNOS and iNOS. Some of the cited problems with this nomenclature are that the so-called constitutive isoforms (nNOS and eNOS) can be expressionally regulated (upregulation and downregulation), and that certain isoforms can be found in locations other than those of their principal designation. This led some to propose the use of type I (nNOS), type II (iNOS) and type III (eNOS), according to the chronological order of their isolation and purification. The main problem with this latter nomenclature is the non-descriptive nature of the terms. In general, the NOS isoforms catalyze the oxidation or oxygenation of arginine to NO plus citrulline (Fig. 1). One atom of dioxygen (molecular oxygen) is incorporated into NO and a second atom of dioxygen is incorporated into citrulline (Kwon et al., 1990; Leone et al., 1991). One mole of L-arginine yields one mole of NO plus one mole of L-citrulline (Taych and Marietta, 1989; Bush et al., 1992d). This is a cytochrome P450-1ike oxidation reaction and requires NADPH as the principal electron donor. Like cytochrome P450, NOS contains heine as a prosthetic group for oxygen binding and subsequent incorporation into substrate to yield the products of the reaction (Griffith and Stuehr, 1995). An important intermediate in this enzymatic reaction is N~-hydroxyarginine (Stuehr et al., 1991; Wallace and Fukuto, 1991), which elicits pharmacological and perhaps physiological effects of its own (Buga et al., 1996). In addition to being a hemoprotein, NOS is a flavoprotein and requires both FAD (flavin adenine dinucleotide) and FMN (flavin mononucleotide) for the full expression of catalytic activity (Stuehr et al., 1991; Griffith and Stuehr, 1995). The enzyme-bound flavins function to transfer the electrons from the NADPH to the heine prosthetic group, thereby keeping the heme iron in the reduced state (ferrous: Fe 2+) to facilitate oxygen binding. Thus, NOS is a flavo-hemoprotein, one of the very few known to occur in mammals. Calmodulin, a calcium-binding protein, is also required for NOS catalytic activity (Abu-Soud
Neuronal NO synthase
[
Ch. I
NH
0.5 NADPH 0.5 NADP§
I
I
OH Fig. 1. The conversion of L-arginine to L-citrulline plus nitric oxide (NO) is catalyzed by the enzyme NO synthase. This conversion involves an initial 2-electron oxidation of one of the two equivalent guanidino nitrogen atoms of L-arginine to form NG-hydroxy-L-arginine, which can dissociate from the enzyme. A second, 3-electron oxidation of NG-hydroxy-L-arginine forms L-citrulline plus NO. Two molecules of dioxygen and 1.5 equivalents of NADPH are consumed in the overall enzymatic reaction.
and Stuehr, 1993; Griffith and Stuehr, 1995). Calmodulin binds free calcium to form a complex which binds to. nNOS and eNOS and functions to facilitate the transfer of electrons from enzyme-bound FAD to the heine iron. Since this transfer of electrons is essential for the expression of catalytic activity, calmodulin, and therefore calcium, acts as an on/off switch for NO biosynthesis from arginine. The iNOS isoform contains calmodulin already bound tightly as a subunit and, therefore, does not require calcium for enzyme activation (Cho et al., 1992). An additional cofactor that appears to be required for full NOS catalytic activity is tetrahydrobiopterin (Gross and Levi, 1992; Stuehr and Griffith, 1992; Griffith and Stuehr, 1995). It was speculated initially by some that the pterin may participate in the redox chemistry of the catalytic cycle. It is now believed that tetrahydrobiopterin functions in stabilizing the NOS protein rather than participating in catalysis (Giovanelli et al., 1991), and later reports added to this view based on the findings that tetrahydrobiopterin prevented the direct negative feedback effect of NO on NOS catalytic activity (Rogers and Ignarro, 1992; Griscavage et al., 1993). A summary of some of the properties of the NOS isoforms is given in Table 1. The NOS isoforms appear to catalyze an atypical, odd-numbered electron (5-electron) oxidation of L-arginine to NO plus L-citrulline (Griffith and Stuehr, 1995). In the first step of the reaction, one of the two basic guanidino nitrogen atoms of arginine undergoes a 2electron oxidation to yield NG-hydroxyarginine (typical of cytochrome P450 monooxygenase chemistry), and in the second step of the reaction, NG-hydroxyarginine undergoes a 3-electron oxidation to yield NO and citrulline (atypical of cytochrome P450). The stoichiometry of the NOS catalytic cycle has been studied extensively and often debated, but the conclusion has been reached that if NO is indeed the immediate product of the NADPH-dependent oxidation of NG-hydroxyarginine, then a 5-electron oxidation of arginine must occur. A more typical, even-numbered, 4-electron oxidation of arginine would necessarily yield HNO (nitroxyl in the protonated state) instead of NO (Fukuto et al., 1992, 1993a). Interestingly, HNO is chemically unstable and is readily oxidized to NO by numerous physiologically important oxidants (Fukuto et al., 1993b). Indeed, the pharmacological effects of HNO are virtually identical to those for NO (Fukuto et al., 1993a), and this may be due to the rapid oxidation of HNO to NO. These observations prompted additional studies aimed at elucidating the chemical nature
Ch. I
L.J. Ignarro and A. Jacobs
TABLE 1. Properties of representative NO svnthase isoforms Property
nNOS (I)
eNOS (III)
iNOS (II)
Principal source Subunit Mr (kDa) Subcellular localization Native structure Constitutively expressed Inducible Regulation ECso Ca2+ (nM) Km arginine (IxM) Vmax (gmol min-1 mg-1) Km NG-hydroxyarginine(gM) IC5o NG-methylarginine(gM) IC5o N~-nitroarginine (IxM)
Neuronal 160 Cytosolic Dimer Yes No Ca2.`./calmodulin 300 1-4 1-3 25 1.6 0.9
Endothelial 133 Membrane-bound Dimer Yes No Ca2§ 300 1-5 0.8-1 0.9 0.2
Macrophages 130 Cytosolic Dimer Yes Yes Protein synthesis Ca2+ not required 2-20 1-2 25 7.5 200
See Griffith and Stuehr (1995) and Hobbs and Ignarro (1997) for more details.
of the NOS products. Using a sensitive chemiluminescence technique that is selective for NO (relative to HNO and other oxides of nitrogen), evidence was obtained that HNO is an intermediate in the oxidation of arginine to NO by iNOS and nNOS (Hobbs et al., 1994; Hobbs and Ignarro, 1997). These studies suggested that NOS might catalyze a 4-electron oxidation of arginine to HNO, and the HNO would be readily and rapidly oxidized under physiological conditions to NO. These observations are more consistent with the chemistry of cytochrome P450-type monooxygenases and would solve the potential problem of having to deal with atypical 5-electron oxidation reactions of arginine to yield NO directly. These observations and conclusions have been confirmed by others (Schmidt et al., 1996).
3. PROTEIN STRUCTURE OF NO SYNTHASE ISOFORMS In 1991, Bredt and co-workers reported the cDNA sequence that codes rat cerebellum nNOS, which has a molecular mass of approximately 160 kDa (Bredt et al., 1991). There is good homology of the C-terminal portion of nNOS to the C-terminal portion of iNOS and eNOS, and all NOS isoforms show close homology to NADPH cytochrome P450 reductase (Bredt et al., 1991; Sessa, 1994; Xie et al., 1994; F6rstermann and Kleinert, 1995). NOS isoforms and NADPH cytochrome P450 reductase possess very similar characteristics including consensus sequences for NADPH, FMN and FAD binding sites. Many investigators have shown high homology among the individual NOS isoforms across species (Bredt and Snyder, 1994; Griffith and Stuehr, 1995). Table 2 gives information on the cDNAs encoding the three NOS isoforms (McMillan and Masters, 1993). Fig. 2 illustrates schematically the relationships among the cofactor sequences and other sequences for NOS isoforms and cytochrome P450 reductase. The observations of sequence homology between the C-terminal portion of NOS isoforms and cytochrome P450 reductase, together with the findings that NOS possesses heme that is required for catalysis, suggested that there must be a binding site for heine. In view of the fact that the heme for cytochrome P450 reductase actually resides within a distinct and separate protein (cytochrome P450), and that the NOS protein itself is capable of catalysis,
Neuronal N O synthase
Ch. I
TABLE 2. cDNAs encoding ttm three NO svnthase isq[olvns Isoform
nNOS (I) eNOS (III) iNOS (II)
cDNA source
Brain Endothelium Macrophage Smooth muscle Hepatocyte
Predicted protein Amino acids
Mr (kDa)
1429-1433 1203-1205 1144 1147 1147
160-161 133 130-131 131 131
mRNA (kb) 10-10.5 4.05-4.8 4 4 4.5
See F6rstermann and Kleinert (1995) for more details.
the hypothesis developed that the heme may bind at the N-terminal portion of NOS (Griffith and Stuehr, 1995). This would mean that NOS is composed of a distinct reductase domain (C-terminal) and a distinct oxygenase domain (N-terminal). Initial studies revealed this to be the case for nNOS, as limited trypsin proteolysis generated an N-terminal heme-containing fragment that binds L-arginine, and a C-terminal FMN- and FAD-containing fragment that catalyzes the NADPH-dependent reduction of cytochrome c (Sheta et al., 1994). These studies suggested that nNOS is a bi-domain enzyme in which the oxygenase and reductase domains can fold and function independently of one another. Similar observations were subsequently made with the iNOS isoform (Ghosh and Stuehr, I995). In a relatively short period of time since the initial purification of nNOS from cerebellum (Bredt and Snyder, 1990; Mayer et al., 1990), a great deal has been learned about structurefunction relationships for all three NOS isoforms. As discussed above, NOS binds both arginine and NADPH, and contains heme, tetrahydrobiopterin and flavins. The two constitutive isoforms (nNOS, eNOS) bind calmodulin, whereas the inducible isoform (iNOS) contains
H Fig. 2. Primary sequence map of the three isoforms of human nitric oxide synthase (NOS) and comparison to human NADPH-cytochrome P450 reductase. All NOS isoforms are flavo-hemoproteins which utilize NADPH as a substrate for reducing equivalents. Illustrated in the diagram are binding sites for the cofactors: NADPH, FAD, FMN, and Ca2+/calmodulin. Calmodulin is constitutively bound to the enzyme in the inducible NOS isoform. Not illustrated are the residues which bind tetrahydrobiopterin. The oxygenase domain of NOS contains a conserved cysteine residue which acts as an axial ligand for the heme iron. This contrasts with the cytochrome P450 isoforms, which contain a histidine ligand.
Ch. I
L.J. Ignarro and A. Jacobs
tightly bound calmodulin. The heine is the site of oxygen activation for both sequential monooxygenase reactions catalyzed by NOS. The heine iron must be in the reduced or ferrous (Fe 2+) state to bind oxygen, and the electrons required to achieve iron reduction are derived from NADPH. The nNOS isoform is a bi-functional enzyme comprised of an N-terminal oxygenase domain and a C-terminal reductase domain. The N-terminal oxygenase domain contains binding sites for heme, tetrahydrobiopterin and L-arginine, whereas the C-terminal reductase domain contains binding sites for FMN, FAD and NADPH (Bredt et al., 1990; McMillan and Masters, 1993, 1995: Klatt et al.. 1994: Sheta et al., 1994; Nishimura et al., 1995). The binding of the flavins to NOS is structurally analogous to the binding of flavins to NADPH cytochrome P450 reductase and related proteins (Bredt and Snyder, 1994; Griffith and Stuehr, 1995). The flavins function to transfer NADPH-derived electrons either to an external heme protein acceptor (cytochrome P450) or an internal heme prosthetic group (NOS) (Gachhui et al., 1996). Calmodulin binding to nNOS increases the rate of electron transfer from NADPH to the flavins and triggers the interdomain transfer of electrons from the flavins to the heine iron, providing a basis by which the calcium-calmodulin complex activates nNOS and eNOS (Abu-Soud and Stuehr, 1993: Gachhui et al., 1996). This explains the requirement by nNOS and eNOS of calcium-facilitated calmodulin binding in order to stimulate NOS catalytic activity. Thus, nNOS and eNOS can participate in signal transduction pathways by generating NO only in response to increases in intracellular free calcium. Similarly, prolonged calcium influx, which is characteristic of reperfused or reoxygenated ischemic tissues, can lead to neuropathological conditions attributed to excess localized NO production (Garthwaite and Boulton, 1995). The high-output production of NO by iNOS is attributed to the sustained generation of relatively large quantities of NO by cells for many hours or days. This is explained by the capacity of iNOS to bind calmodulin as a subunit at ambient levels of intracellular free calcium (Cho et al., 1992: Stevens-Truss and Marietta, 1995; Ruan et al., 1996). The nNOS and eNOS isoforms contain a unique polypeptide insert in their FMN binding domains that is not present in the iNOS isoform (Salerno et al., 1997a). This polypeptide insert may function as an autoinhibitory domain by binding to endogenous peptides that could compete with calmodulin for binding sites on nNOS and eNOS but not iNOS. Further advances in this field could lead to the development of potent peptide inhibitors of nNOS or eNOS. The eNOS isoform resembles the other NOS isoforms in possessing similar heme ligation geometry (Salerno et al., 1997b). In each isoform, the heine is 5-coordinate and retains the axial thiolate ligand. Utilization of optical difference spectroscopy (McMillan and Masters, 1993) and EPR spectroscopy (Salerno et al., 1995) on all three NOS isoforms expressed in, and purified from, stably transfected human kidney embryonic cells or from Escherichia coli has allowed a comprehensive analysis of the interactions between isoforms and probes such as substrate, intermediate and substrate analog inhibitors (Salerno et al., 1997b). This work makes it possible to map the active sites of the three NOS isoforms via analysis of various substrate analogs and. therefore, to design more isoform-specific NOS inhibitors. The eNOS isoform is distinct from nNOS and iNOS in having a particulate or membrane-bound subcellular distribution (F6rstermann et al., 1991; Pollock et al., 1991; Busconi and Michel, 1993; Feron et al., 1996). The eNOS isoform appears to undergo a complex series of covalent modifications that influence its subcellular targeting. In endothelial cells, N-myristoylation and thiopalmitoylation of eNOS represent important determinants for its subcellular localization (Busconi and Michel, 1993: Liu and Sessa, 1994; Sase and Michel, 1997). Moreover, eNOS is specifically targeted to plasmalemmal caveolae as a consequence
Neuronal NO synthase
Ch. I
of palmitoylation of eNOS (Shaul et al., 1996). The subcellular translocation of eNOS suggests that the targeting of eNOS to endothelial cell caveolae may be dynamically regulated (Robinson and Michel, 1995; Robinson et al., 1995). Plasmalemmal caveolae are signal-transducing membrane microdomains consisting of cholesterol- and glycosphingolipid-enriched domains that may function to sequester diverse membrane-targeted signaling proteins (Anderson, 1993). Caveolin is an oligomeric integral membrane protein that appears to serve as a structural scaffold within caveolae, and can interact with and inhibit numerous structurally diverse signaling proteins (Li et al., 1995, 1996; Couet et al., 1997). It appears that the caveolin-scaffolding domain can specifically and potently inhibit eNOS catalytic activity and may function as a competitive inhibitor of the allosteric activation of eNOS by calmodulin (Garcia-Cardena et al., 1996; Michel et al., 1997a). More recent work using myristoylationand palmitoylation-deficient eNOS mutants suggests that the association between eNOS and caveolin is independent of the state of acylation of eNOS and that agonist-evoked, calmodulin-dependent disruption of the caveolin-NOS complex is what attenuates caveolin-mediated tonic inhibition of eNOS catalytic activity (Feron et al., 1998). Therefore, caveolin may play a role as an eNOS chaperone by regulating NO production independently of the presence of eNOS within caveolae or its state of acylation. Information on the crystal structure of the three NOS isoforms has recently become available (Crane et al., 1997, 1998; Raman et al., 1998). Crane et al. (1997) determined the crystal structure for iNOS, which revealed an unusual fold and heme environment for stabilization of activated oxygen intermediates that are key for enzyme catalysis. An active center created by an interface allows substrate and effector molecules such as tetrahydrobiopterin and calmodulin to modulate catalysis by altering the association between domains and subunits. NOS appears to be highly conducive to multiple regulatory pathways, and the authors believe that NO may have evolved to be a very effective signaling molecule in higher organisms. Additional studies by this group (Crane et al., 1998) revealed the dynamic structure of the iNOS dimer containing binding sites for arginine substrate and tetrahydrobiopterin cofactor at the catalytic center of the enzyme protein. The authors interpreted their findings to suggest that pterin binding causes a conformational change at the central interface region to expose the heine prosthetic group for interactions with the reductase domain. Pterin binding may also have electronic influences on heine-bound oxygen. L-Arginine appears to bind to glutamic acid-371 via hydrogen bonding and interacts with heine in a hydrophobic pocket to facilitate activation of heine-bound oxygen. This interaction may help to explain the two steps of oxidation of arginine, first to NG-hydroxyarginine and second to NO plus citrulline. The crystal structure of the constitutive isoform eNOS has been recently reported (Raman et al., 1998) and the conclusions drawn by these authors are considerably different from those drawn by Crane et al. for the inducible iNOS isoform (Crane et al., 1997, 1998). Raman et al. (1998) have addressed pterin function in NOS by determining the high-resolution crystal structure of the dimeric eNOS home domain. The protein structures reveal that pterin binding is not required for dimerization, as suggested earlier (Crane et al., 1997, 1998), but rather may be critical for enzyme catalysis. Moreover, Raman et al. (1998) argue that pterin binding fails to cause any conformational changes in the enzyme protein either at the pterin binding site or anywhere else in the protein. Another difference between these two groups is the finding by Raman et al. (1998) that the bottom region of the interface between monomers contains two conserved cysteine residues, rather than a disulfide bridge (Crane et al., 1997), that are involved in coordinating a zinc atom. The function of zinc may be stabilization of the pterin binding site and facilitation of stereospecific pterin recognition. The electropositive surface around the zinc metal center may serve as a docking site for the reductase domain of NOS.
Ch. I
L.J. lgnarro and A. Jacobs
These observations may have direct implications for understanding the molecular basis of vascular dysfunction in pterin-deficient disorders.
4. NEURONAL NO SYNTHASE The biochemical properties of constitutive neuronal NOS (nNOS) are strikingly similar to those for constitutive eNOS and inducible iNOS. The crystal structure of the nNOS dimer should prove to be closely similar to the crystal structures of eNOS and iNOS. Like the other isoforms of NOS, nNOS is a modular enzyme which consists of a flavin-containing reductase domain and a heine-containing oxygenase domain linked by a chain of amino acids containing a calmodulin binding site. Calmodulin binding to nNOS facilitates the transfer of NADPH-derived electrons from the reductase domain to the oxygenase domain, thereby resulting in the oxygenation of arginine to yield NO plus citrulline. Like the other NOS isoforms, nNOS is capable of generating superoxide anion (O_;-) from oxygen when arginine availability is limited (Miller et al., 1997). It is not only interesting but also important to recognize that nearly all organs in the mammal are innervated by neurons that release NO as a neurotransmitter, which elicit both physiological and pathophysiological actions. The nNOS is distributed to both the cytosolic and particulate or membrane-bound fractions in most peripheral neurons. The membrane-bound nNOS may be attributed to the PDZ/GLGF motif found in the NH2-terminal sequence of the nNOS protein (Brenman et al., 1996a,b). nNOS is also distributed in skeletal muscle mainly to the particulate fraction, where it is attached to the sarcolemma-dystrophin complex via the PDZ/GLGF motif and interacts with (L-syntrophin (Brenman et al., 1995). The significance of these findings is that a selective loss of sarcolemmal nNOS is associated with muscular dystrophy where the dystrophin gene is mutated (Brenman et al., 1995" Chao et al., 1996; Grozdanovic et al., 1996). Although nNOS is generally considered to be present constitutively in most neurons and other tissues, there is increasing evidence that nNOS can undergo expressional regulation. Upregulation of nNOS mRNA seems to represent a general response of neuronal cells to stress induced by a widespread diversity of physical, chemical and biological agents (F6rstermann et al., 1998). This upregulation of nNOS may represent a part of a more global expression of numerous genes, in response to cellular stress, ultimately resulting in cellular injury and apoptosis. Downregulation of nNOS may occur in response to endotoxin and cytokines that cause induction of iNOS. Since expressional changes in constitutive nNOS may lead to changes in the quantity of NO generated and released from neurons, it is important to develop a better understanding of genetic control of nNOS expression. The human nNOS gene has been mapped to the q l4-qter position of chromosome 12 (Kishimoto et al., 1992), and the genomic structure of nNOS is well documented from human brain (Hall et al., 1994; Marsden et al., 1994). The catalytic activity of nNOS is turned on in neuronal cells by an increase in the intracellular concentration of free calcium as a result of the action potential or sodium current. Calcium binding to calmodulin allows the calcium-calmodulin complex to bind to the appropriate amino acid sequence in nNOS. As discussed above, the binding of calmodulin triggers the electron transport cycle in nNOS, which results in activation of heine iron-bound molecular oxygen and consequent oxygenation of arginine to yield NO plus citrulline. Although depriving cells of flavins, heine, tetrahydrobiopterin or arginine can each lead to diminished catalytic activity, the principal physiological mode of regulation of nNOS activity 10
Neuronal NO synthase
Ch. 1
is a change in the intracellular concentration of free calcium. This m e c h a n i s m affords rapid changes in the catalytic activity of nNOS, whereas expressional changes in nNOS protein levels in response to cellular stress represents a much slower and delayed or long-term regulation of nNOS activity and N O production. Therefore, rapid increases in N O production by n N O S result primarily from the firing of action potentials in the neuron. The only known m e c h a n i s m for rapid decreases in N O production by nNOS is negative feedback control of n N O S catalytic activity by N O itself (Rogers and Ignarro, 1992; Buga et al., 1993; Griscavage et al., 1993, 1994; A b u - S o u d et al., 1995; Hyun et al., 1995; Cohen et al., 1996). Evidence from experiments using e n z y m e s , isolated tissues, cell culture and in vivo experiments indicate that p h y s i o l o g i c a l l y relevant concentrations of NO directly inhibit the catalytic activity of all three NOS isoforms, and that NO plays an important autoregulatory role.
5. REFERENCES Abu-Soud HM, Stuehr DJ (1993): Nitric oxide synthases reveal a role for calmodulin in controlling electron transfer. Proc Natl Acad Sci USA 90:10769-10772. Abu-Soud HM, Wang J, Rousseau DL, Fukuto JM, Ignarro LJ, Stuehr DJ (1995): Neuronal nitric oxide synthase self-inactivates by forming a ferrous-nitrosyl complex during aerobic catalysis. J Biol Chem 270:22997-23006. Anderson RG (1993): Caveolae: where incoming and outgoing messengers meet. Ptvc Natl Acad Sci USA 90:10909-10913.
Arnold WE Mittal CK, Katsuki S, Murad F (1977): Nitric oxide activates guanylate cyclase and increases guanosine 3':5'-cyclic monophosphate levels in various tissue preparations. Proc Natl Acad Sci USA 74:3203-3207. Axelsson KL, Andersson KG (1983): Tolerance towards nitroglycerin, induced in vivo, is correlated to a reduced cGMP response and an alteration in cGMP turnover. EurJ Pharmacol 88:71-79. Axelsson KL, Wikberg JES, Andersson RGG (1979): Relationship between nitroglycerin, cyclic GMP and relaxation of vascular smooth muscle. Life Sci 24:1779-1786. Axelsson KL, Andersson RGG, Wikberg JES (1982): Vascular smooth muscle relaxation by nitro compounds: reduced relaxation and cGMP elevation in tolerant vessels and reversal of tolerance by dithiothreitol. Acta Phapvnacol Toxicol 50:350-357. Azuma H, Ishikawa M, Sekizaki S (1986): Endothelium-dependent inhibition of platelet aggregation. Br J Pharmacol 88:411-415.
Boeckxstaens GE, Pelckmans PA, Ruytjens IF, Bult H, De Man JG, Herman AG, Van Maercke YM (1991): Bioassay of nitric oxide released upon stimulation of non-adrenergic non-cholinergic nerves in the canine ileocolonic junction. Br J Pharmacol 103:1085-1091. B6hme E, Graf H, Schultz G (1978): Effects of sodium nitroprusside and other smooth muscle relaxants on cyclic GMP formation in smooth muscle and platelets. Adv Cyclic Nucleotide Res 9:131-143. Bredt DS, Snyder SH (1989): Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci USA 86:9030-9033. Bredt DS, Snyder SH (1990): Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 87:632-685. Bredt DS, Snyder SH (1994): Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem 63:175-195. Bredt DS, Hwang PM, Snyder SH (1990): Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 347:768-770. Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR, Snyder SH (1991): Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 351:713-714. Brenman JE, Chart DS, Xia H, Aldape K, Bredt DS (1995): Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell 82:743-752. Brenman JE, Chao DS, Gee SH, McGee AW, Craven SE, Santillano DR, Wu Z, Huang F, Xia H, Peters ME Froehner SC, Bredt DS (1996a): Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alphal-syntrophin mediated by PDZ domains. Cell 84:757-767. Brenman JE, Christopherson KS, Craven SE, McGee AW, Bredt DS (1996b): Cloning and characterization of postsynaptic density 93, a nitric oxide synthase interacting protein. J Neutvsci 16:7407-7415. Buga GM, Griscavage JM, Rogers NE, Ignarro LJ (1993): Negative feedback regulation of endothelial cell function by nitric oxide. Circ Res 73:808-812. 11
Ch. I
L.J. I g n a r r o a n d A. J a c o b s
Buga GM, Singh R, Pervin S, Rogers NE. Schmitz DA. Jenkinson CR Cederbaum SD, Ignarro LJ (1996): Arginase activity in endothelial cells" inhibition by NG-hydroxy-L-arginine during high-output NO production. Am J Phvsiol 271:H1988-H1998. Bult H, Boeckxstaens GE, Pelckmans PA, Jordaens FH, Van Maercke YM, Herman AG / 1990) Nitric oxide as an inhibitory non-adrenergic noncholinergic neurotransmitter. Nature 345:346-347. Burnett AL, Lowenstein CJ, Bredt DS, Chang TS, Snyder SH 11992): Nitric oxide: a physiologic mediator of penile erection. Science 257:401-403. Busconi L, Michel T (1993): Endothelial nitric oxide synthase. N-terminal myristoylation determines subcellular localization. J Biol Chem 268:8410-8413. Bush PA, Gonzalez NE, Ignarro LJ (1992a): Biosynthesis of nitric oxide and citrulline from L-arginine by constitutive nitric oxide synthase present in rabbit corpus cavernosum. Biochem Biophys Res Commun 186:308314. Bush PA, Aronson WJ, Buga GM, Rajfer J, Ignarro LJ 11992b): Nitric oxide is a potent relaxant of human and rabbit corpus cavernosum. J Utvl 147:1650-1655. Bush PA, Aronson WJ, Rajfer J, Buga GM, Ignarro LJ I1992c): Comparison of nonadrenergic, noncholinergic- and nitric oxide-mediated relaxation of corpus cavernosum, lnt J Impotence Res 4"85-93. Bush PA, Gonzalez NE, Griscavage JM. Ignarro LJ 11992d): Nitric oxide synthase from cerebellum catalyzes the formation of equimolar quantities of nitric oxide and citrulline from L-arginine. Biochem Biophys Res Commun 185:960-966. Chao DS, Gorospe JR, Brenman JE, Rafael JA, Peters MF, Froehner SC, Hoffman EE Chamberlain JS, Bredt DS (1996)" Selective loss of sarcolemmal nitric oxide synthase in Becker muscular dystrophy. J Exp Med 184" 609-618. Cho HJ, Xie QW, Calaycay J, Mumford RA, Swiderek KM, Lee TD. Nathan C 11992): Calmodulin is a subunit of nitric oxide synthase from macrophages. J Exp Med 176:599-604. Choi DW (1988) Glutamate toxicity and diseases of the nervous system. Neuron 1:623-634. Cohen GA, Hobbs AJ, Fitch RM, Zinner MJ, Chaudhuri G, Ignarro LJ (1996): Nitric oxide regulates endothelium-dependent vasodilator responses in rabbit hindquarters vascular bed in vivo. Am J Phvsiol 271:HI33H139. Couet J, Li S, Okamoto T, Ikezu T, Lisanti MP 11997)" Identification of peptide and protein ligands lbr the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. J Biol Chem 272:6525-6533. Crane BR, Arvai AS, Gachhui R, Wu C, Ghosh DK, Getzoff ED, Stuehr DJ. Tainer JA (1997): The structure of nitric oxide synthase oxygenase domain and inhibitor complexes. Science 278:425-431. Crane BR, Arvai AS, Ghosh DK, Wu C, Getzoff ED, Stuehr DJ, Tainer JA /1998): Structure of nitric oxide synthase oxygenase dimer with pterin and substrate. Science 279:212 !-2126. Craven PA, DeRubertis FR (1978)" Restoration of the responsiveness of purified guanylate cyclase to nitrosoguanidine, nitric oxide, and related activators by heine and hemeproteins. Evidence for involvement of the paramagnetic nitrosyl-heme complex in enzyme activation. J Biol Chem 253:8433-8443. Craven PA, DeRubertis FR, Pratt DW (1979): Electron spin resonance study of the role of NO catalase in the activation of guanylate cyclase by NaN3 and NH2OH. Modulation of enzyme responses by heine proteins and their nitrosyl derivatives. J Bioi Chem 254:8213-8222. Dawson TM, Bredt DS, Fotuhi M, Hwang PM, Snvder SH t1991 )" Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues. Proc Natl Acad Sci USA 88:7797-7801. Deguchi T (1977): Endogenous activating factor Ibr guanylate cyclase in synaptosomal-soluble traction of rat brain. J Biol Chem 252"7617-7619. Deguchi T, Yoshioka M (1982): L-Arginine identified as an endogenous activator for soluble guanylate cyclase from neuroblastoma cells. J Biol Chem 257:10147-10151. DeRubertis FR, Craven PA (1976): Calcium-independent modulation of cyclic GMP and activation of guanylate cyclase by nitrosamines. Science 193:897-899. Desai KM, Sessa WC, Vane JR (1991): Involvement of nitric oxide in the reflex relaxation of the stomach to accommodate food or fluid. Nature 351:477-479. Feron O, Belhassen L, Kobzik L, Smith TW, Kelly RA, Michel T (1996): Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J Biol Chem 271:22810-22814. Feron O, Michel JB, Sase K, Michel T (1998): Dynamic regulation of endothelial nitric oxide synthase: complementary roles of dual acylation and caveolin interactions. Biochemistp~' 37:193-200. 12
Neuronal NO svnthase
Ch. I
Ferrendelli JA, Chang MM, Kinscherf DA (1974): Elevation of cyclic GMP levels in central nervous system by excitatory and inhibitory amino acids. J Neurochem 22:535-540. Ftirstermann U, Kleinert H (1995): Nitric oxide synthase: expression and expressional control of the three isoforms. Naunyn-Schmiedebergs Arch Pharmaco1352:351-364. F6rstermann U, Mulsch A, B/3hme E, Busse R (1986): Stimulation of soluble guanylate cyclase by an acetylcholine-induced endothelium-derived factor from rabbit and canine arteries. Circ Res 58:531-538. F6rstermann U, Pollock JS, Schmidt HHHW. Heller M. Murad F t1991): Calmodulin-dependent endotheliumderived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic tYactions of bovine aortic endothelial cells. Proc Natl Acad Sci USA 88:1788-1792. F6rstermann U, Closs EI, Pollock JS, Nakane M, Schwarz E Gath I, Kleinert H (1994): Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions. Hypertension 23:1121-1131. F6rstermann U, Boissel J, Kleinert H (1998): Expressional control of the "constitutive" isoforms of nitric oxide synthase (NOS I and NOS III). FASEB J 12:773-790. Fukuto JM, Wallace GC, Hszieh R, Chaudhuri G (1992): Chemical oxidation of N-hydroxyguanidine compounds. Release of nitric oxide, nitroxyl and possible relationship to the mechanism of biological nitric oxide generation. Biochem Pharmacol 43:607-613. Fukuto JM, Stuehr DJ, Feldman PL, Bova MR Wong P (1993a): Peracid oxidation of an N-hydroxyguanidine compound: a chemical model for the oxidation of N-hydroxyl-t.-arginine by nitric oxide synthase. J Med Chem 36:2666-2670. Fukuto JM, Hobbs AJ, Ignarro LJ (1993b): Conversion of nitroxyl (HNO) to nitric oxide (NO) in biological systems: the role of physiological oxidants and relevance to the biological activity of HNO. Biochem Biophys Res Commun 196:707-713. Furchgott RF, Zawadzki JV (1980): The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373-376. Gachhui R, Presta A, Bentley DF, Abu-Soud HM, McArthur R. Brudvig G, Ghosh DK, Stuehr DJ (1996): Characterization of the reductase domain of rat neuronal nitric oxide synthase generated in the methylotrophic yeast Pichia pastoris. Calmodulin response is complete within the reductase domain itself. J Biol Chem 271:20594-20602. Galvas PE, DiSalvo J (1983): Concentration and time-dependent relationships between isosorbido dinitrate-induced relaxation and formation of cyclic GMP in coronary arterial smooth muscle. J Pharmacol Exp Ther 224:373378. Garcia-Cardena G, Fan R, Stern DE Liu J, Sessa WC (1996): Endothelial nitric oxide synthase is regulated by tyrosine phosphorylation and interacts with caveolin-l. J Biol Chem 271:27237-27240. Garthwaite J (1990): Nitric oxide synthesis linked to activation of excitatory neurotransmitter receptors in the brain. In: Moncada S, Higgs FA (Eds), Nitric Oxide jhml L-Arginine: A Bioregulatoly System. Amsterdam: Excerpta Medica, Elsevier, pp 115-137. Garthwaite J, Boulton CL (1995): Nitric oxide signaling in the central nervous system. Antlu Rev Phvsiol 57:683706. Garthwaite J, Charles SL, Chess-Williams R (1988): Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 336:385-388. Ghosh DK, Stuehr DJ (1995): Macrophage NO synthase: characterization of isolated oxygenase and reductase domains reveals a head-to-head subunit interaction. Biochemistry 34:801-807. Giovanelli J, Campos KL, Kaufman S (1991): Tetrahydrobiopterin, a cofactor for rat cerebellar nitric oxide synthase, does not function as a reactant in the oxygenation of arginine. Proc Natl Acad Sci USA 88:7091-7095. Green LC, Tannenbaum SR, Goldman R (1981): Nitrate synthesis in the germfree and conventional rat. Science 212:56-58. Griffith OW, Stuehr DJ (1995): Nitric oxide synthases: properties and catalytic mechanism. Atmu Rev Phvsiol 57:707-736. Griscavage JM, Rogers NE, Sherman ME Ignarro LJ (1993): Inducible nitric oxide synthase from a rat alveolar macrophage cell line is inhibited by nitric oxide. J hnmtmol 151:6329-6337. Griscavage JM, Fukuto JM, Komori Y, Ignarro LJ (1994): Nitric oxide inhibits neuronal nitric oxide synthase by interacting with the heme prosthetic group. Role of tetrahydrobiopterin in modulating the inhibitory action of nitric oxide. J Biol Chem 269:21644-21649. Gross SS, Levi R (1992): Tetrahydrobiopterin synthesis. An absolute requirement for cytokine-induced nitric oxide generation by vascular smooth muscle. J Biol Chem 267:25722-25729. Grozdanovic Z, Gosztonyi G, Grossrau R (1996): Nitric oxide synthase I tNOS-I) is deficient in the sarcolemma of
13
Ch. I
L.J. I g n a r r o a n d A. J a c o b s
striated muscle fibers in patients with Duchenne muscular dystrophy, suggesting an association with dystrophin. Acta Histochem 98:61-69. Gruetter CA, Barry BK. McNamara DB. Gruetter DY. Kadowitz PJ. Ignarro LJ (1979)" Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoarnino. J Cyclic Nucleotide Res 5:211-224. Gruetter CA, Barry BK, McNamara DB. Kadov,itz PJ. Ignarro LJ (1980): Coronary arterial relaxation and guanylate cyclase activation by cigarette smoke, N'-nitrosonornicotine and nitric oxide. J Pharmcoi Exp Ther 214:9-15. Gruetter CA, Gruetter DY, Lyon JE, Kadowitz PJ. Ignarro LJ (1981): Relationship between cyclic guanosine 3':5'-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide: effects of methylene blue and methemoglobin. J Pharmcol Exp Ther 219:181186. Hall AV, Antoniou H, Wang Y, Cheung AH, Arbus AM. Olson SL. Lu WC, Kau CL, Marsden PA (1994): Structural organization of the human neuronal nitric oxide synthase gene (NOS-I). J Biol Chem 269:33082-33090. Hibbs JB, Vavrin Z, Taintor RR (1987a): L-Arginine is required tk)r expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J hnmunol 138:550-556. Hibbs JB, Taintor RR, Vavrin Z (1987b): Macrophage cytotoxicity role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Sciem'e 235:473-476. Hibbs JB, Taintor RR, Vavrin Z, Rachlin EM (1988): Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 157:87-94. Hobbs AJ, Ignarro LJ (1997)" The nitric oxide-cyclic GMP signal transduction system. In: Zapol WM, Bloch KD (Eds), Nitric Oxide and the Lung. New York. NY: Marcel Dekker, pp 1-57. Hobbs AJ, Fukuto JM, Ignarro LJ (1994)" Formation of free nitric oxide from L-arginine by nitric oxide synthase: direct enhancement of generation by superoxide dismutase. Proc Natl Acad Sci USA 91:10992-10996. Horowitz JD, Antman EM, LorelI BH, Barry WH. Smith TW t1983): Potentiation of the cardiovascular effects of nitroglycerin by N-acetylcysteine. Circulation 68:1247-1253. Hyun J, Komori Y, Chaudhuri G, Ignarro LJ. Fukuto JM I1995)" The protective effect of tetrahydrobiopterin on the nitric oxide-mediated inhibition of purified nitric oxide synthase. Biochem Biophys Res Commtm 206:380-386. Ignarro LJ (1989)" Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res 65:1-21. Ignarro LJ, Gruetter CA (1980)" Requirement of thiols for activation of coronary arterial guanylate cyclase by glyceryl trinitrate and sodium nitrite: possible involvement of S-nitrosothiols. Biochim Biophys Acta 631:221231. Ignarro LJ, Kadowitz P (1985): The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. Annu Rev Pharmacol Toxico125:171 - 191. Ignarro LJ, Edwards JC. Gruetter DY, Barry BK, Gruetter CA (1980a)" Possible involvement of S-nitrosothiols in the activation of guanylate cyclase by nitroso compounds. FEBS Lett 110:275-278. Ignarro LJ, Barry BK, Gruetter DY. Edwards JC. Ohlstein EH, Gruetter CA. Baricos WH (1980b): Guanylate cyclase activation of nitroprusside and nitrosoguanidine is related to formation of S-nitrosothiol intermediates. Biochem Biophys Res Commun 94:93-100. Ignarro LJ, Lippton H, Edwards JC, Baricos WH, Hyman AL. Kadowitz PJ. Gruetter CA 11981): Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 218:739-749. Ignarro LJ, Wood KS, Wolin MS (1984): Regulation of purified soluble guanylate cyclase by porphyrins and metalloporphyrins: a unifying concept. Adv Cyclic" Nucleotide Prot Pho.whoo'! Res 17:267-274. Ignarro LJ, Byrns RE, Wood KS (1986a): Pharmacological and biochemical properties of endothelium-derived relaxing factor (EDRF): evidence that EDRF is closely related to nitric oxide (NO) radical. Circulation 74:II-287. Ignarro LJ, Harbison RG, Wood KS, Kadowitz PJ (1986b): Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapuimonary artery and vein: stimulation by acetylcholine, bradykinin and arachidonic acid. J Pharmacol Exp Ther 237:893-900. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G (1987a): Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84:9265-9269. Ignarro LJ, Byrns RE, Buga GM, Wood KS (1987b): Endothelium derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ Res 6I:866-879. Ignarro LJ, Bush PA, Buga GM, Wood KS. Fukuto JM, Rajfer J (1990)" Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle. Biochem Biophys Res Commun 170:843-850. 14
Neuronal NO svnthase
Ch. 1
Iyengar R, Stuehr DJ, Marietta MA (1987): Macrophage synthesis of nitrite, nitrate, and N-nitrosamines: precursors and role of the respiratory burst. Proc Natl Acad Sci USA 84:6369-6373. Katsuki S, Murad F (1977): Regulation of adenosine cyclic 3',5'-monophosphate and guanosine cyclic 3',5'-monophosphate levels and contractility in bovine tracheal smooth muscle. Mol Pharmacol 13:330-341. Katsuki S, Arnold W, Mittal C, Murad F (1977): Stimulation of guanylate cyclase by sodium nitroprusside. nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. J Cyclic Nucleotide Res 3:23-35. Keith RA, Burkman AM, Sokoloski TD, Fertel RH 11982): Vascular tolerance to nitroglycerin and cyclic GMP generation in rat aortic smooth muscle. J Pharntcol Exl~ Ther 221:525-531. Kishimoto J, Spurt N, Liao M, Lizhi L, Emson P, Xu W t 1992): Localization of brain nitric oxide synthase (NOS) to human chromosome 12. Genomics 14:802-804. Klatt E Schmidt K, Brunner F, Mayer B (1994): Inhibitors of brain nitric oxide synthase. Binding kinetics, metabolism, and enzyme inactivation. J Biol Chem 269:1674-1680. Kukovetz WR, Holzmann S, Wurm A, Poch G (1979): Evidence for cyclic GMP-mediated relaxant effects of nitro compounds in coronary smooth muscle. Naunyn-Schmiedehergs Arch Pharmacol 310:129-138. Kwon NS, Nathan CF, Gilker C, Griffith OW, Matthews DE, Stuehr DJ (1990): L-Citrulline production from L-arginine by macrophage nitric oxide synthase. The ureide oxygen derives from dioxygen. J Biol Chem 265:13442-13445. Leone AM, Palmer RM, Knowles RG, Francis PL, Ashton DS, Moncada S (1991): Constitutive and inducible nitric oxide synthases incorporate molecular oxygen into both nitric oxide and citrulline. J Bioi Chem 266:2379023795. Li S, Okamoto T, Chun M, Sargiacomo M, Casanova JE, Hansen SH, Nishimoto I, Lisanti MP (1995): Evidence for a regulated interaction between heterotrimeric G proteins and caveolin. J Bioi Chem 270:15693-15701. Li S, Couet J, Lisanti MP (1996): Src tyrosine kinases, galpha subunits, and H-ras share a common membrane anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. J Biol Chem 271:29182-29190. Liu J, Sessa WC (1994): Identification of covalently bound amino-terminal myristic acid in endothelial nitric oxide synthase. J Biol Chem 269:11691 - 11694. Marietta MA, Yoon PS, Iyengar R, Leaf CD, Wishnok JS (1988): Macrophage oxidation of L-arginine to nitrite and nitrate; nitric oxide is an intermediate. Biochemistry 27:8706-8711. Marsden PA, Antoniou H, Cheung A, Arbus A, Hall AV (1994): Characterization of the human neuronal nitric oxide synthase (NOS) gene: novel allelic structural mRNA diversity. In: lgnarro LJ, Murad F (Eds), Abstracts of the First h~ternational Conference on Biochemistla" and Molecular Biology of Nitric Oxide. 31. Los Angeles, CA: University of California. Mayer B, John M, BOhme E (1990): Purification of a Ca-~-/calmodulin-dependent nitric oxide synthase from porcine cerebellum. Cofactor-role of tetrahydrobiopterin. FEBS Lett 277:215-219. McMillan K, Masters BSS (1993): Optical difference spectrophotornetry as a probe of rat brain nitric oxide synthase heme-substrate interaction. Biochemistry 32:9875-9880. McMillan K, Masters BSS (1995): Prokaryotic expression of the herne- and flavin-binding domains of rat neuronal nitric oxide synthase as distinct polypeptides: identification of the heine-binding proximal thiolate ligand as cysteine-415. Biochemistta" 34:3686-3693. Mellion BT, Ignarro LJ, Ohlstein EH, Pontecorvo EG, Hyman AL, Kadowitz PJ ( 1981 ): Evidence for the inhibitory role of guanosine 3',5'-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood 57:946-955. Mellion BT, Ignarro LJ, Myers CB, Ohlstein EH, Ballot BA, Hyman AL, Kadowitz PJ / 1983): Inhibition of human platelet aggregation by S-nitrosothiols. Heine-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation. Mol Pharmacol 23:653-664. Michel JB, Feron O, Sase K, Prabhakar E Michel T (1997a): Caveolin versus calrnodulin. J Biol Chem 41:2590725912. Miki N, Kawabe Y, Kuriyama K (1977): Activation of cerebral guanylate cyclase by nitric oxide. Biochem Biophys Res Commun 75:851-856. Miller RT, Martfi.sek P, Roman L, Nishimura JS, Masters BSS (1997): Involvement of the reductase domain of neuronal nitric oxide synthase in superoxide anion production. Biochemistta" 36"15277-15284. Miwa M, Stuehr DJ, Maretta MA, Wishnok JS, Tannenbaum SR (1987): Nitrosation of amines by stimulated macrophages. Carcinogenesis 8:955-958. Moncada S, Palmer RM, Higgs EA (1991): Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109-142.
15
Ch. 1
L.J. Ignarro and A. Jacobs
Murad F, Mittal CK, Arnold WE Katsuki S, Kimura H (1978): Guanylate cyclase activation by azide, nitro compounds, nitric oxide, and hydroxyl radical and inhibition by hemoglobin and myoglobin. Adv Cyclic Nucleotide Res 9:145-158. Napoli SA, Gruetter CA, Ignarro LJ, Kadowitz PJ (1980): Relaxation of bovine coronary arterial smooth muscle by cyclic GMP, cyclic AMP and analogs. J Pha~vlacol Exp Ther 212:469-473. Nishimura JS, Martasek F, McMillan K. Salerno J. Liu Q, Gross SS. Masters BS (1995): Modular structure of neuronal nitric oxide synthase: localization of the arginine binding site and modulation by pterin. Biochem Biophys Res Commun 210:288-294.
Palmer RM, Ferrige AG, Moncada S (1987): Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524-526. Palmer RM, Ahton DS, Moncada S (1988): Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333:664-666.
Pollock JS, F6rstermann U, Mitchell JA, Warner TD. Schmidt HHHW, Nakane M, Murad F (1991): Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc Natl Acad Sci USA 88:10480-10484. Radomski MW, Palmer RM, Moncada S (1987): The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. B r J Pharmacol 92:639-646. Rajfer J, Aronson WJ, Bush PA, Dorey FJ. Ignarro LJ (1992): Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. New Engl J Med 326:90-94. Raman CS, Li H, Mart~sek F, Kr~il V, Masters BSS. Poulos TL (1998): Crystal structure of constitutive endothelial nitric oxide synthase: a paradigm for pterin function involving a novel metal cofactor. Cell 95:939-950. Rimele TJ, Sturm RJ, Adams LM, Henry DE. Heaslip RJ, Weichman BM, Grimes D (1988): Interaction of neutrophils with vascular smooth muscle: identification of a neutrophil-derived relaxing factor. J Pharmacol Exp Ther 245:102-111.
Robinson LJ, Michel T (1995): Mutagenesis of palmitoylation sites in endothelial nitric oxide synthase identifies a novel motif for dual acylation and subcellular targeting. Proc Natl Acad Sci USA 92:11776-11780. Robinson LJ, Busconi L, Michel T (1995): Agonist-modulated palmitoylation of endothelial nitric oxide synthase. J Biol Chem 270:995-998.
Rogers NE, Ignarro LJ (1992): Constitutive nitric oxide synthase from cerebellum is reversibly inhibited by nitric oxide formed from L-arginine. Biochem Biophys Res CotTltTllllI 189:242-249. Ruan J, Xie QW, Hutchinson N. Cho H. Wolfe GC. Nathan C (1996): Inducible nitric oxide synthase requires both the canonical calmodulin-binding domain and additional sequences in order to bind calmodulin and produce nitric oxide in the absence of free Ca '+. J Biol Chem 271:22679-22686. Salerno JC, Frey C, McMillan K, Williams RF, Masters BS. Griffith OW (1995): Characterization by electron paramagnetic resonance of the interactions of L-arginine and L-thiocitrulline with the heme cofactor region of nitric oxide synthase. J Biol Chem 270:27423-27428. Salerno JC, Dawn HE, Irizarry K, Patel B, Morales AJ, Smith SME, Mart~sek E Roman LJ, Masters BSS, Jones CL, Weissman BA, Lane E Liu Q, Gross SS (1997a): An autoinhibitory control element defines calcium-regulated isoforms of nitric oxide synthase. J Biol Chem 272:29769-29777. Salerno JC, Mart~isek E Williams RE Masters BSS (1997b): Substrate and substrate analog binding to endothelial nitric oxide synthase: electron paramagnetic resonance as an isoform-specific probe of the binding mode of substrate analogs. Biochemistry 36:11821-11827. Sase K, Michel T (1997): Expression and regulation of endothelial nitric oxide synthase. Trends Cardiovasc Med 7:28-37. Schmidt HHHW, Hofmann H, Schindler U. Shutenko ZS, Feelisch M (1996): No -NO from NO synthase. Proc Natl Acad Sci USA 93:14492-14497. Schultz KD, Schultz K, Schultz G (1977): Sodium nitroprusside and other smooth muscle relaxants increase cyclic GMP levels in rat ductus deferens. Nature 265:750-751. Sessa WC (1994): The nitric oxide synthase family of proteins. J Vasc Res 31:131-143. Shaul PW, Smart EJ, Robinson LJ, German Z, Yuhanna IS, Ying Y. Anderson RG, Michel T (1996): Acylation targets endothelial nitric-oxide synthase to plasmalemmal caveolae. J Biol Chem 271:6518-6522. Sheta EA, McMillan K, Masters BS (1994): Evidence for a bidomain structure of constitutive cerebellar nitric oxide synthase. J Biol Chem 269:15147-15153. Stevens-Truss R, Marietta MA (1995): Interaction of calmodulin with the inducible murine macrophage nitric oxide synthase. BiochemistrT 34:15638-15645. Stuehr DJ, Griffith OW (1992): Mammalian nitric oxide synthases. Adv En~vmol Relat Areas Mol Bio165:287-346.
16
Neuronal NO synthase
Ch. 1
Stuehr DJ, Marietta MA (1985): Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc Natl Acad Sci USA 82"7738-7742. Stuehr DJ, Marletta MA (1987a): Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines, or interferon-gamma. J Immunol 139:518-525. Stuehr PJ, Marletta MA (1987b): Synthesis of nitrite and nitrate in routine macrophage cell lines. Cancer Res 47:5590-5594. Stuehr DJ, Gross SS, Sakuma I, Levi R, Nathan CF (1989)" Activated routine macrophages secrete a metabolite of arginine with the bioactivity of endothelium-derived relaxing factor and the chemical reactivity of nitric oxide. J Exp Med 169:1011 - 1020. Stuehr DJ, Kwon NS, Nathan CE Griffith OW. Feldman PL. Wiseman J (1991): N(-hydroxy-L-arginine is an intermediate in the biosynthesis of nitric oxide from L-arginine. J Biol Chem 2666259-6263. Sturm RJ, Adams LM, Holloway DA, Weichman BM, Rimele TJ (1988)" Functional comparison of a rat polymorphonuclear leukocyte (PMN)-derived relaxing factor with nitric oxide (NO), sodium nitrite (NaNO~), sodium nitrate (NaNO3), and sodium nitroprusside (NP) (abstract). FASEB J 2:A519. Taych MA, Marletta MA (1989): Macrophage oxidation of L-arginine to nitric oxide, nitrite, and nitrate. Tetrahydrobiopterin is required as a cofactor. J Biol Chent 264:19654-19658. Tottrup A, Svane D, Forman A (1991): Nitric oxide-mediating NANC inhibition in opossum lower esophageal sphincter. Am J Phvsiol 260:G385-G389. Trigo-Rocha F, Aronson WJ, Hohenfellner M, Ignarro LJ, Rajfer J, Lue T (1993): Nitric oxide and cGMP: mediators of pelvic nerve-stimulated erection in dogs. Am J Phvsiol 264:H419-H422. Wagner DA, Young VR, Tannenbaum SR (1983): Mammalian nitrate biosynthesis" incorporation of 15NH3 into nitrate is enhanced by endotoxin treatment. Proc Natl Acad Sci USA 80:4518-4521. Wallace GC, Fukuto JM (1991)" Synthesis and bioactivity of N'"-hydroxyarginine: a possible intermediate in the biosynthesis of nitric oxide from arginine. J Med Chem 34:1746-1748. Xie QW, Cho H, Kashiwabara Y, Baum M, Weidner JR, Elliston K. Mumford R, Nathan C (1994): Carboxyl terminus of inducible nitric oxide synthase contribution to NADPH binding and enzymatic activity. J Biol Chem 269:28500-28505.
17
This Page Intentionally Left Blank
CHAPTER II
Histochemistry of nitric oxide synthase in the central nervous system S.R. VINCENT
1. INTRODUCTION Our current understanding of the distribution of the neurons that can produce nitric oxide has been built on a number of complementary technical developments. The introduction of NADPH diaphorase histochemistry in formaldehyde-fixed material led to the frequent use of this method for neuroanatomical studies even before the nature of the enzyme responsible was discovered (Scherer-Singler et al., 1983). The demonstration that the NADPH diaphorase histochemical staining is due to the activity of nitric oxide synthase (NOS) (Hope et al., 1991) quickly enabled the detailed anatomical analysis of NO-producing neurons throughout the nervous system (Vincent and Hope, 1992; Vincent and Kimura, 1992). The direct relationship between NADPH diaphorase staining and NOS expression has been well documented (Bredt et al., 1991; Dawson et al., 1991 ). The absence of neuronal expression of NOS immunoreactivity and NADPH diaphorase activity in knockout mice lacking nNOS provided definitive evidence for the specificity of this simple histochemical procedure (Huang et al., 1993). The distribution of NADPH diaphorase-positive neurons in the rat brain has been reviewed previously, together with discussions on the specificity of this method (Leigh et al., 1990; Vincent and Hope, 1992; Vincent and Kimura, 1992; Vincent, 1994; Blottner et al., 1995; Norris et al., 1995). Ultrastructural examination of NADPH diaphorase has also been described (Hope and Vincent, 1989; Rothe et al., 1998). The relationship of NADPH diaphorase staining and NOS immunohistochemistry to soluble guanylyl cyclase (Schmidt et al., 1992a) and to NO-induced cGMP-immunoreactivity has been reviewed (Southam and Garthwaite, 1993; De Vente et al., 1998). More recently, the development of a World Wide Web accessible digital atlas of NADPH diaphorase staining in the mouse brain [http://nadph.anatomy.lsumc.edu] presents an exciting new tool for the neuroscience community. The results obtained with NADPH diaphorase histochemistry have been confirmed and extended using antibodies against the various NOS isoforms (Bredt et al., 1990) as well as in situ hybridization (Bredt et al., 1991). Of particular irnportance has been the description of alternatively spliced forms of nNOS expressed in certain brain regions (Brenman et al., 1997; Eliasson et al., 1997). Another approach for localizing NOS that has been use~t is the autoradiographic localization of [3H]L-NG-nitro-arginine binding to the enzyme (Burazin and Gundlach, 1995; Kidd et al., 1995; Hara et al., 1996; Rao and Butterworth, 1996). Certain caveats must of course be kept in mind when using any of these techniques. For example, the NADPH diaphorase staining observed in cell groups lacking NOS expression Hamlhook ,{f CIwmical Neuroanatomx. Vol. 17: Functional Nettroanatomy ,!t the Nitric Oxide System H.W.M. Steinbusch, J. De Vente and S.R. Vincent. editors @ 2000 Elsevier Science B.V. All rights reserved.
19
Ch. H
S.R. Vincent
often appears to be due to technical artifacts, including fixation difficulties (Hope and Vincent, 1989; Matsumoto et al., 1993; Spessert and Layes, 1994; Buwalda et al., 1995; Gonzalez-Hernandez et al., 1996). Indeed, some have suggested running the NADPH diaphorase reaction in the presence of formaldehyde to overcome this problem (Nakos and Gossrau, 1994; Grozdanovic et al., 1995). Poor fixation has been reported to result in the NADPH diaphorase staining of astrocytes as well (Gabbott and Bacon, 1996: Kugler and Drenckhahn, 1996). Alkaline phosphatase activity can sometimes hydrolyze NADPH to NADH which can then be used as a substrate for other diaphorase reactions leading to false-positive formazan formation (Song et al., 1994; Grozdanovic and Gossrau, 1995b). Cytochrome-P450 reductase has also been suggested as a possible source for NADPH diaphorase activity, however, although some neuronal populations do express both NOS and cytochrome-P450 reductase-immunoreactivity, this enzyme does not appear to contribute to NADPH diaphorase staining (Norris et al., 1994; Young et al., 1997). Poor fixation may also contribute to false-positive staining with NOS antibodies (Wendland et al., 1994; Kugler and Drenckhahn, 1996). Finally, some neurons deep in the rat cortex have been reported to be diaphorase-positive but nNOS-immunonegative (Kharazia et al., 1994). It may be that these cells contain an isozyme of nNOS which is detected histochemically but not with the particular antibody used. There have been attempts to develop pharmacological methods to help ensure the specificity of NADPH diaphorase staining for NOS. Biochemical studies on the unfixed enzyme indicate that the NADPH diaphorase activity of nNOS is Ca 2+/calmodulin-independent (Schmidt et al., 1992b). This is consistent with observations that calcium chelators are without effect on NADPH diaphorase histochemistry (Hope and Vincent, 1989; Spessert et al., 1994). However, one group has reported that EDTA can inhibit neuronal NADPH diaphorase staining (Sancesario et al., 1993). Furthermore, studies by Morris et al. (1997) indicate that neuronal NADPH diaphorase staining is dependent on Ca2+/calmodulin and suggest that the intensity of the NADPH diaphorase staining may be related to the level of enzyme activation at the moment of tissue fixation. A number of groups have reported inhibition of NADPH diaphorase with the non-selective flavoprotein inhibitor, diphenyleneiodonium (Blottner and Baumgarten, 1992, 1995; Spessert and Claassen, 1998). NADPH diaphorase staining of formaldehyde-fixed intermediolateral spinal neurons was blocked by NG-nitro-L-arginine (L-NNA), but was still observed in the presence of NG-monomethyl-L-arginine (NMMA) and 7-nitroindazole (Blottner and Baumgarten, 1992, 1995). The NADPH diaphorase staining in the olfactory epithelium was stimulated by addition of the NOS substrate L-arginine, and was inhibited by the NOS inhibitor L-NG-nitro arginine (Dellacorte et al., 1995). Methylene blue, which is a very non-specific inhibitor of NOS, can also block NADPH diaphorase staining (Luo et al., 1995). ~-NADPH can be substituted for the physiological [3-NADPH, and this may result in a diaphorase staining more specific for NOS (Hope and Vincent, 1989; Grozdanovic and Gossrau, 1995a), although one group found that neuronal NADPH diaphorase in the olfactory bulb could not utilize ~-NADPH (Spessert et al., 1994; Spessert and Claassen, 1998). Over the past decade, the use of NADPH diaphorase histochemistry, complemented by these other methods, has allowed NO-producing neurons to be described in a wide variety of species. The comparative anatomy of the NO system in various vertebrates is reviewed in another chapter in this volume (Alonso et al. this volume). In this chapter, the distribution and characteristics of such cells in the mammalian central nervous system will be reviewed. Unless otherwise mentioned, this description is based on work in the rat brain.
20
Histochemistry of nitric oxide synthase in the central nervous system
Ch. II
2. LOCALIZATION OF NITRIC OXIDE SYNTHASE IN THE BRAIN
2.1. THE OLFACTORY BULB Within the nasal mucosa, a dense innervation of NOS-positive fibers derived from the sphenopalatine ganglion is present (Hanazawa et al., 1993; Kulkarni et al., 1994; Lee et al., 1995; Jeon et al., 1997; Kim et al., 1997). NADPH diaphorase staining has also been reported in cells with morphology reminiscent of microvillar olfactory cells, but not in the respiratory epithelium and the sustentacular cells (Dellacorte et al., 1995). nNOS is expressed in the presumptive nervous layer of the olfactory placode and the cells that differentiate into embryonic olfactory receptor neurons (Roskams et al., 1994). However, no evidence for NOS expression was found either in the mature main olfactory epithelium nor in the vomeronasal organ, in spite of the strong diaphorase staining of the surface of the main olfactory epithelium (Kishimoto et al., 1993; Kulkarni et al., 1994; Roskams et al., 1994; Lee et al., 1995). There is intense NADPH diaphorase staining of the glomeruli of the olfactory bulb (Vincent and Kimura, 1992). In the accessory olfactory bulb the entire vomeronasal nerve and all vomeronasal glomeruli were strongly labeled, contrary to the main olfactory bulb, where only dorsomedial olfactory glomeruli displayed NADPH diaphorase activity. This glomerular NADPH diaphorase reaction is pharmacologically different from that due to NOS, and does not co-localize with NOS immunohistochemistry (Spessert et al., 1994). Thus NOS does not appear to be present in mature primary olfactory neurons. Interneurons containing NOS protein and mRNA, and exhibiting NADPH diaphorase activity have been well described in the plexiform layer of the main olfactory bulb and the granule cell layer of main and accessory olfactory bulbs (Fig. 1A,C) (Kishimoto et al., 1993). Periglomerular cells (Fig. 1B) and granule cells in the main olfactory bulb were also NOS-positive (Kishimoto et al., 1993). NADPH diaphorase-positive neurons were identified as periglomerular cells in the glomerular layer and external plexiform layer, horizontal cells in the internal plexiform layer, and granule cells and deep short-axon cells in the granule cell layer (Porteros et al., 1994). Some of these cells appear to correspond to the superficial short-axon cell described in Golgi and electron microscopic studies, and the dendrites of these cells lie within the periglomerular region and in the superficial external plexiform layer (Scott et al., 1987). In addition to NOS, these cells also express somatostatin as well as NPY and the C-terminal flanking peptide of NPY, C-PON (Scott et al., 1987; Villalba et al., 1989). Positive periglomerular cells are more frequently associated with typical than atypical glomeruli (Crespo et al., 1996). The NADPH diaphorase-positive periglomerular cells appear to form a distinct population, and do not express tyrosine hydroxylase (Samama and Boehm, 1996), calbindin Dzgk (Alonso et al., 1993), calretinin or parvalbumin (Brifirn et al., 1997). A type of short-axon cell which is also stained for NADPH diaphorase, NPY, C-PON and somatostatin, lies deep in the granule cell layer, frequently near the ventricular layer and its dendrites lie parallel to that layer (Scott et al., 1987; Villalba et al., 1989). Many NADPH-stained neurons are also found in regions known to provide centrifugal inputs to the olfactory bulb, including all subdivisions of the anterior olfactory nucleus (Fig. 1D), the anterior hippocampal rudiment, anterior and posterior levels of the piriform cortex, and the vertical and horizontal limbs of the diagonal band of Broca (Davis, 1991; Garcia-Ojeda et al., 1994).
21
Ch. H
S.R. Vincent
R
,,
<-
,
#
-
..~
Fig. 1. NADPH diaphorase staining in the olfactory bulb (A) is present in periglomerular cells (B) as well as the inner plexiform layer. The granule cell layer of the accessory olfactory bulb is particularly heavily stained (A, C). Many large multipolar cells are present in the anterior olfactory nucleus lying about the intrabuibar anterior commissure. Bar indicates 500 ~tm in A, 75 I,m in B, 100 Itm in C. and 150 Itm in D.
2.2. THE CEREBRAL CORTEX Neurons expressing NOS are widely scattered throughout layers II-VI and in the subcortical white matter of the cortex (Fig. 2A,B). Although these cells represent only a very small proportion of cortical neurons (0.5-2%), they give rise to an extensive fiber network throughout the entire cortical neuropil (Vincent and Kimura, 1992: Valtschanoff et al., 1993b). An electron microscopic examination of NADPH diaphorase-stained material found that postsynaptic elements were only very rarely stained in the cortex and that most staining was in presynaptic elements (Faber-Zuschratter and Wolf, 1994). Pyramidal neurons of the rat neocortex do not normally express NADPH diaphorase reactivity (Vincent and Kimura, 1992; Kitchener et al., 1993). Some cortical NADPH diaphorase neurons are aspiny, while others possess moderate numbers of spines (Gabbott et al., 1995). Cortical NOS neurons have been shown to be GABAergic (Chesselet and Robbins, 1989; Gabbott and Bacon, 1995) 22
Histochemistry of nitric oxide svnthase in the central ner~'ous system
____..-
Ch. H
a m
Fig. 2. Scattered multipolar cells are lound throughout the neocortex, giving rise to a dense fiber network that is often associated with blood vessels (arrow)(A). Similar muitipolar cells are common in the subcorticai white matter (B). Similar multipolar cells are found scattered in the ventral (C, D, E) and dorsal striatum (F). The granule cells in the islands of Calleja are very heavily stained (C, D, E). Bar indicates 50 ~m in A and E, 75 Ixm in B, C and F, and 250 g m in D.
23
Ch. II
S.R. Vincent
and to express somatostatin and NPY (Vincent et al., 1983a.c; Kowall and Beal, 1988). The intermediate filament protein peripherin is present in a discrete population of aspiny intemeurons which are stained by NADPH diaphorase or NOS immunohistochemistry in the adult rat neocortex, although the functional significance of this is unclear at present (Rhrich-Haddout et al., 1997). Most of the neurons found in the subcortical white matter in the rat express NOS (Fig. 2B; Meyer et al., 1991). Similar interstitial cells in the subcortical white matter have also been noted in the cat (Mizukawa et al., 1988b). These interstitial neurons in the subcortical white matter give rise to association fibers which project mostly to the gray matter of the overlying cytoarchitectonic area, but which may extend also over different cytoarchitectonic areas (Meyer et al., 1991 ). An association of NADPH diaphorase staining with developing barrel fields has been described in the mouse (Mitrovic and Schachner, 1996). The somatosensory barrel fields of the rat show stronger NADPH diaphorase staining than the surrounding neuropil, but positive neurons are more frequently found outside the barrels (Valtschanoff et al., 1993b; Franca and Volchan, 1995). The NADPH diaphorase activity in the neuropil of the rat visual cortex appears to vary in a unimodal circadian manner, being highest at 0600 h and decreasing between 1200 h and 1800 h (Hilbig and Punkt, 1997). Together, these observations suggest that NO may play a role in sensory processing in the cortex. The well-documented role of NO as a vascular regulator has led to suggestions that it may serve a similar role in the brain. NADPH diaphorase-positive neurons are often found in close proximity to the intracerebral vascular profiles, sending processes to the vessels and/or being directly apposed to their walls (Fig. 2A) (Estrada et al., 1993; Samama et al., 1995). Neurovascular contacts are preferentially located close to the interface between the cerebral cortex and white matter (Estrada et al., 1993). NADPH diaphorase-positive neurons often lie near branching points of the arteriolae which descend through the cerebral cortex from its pial surface. This spatial relationship is consistent with their involvement in the neural control of cortical blood flow (Regidor et al., 1993). 2.3. THE HIPPOCAMPAL FORMATION Following the original suggestion that NO may be able to function as a retrograde messenger in the brain (Garthwaite et al., 1988), much attention has focussed on the localization of NOS in the hippocampus, and its possible involvement in learning and memory. Pyramidal cells in the rat subiculum are NADPH diaphorase-positive and immunoreactive for neuronal NOS, while the adjacent cells in the CA1 region are not (Fig. 3) (Vincent and Kimura, 1992; Valtschanoff et al., 1993a; Greene et al., 1997). In the ventral subiculum, the majority of NADPH diaphorase-positive pyramidal neurons were found in the superficial cell layer (Greene et al., 1997). This distribution of NADPH diaphorase activity was mimicked by that of immunoreactivity for the neuronal isoform of NOS (Greene et al., 1997). Electrophysiological analysis indicates that NADPH diaphorase activity is preferentially found in subicular neurons exhibiting a regular spiking phenotype and is absent from the intrinsically burst-firing neurons (Greene et al., 1997). One group reported that neurons in the olfactory bulb and striatum, the cerebellar granule cells, dentate granule cells and CA1 pyramidal cells express immunoreactivity corresponding to endothelial NOS (eNOS) (Dinerman et al., 1994). This observation has led to suggestions that eNOS in CA1 pyramidal cells may play a role in hippocampal synaptic plasticity (O'Dell et al., 1994). However, in these studies both NADPH diaphorase and eNOS staining were 24
Histochemistr?' of nitric oxide synthase in the central nervous system
Ch. H
!i:e i~i -
tr
o
1~3
~
~!i ~ ~
'-.2 :,:;,
Fig. 3. NADPH diaphorase staining in the ventral hippocampal formation is illustrated in this horizontal section (A). There is dense fiber staining in entorhinal cortex (EC), the pyramidal cells in the subiculum (S) are positively stained (B), while those in the adjacent CA1 region lack NADPH diaphorase staining (C). The granule cells of the dentate gyrus (DG) are also unstained (D). Instead basket cells (D) and other interneurons are stained throughout the hippocampus. Bar indicates 400 ~tm in A, and 200 Ixm in B, C and D.
found to be highly variable and dependent on fixation parameters (Dinerman et al., 1994; Vaid et al., 1996), and other groups have not observed any neuronal staining for eNOS (Seidel et al., 1997; Stanarius et al., 1997). Indeed, the first immunohistochemical study of NOS in the brain used an antibody which stained both endothelial cells and neurons, but did not result in staining of CA1 pyramidal cells (Bredt et al., 1990). Endothelial cells in the brain clearly show a strong NADPH diaphorase activity indicative of eNOS expression (Gabbott and Bacon, 1993), and neuronal NADPH diaphorase is completely absent in nNOS knockout mice which still express eNOS (Huang et al., 1993). These observations indicate that the suggestion that eNOS is expressed in neurons should be treated with some skepticism. Detailed double-staining experiments have demonstrated that nearly all of the NADPH diaphorase-positive neurons in the hippocampus also contain GABA (Valtschanoff et al., 25
Ch. H
S.R. Vincent
1993a), suggesting that they are interneurons. Within the dentate gyrus, NOS and NADPH diaphorase are found in basket cells and other interneurons, but are absent from the granule cells (Fig. 3D) (Mizukawa et al., 1989: Leigh et al., 1990: Vincent and Hope, 1992; Vincent and Kimura, 1992; Hong et al., 1993). These NADPH diaphorase neurons in the infragranular zone of the dentate gyrus may be selectively vulnerable to transient ischemic insults (Hong et al., 1993). A scattered population of NADPH diaphorase-positive neurons similar to that in cortical regions has been noted in the amygdala of various species. All nuclei of the amygdala contained subpopulations of diaphorase-positive neurons and the highest density is seen in the lateral nucleus (Mizukawa et al., 1988a: McDonald et al., 1993). Positive cells have also been noted in the claustrum in the cat (Hinova-Palova et al., 1997). 2.4. THE BASAL FOREBRAIN The granule cells of the islands of Calleja are intensely positive for NADPH diaphorase (Figs. 2 and 4) and display nNOS mRNA (Meyer et al., 1994: Sugaya and McKinney, 1994). These cells closely surround the arterioles perfusing the ventral striatum and pallidum and
¢ , .....
Fig. 4. Many of the magnocellular cholinergic neurons of the basal forebrain are strongly NADPH diaphorase-positive such as these in the horizontal limb of the nucleus of the diagonal band of Broca (A, B). The granule cells of the major island of Calleja are also strongly stained (,4, C). Bar indicates 100 rtm in A, and 50 l~tm in B and C.
26
Histochemistry of nitric oxide svnthase in the central ner~'ous system
Ch. H
may play a role in the regulation of blood flow to specific centers of the limbic forebrain (Meyer et al., 1994). The presence of magnocellular NADPH diaphorase neurons in the basal forebrain has been well described (Brauer et al., 1991). In the rat, many NADPH diaphorase-positive cells located in the medial septum and the nucleus of the horizontal limb of the diagonal band of Broca (Fig. 4A,B) project to the hippocampus (Kinjo et al., 1989). Some NADPH diaphorasepositive, calbindin-D2sk-negative cells have also been described in the lateral septum in the guinea pig (Doutrelant-Viltart and Poulain, 1996). Double- and triple-staining experiments indicate that NADPH diaphorase labels a majority of the magnocellular cholinergic neurons in the medial septum and diagonal band nuclei (Pasqualotto and Vincent, 1991). Virtually all NADPH diaphorase-reactive magnocellular neurons in the medial septum and the vertical and horizontal limbs of the diagonal band of Broca were choline acetyltransferase-immunoreactive (Kitchener and Diamond, 1993). In the most rostral sections of the medial septum and diagonal band, approximately 70% of the choline acetyltransferase-immunoreactive neurons were NADPH diaphorase-reactive, whereas the proportion decreased progressively to about 30% at the level of the decussation of the anterior commissure (Kitchener and Diamond, 1993). A similar number of the ChAT-positive cells in these regions expressed NOS mRNA (Sugaya and McKinney, 1994). Most of these neurons also contain galanin immunoreactivity (Pasqualotto and Vincent, 1991). However, small populations of galanin-positive/diaphorase-negative or diaphorase-positive/galanin-negative cholinergic neurons were also observed. In the more caudal portions of the cholinergic basal forebrain, very few galanin or NADPH diaphorasepositive neurons were observed. Thus, galanin and NADPH diaphorase coexist in the majority of cholinergic basal forebrain neurons in the regions innervating limbic structures (Pasqualotto and Vincent, 1991). These cells also express the low-affinity p75 NGF receptor (Peng et al., 1994), but do not express the alpha 1 subunit of GABA1 receptors (Hartig et al., 1995). In the nucleus basalis magnocellularis of the cat, large cholinergic cells that project to striate cortex have been reported to contain NADPH diaphorase, and calbindin (Bickford et al., 1994). However, it is interesting to note that while NADPH diaphorase activity occurred in about one third of the basal forebrain cholinergic neurons in the rat it is found in virtually none of these neurons in the monkey, baboon or human (Ellison et al., 1987; Mesulam et al., 1989; Geula et al., 1993). Thus it is difficult to generalize regarding the role of a septohippocampal NOS system in hippocampal synaptic plasticity. 2.5. THE BASAL GANGLIA Within the striatum, NOS is expressed in a small population of medium-aspiny interneurons. These NADPH diaphorase neurons are evenly distributed throughout the striatum and nucleus accumbens (Fig. 2C-F) (Kowall et al., 1985: Vincent and Kimura, 1992). Essentially all striatal NADPH diaphorase neurons show somatostatin immunoreactivity, and most also display NPY and C-PON immunoreactivities (Vincent et al., 1982, 1983a,c; Vincent and Johansson, 1983; Villalba et al., 1988; Rushlow et al., 1995; Figueredo-Cardenas et al., 1996). These cells were initially reported to lack GAD expression (Chesselet and Robbins, 1989), although others have reported the presence of GAD67-immunoreactivity in these cells (Kubota and Kawaguchi, 1994). The giant striatal cholinergic neurons and the medium-spiny GABA output neurons do not express NADPH diaphorase activity (Vincent et al., 1983a,c; Geula et al., 1993). The striatal NOS neurons appear to receive a direct dopaminergic input (Fujiyama and Masuko, 1996) and the intensity of NADPH diaphorase staining in rat striatal neurons 27
Ch. H
S.R. Vincent
is decreased following systemic treatment with the D l-like dopamine receptor antagonist SCH23390, and increased by the D2-1ike antagonist eticlopride (Morris et al., 1997). These cells also express mRNA for substance P receptors (Kaneko et al., 1993) and muscarinic cholinergic receptors (Bernard et al., 1992). The NOS interneurons lack calretinin (Bennett and Bolam, 1993a: Kubota and Kawaguchi, 1994), and parvalbumin (Kita et al., 1990: Kubota and Kawaguchi, 1994), although some express calbindin D28k (Bennett and Bolam, 1993b). Similar results have been seen in accumbens neurons (Hussain and Totterdell, 1994: Hussain et al.. 1996). Calcineurin, the calmodulindependent protein phosphatase also appears to be absent from these cells (Goto et al., 1987). Most striatal NADPH diaphorase neurons show low levels of glutamate receptor NR1 immunoreactivity, although a small number of these cells do express high levels of the NMDA receptor mRNA (Price et al., 1993; Augood et al., 1994). There appears to be some controversy concerning the extent to which the huntingtin protein is expressed in the striatal NADPH diaphorase neurons (Kumar et al., 1997: Fusco et al., 1999). These cells also express high levels of Mn-superoxide dismutase (Inagaki et al., 1991), which may protect them from damage from NO and other radicals. This might be one reason for the sparing of these neurons seen in Huntington's disease (Fen'ante et al., 1985). Age-related declines in NADPH diaphorase-positive neuronal density and in neuropil staining have been noted (Kuo et al., 1997). The striatal NADPH diaphorase neurons have been characterized electrophysiologically as PLTS cells (persistent and low-threshold spike cells) (Kawaguchi, 1993). These cells fired both sodium-dependent, persistent depolarization spikes and calcium-dependent, low-threshold spikes in addition to fast spikes. It is possible that activation of these low-threshold calcium spikes may act as one trigger for NO production in these cells. 2.6. THE THALAMUS NOS-positive cell bodies are not common in the thalamus (Fig. 5). NADPH diaphorasepositive and NOS-immunoreactive perikarya are principally seen along the midline in the paraventricular (Fig. 5A), rhomboid, and central medial nuclei, and in the dorsal and ventral lateral geniculate nuclei (Fig. 5D) (Bertini and Bentivoglio, 1997). Scattered neurons are found in the lateral posterior nucleus, in the dorsal part of the medial geniculate nucleus, and in the ventromedial nucleus (Bertini and Bentivoglio, 1997). NADPH diaphorase-positive neurons are also present in the paratenial nucleus up until postnatal day 15 (Garcia-Ojeda et al., 1997). Intensely stained NADPH diaphorase neurons are restricted to the lateral half of the magnocellular division of ventral lateral geniculate (Mitrofanis, 1992; Gonzalez-Hernandez et al., 1994). There is evidence that NADPH diaphorase is present in both geniculotectal projection neurons and local-circuit GABAergic neurons in the ventral lateral geniculate nucleus (Gabbott and Bacon, 1994a,b; Gonzalez-Hernandez et al., 1994). The anteroventral and anteromedial nuclei, the midline nuclei, the anterior intralaminar nuclei, and the lateral and medial geniculate nuclei have high densities of NADPH diaphorase-positive fibers (Fig. 5) (Bertini and Bentivoglio, 1997). NADPH diaphorase is found in patches in the mediodorsal and midline thalamic nuclei of cats. These patches match acetylcholinesterase (AChE)-rich patches within the medial thalamus (Mengual et al., 1993) and appear to derive from the cholinergic NOS neurons of the laterodorsal and pedunculopontine tegmental nuclei. NADPH diaphorase fibers in the paraventricular thalamic nucleus derive from both the lateral hypothalamus and the brainstem (Otake and Ruggiero, 1995). A group of positive cells is present in the subthalamic nucleus of rat (Fig. 5C) and cat (Mizukawa et al., 1989). Subthalamic neurons also express high levels of guanylyl cyclase 28
Histochemistry of nitric oxide svnthase in the central nervous system
Ch. II
J
\
Fig. 5. Although there are few NADPH diaphorase-positive neurons in the thalamus, there is an extensive fiber network, particularly in the ventrolateral anteroventral nucleus and the midline (A). Note also the very strong staining of the axons in the stria terminalis (arrow). Positive cells are found in the paraventricular nucleus (B), the subthalamic nucleus (C) and the magnocellular portion of the ventral lateral geniculate (D). Bar indicates 1 mm in A, and 200 g m in B, C and D.
(Giuili et al., 1994) and type II cGMP-dependent protein kinase mRNA (E1-Husseini et al., 1995), which suggests that NO may act in an autocrine fashion in these cells• 2.7. THE SUPERIOR COLLICULUS In the pretectal complex, NADPH diaphorase activity is restricted to neurons and terminals in the nucleus of the optic tract and the dorsal terminal nucleus (Hilbig et al., 1995). The superior 29
Ch. H
S.R. Vincent
:
i
Fig. 6. The tectum contains a dense network of NADPH diaphorase-positive cells and fibers found throughout both the superior (A) and inferior (B) colliculi. In the superior colliculus, cells are most common in the superficial layers (C). A cluster of cells is also found in the dorsolaterai periaqueductal gray, extending from the aqueduct (A) into the deeper layers of the superior colliculus tD). In the inferior colliculus, positive multipolar cells are present in both the external cortex (E) and in the central nuclei (F). Bar indicates 125 ttm in A and B, 60 Itm in C, E and F, and 100 I,tm in D.
colliculus displays a complex pattern of NADPH diaphorase staining (Fig. 6A) (Tenorio et al., 1995, 1996). The highest activity occurs in the stratum zonale and stratum griseum superficiale (Fig. 6C), contrasting with the pale neuropil in the stratum opticum, where only a few positive neurons are found. In the stratum griseum-intermedium, positive neurons are grouped in patches separated by narrow, NADPH diaphorase-negative bands. In the deeper layers, the neuropil is NADPH diaphorase-negative, and few neurons show enzymatic activity. 30
Histochemist©' of nitric oxide synthase in the central nervous system
Ch. II
In contrast, numerous neurons in the dorsolateral part of the periaqueductal gray are intensely positive and continuous with the positive neurons in the stratum album profundum (Fig. 6D) (Gonzalez-Hernandez et al., 1992). 2.8. THE AUDITORY SYSTEM NADPH diaphorase-positive neurons are very common in the auditory system (Druga and Syka, 1993). Within the cochlea, hair cells, nerve fibers and ganglion cells were labeled by nNOS immunohistochemistry as well as NADPH diaphorase histochemistry in various species (Gosepath et al., 1997; Ruan et al., 1997; Hess et al., 1998; Fessenden et al., 1999). Positive cells are also seen in the medial nucleus of the trapezoid body and the periolivary nuclei (Reuss, 1998; Fessenden et al., 1999). Many positive cells are found in the dorsal and external cortices of the inferior colliculus and in the intercollicular commissure (Fig. 6B,E,F). Stained neurons are present in the dorsal part of the suprageniculate nucleus and in the basal part of the medial division of the medial geniculate. NADPH diaphorase-positive cells are also dispersed in the auditory temporal cortex within layers II-VI (Druga and Syka, 1993). 2.9. THE HYPOTHALAMUS There is a widespread distribution of NOS-positive neurons throughout the hypothalamus, suggestive of a major role for NO in autonomic regulation. A large group of multipolar, NADPH diaphorase-positive cells is present in the lateral hypothalamus (Fig. 7C,E) (Vincent and Kimura, 1992; Vanhatalo and Soinila, 1995). In addition, positive cells have been reported in the bed nucleus of the stria terminalis, and the axons of the stria terminalis are intensely stained (Fig. 5A) (Mizukawa et al., 1989; Bruning et al., 1994; Iwase et al., 1998b; Briski and Sylvester, 1999). This suggests that a NOS pathway from the hypothalamus to the amygdala may be present. The staining of the magnocellular neurosecretory neurons has been confirmed by many groups (Fig. 7C,D) (Sagar and Ferriero, 1987; Ar6valo et al., 1992). Many hypothalamic NADPH diaphorase neurons innervate the pituitary (Vanhatalo and Soinila, 1995), and the NADPH diaphorase activity in the posterior pituitary can be markedly increased by stimulation of the hypothalamo-neurohypophyseal system with salt loading (Sagar and Ferriero, 1987). NADPH diaphorase is found in magnocellular neurons expressing both argininevasopressin and oxytocin (Calka and Block, 1993; Miyagawa et al., 1994; Sanchez et al., 1994). Virtually all PACAP-38-immunoreactive neurons in the paraventricular and supraoptic nuclei exhibited NADPH diaphorase activity (Okamura et al., 1994a). Some NADPH diaphorase neurons in the periventricular parvicellular subdivision of the paraventricular nucleus displayed somatostatin immunoreactivity (Alonso et al., 1992a,b). Many magnocellular neurosecretory NADPH diaphorase neurons express calbindin D2sk (Alonso et al., 1992a), but the hypothalamic NADPH diaphorase neurons only rarely express calretinin (Ar6valo et al., 1993). Some are also tyrosine hydroxylase-immunoreactive (Blanco et al., 1997), and many hypothalamic NADPH diaphorase neurons display NMDA R l-immunoreactivity (Bhat et al., 1995). The retinorecipient cells in the suprachiasmatic region are not NADPH diaphorase-positive (Amir et al., 1995), but NOS fibers have been reported in the suprachiasmatic region (Amir et al., 1995; Chen et al., 1997). NOS cells are reported to be a subgroup of the suprachiasmatic population characterized also by immunoreactivity to vasoactive intestinal polypeptide (Reuss et al., 1995). 31
Ch. II
S.R. Vincent
Fig. 7. Positive cells are common beneath the fornix (F)in the subfornical organ (A) and the organum vasculosum of the lamina terminalis above the third ventricle (3V) (B). Within the hypothalamus, an extensive group of multipolar cells is present in the lateral hypothalamus {LH) {C. E). Many of the magnocellular neurosecretory neurons in the supraoptic nucleus (SO) beside the optic tract {OT) are also well stained {C. D). In the caudal hypothalamus, an extensive cell group is present in the supramammillary nucleus (SM), and the cells in the lateral medial mammillary nucleus (LM). The medial mammillary nucleus is unstained {MM). Bar indicates 50 Ixm in A and B, 200 ~m in C, 30 ~m in D and E. and 500 lJtm in F.
Some, but not all, neurons in the ventrolateral subdivision of the ventromedial nucleus display both NADPH diaphorase and NOS immunoreactivity (Rachman et al., 1996). Double-labeling histochemistry revealed that more than 70% of the NADPH diaphorase-positive neurons in the ventromedial nucleus express estrogen receptors (Okamura et al., 1994b; Rachman et al., 1996). Indeed, treatment with estradiol benzoate for two days elevated the 32
Histochemistry of nitric oxide synthase in the central ner~'ous system
Ch. H
number of NADPH diaphorase-positive neurons in female but not male rats (Okamura et al., 1994b). In the caudal hypothalamus, the presence of NADPH diaphorase activity in the circularis and anterior and posterior fornical nuclei has been noted (Ar6valo et al., 1992). There is an extensive network of NADPH diaphorase neurons in the various nuclei of the mammillary body (Fig. 7F) (Vincent and Kimura, 1992). Some of these neurons expressed enkephalin-, cholecystokinin-, or substance P-like immunoreactivities (Yamada et al., 1996). 2.10. CIRCUMVENTRICULAR ORGANS The cells of the organum vasculosum of the lamina terminalis stain intensely for NADPH diaphorase (Fig. 7B) (Bhat et al., 1995). nNOS immunolabeling has also been reported in the two most rostrally located circumventricular organs, the organum vasculosum of the lamina terminalis and the subfornical organ (Fig. 7A), and in the latter, some coexistence with arginine vasopressin has been observed (Alto et al., 1997). However, no nNOS immunoreactivity or NADPH diaphorase could be found in the subcommissural organ or in the area postrema (Vincent and Kimura, 1992; Alm et al., 1997). Both supra- and sub-ependymally localized NADPH diaphorase neurons and fibers in the wall of the third and lateral ventricles have extensive contact with the CSF (Sancesario et al., 1996a,b; Rodrigo et al., 1997). A similar contact is seen along the spinal canal (Tang et al., 1995a,b). Scattered NADPH diaphorase-positive cells have been noted in the pineal, and positive, non-sympathetic nerve fibers are located in the pineal capsule and intraparenchymally between the pinealocytes (Lopez-Figueroa and Moller, 1996; Aim et al., 1997). NADPH diaphorase or nNOS-positive nerve fibers derived from the sphenopalatine ganglion accompany blood vessels in the choroidal stroma and the choroidal epithelial cells have also been reported to be stained (Lin et al., 1996; Szmydynger-Chodobska et al., 1996). However, some groups find the choroidal epithelial cells do not display immunoreactivity for neuronal NOS (Sancesario et al., 1996b) while other groups find nNOS immunoreactivity in the epithelium of the choroid plexus (Lin et al., 1996; Alm et al., 1997). The NADPH diaphorase activity that has been reported in choroid epithelium (Lin et al., 1996) appears distinct from that in neurons (Sancesario et al., 1993, 1996a,b). There is also evidence for eNOS in the choroidal epithelial cells (Stanarius et al., 1997). These observations are consistent with a role of NO and the cGMP system in water homeostatic mechanisms, both via the hypothalamohypophyseal system and via the production of cerebrospinal fluid. 2.11. THE MESOPONTINE TEGMENTUM There is a dense cluster of NADPH diaphorase neurons in the interpeduncular nucleus (Fig. 8) (Mizukawa et al., 1989; Leigh et al., 1990; Vincent and Kimura, 1992; Dun et al., 1994; Iwase et al., 1998a), which are also known to express NOS mRNA (Sugaya and McKinney, 1994). NO produced in these neurons may act on the terminals of the neurons projecting there from the medial habenula, since these cells express very high levels of guanylyl cyclase and cGMP-dependent protein kinase mRNA (Matsuoka et al., 1992; E1-Husseini et al., 1995). The neurons of the magnocellular nucleus of the posterior commissure are intensely stained for NADPH diaphorase (Fig. 8C) (Vincent and Kimura, 1992; Iwase et al., 1998b) and also express NOS mRNA (Iwase et al., 1998a). A small band of NADPH diaphorase-positive neurons located in the middle of the antero-posterior extent of the periaqueductal gray below the level of the aqueduct and 33
Ch. H
S.R. Vincent
y, ~
%~ .
,,
.
e
~
7
~
~.
.
.
.
.
.
.
~:
Fig. 8. A horizontal section through the interpeduncular nucleus illustrating the distinct staining pattern of neurons in the caudal (IPC) and rostral (IPR) nuclei (A). The positive cells in the IPR are shown in parasagittal section in (B). The strongly stained cells of the magnocellular nucleus of the posterior commissure are illustrated in this parasagittal section (C). Bar indicates 50 jtm in A and B. and 100 Itm in C.
directly above the supraoculomotor gray has been described and termed the supraoculomotor cap (Carrive and Paxinos, 1994). Numerous neurons in the caudal linear, dorsal, median, supralemniscal, and pontine raphe nuclei contained both serotonin-like immunoreactivity and NADPH diaphorase activity (Fig. 9) (Johnson and Ma, 1993: Dun et al., 1994). No NADPH diaphorase activity was detected in serotonergic neurons in the medullary nuclei (Johnson and Ma, 1993; Dun et al., 1994). Tyrosine hydroxylase-like immunoreactive neurons in the substantia nigra, locus cemleus, hypothalamus, olfactory bulb, and dorsal raphe nucleus of the rat do not display NADPH 34
Histochemistr 3' of nitric oxide svnthase in the central nerl'olts system
#
:./ : : :
Ch. H
!! ......
?.
L.I
.~
Fig. 9. A horizontal section through the mesopontine tegmentum caudal to the fourth ventricle (4v) illustrates the intense staining of the neurons in the laterodorsal tegmental nuclei (A, B) and the strong staining of the domal raphe nucleus in the midline (A, C). Bar indicates 250 ~tm in ,4, and 100 It m in B and C.
diaphorase activity (Vincent and Kimura, 1992; Johnson and Ma, 1993). The NOS neurons in the dorsal mesopontine tegmental nuclei have received much attention (Petrovicky and Nemcova, 1995; Nemcova et al., 1997). Essentially all of the cholinergic neurons in the laterodorsal and pedunculopontine tegmental nuclei express very high levels of NADPH diaphorase activity (Fig. 9) (Vincent et al., 1983b; Dun et al., 1994), and 35
Ch. II
S.R. Vincent
expressed NOS mRNA at high levels (Sugaya and McKinney, 1994). The high expression of NOS in these cholinergic neurons is seen in many species (Geula et al., 1993). Many of these cells also express a number of neuropeptides including substance P, CRF, GRP and the atriopeptides (Vincent et al., 1986; Nemcova et al., 1997). These neurons express a variety of glutamate receptor subtypes (Inglis and Semba, 1996), but do not display calbindin-D28k immunoreactivity (Geula et al., 1993). In the rat, these cells demonstrate a mild, but continuous regression of the dendritic tree during normal aging (Lolova et al., 1997). 2.12. THE CEREBELLUM Purkinje cells do not express NOS, which instead is found in the granule cells and basket cells of the cerebellar cortex (Fig. 10A) (Vincent and Kimura, 1992; Buwalda et al., 1995). In the mouse, NADPH diaphorase staining is seen in patches of granule cells and synaptic glomeruli. The patches are robust, and seen in all lobules, and are topographically ordered with respect to the Purkinje cell compartments (Hawkes and Turner, 1994). A similar patchy NADPH diaphorase pattern is seen in rat cerebellum (Li et al., 1997). cGMP immunostaining in cerebellar slices stimulated with the NO donors, nitroprusside and SIN-1, was found in granule cells, glomeruli, fibers, Bergmann glia and in other astrocytes (De Vente et al., 1989, 1990; Southam et al., 1992). However, type I cGMP-dependent protein kinase is very highly expressed in the Purkinje cells, suggesting that these cells are an important target of NO in the cerebellum (Vincent et al., 1998). 2.13. THE MEDULLA Within the medulla, NADPH diaphorase has been found in neurons displaying glutamate and somatostatin immunoreactivities in the paramedian region, lateral reticular field, the nucleus prepositus hypoglossi and the rostral nucleus of the solitary tract (Fig. 10B,C) (Maqbool et al., 1995). Within the nucleus of the solitary tract, the majority of NADPH diaphorase-positive cells are found within the central, medial, and ventral/ventrolateral subnuclei (Fig. 10B) (Takemura et al., 1994; Maqbool et al., 1995; Krowicki et al., 1997). Fiber staining is present in the subnucleus centralis, subnucleus gelatinosus, subpostremal zone, and the medial nucleus tractus solitarius (Krowicki et al., 1997). Most of the axon terminals with NADPH diaphorase in the nucleus of the solitary tract derive from the primary afferent neurons in the nodose ganglion (Lu et al., 1994). The NOS-immunoreactive neurons in the central subnucleus of the nucleus of the solitary tract have been shown to provide a projection to the nucleus ambiguus in rabbit, connecting esophageal afferents and efferents (Gai et al., 1995). In the dorsal motor nucleus of the vagus there are positively stained cells caudal to the obex and at its most rostral extent, but not at the intermediate level (Krowicki et al., 1997). A portion of these NOS-containing neurons are preganglionic vagal neurons which project to the abdominal viscera (Krowicki et al., 1997). NADPH diaphorase-positive neurons have been described in the medial vestibular nucleus and the spinal vestibular nuclei (Shaer et al., 1996; Takemura et al., 1996; Krukoff and Khalili, 1997). NADPH diaphorase staining has also been localized in a subpopulation of vestibular efferents (Singer and Lysakowski, 1996). There are neurons in the gracile nucleus which display both NOS mRNA and NADPH diaphorase staining and this staining increases with aging (Ma et al., 1997). In the spinal trigeminal nucleus (Fig. 10D), NOS is found in interneurons located in nucleus caudalis which give rise to processes that innervate trigeminothalamic neurons (Dohrn et al., 36
Histochemistrv of nitric oxide swTthase in the central ner~'ous system
Ch.//
S Fig. 10. Strong staining is present in granule cells and glomeruli in the granule cell layer, and in basket cells and parallel fibers in the molecular layer of the cerebellar cortex (A). The large Purkinje cells are not stained. In the medulla, stained cells and fibers are present in the nucleus of the solitary tract (B), the medullary raphe (C) and the spinal nucleus of the trigeminal (D). Bar indicates 20 Itin in A, 100 Itm in B and C, and 50 t~m in D.
1994). This suggests that NO may indirectly influence orofacial nociceptive processing at the level of the spinal trigeminal nucleus. Similar staining is observed in the dorsomedial spinal trigeminal nucleus oralis where NO may regulate gustatory inputs (Takemura et al., 1994). The rostral ventral medulla contains a well-defined group of NADPH diaphorase neurons that are distinct from the adrenergic neurons of the C1 group. These have only limited monosynaptic projections to the spinal cord (Iadecola et al., 1993; Maqbool et al., 1995). These NADPH diaphorase neurons are also glutamate-immunoreactive and overlap the nucleus ambiguus, the lateral reticular nucleus and the A1/C1 catecholaminergic cell groups. A few NADPH diaphorase and glutamate-immunoreactive cells are found in the paraolivary area and gigantocellular tegmental field, in the external cuneate and infratrigeminal nuclei (Maqbool et al., 1995). In the rostral ventrolateral medulla NADPH diaphorase and somatostatin-immunoreactive cells are present in the paragigantocellular nucleus. 2.14. THE SPINAL CORD Neurons which stain intensely for NOS are found in laminae I-IV and X throughout the entire spinal cord. Preganglionic sympathetic neurons in the intermediolateral cell column 37
Ch. H
S.R. Vincent
of the thoracic and lumbar spinal cord are also intensely stained for NOS and express NOS mRNA (Vogel et al., 1997). Preganglionic parasympathetic neurons in the sacral cord also show substantial NOS immunostaining. Scattered neurons in laminae V, VI, VII, and VIII at all cord levels are weakly positive. In addition, punctate NOS staining is found throughout laminae I, III and surrounding some large motor neurons in the ventral horn (Valtschanoff et al., 1992; Saito et al., 1994). In the upper thoracic cord, positive cells are seen in the dorsal horn, the dorsolateral funiculus and lateral spinal neurons, the central canal region (Rexed lamina X) and in preganglionic sympathetic neurons in the intermediolateral nuclei (Blottner and Baumgarten, 1992; Valtschanoff et al., 1992; Blottner et al., 1993; Spike et al., 1993; Tang et al., 1995a,b; Vogel et al., 1997). In laminae I-III of the rat dorsal horn, NADPH diaphorase-positive neurons may contain GABA, glycine and acetylcholine (Spike et al., 1993; Laing et al., 1994), but they do not express NPY or enkephalin (Laing et al., 1994). Some of the lamina X NOS neurons were reported to be retrogradely labeled from the thalamus suggesting that they may be spinothalamic neurons (Lee et al., 1993). In the intermediolateral cell column at mid-thoracic levels, about half of cholinergic neurons stained for NADPH diaphorase (Blottner and Baumgarten, 1992). In particular, NADPH diaphorase is seen in the preganglionic cholinergic neurons innervating the adrenal gland, which also express enkephalin (Blottner and Baumgarten, 1992; Holgert et al., 1995). In the sacral spinal cord of the rat, the majority of both sympathetic and parasympathetic preganglionic neurons showed staining for NADPH diaphorase (Anderson, 1992; Hamilton et al., 1995). NADPH diaphorase staining may also be present in a few motoneurons in the aged rat spinal cord and may lead these neurons to eventual death (Kanda, 1996). A similar pattern of NADPH diaphorase staining has been described in the mouse spinal cord (Bruning, 1992).
3. ARGININE METABOLISM IN THE BRAIN
The discovery of NOS, and the generation of NO and citrulline from arginine has reawakened interest in arginine metabolism in the brain. Double-staining experiments have indicated that citrulline immunoreactivity is present in a subpopulation of NADPH diaphorase-positive neurons (Pasqualotto et al., 1991). In the neuropil in the ventroposterior nucleus of the thalamus NADPH diaphorase-positive fibers are often apposed to arginine-immunoreactive astrocytes and oligodendrocytes, and NADPH diaphorase-positive endothelial cells are often adjacent to arginine-positive astrocytes (Kharazia et al., 1997). These observations suggests that arginine may be stored in supporting cells, and supplied to nearby nerve fibers or endothelial cells as substrate for NOS. Indeed, many NOS-positive neurons express the neutral and basic amino acid transporter (NBAT) which facilitates the sodium-independent transport of arginine and other amino acids (Pickel et al., 1999). In rat brain slices, the arginine uptake inhibitor L-lysine reduced the cyclic GMP response to NMDA indicating that extracellular arginine availability can influence NO production (Grima et al., 1998). The relationship of NOS-positive neurons to those expressing argininosuccinate synthetase and lyase has been described in the rat brain (Arnt-Ramos et al., 1992) and spinal cord (Nakamura, 1997) and in cat hypothalamus (Isayama et al., 1997). The results indicate that some NOS neurons possess the enzymes required to directly recycle citrulline back to arginine. In other situations NOS appears to be expressed in neurons lacking this capability, and instead, a trans-cellular pathway for arginine and citrulline metabolism appears likely to occur (Arnt-Ramos et al., 1992). 38
Histochemistry of nitric oxide synthase in the central nervous system
Ch. H
4. HEME OXYGENASE Following the demonstration that nitric oxide was the physiological EDRF the suggestion was made that carbon monoxide might be a similar sort of messenger (Marks et al., 1991; Schmidt, 1992; Verma et al., 1993). Carbon monoxide is produced by heine oxygenase during the degradation of heme to bile pigments. This enzyme reaction is not regulated, and heine concentrations in cells are limited. Furthermore, although carbon monoxide can bind to the heme of soluble guanylyl cyclase, it does so in a manner distinct from that of nitric oxide, and can only weakly activate the cyclase (Burstyn et al., 1995; Kharitonov et al., 1995). Thus it is unlikely that CO plays a significant role as a physiological messenger. Instead, the properties of heme oxygenase suggest that it may regulate the activities of the hemoproteins NOS and guanylyl cyclase by degrading free heme in cells containing these enzymes (Turcanu et al., 1998). Similar conclusions have been reached based upon immunohistochemical studies of the localization of the two heme oxygenase isoforms in many of the neurons in the brain which express NOS or soluble guanylyl cyclase (Vincent et al., 1994).
5. CONCLUSIONS Work over the past decade has led to a very complete understanding of the distribution of neurons which can generate nitric oxide in the central nervous system. NOS often co-localizes with classical neurotransmitters or neuropeptides, and thus NO synthesis is likely often coupled to the release of these transmitters. In this regard, it is interesting to note that NOS is found in neurons using the excitatory transmitter glutamate or the inhibitory neurotransmitter GABA. It is also found in cholinergic neurons and other aminergic cells. NOS is present in local circuit interneurons in many brain regions; however, in some areas it is found in principal neurons with long projections throughout the brain. NOS is also found in neurosecretory neurons and cells in some circumventricular organs. Thus, as with other neurotransmitters, it is difficult to generalize regarding the role of NO in the nervous system. NOS is localized in both cell bodies and dendrites, as well as in axons and nerve terminals. Thus, NO production is probably triggered by activation of postsynaptic calcium channels and the release of intracellular calcium stores in dendrites and cell bodies, or by the opening of voltage-gated calcium channels in nerve terminals. Hopefully our knowledge of NOS localization will lead to studies in the coming decade which will define the role of NO in these various sites in the nervous system.
6. REFERENCES Alm P, Skagerberg G, Nylen A, Larsson B, Andersson KE (1997): Nitric oxide synthase and vasopressin in rat circumventricular organs. An immunohistochemical study. Exp Brain Res 117:59-66. Alonso JR, Sanchez F, Ar6valo R, Carretero J, Aij6n J, Vazquez R (1992a): CaBP D-28k and NADPH-diaphorase coexistence in the magnocellular neurosecretory nuclei. Neuroreport 3:249-252. Alonso JR, Sanchez F, Ar6valo R, Carretero J, Vazquez R, Aij6n J (1992b): Partial coexistence of NADPHdiaphorase and somatostatin in the rat hypothalamic paraventricular nucleus. Neurosci Len 148:101-104. Alonso JR, Ar6valo R, Porteros A, Brifi6n JG, Lara J, Aij6n J (1993): Calbindin D-28K and NADPH-diaphorase activity are localized in different populations of periglomerular cells in the rat olfactory bulb. J Chem Neuroanat 6:1-6. Amir S, Robinson B, Edelstein K (1995): Distribution of NADPH-diaphorase staining and light-induced Fos
39
Ch. H
S.R. V i n c e n t
expression in the rat suprachiasmatic nucleus region supports a role for nitric oxide in the circadian system. Neuroscience 69:545-555. Anderson CR (1992): NADPH-diaphorase-positive neurons in the rat spinal cord include a subpopulation of autonomic preganglionic neurons. Neurosci Lett 139:280-284. Ar6valo R, Sanchez F, Alonso JR, Carretero J, Vazquez R. Aij6n J (1992): NADPH-diaphorase activity in the hypothalamic magnocellular neurosecretory nuclei of the rat. Brain Res Bull 28:599-603. Ar6valo R, Sanchez F, Alonso JR, Rubio M, Aijon J, Vazquez R {1993): Infrequent cellular coexistence of NADPH-diaphorase and calretinin in the neurosecretory nuclei and adjacent areas of the rat hypothalamus. J Chem Neuroanat 6:335-341. Arnt-Ramos LR, O'Brien WE, Vincent SR (1992): Immunohistochemical localization of argininosuccinate synthetase in the rat brain in relation to nitric oxide synthase-containing neurons. Neuroscience 5•:773-789. Augood SJ, McGowan EM, Emson PC ( 1994): Expression of N-methyl-D-aspartate receptor subunit NR1 messenger RNA by identified striatal somatostatin cells. Neuroscience 59:7-12. Bennett BD, Bolam JP (1993a): Characterization of calretinin-immunoreactive structures in the striatum of the rat. Brain Res 609:137-148. Bennett BD, Bolam JP (1993b): Two populations of calbindin D28k-immunoreactive neurones in the striatum of the rat. Brain Res 610:305-310. Bernard V, Normand E, Bloch B (1992): Phenotypical characterization of the rat striatal neurons expressing muscarinic receptor genes. J Neulvsci 12:3591-3600. Bertini G, Bentivoglio M (1997): Nitric oxide synthase in the adult and developing thalamus: histochemical and immunohistochemical study in the rat. J Comp Neurol 388:89-105. Bhat GK, Mahesh VB, Lamar CA, Ping L, Aguan K, Brann DW {1995): Histochemical localization of nitric oxide neurons in the hypothalamus: association with gonadotropin-releasing hormone neurons and co-localization with N-methyl-D-aspartate receptors. Neutvendocrinoiogy 62:187-197. Bickford ME, Gunluk AE, Van Horn SC, Sherman SM {1994): GABAergic projection from the basal forebrain to the visual sector of the thalamic reticular nucleus in the cat. J Comp Neurol 348:481-510. Blanco E, Jirikowski GF, Riesco JM, Juanes JA. Vazquez R (1997): Coexistence of NADPH-diaphorase with tyrosine hydroxylase in hypothalamic magnocellular neurons of the rat. Neuropeptides 3•:227-230. Blottner D, Baumgarten HG (1992): Nitric oxide synthetase (NOS)-containing sympathoadrenal cholinergic neurons of the rat IML-cell column: evidence from histochemistry, immunohistochemistry, and retrograde labeling. J Comp Neurol 316:45-55. Blottner D, Baumgarten HG (1995): L-NNA inhibits the histochemical NADPH-d reaction in rat spinal cord neurons. Histochem Cell Biol 103:379-385. Blottner D, Schmidt HH, Baumgarten HG (1993): Nitroxergic autonomic neurones in rat spinal cord. Neutvreport 4:923-926. Blottner D, Grozdanovic Z, Gossrau R (1995): Histochemistry of nitric oxide synthase in the nervous system. Histochem J 27:785-811. Brauer K, Schober A, Wolff JR, Winkelmann E. Luppa H, Luth HJ et al. (1991): Morphology of neurons in the rat basal forebrain nuclei: comparison between NADPH-diaphorase histochemistry and immunohistochemistry of glutamic acid decarboxylase, choline acetyltransferase, somatostatin and parvalbumin. J Hirnforsch 32:1-17. Bredt DS, Hwang PM, Snyder SH (1990): Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 347:768-770. Bredt DS, Glatt CE, Hwang PM, Fotuhi M, Dawson TM, Snyder SH (1991): Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPHdiaphorase. Neuron 7:615-624. Brenman JE, Xia H, Chao DS, Black SM. Bredt DS (1997): Regulation of neuronal nitric oxide synthase through alternative transcripts. Dev Neurosci 19:224-231. Brifi6n JG, Alonso JR, Garcia-Ojeda E, Crespo C, Ar6valo R. Aij6n J (1997): Calretinin- and parvalbuminimmunoreactive neurons in the rat main olfactory bulb do not express NADPH-diaphorase activity. J Chem Neuroanat 13:253-264. Briski KP, Sy!vester PW (1999): Site-specific induction of Fos immunoreactivity in preoptic and hypothalamic NADPH-positive neurons during glucoprivation. Neuroendocrinology 69:181-190. Bruning G (1992): Localization of NADPH-diaphorase, a histochemical marker for nitric oxide synthase, in the mouse spinal cord. Acta Histochem 93:397-401. Bruning G, Wiese S, Mayer B (1994): Nitric oxide synthase in the brain of the turtle Pseudemys scripta elegans. J Comp Neurol 348:183-206. 40
H i s t o c h e m i s t r y o f nitric o x i d e s y n t h a s e in the c e n t r a l n e r v o u s s y s t e m
Ch. H
Burazin TC, Gundlach AL (1995): Localization of NO synthase in rat brain by [3H]L-NG-nitro-arginine autoradiography. Neuroreport 6:1842-1844. Burstyn JN, Yu AE, Dierks EA, Hawkins BK, Dawson JH (1995): Studies of the heme coordination and ligand binding properties of soluble guanylyl cyclase (sGC): characterization of Fe(II)sGC and Fe(II)sGC(CO) by electronic absorption and magnetic circular dichroism spectroscopies and failure of CO to activate the enzyme. Biochemistry' 34:5896-5903. Buwalda B, Nyakas C, Gast J, Luiten PG, Schmidt HH (1995): Aldehyde fixation differentially affects distribution of diaphorase activity but not of nitric oxide synthase immunoreactivity in rat brain. Brain Res Bul! 38:467-473. Calka J, Block CH (1993): Relationship of vasopressin with NADPH-diaphorase in the hypothalamo-neurohypophysial system. Brain Res Bull 32:207-210. Carrive P, Paxinos G (1994): The supraoculomotor cap: a region revealed by NADPH-diaphorase histochemistry. Neuroreport 5:2257-2260. Chen D, Hurst WJ, Ding JM, Faiman LE, Mayer B, Gillette MU (1997): Localization and characterization of nitric oxide synthase in the rat suprachiasmatic nucleus: evidence for a nitrergic plexus in the biological clock. J Neurochem 68:855-861. Chesselet MF, Robbins E (1989): Characterization of striatal neurons expressing high levels of glutamic acid decarboxylase messenger RNA. Brain Res 492:237-244. Crespo C, Porteros A, Arrvalo R, Brifirn JG, Aijrn J, Alonso JR (1996): Segregated distribution of nitric oxide synthase-positive cells in the periglomerular region of typical and atypical olfactory glomeruli. Neurosci Lett 205:149-152. Davis BJ (1991): NADPH-diaphorase activity in the olfactory system of the hamster and rat. J Comp Neurol 314:493-511. Dawson TM, Bredt DS, Fotuhi M, Hwang PM, Snyder SH (1991): Nitric oxide synthase and neuronal NADPHdiaphorase are identical in brain and peripheral tissues. Proc Nat1Acad Sci USA 88:7797-7801. Dellacorte C, Kalinoski DL, Huque T, Wysocki L, Restrepo D (1995): NADPH-diaphorase staining suggests localization of nitric oxide synthase within mature vertebrate olfactory neurons. Neuroscience 66:215-225. De Vente J, Bol JGJM, Steinbusch HWM (1989): Localization of cGMP in the cerebellum of the adult rat: an immunohistochemical study. Brain Res 504:332-337. De Vente J, Bol JGJM, Berkelmans HS, Schipper J, Steinbusch HWM (1990): Immunocytochemistry of cGMP in the cerebellum of the immature, adult, and aged rat: the involvement of nitric oxide. A micropharmacological study. Eur J Neurosci 2:854-862. De Vente J, Hopkins DA, Markerink-van Ittersum M, Emson PC, Schmidt H, Steinbusch HWM (1998): Distribution of nitric oxide synthase and nitric oxide-receptive, cyclic GMP-producing structures in the rat brain. Neuroscience 87:207-241. Dinerman JL, Dawson TM, Schell MJ, Snowman A, Snyder SH (1994): Endothelial nitric oxide synthase localized to hippocampal pyramidal cells: implications for synaptic plasticity. Proc Natl Acad Sci USA 9•:4214-4218. Dohrn CS, Mullett MA, Price RH, Beitz AJ (1994): Distribution of nitric oxide synthase-immunoreactive interneurons in the spinal trigeminal nucleus. J Comp Neurol 346:449-460. Doutrelant-Viltart O, Poulain P (1996): Distribution of NADPH-diaphorase and calbindin-D28k neurons in the lateral septal area of the guinea pig, with special reference to the enkephalinergic hypothalamo-septal tract. J Chem Neuroanat 11:199-207. Druga R, Syka J (1993): NADPH-diaphorase activity in the central auditory structures of the rat. Neuroreport 4:999-1002. Dun NJ, Dun SL, Forstermann U (1994): Nitric oxide synthase immunoreactivity in rat pontine medullary neurons. Neuroscience 59:429-445. E1-Husseini AE, Bladen C, Vincent SR (1995): Molecular characterization of a type II cyclic GMP-dependent protein kinase expressed in the rat brain. J Neurochem 64:2814-2817. Eliasson MJ, Blackshaw S, Schell MJ, Snyder SH (1997): Neuronal nitric oxide synthase alternatively spliced forms: prominent functional localizations in the brain. Proc Nat1Acad Sci USA 94:3396-3401. Ellison DW, Kowall NW, Martin JB (1987): Subset of neurons characterized by the presence of NADPH-diaphorase in human substantia innominata. J Comp Neurol 260:233-245. Estrada C, Mengual E, Gonzalez C (1993): Local NADPH-diaphorase neurons innervate pial arteries and lie close or project to intracerebral blood vessels: a possible role for nitric oxide in the regulation of cerebral blood flow. J Cereb Blood Flow Metab •3:978-984. Faber-Zuschratter H, Wolf G (1994): Ultrastructural distribution of NADPH-diaphorase in cortical synapses. Neuroreport 5:2029-2032. 41
Ch. H
S.R. V i n c e n t
Ferrante RJ, Kowall NW, Beal ME Richardson Jr. EE Bird ED, Martin JB (1985): Selective sparing of a class of striatal neurons in Huntington's disease. Science 230:561-563. Fessenden JD, Altschuler RA, Seasholtz AE Schacht J (1999): Nitric oxide cyclic guanosine monophosphate pathway in the peripheral and central auditory system of the rat. J Comp Neurol 404:52-63. Figueredo-Cardenas G, Morello M, Sancesario G, Bernardi G, Reiner A (1996): Colocalization of somatostatin, neuropeptide Y, neuronal nitric oxide synthase and NADPH-diaphorase in striatal interneurons in rats. Brain Res 735:317-324. Franca JG, Volchan E (1995): NADPH-diaphorase histochemistry as a marker for barrels in rat somatosensory cortex. Braz J Med Biol Res 28:787-790. Fujiyama F, Masuko S (1996): Association of dopaminergic terminals and neurons releasing nitric oxide in the rat striatum: an electron microscopic study using NADPH-diaphorase histochemistry and tyrosine hydroxylase immunohistochemistry. Brain Res Bull 40:121-127. Fusco FR, Chen Q, Lamoreaux WJ, Figueredo-Cardenas G, Jiao Y, Coffman JA et al. (1999): Cellular localization of huntingtin in striatal and cortical neurons in rats: lack of correlation with neuronal vulnerability in Huntington's disease. J Neurosci 19:1189-1202. Gabbott PL, Bacon SJ (1993): Histochemical localization of NADPH-dependent diaphorase (nitric oxide synthase) activity in vascular endothelial cells in the rat brain. Nemvscience 57:79-95. Gabbott PL, Bacon SJ (1994a): An oriented framework of neuronal processes in the ventral lateral geniculate nucleus of the rat demonstrated by NADPH-diaphorase histochemistry and GABA immunocytochemistry. Neuroscience 60:417-440. Gabbott PL, Bacon SJ (1994b): Two types of interneuron in the dorsal lateral geniculate nucleus of the rat: a combined NADPH-diaphorase histochemical and GABA immunocytochemical study. J Comp Neurol 350:281301. Gabbott PL, Bacon SJ (1995): Co-localisation of NADPH-diaphorase activity and GABA immunoreactivity in local circuit neurones in the medial prefrontal cortex (mPFC)of the rat. Brain Res 699:321-328. Gabbott PL, Bacon SJ (1996): Localisation of NADPH-diaphorase activity and NOS immunoreactivity in astroglia in normal adult rat brain. Brain Res 714:135-144. Gabbott PL, Dickie BG, Bacon SJ (1995): Dendritic spine density of NADPH-diaphorase reactive neurons in the medial prefrontal cortex (mPFC) of the rat. Brain Res 698:253-258. Gai WE Messenger JE Yu YH, Gieroba ZJ, Blessing WW (1995): Nitric oxide-synthesising neurons in the central subnucleus of the nucleus tractus solitarius provide a major innervation of the rostral nucleus ambiguus in the rabbit. J Comp Neurol 357:348-361. Garcia-Ojeda E, Alonso JR, Arfivalo R, Weruaga E, Brifi6n JG, Aij6n J (1994): Nicotinamide-adenine-dinucleotidephosphate diaphorase-positive neurons and fibers in the nucleus olfactorius anterior of the rat. Arch ltal Biol 132:13-24. Garcia-Ojeda E, Alonso JR, Crespo C, Weruaga E, Brifi6n JG, Ar6valo R et al. (1997): Transient expression of NADPH-diaphorase/nitric oxide synthase in the paratenial nucleus of the rat thalamus. Brain Res Dev Brain Res 101:177-186. Garthwaite J, Charles SL, Chess-Williams R (1988): Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 336:385-388. Geula C, Schatz CR, Mesulam MM (1993): Differential localization of NADPH-diaphorase and calbindin-D28k within the cholinergic neurons of the basal forebrain, striatum and brainstem in the rat, monkey, baboon and human. Neuroscience 54:461-476. Giuili G, Luzi A, Poyard M, Guellaen G (1994): Expression of mouse brain soluble guanylyl cyclase and NO synthase during ontogeny. Brain Res Dev Brain Res 8•:269-283. Gonzalez-Hernandez T, Conde-Sendin M, Meyer G (1992): Laminar distribution and morphology of NADPHdiaphorase containing neurons in the superior colliculus and underlying periaqueductal gray of the rat. Anat Embo'ol 186:245-250. Gonzalez-Hernandez T, Mantolan-Sarmiento B, Gonzalez-Gonzalez B, Ferres-Torres R, Meyer G ( 1994): NADPH-d (dihydronicotinamide adenine dinucleotide phosphate diaphorase) activity in geniculo-tectal neurons of the rat. Neurosci Lett 16 7:77-80. Gonzalez-Hernandez T, Perez de la Cruz MA, Mantolan-Sarmiento B (1996): Histochemical and immunohistochemical detection of neurons that produce nitric oxide: effect of different fixative parameters and immunoreactivity against non-neuronal NOS antisera. J Histo~'hem Cvtochem 44:1399-1413. Gosepath K, Gath I, Maurer J, Pollock JS, Amedee R. Forstermann U et al. (1997): Characterization of nitric oxide synthase isoforms expressed in different structures of the guinea pig cochlea. Brain Res 747:26-33. 42
Histochemisto" of nitric oxide synthase in the central nervous system
Ch. H
Goto S, Matsukado Y, Miyamoto E, Yamada M (1987): Morphological characterization of the rat striatal neurons expressing calcineurin immunoreactivity. Neuroscience 22:189-201. Greene JR, Lin H, Mason AJ, Johnson LR, Totterdell S (1997): Differential expression of NADPH-diaphorase between electrophysiologically-defined classes of pyramidal neurons in rat ventral subiculum, in vitro. Neuroscience 80:95-104. Grima G, Cuenod M, Pfeiffer S, Mayer B, Do KQ 11998): Arginine availability controls the N-methyl-D-aspartate-induced nitric oxide synthesis m involvement of a glial-neuronal arginine transfer. J Neurochem 71:2139-2144. Grozdanovic Z, Gossrau R (1995a): Alpha-NADPH appears to be primarily oxidized by the NADPH-diaphorase activity of nitric oxide synthase (NOS). Acta Histochem 97:313-320. Grozdanovic Z, Gossrau R (1995b): Nonspecific alkaline phosphatase activity can be responsible for staining of NADPH-diaphorase activity in certain non-neural cells. Folia Histochem Cvtobiol 33:3-10. Grozdanovic Z, Nakos G, Mayer B, Gossrau R (1995): A modified method allows for correlation between NADPH-diaphorase histochemistry and immunohistochemistry for the demonstration of neuronal nitric oxide synthase (nNOS). Folia Histochem Cvtobiol 33:11-18. Hamilton MO, Papka RE, O'Donoghue DE, Vaidya AM, Williams SJ, Poff CR et al. (1995): Spinal projection neurons to the laterodorsal pontine tegmental nucleus: relationship to preganglionic neurons and nitric oxide synthase. J Comp Neurol 353:1-8. Hanazawa T, Motosugi H, Konno A, Kaneko T. Tanaka K, Chiba T (1993): Distribution of NADPH-diaphorase positive nerve fibers in the rat nasal mucosa. Neu~vsci Lett 159:71-74. Hara H, Waeber C, Huang PL, Fujii M, Fishman MC, Moskowitz MA (1996): Brain distribution of nitric oxide synthase in neuronal or endothelial nitric oxide synthase mutant mice using [3H]L-NG-nitro-arginine autoradiography. Neuroscience 75:881-890. Hartig W, Brauer K, Fritschy JM, Bruckner G, Bigl V 11995): Regional and cellular expression sites of the alpha 1 subunit of GABAA receptors in the rat basal forebrain: a cytochemical study with glutamic acid decarboxylase, choline acetyltransferase, calcium-binding-proteins and nitric oxide synthase as second markers. Brain Res 692:215-226. Hawkes R, Turner RW (1994): Compartmentation of NADPH-diaphorase activity in the mouse cerebellar cortex. J Comp Neurol 346:499-516. Hess A, Bloch W, Arnhold S, Andressen C, Stennert E, Addicks K et al. t1998): Nitric oxide synthase in the vestibulocochlear system of mice. Brain Res 813:97-102. Hilbig H, Punkt K (1997): 24-hour rhythmicity of NADPH-diaphorase activity in the neuropil of rat visual cortex. Brain Res Bull 43:337-340. Hilbig H, Luth HJ, Winkelmann E (1995): On the structure of the pretectal nuclei of the rat: an immunocytochemical and tracer study. J Hirnforsch 36:283-293. Hinova-Palova DV, Paloff A, Christova T, Ovtscharoff W (1997): Topographical distribution of NADPH-diaphorasepositive neurons in the cat's claustrum. Eur J Motphol 35:105-116. Holgert H, Aman K, Cozzari C, Hartman BK, Brimijoin S, Emson PC 11995): The cholinergic innervation of the adrenal gland and its relation to enkephalin and nitric oxide synthase. Neuroreport 6:2576-2580. Hong SC, Lanzino G, Collins J, Kassell NF, Lee KS t1993): Selective loss of NADPH-diaphorase-containing neurons in the dentate gyrus following transient ischemia. Neuroreport 5:84-86. Hope BT, Vincent SR (1989): Histochemical characterization of neuronal NADPH-diaphorase. J Histochem Cvtochem 37:653-661. Hope BT, Michael GJ, Knigge KM, Vincent SR (1991): Neuronal NADPH-diaphorase is a nitric oxide synthase. Proc Natl Acad Sci USA 88:2811-2814. Huang PL, Dawson TM, Bredt DS, Snyder SH, Fishman MC (1993): Targeted disruption of the neuronal nitric oxide synthase gene. Cell 75:1273-1286. Hussain Z, Totterdell S (1994): Calbindin-D28k immunoreactive neurons form two populations in the rat nucleus accumbens: a compartmental study. Brain Res 656:191- ! 98. Hussain Z, Johnson LR, Totterdell S (1996): A light and electron microscopic study of NADPH-diaphorase-, calretinin- and parvalbumin-containing neurons in the rat nucleus accumbens. J Chem Neuroanat I0:19-39. Iadecola C, Faris PL, Hartman BK, Xu X (1993): Localization of NADPH-diaphorase in neurons of the rostral ventral medulla: possible role of nitric oxide in central autonomic regulation and oxygen chemoreception. Brain Res 603:173-179. Inagaki S, Takagi H, Suzuki K, Akai E Taniguchi N I1991): Intense immunoreactivity for Mn-superoxide dismutase (Mn-SOD) in cholinergic and non-cholinergic neurons in the rat basal forebrain. Brain Res 541:354-357.
43
Ch. H
S.R. V i n c e n t
Inglis WL, Semba K (1996): Colocalization of ionotropic glutamate receptor subunits with NADPH-diaphorasecontaining neurons in the rat mesopontine tegmentum. J Comp Neurol 368:17-32. Isayama H, Nakamura H, Kanemaru H. Kobayashi K. Emson PC. Kawabuchi M et al. (1997): Distribution and co-localization of nitric oxide synthase and argininosuccinate synthetase in the cat hypothalamus. Arch Histol Cytol 60:477-492. Iwase K, Iyama K, Akagi K, Yano S. Fukunaga K, Miyamoto E e t al. (1998a): Precise distribution of neuronal nitric oxide synthase mRNA in the rat brain revealed by non-radioisotopic in situ hybridization. Brain Res Mol Brain Res 53:1-12. Iwase K, Takemura M, Shimada T, Wakisaka S, Nokubi T, Shigenaga Y (! 998b): Ontogeny of NADPH-diaphorase in rat forebrain and midbrain. Anat Embn'ol •97:229-247. Jeon SY, Kim J, Hwang EG (1997): Origin and distribution of NADPH-diaphorase-positive nerves in rat nasal mucosa. Ann Otol Rhinol Lao'ngol 106:688-692. Johnson MD, Ma PM (1993): Localization of NADPH-diaphorase activity in monoaminergic neurons of the rat brain. J Comp Neurol 332:391-406. Kanda K (1996): Expression of neuronal nitric oxide synthase in spinal motoneurons in aged rats. Neurosci Lett 219:41-44. Kaneko T, Shigemoto R, Nakanishi S. Mizuno N (1993): Substance P receptor-immunoreactive neurons in the rat neostriatum are segregated into somatostatinergic and cholinergic aspiny neurons. Brain Res 631:297-303. Kawaguchi Y (1993): Physiological, morphological, and histochemical characterization of three classes of interneurons in rat neostriatum. J Neurosci •3:4908-4923. Kharazia VN, Schmidt HH, Weinberg RJ (1994): Type I nitric oxide synthase fully accounts for NADPH-diaphorase in rat striatum, but not cortex. Neuroscience 62:983-987. Kharazia VN, Petrusz P, Usunoff K, Weinberg RJ, Rustioni A (1997): Arginine and NADPH-diaphorase in the rat ventroposterior thalamic nucleus. Brain Res 744:151-155. Kharitonov VG, Sharma VS, Pilz RB, Magde D, Koesling D (1995): Basis of guanylate cyclase activation by carbon monoxide. Proc Natl Acad Sci USA 92:2568-2571. Kidd EJ, Michel AD, Humphrey PP (1995): Autoradiographic distribution of [3H]L-NC;-nitro-arginine binding in rat brain. Neuropharmacology 34:63-73. Kim YD, Kwon OC, Song SY, Suh JS, Song KW, Kwon SH et al. 11997): Distribution of nitric oxide in the nasal mucosa of the rat: a histochemical study. Auris Nasus Larynx 24:373-378. Kinjo N, Skinner RD, Powell EW (1989): A study of NADPH-diaphorase positive septohippocampal neurons in rat. Neurosci Res 7:154-158. Kishimoto J, Keverne EB, Hardwick J, Emson PC (1993): Localization of nitric oxide synthase in the mouse olfactory and vomeronasal system: a histochemical, immunological and in situ hybridization study. Eur J Neurosci 5:1684-1694. Kita H, Kosaka T, Heizmann CW (1990): Parvalbumin-immunoreactive neurons in the rat neostriatum: a light and electron microscopic study. Brain Res 536:1-15. Kitchener PD, Diamond J (1993): Distribution and colocalization of choline acetyltransferase immunoreactivity and NADPH-diaphorase reactivity in neurons within the medial septum and diagonal band of Broca in the rat basal forebrain. J Comp Neurol 335:1-15. Kitchener PD, Van der Zee CE, Diamond J (1993): Lesion-induced NADPH-diaphorase reactivity in neocortical pyramidal neurones. Neuroreport 4:487-490. Kowall NW, Beal MF (1988): Cortical somatostatin, neuropeptide Y, and NADPH-diaphorase neurons: normal anatomy and alterations in Alzheimer's disease. Amt Neurol 23:105-114. Kowall NW, Beal MF, Ferrante RJ, Martin JB (1985): Topography of nicotinamide adenine dinucleotide phosphatediaphorase staining neurons in rat striatum. Neurosci Lett 59:61-66. Krowicki ZK, Sharkey KA, Serron SC, Nathan NA, Hornby PJ (1997): Distribution of nitric oxide synthase in rat dorsal vagal complex and effects of microinjection of nitric oxide compounds upon gastric motor function. J Comp Neuro! 377:49-69. Krukoff TL, Khalili P (1997): Stress-induced activation of nitric oxide-producing neurons in the rat brain. J Comp Neurol 377:509-519. Kubota Y, Kawaguchi Y (1994): Three classes of GABAergic interneurons in neocortex and neostriatum. Jpn J Phvsio144:S 145-148. Kugler P, Drenckhahn D (1996): Astrocytes and Bergmann glia as an important site of nitric oxide synthase I. Glia 16:165-173. Kulkarni AP, Getchell TV, Getchell ML (1994): Neuronal nitric oxide synthase is localized in extrinsic nerves 44
Histochemistr)' of nitric oxide synthase in the central nervous system
Ch. H
regulating perireceptor processes in the chemosensory nasal mucosae of rats and humans. J Comp Neurol 345:125-138. Kumar U, Asotra K, Patel SC, Patel YC (1997): Expression of NMDA receptor-1 (NRI) and huntingtin in striatal neurons which colocalize somatostatin, neuropeptide Y, and NADPH-diaphorase: a double-label histochemical and immunohistochemical study. Exp Neurol 145:412-424. Kuo H, Hengemihle J, Ingram DK (1997): Nitric oxide synthase in rat brain: age comparisons quantitated with NADPH-diaphorase histochemistry. J Getvntol Ser A. Biol Sci Med Sci 52:B 146-151. Laing I, Todd AJ, Heizmann CW, Schmidt HH (1994): Subpopulations of GABAergic neurons in laminae I-III of rat spinal dorsal horn defined by coexistence with classical transmitters, peptides, nitric oxide synthase or parvalbumin. Neuroscience 61:123-132. Lee JH, Price RH, Williams FG, Mayer B, Beitz AJ (1993): Nitric oxide synthase is found in some spinothalamic neurons and in neuronal processes that appose spinal neurons that express Fos induced by noxious stimulation. Brain Res 608:324-333. Lee SH, Iwanaga T, Hoshi O, Adachi I, Fujita T (1995): Nitric oxide synthase in rat nasal mucosa; immunohistochemical and histochemical localization. Acta Oto-Lapyngol 1 •5:823-829. Leigh PN, Connick JH, Stone TW (1990): Distribution of NADPH-diaphorase positive cells in the rat brain. Comp Biochem Phvsiol C 97:259-264. Li J, Chen S, Lin RC, Smith SS (1997): Cerebellar nitric oxide synthase is expressed within granule cell patches innervated by specific mossy fiber terminals: a developmental profile. Dev Neurosci •9:274-282. Lin AYJ, Szmydynger-Chodobska J, Rahman ME Mayer B. Monfils PR, Johanson CE et al. (1996): Immunohistochemical localization of nitric oxide synthase in rat anterior choroidal artery, stromal blood microvessels, and choroid plexus epithelial cells. Cell Tissue Res 285:411-418. Lolova IS, Lolov SR, Itzev DE (1997): Aging and the dendritic morphology of the rat laterodorsal and pedunculopontine tegmental nuclei. Mech Ageing Dev 97:193-205. Lopez-Figueroa MO, Moller M (1996): Localization of NADPH-diaphorase in the rat pineal gland: an experimental enzyme histochemical study. J Pin Res 20:157-163. Lu Y, Ding YQ, Qin BZ, Li JS (1994): The distribution and origin of axon terminals with NADPH-diaphorase activity in the nucleus of the solitary tract of the rat. Neurosci Lett 171:70-72. Luo D, Das S, Vincent SR (1995): Effects of methylene blue and LY83583 on neuronal nitric oxide synthase and NADPH-diaphorase. Eur J Phalvlacol 290:247-251. Ma SX, Holley AT, Sandra A, Cassell MD, Abboud FM (1997): Increased expression of nitric oxide synthase in the gracile nucleus of aged rats. Neuroscience 76:659-663. Maqbool A, Batten TF, McWilliam PN (1995): Co-localization of neurotransmitter immunoreactivities in putative nitric oxide synthesizing neurones of the cat brain stem. J Chem Neuroanat 8:191-206. Marks GS, Brien JF, Nakatsu K, McLaughlin BE (1991): Does carbon monoxide have a physiological function?. Trends Pharmacol Sci 12:185-188. Matsumoto T, Nakane M, Pollock JS, Kuk JE, Forstermann U (1993): A correlation between soluble brain nitric oxide synthase and NADPH-diaphorase activity is only seen after exposure of the tissue to fixative. Neurosci Lett 155:61-64. Matsuoka I, Giuili G, Poyard M, Stengel D, Parma J. Guellaen G e t al. (1992): Localization of adenylyl and guanylyl cyclase in rat brain by in situ hybridization: comparison with calmodulin mRNA distribution. J Neurosci •2:3350-3360. McDonald AJ, Payne DR, Mascagni F (1993): Identification of putative nitric oxide producing neurons in the rat amygdala using NADPH-diaphorase histochemistry. Neuroscience 52:97-106. Mengual E, Velayos JL, Reinoso-Suarez F (1993): Nicotinamide-adenine dinucleotide phosphate diaphorase activity matches acetylcholinesterase-rich patches in the medial thalamic nuclei of the cat. Brain Res 625:165-168. Mesulam MM, Geula C, Bothwell MA, Hersh LB (1989): Human reticular formation: cholinergic neurons of the pedunculopontine and laterodorsal tegmental nuclei and some cytochemical comparisons to forebrain cholinergic neurons. J Comp Neurol 283:611-633. Meyer G, Gonzalez-Hernandez T, Galindo-Mireles D, Castaneyra-Perdomo A, Ferres-Torres R (1991): The efferent projections of neurons in the white matter of different cortical areas of the adult rat. Anat Embrvol 184:99-102. Meyer G, Gonzalez-Hernandez T, Galindo-Mireles D, Carrillo-Padilla E Ferres-Torres R (1994): NADPH-d activity in the islands of Calleja: a regulatory system of blood flow to the ventral striatum/pallidum?. Neuroreport 5:1281-1284. Mitrofanis J (1992): NADPH-diaphorase reactivity in the ventral and dorsal lateral geniculate nuclei of rats. Visual Neurosci 9:211-216.
45
Ch. II
S.R. V i n c e n t
Mitrovic N, Schachner M (1996): Transient expression of NADPH-diaphorase activity in the mouse whisker to barrel field pathway. J Neurocvtol 25:429-437. Miyagawa A, Okamura H, Ibata Y (1994): Coexistence of oxytocin and NADPH-diaphorase in magnocellular neurons of the paraventricular and the supraoptic nuclei of the rat hypothalamus. Nemvsci Lett 171:13-16. Mizukawa K, McGeer PL, Vincent SR, McGeer EG (1988a): Ultrastructure of reduced nicotinamide adenine dinucleotide phosphate (NADPH) diaphorase-positive neurons in the cat cerebral cortex, amygdala and caudate nucleus. Brain Res 452:286-292. Mizukawa K, Vincent SR, McGeer PL, McGeer EG (1988b): Reduced nicotinamide adenine dinucleotide phosphate (NADPH)-diaphorase-positive neurons in cat cerebral white matter. Brain Res 461:274-281. Mizukawa K, Vincent SR, McGeer PL, McGeer EG (1989): Distribution of reduced-nicotinamide-adenine-dinucleotide-phosphate diaphorase-positive cells and fibers in the cat central nervous system. J Comp Neurol 279:281-311. Morris BJ, Simpson CS, Mundell S, Maceachern K, Johnston HM, Nolan AM (1997): Dynamic changes in NADPH-diaphorase staining reflect activity of nitric oxide synthase: evidence for a dopaminergic regulation of striatal nitric oxide release. Neuropharmacology 36:1589-1599. Nakamura H (1997): NADPH-diaphorase and cytosolic urea cycle enzymes in the rat spinal cord. J Comp Neurol 385:616-626. Nakos G, Gossrau R (1994): When NADPH-diaphorase (NADPHd) works in the presence of formaldehyde, the enzyme appears to visualize selectively cells v~ith constitutive nitric oxide synthase (NOS). Acta Histochem 96:335-343. Nemcova V, Petrovicky E Ten Donkelaar HJ (1997): The dorsal tegmentum of the pontomesencephalic junction of the rat-immunohistochemistry (choline acetyitransferase, tyrosine hydroxylase, substance P) and NADPHdiaphorase histochemistry in frontal and horizontal sections. J Hir~!forsch 38:231-241. Norris PJ, Hardwick JE Emson PC (1994): Localization of NADPH cytochrome P450 oxidoreductase in rat brain by immunohistochemistry and in situ hybridization and a comparison with the distribution of neuronal NADPH-diaphorase staining. Nemvscience 61:331-350. Norris PJ, Charles IG, Scorer CA, Emson PC (1995): Studies on the localization and expression of nitric oxide synthase using histochemical techniques. Histochem J 27:745-756. O'Dell TJ, Huang PL, Dawson TM, Dinerman JL, Snyder SH, Kandel ER et al. (1994): Endothelial NOS and the blockade of LTP by NOS inhibitors in mice lacking neuronal NOS. Science 265:542-546. Okamura H, Miyagawa A, Takagi H, Esumi H, Yanaihara N. Ibata Y (1994a): Co-existence of PACAP and nitric oxide synthase in the rat hypothalamus. Nemv~report 5:1177-1180. Okamura H, Yokosuka M, McEwen BS, Hayashi S (1994b): Colocalization of NADPH-diaphorase and estrogen receptor immunoreactivity in the rat ventromedial hypothalamic nucleus: stimulatory effect of estrogen on NADPH-diaphorase activity. Endocpfnology 135:1705-1708. Otake K, Ruggiero DA (1995): Monoamines and nitric oxide are employed by afferents engaged in midline thalamic regulation. J Neutvsci 15:1891-1911. Pasqualotto BA, Vincent SR (1991): Galanin and NADPH-diaphorase coexistence in cholinergic neurons of the rat basal forebrain. Brain Res 551:78-86. Pasqualotto BA, Hope BT, Vincent SR (1991): Citrulline in the rat brain: immunohistochemistry and coexistence with NADPH-diaphorase. Neulvsci Lett 128:155-160. Peng ZC, Chert S, Bertini G, Schmidt HH, Bentivoglio M (I 994): Co-localization of nitric oxide synthase and NGF receptor in neurons in the medial septal and diagonal band nuclei of the rat. Neurosci Lett 166:153-156. Petrovicky P, Nemcova V (1995): Topographical organization of NADPH-diaphorase positive neurons and fibres in dorsal ponto-mesencephalic tegmentum in the rat brain. J Hirnfi~rsch 36:539-545. Pickel VM, Pohorille A, Chart J, Tare SS, Nirenberg MJ (1999): Regional and subcellular distribution of a neutral and basic amino acid transporter in forebrain neurons containing nitric oxide synthase. J Comp Neurol 404:459472. Porteros A, Alonso JR, Ar6valo R, Garcia-Ojeda E, Crespo C, Aij6n J (1994): Histochemical localization of NADPH-diaphorase in the rat accessory olfactory bulb. Chem Senses 19:413-424. Price Jr. RH, Mayer B, Beitz AJ (1993): Nitric oxide synthase neurons in rat brain express more NMDA receptor mRNA than non-NOS neurons. Neuroreport 4:807-810. Rachman IM, Pfaff DW, Cohen RS (1996): NADPH-diaphorase activity and nitric oxide synthase immunoreactivity in lordosis-relevant neurons of the ventromedial hypothalamus. Brain Res 740:291-306. Rao VL, Butterworth RF (1996): Regional distribution of binding sites for the nitric oxide synthase inhibitor L-[3H]nitroarginine in rat brain. Neurochem Res 2•:355-359. 46
Histochemistry of nitric oxide synthase in the central nervous system
Ch. H
Regidor J, Edvinsson L, Divac I (1993): NOS neurones lie near branchings of cortical arteriolae. Neuroreport 4:112-114. Reuss S (1998): Nitric oxide synthase in the auditory brain stem. Neuroreport 9:3643-3646. Reuss S, Decker K, Rosseler L, Layes E, Schollmayer A, Spessert R (1995): Nitric oxide synthase in the hypothalamic suprachiasmatic nucleus of rat: evidence from histochemistry, immunohistochemistry and Western blot; and colocalization with VIP. Brain Res 695:257-262. Rhrich-Haddout F, Klosen P, Portier MM, Horvat JC (1997): Expression of peripherin, NADPH-diaphorase and NOS in the adult rat neocortex. Neuroreport 8:3313-3316. Rodrigo J, Riveros-Moreno V, Bentura ML, Uttenthal LO, Higgs EA, Fernandez AP et al. (1997): Subcellular localization of nitric oxide synthase in the cerebral ventricular system, subfornical organ, area postrema, and blood vessels of the rat brain. J Comp Neurol 378:522-534. Roskams AJ, Bredt DS, Dawson TM, Ronnett GV (1994): Nitric oxide mediates the formation of synaptic connections in developing and regenerating olfactory receptor neurons. Neuron •3:289-299. Rothe F, Canzler U, Wolf G (1998)" Subcellular localization of the neuronal isoform of nitric oxide synthase in the rat brain: a critical evaluation. Neuroscience 83:259-269. Ruan RS, Leong SK, Yeoh KH (1997): Localization of nitric oxide synthase and NADPH-diaphorase in guinea pig and human cochleae. J Hirnforsch 38:433-441. Rushlow W, Flumerfelt BA, Naus CC (1995): Colocalization of somatostatin, neuropeptide Y, and NADPHd~aphorase in the caudate-putamen of the rat. J Comp Neurol 351:499-508. Sagar SM, Ferriero DM (1987): NADPH-diaphorase activity in the posterior pituitary: relation to neuronal function. Brain Res 400:348-352. Saito S, Kidd GJ, Trapp BD, Dawson TM, Bredt DS, Wilson DA et al. (1994): Rat spinal cord neurons contain nitric oxide synthase. Neuroscience 59:447-456. Samama B, Boehm N (1996): Ontogenesis of NADPH-diaphorase activity in the olfactory bulb of the rat. Brain Res Dev Brain Res 96:192-203. Samama B, Chateau D, Boehm N (1995): Expression of NADPH-diaphorase in the rat forebrain during development. Neurosci Lett 184:204-207. Sancesario G, Morello M, Massa R, Fusco F, Bernardi G (1993): NADPH-diaphorase activity is inhibited by EDTA in neurons but not in choroid plexus epithelium. Neurosci Lett 158:101-104. Sancesario G, Morello M, Massa R, Fusco FR, D'Angelo V, Bernardi G (1996a)" NADPH-diaphorase neurons contacting the cerebrospinal fluid in the ventricles of rat brain. J Cereb Blood Flow Metab 16:517-522. Sancesario G, Reiner A, Figueredo-Cardenas G, Morello M, Bernardi G (1996b): Differential distribution of nicotinamide adenine dinucleotide phosphate-diaphorase and neural nitric oxide synthase in the rat choroid plexus. A histochemical and immunocytochemical study. Neurosciem'e 72:365-375. Sanchez F, Alonso JR, Ar6valo R, Blanco E, Aij6n J, Vazquez R (1994): Coexistence of NADPH-diaphorase with vasopressin and oxytocin in the hypothalamic magnocellular neurosecretory nuclei of the rat. Cell Tissue Res 276:31-34. Scherer-Singler U, Vincent SR, Kimura H, McGeer EG (1983): Demonstration of a unique population of neurons with NADPH-diaphorase histochemistry. J Neurosci Methods 9:229-234. Schmidt HHHW (1992): NO., CO and .OH. Endogenous soluble guanylyl cyclase-activating factors. FEBS Lett 307:102-107. Schmidt HHHW, Gagne GD, Nakane M, Pollock JS, Miller MF, Murad F (1992a): Mapping of neural nitric oxide synthase in the rat suggests frequent co-localization with NADPH-diaphorase but not with soluble guanylyl cyclase, and novel paraneural functions for nitrinergic signal transduction. J Histochem Cytochem 40:1439-1456. Schmidt HHHW, Smith RM, Nakane M, Murad F (1992b): Ca-"+ /calmodulm-dependent NO synthase type I: a biopteroflavoprotein with Ca2+/calmodulin-independent diaphorase and reductase activities. Biochemistr3' 3•:3243-3249. Scott JW, McDonald JK, Pemberton JL (1987): Short axon cells of the rat olfactory bulb display NADPHdiaphorase activity, neuropeptide Y-like immunoreactivity, and somatostatin-like immunoreactivity. J Comp Neurol 260:378-391. Seidel B, Stanarius A, Wolf G (1997): Differential expression of neuronal and endothelial nitric oxide synthase in blood vessels of the rat brain. Neurosci Lett 239:109-112. Shaer JL, Fernandez-Rodriguez P, Martinelli GP, Holstein GR (1996): NADPH-diaphorase histochemical staining in the rat vestibular nuclei during postnatal development. Am~ NY Acad Sci 781:696-699. Singer M, Lysakowski A (1996): Nitric oxide synthase localized in a subpopulation of vestibular efferents with NADPH-diaphorase histochemistry. Ann NY Acad Sci 781:658-662.
47
Ch. II
S.R. Vincent
Song ZM, Brookes SJ, Costa M (1994): Characterization of alkaline phosphatase-reactive neurons in the guinea-pig small intestine. Neuroscience 63:1153-1167. Southam E, Garthwaite J (1993): The nitric oxide-cyclic GMP signalling pathway in rat brain. Neuropharmacology 32:1267-1277. Southam E, Morris R, Garthwaite J (1992): Sources and targets of nitric oxide in rat cerebellum. Neurosci Lett 137:241-244. Spessert R, Claassen M (1998)" Histochemical differentiation between nitric oxide synthase-related and-unrelated diaphorase activity in the rat olfactory bulb. Histochem J 30:41-50. Spessert R, Layes E (1994): Fixation conditions affect the intensity but not the pattern of NADPH-diaphorase staining as a marker for neuronal nitric oxide svnthase in rat olfactory bulb. J Histo~'hem Cvtochem 42:13091315. Spessert R, Wohlgemuth C. Reuss S. Layes E {1994) NADPH-diaphorase activity of nitric oxide synthase in the olfactory bulb: co-factor specificity and characterization regarding the interrelation to NO formation. J Histochem Cvtochem 42:569-575. Spike RC, Todd AJ, Johnston HM (1993) Coexistence of NADPH-diaphorase with GABA. glycine, and acetylcholine in rat spinal cord. J Comp Neuroi 335:320-333. Stanarius A, Topel I, Schulz S. Noack H. Wolf G (1997): Immunocytochemistry of endothelial nitric oxide synthase in the rat brain: a light and electron microscopical study using the tyramide signal amplification technique. Acta Histochem 99:411-429. Sugaya K, McKinney M (1994): Nitric oxide synthase gene expression in cholinergic neurons in the rat brain examined by combined immunocytochemistry and in situ hybridization histochemistry. Brain Res Mol Brain Res 23:111-125. Szmydynger-Chodobska J, Monfils PR. Lin AY. Rahman ME Johanson CE. Chodobski A (1996): NADPHdiaphorase histochemistry of rat choroid plexus blood vessels and epithelium. Neurosci Lett 208:179-182. Takemura M, Wakisaka S, Yoshida A, Nagase Y. Bae YC. Shigenaga Y {1994): NADPH-diaphorase in the spinal trigeminal nucleus oralis and rostral solitary tract nucleus of rats. Neuroscience 61:587-595. Takemura M, Wakisaka S. Iwase K. Yabuta NH. Nakagawa S. Chen K et al. 11996) NADPH-diaphorase in the developing rat: lower brainstem and cervical spinal cord. with special reference to the trigemino-solitary complex. J Comp Neurol 365:511-525. Tang FR, Tan CK, Ling EA (1995a)" The distribution of NADPH-d in the central grey region (lamina X) of rat upper thoracic spinal cord. J Neurocvtoi 24735-743. Tang FR, Tan CK, Ling EA (1995b) Light and electron microscopic studies of the distribution of NADPHdiaphorase in the rat upper thoracic spinal cord with special reference to the spinal autonomic region. Arch Histol Cvtol 58:493-505. Tenorio F, Giraldi-Guimaraes A. Mendez-Otero R (1995)" Developmental changes of nitric oxide synthase in the rat superior colliculus. J Neutvsci Res 42:633-637. Tenorio F, Giraldi-Guimaraes A. Mendez-Otero R {1996): Morphology of NADPH-diaphorase-positive cells in the retinoceptive layers of the developing rat superior colliculus. Int J Dev Neurosci 14" 1-10. Turcanu V, Dhouib M, Poindron P (1998): Heine oxygenase inhibits nitric oxide synthase by degrading heine: a negative feedback regulation mechanism for nitric oxide production. Tran.splant Proc 30:4184-4185. Vaid RR, Yee BK, Rawlins JN. Totterdeil S t1996~: NADPH-diaphorase reactive pyramidal neurons in Ammon's horn and the subiculum of the rat hippocampal formation. Brain Res 733:31-40. Valtschanoff JG, Weinberg RJ, Rustioni A (1992): NADPH-diaphorase in the spinal cord of rats. J Comp Neurol 321:209-222. Valtschanoff JG, Weinberg RJ, Kharazia VN. Nakane M, Schmidt HH (1993a): Neurons in rat hippocampus that synthesize nitric oxide. J Comp Neurol 331:111-121. Valtschanoff JG, Weinberg RJ, Kharazia VN, Schmidt HH. Nakane M. Rustioni A (1993b): Neurons in rat cerebral cortex that synthesize nitric oxide" NADPH-diaphorase histochemistry, NOS immunocytochemistry, and colocalization with GABA. Neurosci Lett 157:157-161. Vanhatalo S, Soinila S (1995)" Nitric oxide synthase in the hypothalamo-pituitary pathways. J Chem Neutvanat 8:165-173. Verma A, Hirsch DJ, Glatt CE. Ronnett GV, Snyder SH (1993): Carbon monoxide: a putative neural messenger [see comments] [published erratum appeared in Science 1994 Jan 7:26315143)15]. Science 259:381-384. Villalba RM, Martinez-Murillo R, Blasco I. Alvarez FJ. Rodrigo J 11988): C-PON containing neurons in the rat striatum are also positive for NADPH-diaphorase activity. A light microscopic study. Brain Res 462:359-362. Villalba RM, Rodrigo J, Alvarez FJ. Achaval M. Martinez-Murillo R (1989): Localization of C-PON immunoreac-
48
Histochemistry of nitric oxide svnthase in the central nervous system
Ch. II
tivity in the rat main olfactory bulb. Demonstration that the population of neurons containing endogenous C-PON display NADPH-diaphorase activity. Neuroscience 33:373-382. Vincent SR (1994),;. Nitric oxide: a radical neurotransmitter in the central nervous system. Prog Neurobiol 42:129160. Vincent SR, Hope BT (1992): Neurons that say NO. Trends Netuvsci 15:108-113. Vincent SR, Johansson O (1983): Striatal neurons containing both somatostatin- and avian pancreatic polypeptide (APP)-like immunoreactivities and NADPH-diaphorase activity: a light and electron microscopic study. J Comp Neurol 217:264-270. Vincent SR, Kimura H (1992): Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience 46:755-784. Vincent SR, Johansson O, Skirboll L, H6kfelt T (1982): Coexistence of somatostatin- and avian pancreatic polypeptide-like immunoreactivities in striatal neurons which are selectively stained for NADPH-diaphorase activity. Adv Biochem Psychopharmacol 33:453-462. Vincent SR, Johansson O, H6kfelt T, Skirboll L, Elde RE Terenius Let al. (1983a): NADPH-diaphorase: a selective histochemical marker for striatal neurons containing both somatostatin- and avian pancreatic polypeptide (APP)-like immunoreactivities. J Comp Neurol 217:252-263. Vincent SR, Satoh K, Armstrong DM, Fibiger HC (1983b): NADPH-diaphorase: a selective histochemical marker for the cholinergic neurons of the pontine reticular formation. Neurosci Lett 43:31-36. Vincent SR, Staines WA, Fibiger HC (1983c): Histochemical demonstration of separate populations of somatostatin and cholinergic neurons in the rat striatum. Neurosci Len 35:111-114. Vincent SR, Satoh K, Armstrong DM, Panula P, Vale W. Fibiger HC (1986): Neuropeptides and NADPH-diaphorase activity in the ascending cholinergic reticular system of the rat. Neuroscience 17:167-182. Vincent SR, Das S, Maines MD (1994): Brain heme oxygenase isoenzymes and nitric oxide synthase are co-localized in select neurons. Neuroscience 63:223-231. Vincent SR, Williams JA, Reiner PB, EI-Husseini AD (1998): Monitoring neuronal NO release in vivo in cerebellum, thalamus and hippocampus. In: Mize RR. Dawson TM, Dawson VL, Friedlander MJ (Eds), P~vgress in Brain Research. Amsterdam: Elsevier, pp 27-35. Vogel M, Luck G, Bachmann S, Blottner D (1997): NOS type-1 mRNA expression and protein localization in spinal autonomic neurons. Neuroreport 8:3389-3393. Wendland B, Schweizer FE, Ryan TA, Nakane M, Murad E Scheller RH et al. (1994): Existence of nitric oxide synthase in rat hippocampal pyramidal cells. Proc Natl Acad Sci USA 91:2151-2155. Yamada K, Emson E H6kfelt T (1996): Immunohistochemical mapping of nitric oxide synthase in the rat hypothalamus and colocalization with neuropeptides. J Chem Neutvanat 10:295-316. Young HM, O'Brien AJ, Furness JB, Ciampoli D, Hardwick JR McCabe TJ et al. (1997): Relationships between NADPH diaphorase staining and neuronal, endothelial, and inducible nitric oxide synthase and cytochrome P450 reductase immunoreactivities in guinea-pig tissues. Histochem Cell Biol 107:19-29.
49
This Page Intentionally Left Blank
CHAPTER III
Comparative and developmental neuroanatomical aspects of the NO system J.R. ALONSO, R. AREVALO, E. WERUAGA, A. PORTEROS, J.G. BRII~ON AND J. AIJON
1. I N T R O D U C T I O N Neurons labeled with NADPH-diaphorase (NADPH-d) histochemistry are widely distributed in the brain of all vertebrates. Literally thousands of papers have been published describing the characteristics of NADPH-d-positive cells in the brain, their distribution or comparison with other neuroactive substances, and their variations after experimental or pathological conditions. There are several reasons that explain why the study of these cells has attracted so much attention. First, the relatively simple NADPH-d histochemical technique allows the demonstration of specific populations and subpopulations of neurons and fibers throughout both central and peripheral nervous systems. Positive elements are frequently stained in a Golgi-like manner with considerable detail of dendritic and axonal prolongations, thus providing valuable morphological information. Then, a new "NADPH-diaphorase system' has been progressively described in the brain in parallel with a refinement of the preexistent classifications of anatomical divisions and neural populations. The second, more important and attractive reason for the interest of neuroanatomists in this histochemical staining arose when NADPH-d was identified as a marker for nitric oxide synthase (NOS, Hope et al., 1991). This makes this staining (with the technical conditions formulated below) a robust tool to identify nitric oxide-producing elements in the brain (Vincent, 1994). Nevertheless, this identification is not total and it has to be validated in each particular case (see Section 4). In the central nervous system, all three NOS isoforms (neuronal, endothelial and immunological, or I, II and III) have been detected, the neuronal isoform being the most widely expressed, but not exclusive, in neural elements. Although the NOS-positive neurons were originally described as 'solitary active cells' (Thomas and Pearse, 1961, 1964), there are brain regions where neuronal NOS is not expressed by isolated, scattered cells but by dense populations of neurons, such as the cerebellum, the olfactory bulb, or the hypothalamic supraoptic nucleus. Endothelial NOS is constitutively expressed not only in blood vessels but also in some neural cells, occasionally in the same population as neuronal NOS (Dinerman et al., 1994). While both neuronal and endothelial isoforms are constitutively expressed in the nervous system, immunQlogical NOS can be detected in neural elements only after induction of its expression in experimental or pathological situations (Endoh et al., 1994b; Minc-Golomb et al., 1996). Whereas more and more is known about the cells containing nitric oxide, important questions about the meaning of this expression remain still unsolved. Why is NOS widely
Handbook of Chemical Neuroanatom~, Vol. 17: Functional Neuroamaomy of the Nitric Oxtde S~ ~tem H.W.M. Steinbusch, J. De Vente and S.R. Vincent. editor.,, ~ 2000 Elsevier Science B.V. All rights reserved.
51
Ch. III
J.R. Alonso et al.
distributed in the brain but is only present in discrete populations of cells? Why is it that some cells of a particular neuronal type express NADPH-d/NOS whereas cells with similar morphology, connections, and presumably functions are NADPH-d/NOS-negative? Nitric oxide is a diffusible messenger with a wide range of spatial action, then, what is the meaning of such amounts of intermingled neurites of different NOS-positive elements in the same brain region? What is the relationship between nitric oxide synthesis in neurons, glial cells and endothelial cells? Has nitric oxide produced in astrocytes the same targets as nitric oxide produced in nearby neurons? Is nitric oxide involved in the same functions in the adult and during the development? If the nitrergic system is such a simple and conserved transmitter system, why is the NADPH-d staining pattern so variable between phylogenetically close species? Any hypothesis answering these questions has to be confronted with what is known on the distribution of nitric oxide producing systems. The aim of this chapter is to provide an overview on the anatomical aspects of the distribution of nitric oxide synthase and NADPH-d activity in the nervous system of all major groups of vertebrates and during the development of the mammalian brain. First, we comment the methodological aspects concerning the localization of these neuronal markers, then we describe the general aspects of their distribution patterns in fish, amphibians, reptiles, birds and mammals, third, we report the changes during prenatal and postnatal development in the rat brain, and finally, we comment on some functional aspects of nitric oxide derived from the fine localization of markers for their synthases. We hope that this morphological information will provide baseline data for a selection of the best experimental model as well as for the design of new experiments.
2. METHODS TO LOCALIZE NITRIC OXIDE AND NITRIC OXIDE SYNTHASES IN BRAIN TISSUE
There are two main approaches to study nitric oxide production in the brain and, subsequently, two main ways to treat tissue. Firstly, it is possible to visualize directly the expression of the NOS messenger RNA, the protein, or its related NADPH-d activity using histological techniques. On the other hand, the estimation of quantitative temporal patterns of expression (in development or under experimental conditions) is difficult to estimate with these methods. Following this approach, it is possible to observe the cells containing NOS, but it is difficult to be certain about how much enzyme they contain, how much of it is active, and how much nitric oxide is really produced. The second approach is to detect and to measure nitric oxide itself, its production, and its synthases by biochemical methods using homogenates of whole brain tissue or from defined neuroanatomical regions. Although it provides a better functional representation, the anatomical resolution is much worse; it strongly depends on the quality of brain or peripheral nerve tissue dissection, that can be improved using the micropunching technique of thick tissue slices (Palkovits and Brownstein, 1988). The histological methods, especially NADPH-d histochemistry, have been fruitfully employed during last decades to determine the cellular nitric oxide sources, therefore, in the following paragraphs we shall summarize and compare them. 2.1. HISTOLOGICAL DETECTION OF NADPH-DIAPHORASE/NITRIC OXIDE SYNTHASE The immunohistochemical localization of the protein and the in situ hybridization of its mRNA are classical methods to detect any neuroactive, protein-related molecule, as NOS is. 52
Comparative and developmental neuroanatomical aspects of the NO system
Ch. III
Furthermore, NADPH-d staining has been used since the sixties to label discrete populations of neurons. Bredt et al. (1991a), using an antibody to NOS from rat brain, oligonucleotide probes of rat NOS, and NADPH-d histochemistry, demonstrated that NOS protein and message are coincident with NADPH-d activity. The histochemical staining remains the most used technique to study nitrergic patterns because of its technical simplicity and valuable morphological results. NOS immunohistochemistry and NOS mRNA in situ hybridization are increasingly employed as parallel or complementary technical approaches. In addition, new methods such as the autoradiographic localization of NOS by the demonstration of the binding of its irreversible inhibitor [-~H]t,-nitro-arginine are also available (Burazin and Gundlach, 1995).
2.1.1. NADPH-diaphorase histochemistry The histochemical staining for NADPH-d is a simple technique that is accomplished in a one-step incubation: the medium usually contains a highly soluble salt of [3-NADPH, an artificial acceptor of reducing equivalents (chromogen), a detergent to permeate tissue, and a buffer with a pH of about 7.4-8.0 (Thomas and Pearse, 1961; see also Alonso et al., 1995a). The standard chromogen for optic microscopy examination is a salt of NBT (nitroblue tetrazolium), which precipitates and turns dark-blue when reduced, transforming itself into formazan (Thomas and. Pearse, 1961; Kuonen et al., 1988; Hope and Vincent, 1989). The detergent of choice is Triton X-100, which also helps to solubilize NBT. Incubation can be developed onto air-dried sections on gelatin-coated slides or with free-floating sections. The reaction runs in darkness at 37~ in 45-90 rain, and it should be controlled under the microscope because of non-specific formazan crystal accumulation. The result of this incubation is neural elements frequently stained in a perfect Golgi-like manner, even within sections of 50-100 btm thickness. Foresights have to be taken to obtain satisfactory results, otherwise imprecise staining may result: (1) aldehyde fixation is necessary to eliminate stainings non-related to NOS, (2) excessively short or prolonged fixation (e.g. stocking in formalin of autopsy material) results in a loss of visualization of weakly stained NOS-positive elements, (3) fixed material should be properly frozen and stored at -80~ for long periods, (4) time between thawing sections and their histochemical incubation should not exceed 2 weeks, even if they are stored in buffer at 4~ (5) paraffin sections are not suitable for NADPH-d staining, and (6) incubation medium should be always freshly prepared. NADPH-d histochemistry can also be resolved successfully for electron microscopic observation, by changing the chromogen. BSPT, the synonym for 2-(2'-benzothiazolyl)-5-styril-3-(4'-phthalhydrazidyl) tetrazolium chloride, turns highly electron dense and osmiophilic when reduced by accepting protons from [3-NADPH (see Wolf et al., 1992, 1993, 1995). On the other hand, BSPT needs a higher concentration of Triton X-100 or formamide to solubilize, which, together with the incubation at 37~ renders the observation of some cell details troublesome (e.g. synaptology) because of loss of membrane integrity.
2.1.2. Immunohistochemistry The fixation protocol for the histological visualization of NADPH-d activity lined above is valid for NOS immunolocalization (W6rl et al., 1994; Alonso et al., 1995a; Buwalda et al., 1995; Gonz~ilez-Hern~indez et al., 1996; Spessert and Claassen, 1998). There are available antisera for all three isoforms of the enzyme, but immunolocalization of NOS is possible only 53
Ch. III
J.R. Alonso et al.
if aldehyde fixation is not excessive (Buwalda et al., 1995). Glutaraldehyde is a good fixative for electron microscopy observation, but its use results in a clear reduction in the labeling of NOS-positive elements. Immunostaining of formaldehyde-fixed and paraffin-embedded tissue is possible, but the labeling in the antisera test in our laboratory was reduced in weakly stained elements as compared with similarly fixed, cryostat sections.
2.1.3. In situ hybridization Several authors have used in situ hybridization with radioactive labeled probes to study the distribution of NOS message in neural tissue (Bredt et al., 1991a; Kishimoto et al., 1993). These antisense oligoprobes are normally formed by 40-50 nucleotides sequences fitting with a conserved region in both human and rat. These terminal-labeled oligoprobes were employed in the first studies (Dawson et al., 1991), but thereafter, radioactive or non-radioisotopic riboprobes of higher specificity and sensitivity have been used (Endoh et al., 1994a; Iwase et al., 1998a). 2.2. BIOCHEMICAL DETECTION OF NITRIC OXIDE SYNTHASE, NITRIC OXIDE PRODUCTION, AND NITRIC OXIDE PROPER Nitric oxide is formed by the stoichiometric conversion of L-arginine to L-citrulline and NO through an oxidative-reductive pathway. Benefitting on the change in net charge of both amino acids, Bredt and Snyder (1990) developed a simple assay for NOS catalytic activity based on the conversion of [3H]L-arginine to [3H]L-citrulline followed by separation of both substances over an anion-exchange column. The possibility of detection and measure of the message and protein of NOS (or any protein) by Northern and Western blot, respectively, is obvious in most biochemical laboratories. Measuring of nitrites/nitrates of fresh tissue homogenates allows indirect detection of nitric oxide, as it is oxidized to those metabolites by different cellular pathways (see Crow and Beckman, 1995). Nitrates can be reduced to nitrites by a one-step enzymatic reaction catalyzed by nitrate reductase, using FAD and NADPH as cofactors (Bories and Bories, 1995). Nitrites are easily detected by Griess reaction (Green et al., 1982). Currently, both primary nitrites and enzymatic reduced nitrates are used as indicators of total concentration of nitric oxide in a tissue extract (Ta~kiran et al., 1997; Yamada and Nabeshima, 1997). Other methods to directly measure nitric oxide in vivo or in vitro are electronic paramagnetic resonance using nitric oxide-high-affinity nitrous complexes (Kubrina et al., 1992; Xia and Zweier, 1997) or by differential normal-pulse voltammetry using porphyrinic microsensors. With the latter technique, it has been claimed that it is possible to measure in vivo levels of extracellular nitric oxide (Desvignes et al., 1997).
3. RESULTS The number of published studies on the distribution of NADPH-d/NOS-positive cells is very varied from one group of vertebrates to another. The following results are mainly based on results and collaborations from our group carried out in teleosts (Ar6valo et al., 1995), amphibians (Gonz~ilez et al., 1996; Mufioz et al., 1996), reptiles (Smeets et al., 1997), birds (Panzica et al., 1994) and mammals (Ar6valo et al., 1992; Alonso et al., 1993, 1995b, 1998; Porteros et al., 1994; Brifi6n et al., 1998; Weruaga et al., 1998). These results are compared 54
Comparative and developmental neuroanatomical aspects of the NO system
Ch. III
with other articles, usually in different species of the same group although the technical procedures are normally very similar. We describe the general characteristics of the labeling in each major vertebrate group following the main brain subdivisions. 3.1. FISH
3.1.1. Cyclostomes The presence of NADPH-d activity has been described in the central nervous system of the larval lamprey Lampetra planeri (Schober et al., 1994) and in the olfactory mucosa of the larval sea lamprey Petromyzon marinus (Zielinski et al., 1996). In the brain of larval Lampetra planeri, NADPH-d labeling is observed in the olfactory fibers and glomerular layer of the olfactory bulb. NADPH-d staining in the telencephalon is exclusively located in fibers. In the diencephalon, NADPH-d activity appears in the pineal organ, the parapineal organ, the habenula and in the subcommissural organ. NADPH-d activity is present in the giant cells of the cyclostome mesencephalon and brainstem. These cells are reticulospinal neurons located in the mesencephalon, the aqueductalisthmic region and in the anterior portion of the spinal cord. Other groups of neurons appear in the vagal region and in the spinal cord. The distribution of NADPH-d has also been studied in the brain of the adult lamprey (Pombal and Gonz~ilez, pers. commun., 1999). The distribution pattern of NADPH-d in the adult brain shows significant differences from what has been described in the larval brain. NADPH-d-positive cells appear within the pallium, the thalamus, the habenula, the hypothalamus, tectal and pretectal areas, the isthmus, the formatio reticularis of the rhombencephalon, and in the spinal cord.
3.1.2. Teleosts Using the histochemical technique, NADPH-d reactivity has been demonstrated in the brains of cyprinid teleosts: the tench Tinca tinca (Ar6valo et al., 1995) and the goldfish Carassius auratus (Brtining et al., 1995" Villani and Guarnieri, 1995); in the brain of an atherinomorph teleost, the swordtail fish Xiphophorus helleri (Anken and Rahmann, 1996); in the electrosensory and electromotor systems of a gymnotiform teleost, Apteronotus leptorhynchus (Turner and Moroz, 1995); in a salmonid teleost, the Atlantic salmon Salmo salar (Holmqvist et al., 1994) and studies restricted to the diencephalon of the rainbow trout Oncorhynchus mykiss (Schober et al., 1993), to the Mauthner cells of the tench, (Crespo et al., 1998a) and goldfish (Bell et al., 1997) and to the retina of the Atlantic salmon (Ostholm et al., 1994). Telencephalon. In the olfactory bulb of the tench, all olfactory fibers and glomeruli are positive for NADPH-d. However, NADPH-d appears to be absent from the olfactory bulb of the goldfish and the swordtail fish. Within the telencephalic hemispheres, the NADPH-d staining follows dorsoventral and rostrocaudal gradients. In all teleosts studied, NADPH-d-positive cells are seen in the area dorsalis telencephali pars centralis and the area dorsalis telencephali zona posterior (Fig. 1a,b). In addition, positive cells are observed in the area dorsalis telencephali pars lateralis in the goldfish and in the area dorsalis telencephali pars medialis in the swordtail fish and goldfish. A larger number of NADPH-d-stained cells appears in the area ventralis telencephali in tench and swordtail fish. They are found in the pars ventralis, lateralis, centralis and 55
Ch. III
J.R. Alonso et al.
Fig. I. Camera lucida drawings of coronal sections from rostral (a) to caudal Ik) levels through the brain of the tench, Tinca tinca.
supracommissuralis (Fig. la). In goldfish, Villani and Guarnieri (1995) do not report positive cells in the ventral telencephalon, whereas Braining et al. (1995) find positive cells in the pars ventralis, centralis and supracommissuralis. 56
Comparative and developmental neuroanatomical aspects of the NO system
Ch. ///
In the telencephalon, NADPH-d-positive fibers are only described in the commissura anterior of the tench. Diencephalon. In the swordtail fish, NADPH-d-positive cells are observed within the nucleus entopeduncularis, which does not contain the enzyme in the tench. In the preoptic region, NADPH-d-positive cells are observed in the nucleus magnocellularis praeopticus (Figs. lb,c and 2a). In the epithalamus, positive neurons in the habenula are missing both in the Atlantic salmon and in the tench, whereas some are labeled in the goldfish. The thalamus contains positive cells in the nucleus centralis posterior of the goldfish and the swordtail fish. NADPH-d staining appears in the posterior tuberculum within the nucleus periventricularis tuberculi posterioris, the corpus mammillare, the nucleus tuberis posterior and the torus lateralis (Fig. l d-g). The preglomerular complex and the lobus inferior hypothalami only contain positive cells in the swordtail fish. Scarce NADPH-d staining is found in the hypothalamus of the tench. Positive cells can be seen in the nucleus periventricularis hypothalami and in the nucleus tuberis anterior (Fig. l e g). In the nucleus fasciculi longitudinalis medialis, and close to the fasciculus retroflexus and commissura posterior, positive neurons are demonstrated in the tench (Fig. l e,f) and in the swordtail fish. In the nucleus praetectalis superficialis, NADPH-d-stained cells are seen in the swordtail fish and in the goldfish. Mesencephalon. Within the tectum opticum, the largest part of the mesencephalon, a few NADPH-d-positive cells are found in the strata periventriculare, album centrale and griseum centrale. The tractus opticus shows a population of stained cells appearing between unstained fibers (Fig. l b-d). Positive cells are also observed in the torus semicircularis of all teleosts studied (Fig. 1f,g). Within the tegmentum, the nucleus nervi oculomotorii and the nucleus nervi trochlearis (Fig. 2b) are positive in the swordtail fish and in the tench. However, NOS is not observed in the nucleus nervi oculomotorii of the goldfish. Moreover, in the mesencephalon of the tench, NADPH-d-positive cells are detected in the nucleus Edinger-Westphal, in the torus longitudinalis, in the nucleus tegmentalis rostralis and in the formatio reticularis mesencephali (Fig. lf-h). In the mesencephalon of swordtail fish, labeled cells are located within the nucleus mesencephalicus nervi trigemini, the nucleus perilemniscaris, the nucleus ruber and the nucleus isthmi. Rhombencephalon. We observed a scarce NADPH-d staining in the tench cerebellum. Occasionally, some labeled cells are observed in its molecular layer (Fig. l i). In Apteronotus leptorhynchus, NADPH-d activity is present in Purkinje cell somata, mossy fiber synaptic glomeruli, granule cells, and parallel fibers both in the corpus cerebelli and in the valvula cerebelli. NADPH-d staining is also present in the Purkinje cell layer of the swordtail fish but the stained cells are not Purkinje cells. The highest number of NADPH-d-positive cells in the brain of teleosts is observed within the myelencephalon. The patterns of distribution of NADPH-d activity in all studied teleosts are very similar. NADPH-d staining is mainly located in the nuclei of the cranial nerves. Thus, we found strongly labeled neurons within the nucleus nervi trigemini, the nucleus nervi abducentis, the nucleus nervi facialis, the nucleus nervi glossopharyngei and the nucleus nervi vagi (Figs. l i - k and 2c,e). In the octaval area, NADPH-d-labeled cells are observed in the nucleus 57
Ch. III
58
J.R. Alonso et al.
Comparative and developmental neuroanatomical aspects of the NO system
Ch. ///
octavus anterior, the nucleus octavus magnocellularis, the nucleus octavus descendens, the nucleus octavolateralis medialis and in the population octavia secundaria (Figs. l i and 2d). In the goldfish, all these nuclei have NADPH-d staining but do not contain NOS (Brtining et al., 1995). Positive cells are also seen in the nucleus fasciculi solitarii, the radix descendens nervi trigemini, the nucleus tangentialis, the columna motoria spinalis and the formatio reticularis (Figs. l h - k and 2f). In the lobus vagi and lobus facialis, some scattered small cells are observed (Fig. lj-k). The Mauthner cells are also stained for NADPH-d. In all subdivisions of the tench brain within tracts and nerves we find NADPH-d-stained cells whose morphological aspect resembled those of oligodendrocytes. Spinal cord. NADPH-d reaction is present in many structures in the spinal cord. In the tench, several cell populations and fibers are observed in the cornu ventrale as well as in the lateral zone of the dorsal spinal cord. However, NADPH-d-stained neurons are present both in the cornu ventrale and cornu dorsale in the goldfish. In addition, many ascending and descending fibers in the white matter, and radial glial fibers are labeled in the goldfish. 3.2. AMPHIBIANS NADPH-d activity has been confirmed in the retina (Sato, 1990b), pineal organ (Sato, 1990a), hypothalamo-hypophysial system (Prasada-Rao et al., 1997), peripheral nervous system of anuran amphibians (Li et al., 1992), and in the olfactory bulb of anuran and urodele amphibians (Porteros et al., 1996). The early fragmentary data of NADPH-d activity in amphibians have become more complete with comprehensive studies on the overall distribution of NADPH-d in the brain of two anuran amphibians, Rana perezi (Mufioz et al., 1996) and Xenopus laevis (Brtining and Mayer, 1996), and in the brain of a urodele amphibian, Pleurodeles waltl (Gonz~,lez et al., 1996). Telencephalon. In the main olfactory bulb of studied amphibians, NADPH-d staining is observed in all olfactory fibers (Fig. 4a) except for Xenopus laevis where only a fraction of fibers is labeled. In the accessory olfactory bulb, vomeronasal fibers are NADPH-d-positive in urodele amphibians but they are NADPH-d-negative in anuran amphibians. NOS-immunoreactivity is not observed in the primary afferents (Porteros et al., 1996). Granule cells are NADPH-d-positive and NOS-immunopositive in the main and accessory olfactory bulb of anures (Figs. 3a and 4b), and in the main olfactory bulb of urodeles. All pallial and subpallial regions of the telencephalon posses a large population of NADPHd-positive cells (Fig. 3a-c). In the ventromedial wall of the hemispheres, NADPH-d-positive neurons are observed in anuran amphibians. They are located in the nucleus of the diagonal band of Broca and in the nucleus accumbens (Fig. 4c), as well as in the septum of all studied amphibians. NADPH-d-labeled cells are also distributed within the dorsal and ventral portions of the striatum, and in the amygdala pars lateralis (Fig. 3b,c). Diencephalon. A high NADPH-d activity has been found throughout the diencephalon of amphibians, both in its dorsal and ventral subdivisions.
,(.__._
Fig. 2. Micrographs of 30 lam thick coronal sections of the tench brain (Tinca tinca) stained with NADPHdiaphorase histochemical technique. (a) Nucleus praeopticus magnocellularis. (b) Nucleus nervi trochlearis. (c) Nucleus nervi facialis. (d) Area octavolateralis. (e) Nucleus nervi glossopharyngei. (f) Spinal cord fascicles. Scale bars are 100 ~tm.
59
Ch. III
J.R. Alonso et al.
Fig. 3. Camera lucida drawings of coronal sections from rostral (a) to caudal (j) levels through the brain of the frog, Rana pere:i.
60
Comparative and developmental neuroanatomical aspects of the NO system
Ch. III
Dorsally in the diencephalon, moderate groups of NADPH-d-positive cells are located in the nucleus habenulae pars dorsalis and ventralis, and dense fibers are found only in the right nucleus habenulae pars dorsalis of the anures. By contrast, no NADPH-d-positive cells are found in the nucleus habenulae of urodeles, where NADPH-d-positive fibers innervate exclusively its left side component. Numerous NADPH-d-positive cells are located in the preoptic area around the recessus praeopticus, in the anterior preoptic area and in the caudal region of the preoptic area, within the nucleus magnocellularis. In the hypothalamus, large cells appear in the infundibular region, in the caudal portion of the nucleus suprachiasmaticus (Fig. 3d) and in the nucleus tuberculi posterioris. Occasionally, a few CSF-contacting cells are observed in the nucleus of the periventricular organ of Rana perezi; however, comparable cells are not found in other anurans nor in urodeles. The thalamus of the frog demonstrates a large population of NADPH-d-positive neurons located in the nuclei anterior, centralis, lateralis anterior and lateralis posterior thalami (Fig. 3d). In contrast, the urodele thalamus lacks NADPH-d-labeled neurons. The most intensely labeled areas of the thalamus correspond to visual centers, where strongly labeled fibers coming from the retina or the tectum opticum can be observed: the neuropil of Bellonci, corpus geniculatum thalamicum, and nucleus superficialis ventralis thalami. Scattered NADPH-d-labeled cells are located in the pretectal area within the nucleus commissurae posterioris and the griseum praetectale (Fig. 3e). NADPH-d-positive fibers appear in the nucleus lentiformis, in the area above the nucleus commissurae posterioris and crossing the commissura tecti and the commissura posterior. Among all studied amphibians, NADPH-d activity is found in the pituitary gland and median eminence only in the frog Rana esculenta (Prasada-Rao et al., 1997). Mesencephalon. Numerous NADPH-d-positive cell bodies are found in the mesencephalon, both in the tectum and in the tegmentum. In the tectum opticum, most labeled cells are found in all layers of the periventricular gray (Fig. 3e,f). These cells have a primary process that ascends perpendicular to the brain surface and arborizes in the deep portion of the tectal fiber layers (Fig. 4d). Occasionally, scattered NADPH-d-stained cells are found in the nucleus mesencephalicus nervi trigemini, these cells being NOS-immunonegative (Gonzfilez et al., 1996). In anuran amphibians all subnuclei of the toms semicircularis demonstrate NADPH-d-positive cell bodies as well as varicose fibers and axon terminals (Fig. 3f). The mesencephalic area of the frog that demonstrates the most strongly labeled cells is the tegmental region. They are located in the nuclei tegmentalis and the nucleus profundus mesencephali (Fig. 3e). Moderately labeled cells are found in the nucleus fasciculi longitudinalis medialis. The nucleus interpeduncularis is densely innervated by NADPH-d-labeled axons. In the isthmic region of the frog, a group of NADPH-d-positive cells is located medial to the nucleus isthmi (Fig. 4f). In this latter nucleus, a peculiar feature is a group of labeled terminals that can be related to the tecto-isthmal projection that arises from cells in the tectum opticum. Rhombencephalon. The population of NADPH-d-positive cells in the frog rhombencephalon is very abundant. The cerebellum has scattered and moderately stained cells in the molecular and granule cell layers (Figs. 3g and 4e). In the granule cell layer, NADPH-d-positive fibers are also present, they arborize profusely and have varicose swellings. The majority of labeled cells in the rhombencephalon are found in the reticular nuclei but other structures also demonstrate labeled cells: the nuclei sensori nervi trigemini, the nuclei 61
Ch. III
62
J.R. Alonso et al.
Comparative and developmental neuroanatomical aspects of the NO system
Ch. III
raphe and the nucleus tractus solitarius (Fig. 3h,i). The motor nuclei of the cranial nerves in the rhombencephalon do not stain for NADPH-d. The octaval nuclei in the frog Rana perezi have stained cell bodies. In this region of the brain, among the numerous labeled fibers, the area of the nucleus olivae superioris is particularly well stained. In addition, the radix descendens nervi trigemini and the tractus solitarii have NADPH-d-positive fibers, and dispersed fibers course caudally in the ventrolateral aspect of the rhombencephalic tegmentum. A population of NADPH-d-positive cells is found in the transition zone between the rhombencephalon and the spinal cord, within the nucleus columna dorsalis. Spinal cord. A large population of densely labeled cells is found from cervical to lumbar levels of the spinal cord (Fig. 3j). Almost all fields of the gray matter have cells showing NADPH-d activity. A dense NADPH-d-positive neuropil can be seen in the dorsal field of the gray matter, principally in the cervical segments. At most caudal levels, abundant labeled fibers course in the funiculus ventralis and in the funiculus lateralis. 3.3. REPTILES The distribution of NADPH-d has been studied in the central nervous system of three species belonging to different groups within the class of Reptilia: the turtle Pseudemvs scripta elegans (Brtining et al., 1994b); the lizard Gekko gecko (Smeets et al., 1997); and the snake Trimeresurus flavoviridis (Jiang and Terashima, 1996). Other studies in reptiles are restricted to the brainstem (Luebke et al., 1992) and to the hippocampus (D~ivila et al., 1995) of lizards. Telencephalon. In the olfactory bulb, the NADPH-d staining is located in a scarce number of weakly stained cell bodies in the internal granular layer, in the inner plexiform layer and in the mitral cell layer. The NADPH-d-positive fibers are very limited in number and intensity and they are dispersed throughout all layers of the olfactory bulb in lizards. In the snake and turtle olfactory bulbs, the olfactory/vomeronasal nerve, glomeruli, and periglomerular cells in the accessory olfactory bulb are NADPH-d-positive. The cortex of turtles and lizards contains a limited number of NADPH-d-positive cell bodies and fibers located in the large-celled portion of the cortex medialis, the cortex dorsalis, the cortex lateralis anterior and the cortex lateralis posterior (Fig. 5a-c). However, the cortex of the snake is NADPH-d-negative. The basal forebrain contains numerous NADPH-d-positive cell bodies and fibers located in the nucleus olfactorius anterioris, the tuberculum olfactorium, the nucleus accumbens, the pallial thickening and mainly, in the dorsal ventricular ridge, the striatum and the amygdaloid complex (Figs. 5a-c and 6a,d). The distribution of the neuronal elements is highly heterogeneous; variations in density of cell bodies and fibers are observed not only between shell and core regions, but also between medial and lateral, as well as between rostral and caudal portions. In contrast to the numerous stained cells in the striatum, in the nucleus
Fig. 4. NADPH-d labeling in the brain of the frog, Rana perezi. (a) Intensely stained glomeruli (G) and varicose centrifugal fibers (arrows) in the main olfactory bulb. (b) NADPH-d staining pattern in the accessory olfactory bulb. Note the absence of staining in the vomeronasal fibers and glomeruli of the stratum glomerulare and the intense staining in granule cells in the stratum granulare and their dendrites in the stratum plexiforme externum. (c) Labeled cells in the diagonal band of Broca. (d) Stained monopolar cells and neuropil in the tectum opticum. (e) Weakly NADPH-d-reactive granule cells in the cerebellum. (0 Strongly stained cells in the limits of the nucleus isthmi. Scale bars: 50 ~tm in a, 100 Ism in b and e, 25 Ixm in c, d and f.
63
Ch. III
J.R. Alonso et al.
Fig. 5. Camera lucida drawings of coronal sections from rostral (a) to caudal (tl) levels through the brain of the lizard Gekko gecko.
64
Comparative and developmental neuroanatomical aspects of the NO system
Ch. III
accumbens of Gekko gecko only a few stained cells are observed. Such a distinction between nucleus accumbens and striatum is not clearly delimited in turtles. In the septum, NADPH-d-positive cell bodies and fibers are distributed heterogeneously. In Gekko gecko, NADPH-d staining is observed in the caudalmost portion of the nucleus septalis anterior, the nucleus septalis medialis, the nucleus septalis lateralis, the nucleus septalis dorsalis, the nucleus of the diagonal band of Broca and the fasciculus medialis telencephali (Figs. 5b-d and 6b). In Pseudemys, NADPH-d-positive cells are only described in the horizontal limb of the diagonal band of Broca. Diencephalon. In lizards, NADPH-d-stained cells are observed at the level of the commissura anterior within the area praeoptica periventricularis (Fig. 6c), dorsally to the chiasma opticum, the nucleus periventricularis hypothalami and in the dorsal portion of the area praeoptica. At postcommissural levels, stained cells occur in the nucleus periventricularis hypothalami, the nucleus medialis posterior thalami, nucleus dorsolateralis thalami pars magnocellularis, nucleus suprapeduncularis and in the area lateralis hypothalami (Fig. 5e). The staining in the diencephalon has similar features in turtles and lizards; however, notable differences are observed in the thalamus and pretectum. Thus, these regions are in Pseudemys essentially devoid of NADPH-d-stained cells whereas several distinct cell groups occur in Gekko. At caudalmost levels of the lizard diencephalon, NADPH-d-positive cells are located in the nucleus lentiformis mesencephali, the nucleus praetectalis ventralis, the nucleus dorsolateralis thalami and in the nucleus profundus mesencephali (Fig. 5e), all of them NADPH-d-negative nuclei in the turtle. Fiber staining was essentially identical in the diencephalon of the studied reptiles. NADPHd-positive fibers are demonstrated in the fasciculus medialis telencephali, the stria medullaris, the nucleus dorsolateralis thalami, the nucleus dorsomedialis thalami, the nucleus medialis thalami, the corpus geniculatum lateralis and in the ganglion habenulae. The nucleus rotundus is characterized by the almost complete lack of NADPH-d-positive fibers. The chiasma opticum and the tractus opticus contain labeled fibers. Mesencephalon. A considerable number of NADPH-d-stained cells and fibers is observed in the tectum and tegmentum mesencephali. In the optic rectum, NADPH-d-positive cells and fibers appear in all tectal layers but most are located in the periventricular zone (Figs. 5e,f and 6e). In the tegmentum, the distributions of NADPH-d in turtles and lizards are similar. NADPH-d-positive cell groups are observed in the area tegmentalis ventralis, the substantia nigra pars compacta, the retrorubral area, the nucleus laminaris of the torus semicircularis and in the nucleus intercollicularis. Additionally, stained cells are scattered throughout the formatio reticularis and in the nucleus centralis of the torus semicircularis (Fig. 5f, g). Stained fibers are widely distributed throughout the tegmentum but are especially abundant in the substantia nigra pars reticulata and around the fasciculus longitudinalis medialis. In both Gekko and Pseudemys, the mesencephalic trigeminal neurons are NADPH-d-positive, but NOS-immunonegative. Rhombencephalon. Weakly stained cells are also found scattered through the molecular and granular layers of the cerebellum in lizards. In the snake, NADPH-d staining is not observed in the cerebellum. No obvious differences are distinguished in the distribution of NADPH-d in the rhombencephalon of turtles and lizards. In both groups, NADPH-d-positive cells are present in the locus coeruleus, the reticular nuclei, the cerebellar nuclei, the nucleus vestibularis dorsolateralis, the nucleus descendens nervi trigemini, the nucleus tractus solitarii, the nucleus 65
Ch. III
66
J.R. Alonso et al.
Comparative and developmental neuroanatomical aspects of the NO system
Ch.
///
perihypoglossum, the tegmentum ventrolaterale and in the nucleus isthmi pars parvocellularis (Fig. 5g,h). A marked difference is observed in the nucleus raphe inferior, which in Gekko contains numerous NADPH-d-positive cells (Fig. 6t-) and in Pseudemvs is not stained. In both species, the densest plexuses of NADPH-d-positive fibers are found in the nucleus isthmi pars parvocellularis and in the locus coeruleus. A dense accumulation of NADPH-d-positive neurons is also found in the locus coeruleus of the snake Trimeresurus. Spinal cord. NADPH-d-positive cell bodies and fibers are found throughout the spinal cord of Gekko, although the number and intensity of staining are variable at different levels. The number of cells and fibers is higher at rostral levels than at caudal ones. In the snake spinal cord, NADPH-d-stained fibers are seen in the radix dorsalis, Lissauer's tract, cornu dorsale and in the funiculus dorsalis. The spinal cord was not analyzed in the turtle. 3.4. BIRDS The distribution of NADPH-d activity has been described in the central nervous system of different species: the chicken Gallus domesticus (Brtining, 1993; BrOning et al., 1994a; S~inchez et al., 1996; Von Bartheld and Schober, 1997); the Japanese quail Coturnixjaponica (Panzica et al., 1994, 1996; S~.nchez et al., 1996); the budgerigar Melopsittacus undulatus (Cozzi et al., 1997); and the zebra finch Taeniopygia guttata (Wallh~iusser-Franke et al., 1995). The general pattern of distribution of NADPH-d shows similarities in all avian species studied. Telencephalon. This region contains a wide population of NADPH-d-positive cells: only few regions of the telencephalon are totally devoid or provided with few positive elements. There are marked differences in the distribution and staining intensity of the labeling, particularly NADPH-d-positive fibers, between the different regions. The olfactory bulb contains only a few NADPH-d-positive fibers in the internal granular layer of the chicken and the quail. Some stained neurons are also observed in the granular layer of the chicken olfactory bulb. Other regions of the olfactory pathway show a medium to high density of NADPH-d-positive processes and neurons: the tuberculum olfactorium, the cortex piriformis, the nucleus taeniae, the stria medullaris and the habenula. The paleostriatal-paraolfactory lobe complex, which is the avian homologue of the mammalian striatal complex, is the region that shows the highest number of NADPH-d-positive neurons and fibers (Fig. 7a-c). The paleostriatum primitivum (Fig. 8a), the paleostriatum augmentatum (Fig. 8c) and the paleostriatum ventrale (Fig. 8b) demonstrate a large number of neurons and fibers stained for NADPH-d. Scattered labeled neurons are observed in the neostriatum and hyperstriatum where a dense network of fibers stained for NADPH-d can also be seen. NADPH-d activity is absent in the ectostriatum. Neurons and fibers are more numerous along the lines subdividing the avian telencephalic regions (lamina frontalis superior, lamina medullaris dorsalis and lamina hyperstriatica) and close to the lateral wall of the telencephalic ventricles. The NADPH-d staining in the striatal structures shows no differences in all'studied avian species.
Fig. 6. Photomicrographs of transverse sections through the brain of the lizard Gekko gecko showing NADPH-dpositive neurons and fibers in the striatum (a), the septum mediale Ib), the area praeoptica periventricularis (c), the nucleus externus amygdalae and the nucleus centralis amygdalae (d), the stratum griseum periventriculare of the tectum opticum (e), and in the nucleus raphe inferior (]3. Scale bars are 100 Itm.
67
Ch. I11
J.R. Alonso et al.
Fig. 7. Camera lucida drawings of coronal sections from rostral (a) to caudal (i) levels through the brain of the Japanese quail, Cotumix japonica.
68
Comparative and developmental neuroanatomical aspects of the NO system
Ch. III
Fig. 8. Photomicrographs of transverse sections through the brain of the Japanese quail, Coturnirjaponica, showing NADPH-d-positive neurons and fibers in the paleostriatum primitivum (a), the paleostriatum ventrale (b), the paleostriatum augmentatum (c), the nucleus pedunculopontinus tegmenti (d), the stratum griseum periventriculare of the tectum opticum (e), and in the nucleus motorius nervi trigemini q). Scale bars are 100 ~tm. 69
Ch. III
J.R. Alonso et al.
The septal region in the quail has several cell clusters embedded in an extremely dense positive neuropil mainly located in the nucleus septalis medialis, the nucleus septalis lateralis and in the nucleus commissurae pallii (Fig. 7b). In the budgerigar, the only nucleus in the septal region showing NADPH-d activity is the nucleus commissurae pallii. The hippocampus is totally devoid of NADPH-d-positive cells in the quail and in the chicken, but in the budgerigar, stained neurons are observed both in the hippocampus and in the region between the area parahippocampalis and the hippocampus. Diencephalon. The NADPH-d staining in the diencephalon is limited to a few cell clusters, and a diffuse, low-intensity network of varicose fibers. The pattern of distribution is comparable in all avian species. In the area praeoptica the positive elements are located close to the tractus septomesencephalicus, in the nucleus praeopticus dorsalis, and in the nucleus praeopticus medialis (Fig. 7b). In the epithalamus, the nucleus habenularis lateralis contains numerous NADPH-d-positive fibers, whereas in the nucleus habenularis medialis both fibers and a few NADPH-d-positive neurons can be observed. In the thalamus, NADPH-d-positive neurons are found in the nucleus dorsomedialis anterior thalami, the nucleus dorsolateralis anterior thalami, periventricularly and dorsally to the nucleus paraventricularis magnocellularis, the nucleus dorsomedialis posterior, the nucleus ovoidalis, the nucleus praetectalis medialis and around the ventral aspect of the nucleus rotundus (Fig. 7c). A high density of positive fibers is also present in the nucleus dorsolateralis anterior thalami and in the nucleus lateralis thalami. Neurons are stained for NADPH-d in the hypothalamus within the nucleus anterior medialis hypothalami and the nucleus suprachiasmaticus, pars lateralis (Fig. 7b,c). Many varicose, positive fibers appear within the decussatio supraoptica and the nucleus geniculatus lateralis, pars ventralis. The larger hypothalamic groups are located within the tuberoinfundibular regions, which are embedded in a dense network of positive fibers and puncta. These regions in the budgerigar display a smaller number of positive cells surrounded by fibers. The nucleus mammillaris shows NADPH-d-positive neurons in the chicken and the quail (Fig. 7d), whereas it is unstained or weakly stained in the budgerigar. Mesencephalon. The pattern of distribution of NADPH-d-positive neurons and fibers in the tectum opticum is quite complex. The strongest reaction and the largest number of positive neurons are observed in the stratum griseum periventricularis. In addition, scattered neurons are observed in many layers of the stratum griseum and fibrosum superficiale and in the stratum griseum centrale (Fig. 8e). Thin, punctate fibers cover all these strata. Scattered neurons are visible in the nucleus intercollicularis, which also shows positive neuropil (Fig. 7d). At mesencephalic levels, NADPH-d staining is mainly located within the nucleus pedunculopontinus tegmenti (Fig. 8d) and the area ventralis tegmentalis. Scattered neurons also appear in the substantia grisea centralis, the formatio reticularis medialis mesencephali, the nucleus mesencephalicus nervi trigemini and in the nucleus isthmoopticus. The nucleus interpeduncularis and the raphe region contain a moderately positive neuropil and a few NADPH-d-positive neurons (Fig. 7e). Rhombencephalon. In the cerebellum, the granule cells show a weak reaction, whereas the Purkinje cells are unstained (Fig. 7e-i). NADPH-d-stained fibers are present in the molecular layer as well as in the cerebellar nuclei. A wide population of NADPH-d-positive cells are located in the locus coeruleus and scattered neurons appear within the nucleus subcoeruleus dorsalis and the nucleus subcoeruleus 70
Comparative and developmental neuroanatomical aspects of the NO system
Ch. ///
ventralis (Fig. 7f), which are embedded in a high density neuropil formed by thin varicose fibers and puncta. Other rhombencephalic regions with NADPH-d-stained cells are the nucleus pontis medialis and lateralis, the vestibular nuclei, the nucleus paragigantocellularis, the nucleus tractus solitarii and the formatio reticularis (Fig. 7g-i). Large neurons are also clustered laterally to the fasciculus longitudinalis medialis (Fig. 7h). NADPH-d-positive fibers are also observed within the vestibular nuclei and in the nucleus tractus solitarii. A high number of positive puncta surrounding unstained cells is observed in the nucleus laminaris. The encephalic motor nuclei are generally unstained, only a few, small neurons are observed in the nucleus nervi glossopharyngei et motorius nervi vagi (Fig. 7i) and in the nucleus nervi trigemini (Fig. 8f). Spinal cord. There are no available data on distribution of NADPH-d in the avian spinal cord. 3.5. MAMMALS Detailed mapping studies of the distribution of NADPH-d and/or NOS are available for mammals (cat: Mizukawa et al., 1989; rat: Vincent and Kimura, 1992, Rodrigo et al., 1994; human: Egberongbe et al., 1994). In addition, there are studies available on the presence of NADPH-d activity restricted to different regions of the nervous system such as the main olfactory bulb (Alonso et al., 1993, 1995b, 1998; Kishimoto et al., 1993; Brifi6n et al., 1998; Weruaga et al., 1998), accessory olfactory bulb (Porteros et al., 1994), nucleus olfactorius anterior (Garcfa-Ojeda et al., 1994), cerebral cortex (Mizukawa et al., 1988), medial septal complex (Kinjo et al., 1989), striatum and nucleus accumbens (Kowall et al., 1985), amygdala (Sims and Williams, 1990), hippocampal formation (Mufson et al., 1990), hypothalamus (Arrvalo et al., 1992), caudatus putamen (Sandell et al., 1986), colliculus superior (Wallace and Fredens, 1989), nucleus pedunculopontinus (Skinner et al., 1989), pontomesencephalic region (Nakamura et al., 1988), nucleus nervi vagi (Gonz~ilez et al., 1987), reticular system (Vincent et al., 1986), and spinal cord (Valtschanoff et al., 1992; Pullen et al., 1997), among others. The distribution of NADPH-d in the mammal brain is relatively similar in all studied species, although it is important to note that most studies are in rodents, and even in relatively closely related species some differences have been found. Telencephalon. In the main olfactory bulb of rodents, a subpopulation of olfactory fibers, and a subpopulation of olfactory glomeruli, located on the dorsomedial side, are positive for NADPH-d (Fig. 10a). In contrast, in the main olfactory bulb of primates all olfactory fibers and glomeruli are NADPH-d-positive. The highest number of positive cells is observed in the glomerular layer in rodents and insectivores. Surrounding both the NADPH-d-positive and NADPH-d-negative glomeruli, there are NADPH-d-positive periglomerular cells (Figs. 9a and 10a). Only a few periglomerular cells are positive in the primate olfactory bulb. Two types of short axon cells are positive for NADPH-d in the rodent and primate olfactory bulb. They are located at the boundary of the glomerular and external plexiform layers. In contrast, in the hedgehog, the superficial short-axon cells are not stained. An other interspecies difference is the presence and relative frequency of NADPH-d-stained cells in the external plexiform layer. These cells are rare in the hedgehog, rodents and primates, whereas they are more abundant in the hamster. In the deep portion of the olfactory bulb, several types of NADPH-d-positive neurons have been described: deep short-axon cells and granule cells in all studied species, horizontal and vertical neurons in rodents and in the hedgehog, and stellate cells in primates. A discrepancy between the NADPH-d and NOS stainings has been found 71
Ch. III
J.R. A l o n s o et al.
NC
"""
."-4'
i Fig. 9. Camera lucida drawings of coronal sections from rostral (a) to caudal (i) levels through the brain of the adult rat, Rattus norvegicus.
in the olfactory fibers. Whereas the NADPH-d and NOS labeling is coincident in all neural types, no NOS-immunoreactivity is detected in the olfactory fibers and glomeruli (Kishimoto et al., 1993; Hopkins et al., 1996: Alonso et al., 1998; Weruaga et al., 1998). In the accessory olfactory bulb, all vomeronasal fibers and glomeruli are NADPH-dlabeled. NADPH-d-positive neurons are identified as periglomerular cells in the glomerular 72
Comparative and developmental neuroanatomical aspects of the NO system
Ch.H/
layer and external plexiform layer, horizontal cells in the internal plexiform layer, and granule cells and deep short-axon cells in the granule cell layer. The labeled dendrites of the granule cells form a dense neuropil in the granule cell layer, internal plexiform layer and external plexiform layer. NADPH-d-positive neurons and fibers are located in the nucleus olfactorius anterior within the lateral, dorsal, ventral, medial, posterior and external subdivisions. The transition areas of the nucleus olfactorius anterior show the same NADPH-d activity distribution patterns as those of the corresponding subdivisions. The corpus callosum is crossed by positive fibers and contains a few stained neurons (Fig. 9b-d). Large neurons strongly stained for NADPH-d are observed in the cerebral cortex (Fig. 9bh). They are located through the neocortex in layers II-VI and have been identified as Martinotti cells. The highest density of NADPH-d-positive cells in the cortex is observed at the junction between gray and white matters. The subcortical white matter also displays NADPH-d-positive neurons. NADPH-d-positive prominent, varicose cell processes are located especially in the deeper layers and in the subcortical white matter. The NADPH-d staining in the cerebral cortex is similar for all cerebral lobes and there are no observable differences between fight and left sides. The nucleus endopiriformis dorsalis and the claustrum contain NADPH-d-positive neurons (Fig. 9b,c), which present long processes that form a small plexus located dorsally along the lateral border of both nuclei. The striatum contains intensely NADPH-d-labeled neurons and the neuropil staining is dense (Figs. 9b-e and 10c). A similar staining pattern appears in the nucleus accumbens and in the tuberculum olfactorium (Fig. 9b,c). Within the tuberculum olfactorium, intense staining is observed in the islands of Calleja, in the fasciculus medialis telencephali and surrounding the islands of Calleja. The islands of Calleja contain a dense plexus of NADPH-d-positive varicose nerve fibers and small positive granular ceils. Strongly stained neurons are located in the diagonal band of Broca, where stained fibers are also present (Fig. 9c). Similar NADPH-d-labeled neurons are observed in the septum medialis and in the septum lateralis in rodents (Figs. 9c and 10b). NADPH-d-positive fibers are located in the septum lateralis and fornix. In the human brain, no NOS-immunoreactivity has been found in the septum. Groups of positive neurons and a high density of NADPH-d-positive fibers are observed in the substantia innominata and in the globus pallidus. The nucleus entopeduncularis shows a large number of positive neurons (Fig. 9c-e). Valtschanoff et al. (1993) described in detail the distribution of NADPH-d/NOS-positive neurons in the rat hippocampal formation. Positive cells are numerous in the pyramidal cell layer of the subiculum, in the stratum radiatum of the hippocampus, and in the subgranular zone of the dentate gyms (Fig. 9e-g); granule cells and pyramidal cells are reported to be NADPH-d-negative. Endoh et al. (1994a), however, have reported neuronal NOS staining in the pyramidal layer of CA1. Wallace and Fredens (1992) reported the presence of strong NADPH-d staining in the pyramidal neurons of CA1 in the mouse and Vaid et al. (1996) reported the presence of NADPH-d/NOS-positive pyramidal neurons in CA1 and in the subiculum. In the macaque monkey hippocampal formation NADPH-d/NOS-positive neurons with different morphological features appeared distributed in the molecular layer and granule cell layer of the dentate gyms and throughout all portions of the hippocampus. Most of the stained neurons have the morphological features and locations of intemeurons, whereas 73
Ch. III
74
J.R. Alonso et al.
Comparative and developmental neuroanatomicaI aspects of the NO system
Ch. ///
hippocampal pyramidal cells in the primate brain were NADPH-d/NOS-negative (Alonso et al., 2000). Studies in different species of monkeys as well as in humans indicate that the same types of NADPH-d/NOS-positive neurons are found in the hippocampal formation of several primates. There are, however, fairly substantial differences in the patterns of fiber staining. The distribution of NADPH-d in the amygdaloid complex is heterogeneous. The highest number of positive neurons is found in the nucleus medialis amygdalae. Scattered positive neurons appear in the nucleus basolateralis amygdalae, the nucleus basomedialis amygdalae and in the amygdalostriatal and amygdalopiriform transition areas (Fig. 9e). Diencephalon. Rostrally, NADPH-d-positive neurons are observed in the nucleus septohypothalamicus, the nucleus praeopticus medialis, the nucleus praeopticus anteroventralis, the nucleus praeopticus anteromedialis, the area praeoptica medialis and in the area praeoptica lateralis. In the hypothalamus, NADPH-d activity is observed in the magno- and parvo-cellular neurons of the nucleus paraventricularis, in the nucleus supraopticus, in the nucleus circularis, in the nuclei fornicalis and in the area posterioris hypothalami, as well as in a population of isolated neurons located among the different nuclei of the hypothalamus (Figs. 9d,e and 10d,e). The mammillary region shows NADPH-d-positive neurons within the ventral and dorsal portion of the nucleus paramammillaris, the ventral part of the nucleus mammillaris lateralis and the nucleus mammillaris medialis, the nucleus supramammillaris and in the decussatio supramammillaris (Fig. 9f). In the nucleus habenularis lateralis, NADPH-d-positive neurons are found in the medial and lateral regions, and labeled fibers are observed in the dorsal region. Many positive fibers are also observed in the commissura habenularis, while only a few NADPH-d-labeled axons are present in the fasciculus retroflexus. NADPH-d-positive neurons are found in the dorsomedial area of the thalamus within the nucleus paraventricularis thalami, the stria medularis and the nucleus anteroventralis thalami (Fig. 9e). Scattered neurons are also located in the nucleus laterodorsalis thalami, the nucleus paraventricularis thalami, the nucleus parafascicularis thalami, the nucleus praecommissuralis, the nucleus praetectalis olivari, the nucleus praetectalis anterior, the nucleus lateroposterioris thalami and in the nucleus geniculatus. However, only NOS-immunoreactive fibers have been demonstrated in the human thalamus. Mesencephalon. The NADPH-d staining in the colliculus superior forms a complex pattern. Neurons are mainly distributed in the superficial gray layer (Fig. 10f). Some scattered neurons also appear in the optic nerve layer and in the medial and lateral portions of the intermediate gray and white layers. Labeled fibers are distributed mainly in the intermediate gray and white layers, including the deep gray and white layers. Horizontally oriented positive fibers appear in the commissure of the colliculus superior. Stained cells and dense fiber plexus are present throughout the cortical nuclei of the colliculus inferior (Fig. 9h). These cortical nuclei also contain a dense NADPH-d-positive fiber plexus.
Fig. 10. Images of 30 ~m thick coronal sections of rodent brain labeled with NADPH-d-histochemistry: (a) from mouse (Mus musculus), and (b-f) from different rat encephalic regions IRattus norvegicus). (a) Within the olfactory bulb, diverse interneurons are NADPH-d-positive l arrows). NADPH-d-positive glomeruli (G+) are intermingled with negative ones (G-). (b) Septum mediale. (c) Caudatus putamen. (d) Nucleus paraventricularis hypothalami. (e) Area posterioris hypothalami. (f) Colliculus superior. Scale bars: 25 ~m in a, 100 gm in (b-z/'). 75
Ch. III
J.R. Alonso et al.
In the nucleus nervi oculomotorii and in the fasciculus longitudinalis medialis of the cat, neurons with stained dendrites can be seen; these cells are not stained in the rat mesencephalon. NADPH-d-positive neurons are observed within the nucleus tegmentalis laterodorsalis, the nucleus interfascicularis, the nucleus paranigralis, the area tegmentalis (rostralis and ventralis), the rostral, rostrolateral and caudal subnuclei of the nucleus interpeduncularis, the nucleus Edinger-Westphal, the nucleus raphe medianus and the rhabdoid nucleus (Fig. 9g,h). A few neurons are located in the pars lateralis, compacta and reticulata of the substantia nigra. Labeled fibers are present in the substantia nigra pars compacta and pars reticulata, the nucleus interfascicularis, the nucleus interpeduncularis dorsomedialis, the nucleus raphe medianus and paramedianus, the parvocellular and magnocellular red nucleus, the area tegmentalis ventrolateralis, the nucleus profundus mesencephali and the rhabdoid nucleus. Rhombencephalon. NADHP-d staining is present in the cerebellum (Fig. 9h,i). The granule cells, basket cells and stellate cells in the inner third of the molecular layer show a weak reaction. The Purkinje cells are reported to be NOS-immunoreactive in the human cerebellum (Egberongbe et al., 1994). In contrast, in all other species studied, the Purkinje cells are unstained. In addition, the molecular layer neuropil is homogeneously stained. Stained fibers are also observed in the subcortical white matter and in the cerebellar nuclei, principally in the nucleus interpositus and nucleus lateralis. The cerebellar nuclei also contain a few weakly stained large cells. Weakly stained neurons are present in the nucleus ventralis lemnisci lateralis, the nucleus parabracchialis lateralis and medialis, the nucleus paralemniscalis, the nucleus of the trapezoid body and in the nucleus reticularis pontis caudalis. Moderately stained fibers are observed within the trapezoid body, the nucleus nervi trigemini and in the nucleus cochlearis dorsalis. No NADPH-d staining is detected in any cranial motor nuclei of the rat. However, in the cat, the cranial nuclei of the nervus facialis and nervus vagus are labeled. Moderately stained cells appear in the nucleus supragenualis, nucleus nervi hypoglossi, the nucleus raphe, the nucleus lateralis paragigantocellularis and in the nucleus reticularis medialis. The nucleus reticularis lateralis only contains scattered stained fibers. Strongly stained cells are observed in the nucleus tracti solitarii, the nucleus commissuralis of the tracti solitarii and in the nucleus ambiguus (Fig. 9i). Moderately stained neurons are scattered in the nucleus vestibularis medialis and in the nucleus paratrigeminus. Labeled fibers are located in the nucleus nervi hypoglossi, the nucleus paratrigeminus, the nucleus gracilis, the nucleus cuneatus and in the substantia gelatinosa of the nucleus spinalis trigemini. Spinal cord. Numerous NADPH-d-positive cells are identified in the superficial cornu dorsale and around the central canal at all spinal levels, and in the intermediolateral cell column at thoracic and sacral levels. Scattered cells are present in the deep cornu dorsale, cornu ventrale and white matter. Labeled fibers are observed in laminae I and II and in the intermediolateral column. 3.6. GENERAL PATTERN OF NADPH-DIAPHORASE EXPRESSION DURING RAT BRAIN DEVELOPMENT The distribution of nitrergic neurons has been studied during the development of the mammalian brain, mainly in the rat, but results are fragmentary and referred to specific 76
Comparative and developmental neuroanatonlical aspects of the NO system
Ch. ///
brain regions. Most studies are carried out using NADPH-d histochemistry. Using the same technique, we have studied the onset and variations of nitrergic neurons during the prenatal and postnatal development of the rat brain. The size of the perikarya and the staining intensity of the NADPH-d-labeled neurons show in most cases a progressive increase until adulthood. In the initial stages, NADPH-d-positive neurons have immature morphologies, with thick and irregular processes, which become longer and more regular during the subsequent developmental stages until they reach the mature phenotype. Thus, morphologic characteristics such as size, number of cell processes, and staining intensity define the NADPH-d-positive cells at each developmental stage. In order to confirm that NADPH-d staining corresponds to nitrergic cells, NOS presence in the brains of developing animals is also analyzed by immunocytochemistry. Both NADPH-d activity and NOS immunoreactivity distribution patterns are similar in animals at the same developmental stage, but NADPH-d-stained elements demonstrate a more complete labeling, including frequently portions of the dendritic tree and lengthy axons that are not so clearly observable with NOS immunocytochemistry. Vascular endothelium is NADPH-d-stained, but it is not neuronal NOS-immunolabeled. This endothelial labeling occurs before the onset of NADPH-d activity in neural elements (is even present at E16, when NADPH-d-positive neurons are absent) and can be explained by the NADPH-d activity shown by endothelial NOS, not recognized by antineuronal NOS antibodies. The developmental pattern of NADPH-d expression is highly variable among the different brain nuclei. NADPH-d appears at the prenatal stage El7 in the telencephalon, diencephalon, mesencephalon and myelencephalon, and later on, at the postnatal day P6, in the metencephalon. Although the general pattern is an increase in the number of NADPH-d-stained cells and in their staining intensity, several nuclei display a transient expression of NADPH-d following three different models. The number of NADPH-d-positive short-axon cells in the main olfactory bulb and NADPH-d-stained cells in the gigantocellular myelencephalic area and in the nucleus praepositus hypoglossi increases progressively until a critical stage when the number of cells decreases up to the final density observed in the adult. In the deep layers of the colliculus superior and in the griseum centrale of the mesencephalon there is a gradual increase from the onset, but there is an interval during the perinatal period when there is an evident decrease of the labeled elements with respect to previous stages. The third model of transient expression of NADPH-d, observed exclusively in the nucleus parataenialis, consists of an initial increase in the number of the labeled elements until a defined stage (P10) when the number of positive cells starts to decrease until the complete depletion in the adult. Telencephalon. Throughout the development, the evolution of NADPH-d expression towards the adult pattern occurs slowly. Only two telencephalic areas lack NADPH-d activity: the globus pallidus and the cortex piriformis. Although other studies indicate that NADPH-d expression in the telencephalon begins at E 15 (Iwase et al., 1998b) we observe NADPH-d labeling for the first time at the prenatal stage E 17, when scarce NADPH-d-positive neurons appear at medial levels of the fundus striati and the caudatus putamen (Fig. 1 la), scattered within the basal telencephalon and in the medial and posterior subdivisions of the bed nucleus of the stria terminalis (Fig. 1 l b,c). Numerous NADPH-d active neurons are detected for the first time at E 18 in the medial and basomedial amygdala. A scarce population of NADPH-d-positive cells is found in the pallium ventrale and in the ansa lenticularis. Regions expressing NADPH-d activity for the first time at El9 are the nucleus olfactorius anterior, the commissura anterior, the nucleus accumbens and the substantia innominata. Occasionally isolated NADPH-d-positive cells are seen in the cortical neuroepithelium and in the cortical intermediate layer. 77
Ch. III
J.R. Alonso et al.
Fig. 11. Camera lucida drawings of coronal sections from rostral (a) to caudal (g) levels through the brain of the E 17 rat embryo.
At the last prenatal developmental stage, E2 l, the onset of NADPH-d activity occurs in the anterior amygdala, and an increase in the number of NADPH-d-positive neurons and fibers is found in the telencephalon (Fig. 12a-d). NADPH-d-active elements are especially abundant in the caudatus putamen. Cortical NADPH-d active neurons display still an immature aspect with respect to the telencephalic nuclei at the same stage. NADPH-d-positive cells are detected at P0 for the first time in the taenia tecta and in the neuroepithelium close to the septal nuclei, and a weak fibrillar staining is observed in some glomeruli of the main olfactory bulb. At P 1, NADPH-d-positive short-axon cells are observed in the main olfactory bulb. Also at P1, the onset of NADPH-d activity occurs in the septum mediale. Regions demonstrating the onset of NADPH-d activity at P2 are the accessory olfactory 78
Comparative and developmental neuroanatomical aspects of the NO system
Fig. 12. Camera
Ch. III
lucida drawings of coronal sections from rostral (a) to caudal (i) levels through the brain of the
E21 rat embryo.
79
Ch. III
J.R. Alonso et al.
Fig. 13. Camera lucida drawings of coronal sections from rostral (a) to caudal Ik) levels through the brain of the P5 postnatal rat.
bulb, the tuberculum olfactorium and the diagonal band of Broca. Weak NADPH-d-positive neurons are found in the anterior amygdala, the nucleus endopiriformis ventralis, and the region located between these nuclei and the cortex. Also at P2, a scarce NADPH-d-pos80
Comparative and developmental neuroanatomical aspects of the NO system
Ch. III
Fig. 14. (a, b) NADPH-d staining in the diagonal band of Broca during rat brain development. At P4 (a) weakly stained NADPH-d-positive cells were present in the horizontal limb, and neurons containing NADPH-d are not observed in the vertical limb. At P25 (b) NADPH-d-positive cells are present in both the horizontal and vertical limb. (c, d) General view of the NADPH-d-staining pattern in the laterodorsai and dorsal pericentral tegmental nuclei at two postnatal stages. Note that in the DPTg, NADPH-d-positive neurons are scarce at both developmental stages (arrowheads), whereas in the LDTg they are scarce at PI (c) and abundant at P25 (d). Scale bars: 100 ~tm in a and b, 500 ~m in c and d.
itive neuronal population becomes visible in the radiatum, pyramidal and oriens strata of the Ammon's horn and in the white matter of the subiculum in the hippocampal formation. 81
Ch. III
J.R. Alonso et al.
At P3, scarce and weak NADPH-d-positive periglomerular cells are labeled in the olfactory bulb by the first time. A strong fibrillar staining is observed in the telencephalic nuclei presenting NADPH-d activity, but not in the cerebral cortex. NADPH-d-positive cells are sparsely distributed in all layers of Ammon's horn. At this developmental stage, NADPH-d-positive neurons of cerebral cortex are also present in the external layers, as a difference to previous stages. Increases in the staining intensity, in the number of ramifications of the dendritic tree, and in the cell size of the NADPH-d-labeled elements are found in the telencephalon at P4. Although at this stage NADPH-d-positive elements demonstrate a lower degree of maturation than those observed in the adult, the general distributions of NADPH-d-labeled fibers and cells in the olfactory peduncle, the cortex, the caudatus putamen, the fundus striati, and in the basal telencephalon are similar to those of the adults. There is a noticeable increase in the density of NADPH-d-positive neurons in the cortical and septal regions. At P5, new elements expressing NADPH-d consist of weak or moderate stained fibers observed in the insula Callejae and both cells and fibers in the nucleus tractus olfactorii (Fig. 13c). After the first week of postnatal life, general increases in the staining intensity, cell size and ramification of the dendritic tree in the NADPH-d-positive neurons are seen. There is an evolution in the NADPH-d staining pattern towards the adult model in the olfactory bulb, the hippocampal formation, the septal nuclei, the amygdaloid complex, and in the cortical areas (Fig. 13a-g) and in the diagonal band of Broca (Fig. 14a,b). At P7, the nucleus entopeduncularis demonstrates moderately stained NADPH-d-positive neurons. A new group of NADPH-d-labeled neurons appears in the presubiculum and parasubiculum of the hippocampal formation at this stage. At P8, both main and accessory olfactory bulbs show lower numbers of NADPH-d-positive elements than in the adult stage; however, the morphological characteristics of the NADPHd-stained neurons included in these structures are already similar to those observed in the adult. In the nucleus olfactorius anterior, in the taenia tecta and in the commissura anterior the density and staining intensity of NADPH-d-stained neurons are similar to the definitive pattern, but their morphological characteristics are still immature. This circumstance also occurs in the caudatus putamen and in the corpus callosum. An increase in the staining intensity and in the degree of maturation of the NADPH-d-positive cells is observed in the different nuclei of the amygdaloid complex. At P8, NADPH-d-positive neurons are seen for the first time in the subfornical organ. At P9, we observe an evident increase in the size of NADPH-d-positive neurons in the nucleus olfactorius anterior, the taenia tecta, the cortex, the corpus callosum, the commissura anterior and in the caudatus putamen in comparison with previous developmental stages. At P10, NADPH-d-stained neurons are seen in the rostralmost and caudalmost levels of the caudatus putamen, where they are not detected at previous stages. Although the general pattern at P10 is very similar to that observed in the adult rat telencephalon, some structures demonstrate variations when the late postnatal stages are analyzed. Thus, in the P I5 main olfactory bulb a lower density of NADPH-d-positive granular cells but a higher density of NADPH-d-labeled short-axon cells than those found in the adult are observed, while the number of NADPH-d-active periglomerular cells is similar. The density of NADPH-d-stained cortical cells undergoes a gradual decrease from P15 onwards (Fig. 15a,b). At P20, the morphological characteristics of the NADPH-d-positive cells in the septal nuclei are more immature as compared with the adult model. At the last subadult stage analyzed, P30, the NADPH-d expression pattern in the telencephalon is similar to that in the adult, except for 82
Comparative and developmental neuroanatomical aspects of the NO system
Ch. III
the higher number of NADPH-d-stained short-axon cells in the granule cell layer of the main olfactory bulb. Diencephalon. At E 17, NADPH-d-positive neurons appear in the nucleus septohypothalamicus, the nucleus mammillaris dorsalis and in the nucleus commissuraae posterioris (Fig. 1 ld). At this stage, this latter nucleus demonstrates the highest density of NADPH-d activity in the whole brain. At El8, the nucleus praeopticus medialis, located between the midline and the nucleus .septohypothalamicus presents NADPH-d-labeled cells. This neuronal population is more numerous than that of the nucleus septohypothalamicus. More caudally, NADPH-d-stained cells are detected in the area lateralis hypothalami and in the nucleus mammillaris ventralis. In the nucleus paraventricularis hypothalami, two different neuronal populations start to express NADPH-d at El8: the population located in its medial part is weakly stained and more abundant than the population located in its dorsal part. At the following prenatal stages, El9, E20, and E21, no substantial variations on the NADPH-d staining pattern are found in the diencephalon. There is only a noticeable general increase in the number of NADPH-d-positive elements and in the staining intensity in the nucleus commissurae posterioris (Fig. 12e), whereas the staining intensity remains weak in the hypothalamic nuclei. After birth (P0), the lateral part of the nucleus ventromedialis thalami and the nucleus supramammillaris demonstrate for the first time weakly labeled NADPH-d-positive neurons. A noticeable increase in the number of NADPH-d-positive cells is detected in the nucleus septohypothalamicus and in the nucleus praeopticus medialis, as well as an increase in the staining intensity of neurons in the area lateralis hypothalami. New nuclei that display NADPH-d activity at P1 are the nucleus circularis hypothalami, the area posterioris hypothalami, the nucleus tuberis medialis and the parataenialis. At P2, NADPH-d activity starts at the nucleus subthalamicus. At P4, NADPH-d-positive neurons are seen for the first time in the nucleus periventricularis hypothalami and in the nucleus centromedialis, the nucleus interanteromedialis and the nucleus romboidalis of the medial thalamus, forming a scarce and scattered neuronal population. The NADPH-d-positive neuronal populations in the area lateralis hypothalami, in the posterior part of the nucleus paraventricularis, and in the nucleus circularis, display stronger staining intensity, larger somatic volume and longer processes than at P3. At P5, new NADPH-d-positive neuronal groups occur in the nucleus mammillaris lateralis, the nucleus mammillaris dorsomedialis and in the nucleus supraopticus hypothalami (Fig. 13f). At P8, a small group of weak NADPH-d labeled neurons is observed in the nucleus supraparafascicularis and in the nucleus intralaminaris posterior thalami. At P9, thin and long fibers are observed in the habenula. At P12 we observe for the first time NADPH-d-stained fibers in the nucleus geniculatus lateralis and in the nucleus ventrolateralis thalami. At P13, we also observe NADPH-d-stained fibers in the area praetectalis anterior. From P10 to P15 there is a gradual decrease in the number of labeled cells in the nucleus parataenialis and also in the staining intensity of the remaining population of this hucleus until the complete abolition in the adult. This transient postnatal expression in the nucleus parataenialis has been previously reported (Garcfa-Ojeda et al., 1997; Gorbatyuk et al., 1997). By contrast, the number of labeled cells and their staining intensity increase progressively during the postnatal development in other diencephalic nuclei. At P20, NADPH-d-positive cells appear in the dorsal and lateral thalamus. At P25, we observe for the first time NADPH-d-stained fibers crossing the tractus mammillaris. At P30, the neuronal NADPH-d staining pattern in the diencephalon is very similar to the adult model, with numerous intense 83
Ch. III
84
J.R. Alonso et al.
Comparative and developmental neuroanatomical aspects of the NO system
Ch./H
NADPH-d labeled neurons and a dense fibrillar staining in both thalamic and hypothalamic nuclei. Mesencephalon. In the mesencephalon, a highly variable NADPH-d staining pattern is observed among different nuclei throughout development. In the tegmental nuclei, a remarkable high density of NADPH-d-positive elements is detected along the prenatal period. A feature of the NADPH-d staining pattern in the mesencephalon is a decrease of the density of NADPH-d-positive neurons in the deep layers of the colliculus superior and in the griseum centrale around the first week of postnatal life. In these developmental periods we also detect an increase of perikarya volume of some neuronal groups of the tegmental nuclei, in agreement with Skinner et al. (1989). At El7, a single group of neurons demonstrates NADPH-d in the mesencephalon. It is located in the midline between the superior colliculi of both hemispheres, at the top of the Sylvian aqueduct (Fig. l 1f). At the following stage, El8, NADPH-d activity appears for the first time in the griseum centrale, in the nucleus pedunculopontinus tegmenti, in the nucleus tegmentalis dorsalis pericentralis and in the nucleus tegmentalis laterodorsalis. New mesencephalic areas expressing NADPH-d at El9 are the deep gray layer of the colliculus superior and the deep mesencephalic area. At E20, the colliculus superior, the stratum griseum intermedium of shows a scarce population of NADPH-d-positive neurons with stained proximal dendrites. At the last prenatal stage, E21, the density of NADPH-d labeled elements remains unchanged (Fig. 12f), and a few neurons located in the colliculus inferior start to express NADPH-d activity (Fig. 12g-i). At P0, the main variation with respect to previous stages was the presence of NADPH-d activity in the area tegmentalis ventralis. At P1, a few neurons in the stratum opticum of the colliculus superior are NADPH-d-stained. A continuous increase of the staining intensity, size, and density of NADPH-d-positive elements in the colliculus superior, in the griseum centrale, and in the tegmental nuclei occurs after P1 and during the first week of postnatal life (Fig. 14c,d). Cells expressing NADPH-d are firstly labeled at P4 in the bracchium colliculi inferioris. At P5 and P6, a dramatic increase of somatic volume of tegmental NADPH-d-positive neurons is observed. Also in the tegmentum, the NADPH-d-positive neurons show a more developed phenotype and stronger staining intensity than at previous stages. A considerable increase in the density of NADPH-d-stained neurons is detected in the tegmental nuclei and also in the colliculus inferior (Fig. 13g,h). After the first week of postnatal life (P7 and P8) we observe a drastic decrease on the density of NADPH-d-positive neurons in the griseum centrale and in the deep and intermediate layers of the colliculus superior (Fig. 15c,d), and the start of expression in the most superficial layers, as it has been previously reported by other authors (Gonz~ilez-Hem~indez et al., 1993). The decrease contrasts with the increase of NADPH-d-positive elements in the tegmental nuclei and colliculus inferior. The gradual decrease in the NADPH-d staining of the colliculus superior and griseum centrale stops at P10. At this developmental stage, the size and shape of the NADPH-d-labeled neurons in these structures are similar to those observed in the adult. From P11 onwards, NADPH-d labeling becomes visible in all layers of the colliculus superior. We also observe a differential distribution of NADPH-d-stained cells between
Fig. 15. (a, b) NADPH-d distribution pattern in the developing cerebral cortex of the rat. A decrease in the number of NADPH-d-positive neurons is detected between P15 la) and P30 (h). I-VI are layers of the cerebral cortex. (c, d) Transversal sections of the colliculus superior at P6 to) and P30 (d). The deep layers are intensely stained in the first postnatal stages, while in the superficial layers, NADPH-d activity increases progressively during the late postnatal development. Scale bars are 100 p.m.
85
Ch. III
J.R. Alonso et al.
cortical and inner regions of the colliculus inferior. In the cortical region, a high density of weak and moderate NADPH-d-positive neurons and a moderate fibrillar staining are seen, whereas in the inner part, a low density of NADPH-d-active neurons is detected. At the following developmental stages (P 15, P20, P25 and adults), this NADPH-d staining pattern is maintained in the colliculus inferior. Rhombencephalon. In the metencephalon, NADPH-d activity appears later than in other brain regions, at postnatal life, but there are discrepancies in the exact onset in this region, from P1 to P14 (Giuili et al., 1994; Black et al., 1995; Li et al., 1997; Iwase et al., 1998b). We observe the first NADPH-d-positive neurons in the granular layer of the cerebellar cortex at P6. Three different NADPH-d-labeled neuronal populations are detected: the most abundant neurons are identified as granule cells, but some horizontal cells and Golgi cells are also labeled. These cells are only located in the central zone of the granule cell layer within the deep cerebellar lobes. At P8, substantial changes are observed. In addition to the labeling in the granule cell layer, NADPH-d-positive neurons are also found in both the molecular layer and the white matter layer of the cerebellar cortex. In the molecular layer, basket cells are labeled after NADPH-d histochemistry. In the white matter, medium-sized NADPH-d-positive internal cells are occasionally observed. At this stage, the NADPH-d-labeled granule cells, in addition to the central region, are distributed in the lateral part of the inner cerebellar lobes. At P11, a scarce population of large NADPH-d-positive neurons is observed in the nucleus interpositus and nucleus lateralis of the cerebellum. In the nucleus medialis of the cerebellum, NADPH-d activity appears at P12, and consists of large and weakly stained neurons located exclusively in the external portion of this nucleus (as a difference with both nuclei interpositus and lateralis, where NADPH-d-positive elements are distributed throughout all their extension). No new cerebellar layers and nuclei show NADPH-d activity from P12 onwards. Purkinje cells are unstained after NADPH-d histochemistry in all developmental stages analyzed. In the nuclei interpositus and lateralis, some NADPH-d-positive fibers are found at P12. After this developmental stage, a quick evolution towards the adult model is observed. At P13, NADPH-d-stained basket cells and granule cells are also detected in the outer cerebellar lobes. At P15, the labeling in the cerebellar nuclei and cerebellar cortex is similar to that described in previous stages. At P25, some NADPH-d-positive fibers are found in the nucleus medialis. At P30, all cerebellar nuclei present a NADPH-d staining pattern identical to those observed in the adult. Most NADPH-d-positive myelencephalic structures have NADPH-d-labeled neurons in the prenatal life. The outstanding characteristic of the NADPH-d expression in the rat myelencephalon throughout development is the partial loss of NADPH-d-positive elements in some nuclei postnatally. At El7, NADPH-d-positive neurons are detected in the raphe and trigeminal nuclei, as described by Takemura et al. (1996). In the caudalmost levels of the myelencephalon, NADPH-d-positive neurons are found in the nucleus raphe obscurus (Fig. 1 l e,f), in the nucleus spinalis trigemini, in both sides of the pyramidal decussation, and in the ventrolateral zone to the nucleus nervi hypoglossi, reaching the dorsal region of the nucleus reticularis (Fig. 1 l g). El8 is the stage of appearance of NADPH-d activity in the gigantocellular and intermediate part of the formatio reticularis. Noticeable is the large cell body size, high number of processes, and variety of cell morphologies exhibited by the NADPH-d-positive neurons in the formatio reticularis from the onset onwards. These phenotypes are not observed in any other brain nuclei throughout the prenatal life. 86
Comparative and developmental neuroanatomical aspects of the NO system
Ch. ///
Other myelencephalic nuclei start to express NADPH-d activity at El9: the pontine nuclei, the lateral part of the formatio reticularis and the vestibular nuclei. At El9, the NADPH-d-labeled cells described at previous stages are more mature (higher size, number and length of processes than those at El7 or El8). However, an increase in the density or staining intensity is not observed. At E20, NADPH-d-positive neuronal populations are observed in the nucleus lemniscalis, the nucleus fasciculi solitarii, the nucleus praepositus hypoglossi and in the nucleus ambiguus. Distinctive neuronal groups display for the first time NADPH-d activity at the last prenatal stage, E21: the paracentral and medullar parts of the formatio reticularis, and the nucleus reticularis paragigantocellularis dorsalis (Fig. 12g-i). At birth (P0), NADPH-d-positive fibers and NADPH-d-labeled neurons occur for the first time in the nucleus trigeminus spinalis. At P1, NADPH-d expression starts in the locus coeruleus, the parabracchialis, the nucleus gracilis, the nucleus raphe dorsalis and also in the nucleus raphe medialis. At this stage, the distribution pattern of NADPH-d-positive elements in these myelencephalic regions is similar to that observed in the adult brain, although the density and maturity of NADPH-d-stained neurons is lower than in the adult. After this developmental stage, the changes in the staining and in the morphological characteristics of NADPH-d-positive neurons occur slowly, and are more evident during the first week of postnatal life. The onset of NADPH-d activity in the nucleus paratrigeminus, and in the rostral levels of the nucleus fasciculi solitarii occurs at P4. At this same stage, we observe a weakly labeled fiber staining in the area postrema. At the following stage, P5, NADPH-d-positive cells are abundant in the raphe nuclei and in the formatio reticularis (Fig. 13h-k). We detected NADPH-d activity for the first time at this same stage in the nucleus interpenduncularis, the nucleus pontinus and in the nucleus cuneatus. After P6, a decrease in the density of NADPH-d-positive cells is observed in some myelencephalic structures. Thus, in the dorsoposterior part of the area gigantocellularis, in the formatio reticularis and in the nucleus praepositus hypoglossi, the density of NADPH-d-positive decreases until adulthood. No new regions express NADPH-d activity from P6 onwards, and most regions undergo a progressive increase in the density, staining intensity and size of NADPH-d-positive cells.
4. DISCUSSION 4.1. METHODOLOGICAL ASPECTS The NADPH-d histochemical technique using NADPH-d as substrate and tetrazolium salts as chromogen allows to localize NADPH-d activity in both fixed and unfixed brain tissue (Alonso et al., 1995a). However, the identification between NADPH-d and NOS staining patterns is only observed after aldehyde fixation. Under these conditions, the colocalization of NADPH-d with NOS protein and mRNA in the same cells (Bredt et al., 1991a) suggests that NOS catalytic activity accounts for NADPH-d staining. Moreover, transgenic knock-out models for NOS do not exhibit NADPH-d staining (Huang et al., 1993; Darius et al., 1995) while a cell line transfected with neuronal NOS cDNA expresses de novo both the enzyme and NADPH-d activity (Dawson et al., 1991). In the nervous system, NADPH-d activity and neuronal NOS-immunoreactivity widely colocalize in specific sets of well characterized cells (Bredt et al., 1991a; Hope et al., 1991; Kishimoto et al., 1993; Kugler and Drenckhahn, 1996; Brifi6n et al., 1998). Nevertheless, the exact matching between neuronal NADPH-d staining and NOS has been discussed (Hope 87
Ch. III
J.R. Alonso et al.
et al., 1991). There are particular examples where NADPH-d staining is not partially or totally coincident with that for NOS, as in the adrenal gland (Afework et al., 1992), in the olfactory and vomeronasal receptors and their projecting axons (Kishimoto et al., 1993; Kulkami et al., 1994; Spessert and Layers, 1994: Brifi6n et al., 1998; Weruaga et al., 1998), cells in the cerebral cortex (Kharazia et al., 1994; Sobreviela and Mufson, 1995), and neuronal populations in specific nuclei of the spinal cord (Vizzard et al., 1995). These discrepancies have been interpreted as lack of neuronal NOS, whereas other oxidative/reductive enzymes would account for the NADPH-d activity in those cells (Kulkami et al., 1994). In fact, NADPH-d activity is present in cells containing other enzymes such as cytochrome C or cytochrome P450-reductase, which show high molecular homology with NOS (Bredt et al., 1991b; L6wenstein and Snyder, 1992; Knowles and Moncada, 1994). NADPH-d activity related with NOS is conserved after fixation with aldehydes (Matsumoto et al., 1993; Tracey et al., 1993), but this affirmation should be certain for other enzymes as well. For both immunohistochemistry and NADPH-d histochemistry, tissue fixation is crucial, but tissue treatment is more determinant for the latter technique. Cryostat or vibratome sectioning are the most widely employed and reliable methods. As a general rule, perfusion of the animal for 15 min with a physiologic-buffered solution containing 4% paraformaldehyde, and postfixation of trimmed pieces of the dissected brain in the same cold solution for 2-4 h is an optimal treatment of tissue for NADPH-d histochemistry. Relatively low concentrations of glutaraldehyde (until 0.5%) increase definition of positive fibers (Alonso et al., 1995a; Buwalda et al., 1995), but glutaraldehyde is a drawback when other techniques, such as immunohistochemistry, are planned (Matsumoto et al., 1993; Tracey et al., 1993). As well as fixative composition, fixation time is important for the reliability of the histochemical technique. Weakly stained NOS-positive neurons in brain tissue slightly fixed (shortly fixed) seem to lose NADPH-d activity (Gonz~ilez-Hern~indez et al., 1996), but a similar phenomenon occurs when the time of fixation is too long (Alonso et al., 1995a; Brifi6n et al., 1998). There are examples of contradictory or inconsistent results attributable to the fixation quality. Thus, identical results have been described with tissue fixed with both paraformaldehyde alone and mixtures of paraformaldehyde-glutaraldehyde (Valtschanoff et al., 1993), whereas other authors found remarkable differences, including the labeling of 'new' neural cells by using the glutaraldehyde-containing fixatives (Dinerman et al., 1994; Buwalda et al., 1995; Vaid et al., 1996). No brain region has elicited so many controversial results on its NADPH-d/NOS-staining as the hippocampus. Valtschanoff et al. (1993) find similar results for tissue fixed both in paraformaldehyde alone and in mixtures containing different amounts (1-2.5%) of glutaraldehyde. Importantly, they find no staining of hippocampal pyramidal neurons. By contrast, Dinerman et al. (1994) have suggested that hippocampal pyramidal cells in the rat are NADPH-d-negative after standard paraformaldehyde fixation but stain robustly following glutaraldehyde-based fixatives. They further suggest that the positive pyramidal cells contain endothelial NOS rather than neuronal NOS (Dinerman et al., 1994; Kantor et al., 1996). A similar observation has been reported in human hippocampus where pyramidal cells do not contain neuronal NOS but do demonstrate endothelial NOS (Doyle and Slater, 1997). In agreement with this observation, we find that pyramidal cells in the macaque monkey hippocampal formation (Alonso et al., 2000) were neuronal NOS-immunonegative and they do not show clear NADPH-d staining after fixation with no, low (0.1%) or high (2.5%) glutaraldehyde amounts. Of course the possibility that low amounts of neuronal NOS are expressed in principal neurons in the primate hippocampal formation but are not detectable with standard histochemical or immunohistochemical procedures cannot be entirely ruled 88
Comparative and developmental neuroanatomical aspects of the NO system
Ch. III
out. In this case, the species difference may be only in the level of NADPH-d/NOS that is expressed in principal neurons. Given the high involvement of the fixation quality in the results of these techniques, it is necessary to be especially cautious when working with autopsy material since this tissue is under suboptimal fixation. In the human hippocampal formation, Sobreviela and Mufson (1995) have found that strongly NADPH-d-labeled cells are always NOS-immunoreactive, while weakly stained neurons do not. Such a difference has also been found in the mouse olfactory bulb, but the colocalization with NOS is usually accomplished when tissue fixation and manipulation are proper (Alonso et al., 1995a; Gonzfilez-Hern~.ndez et al., 1996; Weruaga et al., 1998). Glial labeling with both NOS-immunohistochemistry and NADPH-d histochemistry should be considered apart. First studies employing NADPH-d staining reported labeled glial cells in vivo and in vitro, as well as in gliomas (see Sestan and Kostovi6, 1994). With the standard fixation related below, glial staining is eliminated, although oligodendrocytes are NADPH-d-stained in teleosts (Ar6valo et al., 1995; P6rez et al., 1996; Crespo et al., 1998a). For mammals, the visualization of astrocytes is possible running the NADPH-d staining on very slightly fixed tissue. This staining is absolutely coincident with that obtained with neuronal NOS-immunolabeling, but only with special fixation and cryo-drying of the sections (Gabbott and Bacon, 1996; Kugler and Drenckhahn, 1996). Therefore, when investigating nitric oxide-synthesizing elements, it is recommendable to compare the results with other methods for the localization of NOS, and to test different fixation and incubation protocols when using different species or tissues or different developmental stages until the stainings fit completely or differences are clearly demonstrated. 4.2. INTERSPECIES DIFFERENCES IN THE NADPH-DIAPHORASE DISTRIBUTION PATTERN NADPH-d/NOS-positive elements in the central nervous system of vertebrates are distributed throughout most brain subdivisions, constituting, in general, small neuronal subpopulations within a given structure. From the location and nature of NADPH-d/NOS-stained cells it is hardly possible to extrapolate a common feature such as definite functional pathways or neurotransmitter systems that could match with the distribution of these cells. In a general overview of their distribution in the vertebrate brain, there are structures where nitrergic populations are constantly present throughout the phylogenetic scale and other brain nuclei or zones where the presence of NADPH-d/NOS is not consistently found among different vertebrate groups. In this sense, NADPH-d/NOS-positive elements have been found in all vertebrate species studied in the striatum, amygdaloid complex, medial septum, hypothalamus, midbrain tectum, nucleus spinalis trigemini, solitary tract area, and spinal cord (or their homologous regions). In other brain regions such as the olfactory bulb, cortex, thalamus, ventral tegmental area, substantia nigra, retrobulbar area and raphe nuclei, more striking differences have been detected among vertebrate classes: NADPH-d/NOS-stained cell bodies are frequently found, but not consistently throughout the phylogenetic scale. In this sense, NADPH-d/NOS-stained cell bodies are absent in the olfactory bulb of lampreys (Schober et al., 1994) and teleosts (Ar6valo et al., 1995; Brfining et al., 1995), whereas only a few, weakly stained cells are found in those of reptiles (Brfining et al., 1994b; Smeets et al., 1997) and birds (Brfining et al., 1994a; Panzica et al., 1994). By contrast, numerous stained cell bodies have been observed in the main and accessory olfactory bulbs of both anuran (Mufioz et al., 1996; Porteros et al., 1996) and urodele amphibians (Gonzfilez et al., 1996; Porteros et al., 89
Ch. III
J.R. Alonso et al.
1996), as well as in rodents (Vincent and Kimura, 1992; Porteros et al., 1994), and in the main olfactory bulb of monkey (Alonso et al., 1998) and human (Brifi6n et al., 1998). The mere presence of nitrergic populations in a given structure through the phylogenetic scale does not allow to conclude evident anatomical, physiological and/or evolutionary relationships of this neuronal subsystem given the remarkable differences in their number and distribution among groups, even when comparing functionally or structurally similar brain regions. As an example, significant qualitative and quantitative interspecies variations have been found in the NADPH-d/NOS-positive cells occurring in the midbrain. Whereas in reptiles and birds the ventral tegmental area, substantia nigra and retrobulbar group contain numerous NOS-stained cell bodies, in rats they are mainly confined to the ventral tegmental area. A comparison with anamniotes is difficult, because distinct midbrain groups cannot be distinguished in lampreys (Pierre et al., 1994) and teleost fishes (Meek, 1994; Smeets and Reiner, 1994). However, in the dorsomedial part of the posterior tubercle and rostral tegmentum of amphibians, which are comparable to the ventral tegmental area and the substantia nigra of amniotes (Marfn et al., 1995), only a few NADPH-d/NOS-positive cells are found (Gonz~lez et al., 1996; Mufioz et al., 1996). In addition to these variations among groups, remarkable differences also occur within each class in specific locations. For example, NADPH-d- and NOS-positive cells were found in the thalamus of the reptile Gekko, but not in an other reptile, Pseudemys. A similar discrepancy is observed in amphibians, where a large population of stained cells is present in the thalamus of anurans (Mufioz et al., 1996), but absent in urodeles (Gonz~ilez et al., 1996). Substantial differences in density and distribution were also observed in the avian thalamus, comparing chickens (Brfining, 1993) with quails (Panzica et al., 1994). The significance of the differences must be necessarily related to the distinct organization of each brain structure in each vertebrate group or subgroup. Nevertheless, other factors must be also involved given the remarkable interspecies variability demonstrated by brain regions characterized by their similar structural and functional features along the phylogenetic scale. For example, within mammals there are important differences between NOS-positive elements in the hippocampal formation of the rat (Valtschanoff et al., 1993) with those described in different monkey species (Carboni et al., 1990; Mufson et al., 1990) and human (Sobreviela and Mufson, 1995). In addition, minor differences persist even within a same group such as primates, although the divergences are less dramatic and a relatively common NADPH-d/NOS-staining cell pattern is observed. The interspecies differences on the NADPH-d/NOS staining pattern could be explained by specific variations in the circuitry within a structurally constant region. The hippocampus and the olfactory bulb constitute clear examples for this hypothesis. Whereas the dense NADPH-d/NOS innervation of the rat hippocampal formation has one of its main sources in the cholinergic septohippocampal cells in the rat (Kinjo et al., 1989; Kitchener and Diamond, 1993), in the macaque monkey and human it has a different origin since in both species cholinergic septohippocampal cells do not contain NOS (Ellison et al., 1987; Geula et al., 1993; Alonso et al., 2000). In addition, the practical inexistence of NOS-positive fibers in the primate fimbria (Sobreviela and Mufson, 1995; Alonso et al., 2000) indicates that other non-cholinergic populations of septohippocampal neurons projecting through the fimbria are also NADPH-d/NOS-negative. Therefore, it appears that the dense innervation of NOS-stained fibers found in the primate hippocampal formation has a different origin from those observed in rodents. Concerning the olfactory bulb, the NADPH-d/NOS somal and fiber stainings show striking divergences in different vertebrate species. Even within the mammalian group, 90
Comparative and developmental neuroanatomical aspects of the NO system
Ch. III
differences can be detected in the number, distribution and nature of NADPH-d/NOS-stained elements between macrosmatic and microsmatic species. Detailed analysis of similarities and differences among vertebrate groups suggests that the complexity of NADPH-d/NOS staining in the olfactory bulb could correlate to the developmental level of the olfactory structures and the importance of olfaction in the biology of that species. Thus, the primate olfactory bulb (Alonso et al., 1998; Brifi6n et al., 1998) exhibits a simplified NADPH-d/NOS staining pattern as compared to the staining in rodents (Davis, 1991; Vincent and Kimura, 1992; Alonso et al., 1993). The NADPH-d/NOS-Iabeled neurons in the primate olfactory bulb are less abundant, and show a lower morphological diversity than those described for rats and mice. Similarly, rodents have simpler NADPH-d/NOS staining patterns than the hedgehog, an insectivore with extraordinarily developed olfactory structures (Alonso et al., 1995b). Studies in other groups of vertebrates seem to confirm this hypothesis: no NADPH-d staining is observed in the secondarily simplified olfactory bulb of birds (Panzica et al., 1994), and only olfactory fibers are NADPH-d-positive in the olfactory bulb of teleosts (Ar6valo et al., 1995). Immunohistochemical and in situ hybridization studies have revealed an unique distribution for NOS that does not correlate in an exclusive manner with the distribution of any other neurotransmitter or neuroactive substance or with specific sensory, motor or integrative pathways (Bredt et al., 199 la). Nitric oxide occurs in glutamatergic cells in the cerebellar granule cells, but also in GABAergic basket cells. In the cerebral cortex, NADPH-d/NOS neurons colocalize somatostatin, neuropeptide Y and GABA, and somatostatin and neuropeptide Y in the striatum (Dawson et al., 1991), while in the nucleus pedunculopontinus tegmenti of the brainstem, NOS-positive neurons lack somatostatin and neuropeptide Y, but stain for choline acetyltransferase (Dawson et al., 1991). In the hypothalamus there are partial coexistences of NADPH-d activity with somatostatin, vasopressin, oxytocin, calbindin D-28k, calretinin, parvalbumin, or acetylcholinesterase (Alonso et al., 1992a,b; Ar6valo et al., 1993; S~inchez et al., 1994; Crespo et al., 1998b). In addition, the relationship of nitric oxide and other neuroactive substances in specific regions of the central nervous system is not a general feature throughout the phylogenetic scale. The colocalization of NADPH-d/NOS with catecholamines markers is well documented. In birds and reptiles, NADPH-d/NOS activities extensively colocalize with catecholamines in the midbrain (Panzica et al., 1996; Smeets et al., 1997). By contrast, colocalization in the midbrain of mammals is scarce (Johnson and Ma, 1993). It is also very limited in anuran amphibians (Mufioz et al., 1996) and completely absent in urodeles (Gonz~ilez et al., 1996). All these data suggest that although the coexpression of NADPH-d/NOS staining with catecholaminergic markers exists in the vertebrate brain (mainly in the midbrain), there are considerable variations between groups, and even within groups. The rate of colocalization is hitherto difficult to extrapolate with any functional significance, or with the phylogenetic evolution of the brain. 4.3. IMPLICATIONS OF THE NADPH-DIAPHORASE EXPRESSION DURING THE DEVELOPMENTAL PROCESSES During brain development, NADPH-d-stained cells are initially observed after cell bodies ceased dividing and extended their processes. NADPH-d activity is not expressed during the cell division or the cell migration process, but in late developmental stages, when the establishment of functional connections is taking place. Available data suggest a role for these nitric oxide-producing neurons in the formation of the pattern of connectivity during development. In this sense, NADPH-d expression in several brain regions correlates with the schedule of innervation. This is the case for mossy fibers in the cerebellum, and 91
Ch. III
J.R. Alonso et al.
for thalamo-cortical (Bredt and Snyder, 1994) and nigro-striatal (Derer and Derer, 1993) connections. Also the spatiotemporal pattern of NADPH-d expression observed in thalamic and tectal neurons matches with the arrival of innervation to these regions (Williams et al., 1994; Bertini and Bentivoglio, 1997). NMDA receptor-mediated postsynaptic mechanisms are thought to play important roles in the process of establishment of precise connections between different areas (Cline and Constantine-Paton, 1989, 1990; Simon et al., 1992). Nitric oxide is released in a calciumdependent manner by some NADPH-d-positive cells in response to glutamate activation of NMDA receptors, which suggests that this neuroactive substance may play a role in the establishment of axonal projections, in the elimination of redundant connections and/or in the refinement of axonal synapsis in the late development (Gally et al., 1990). Experimental evidence supports this hypothesis. Nitric oxide synthesis blockade alters the normal pattern of development of connections, e.g. in the transient ipsilateral projection from the retina to the optic tectum in the chicken (Wu et al., 1994), or the complex pattern of lamination of the retinogeniculate projection in the ferret (Cramer et al., 1996). Nitric oxide is also involved in activity-dependent establishment of connections in developing and regenerating olfactory neurons (Roskams et al., 1994). Several brain nuclei display a transient expression of NADPH-d activity in critical periods of development. In the lateral geniculate nucleus, the peak of NADPH-d/NOS activity occurs at the developmental stages that require afferent activity and postsynaptic NMDA receptor activation for the establishment of the definitive pattern of innervation (Bertini and Bentivoglio, 1997). But in other regions this transient expression of NADPH-d/NOS may be due to the influence of nitric oxide in cell survival and differentiation at late developmental stages. Thus, there are evidences indicating a role for nitric oxide in the regulation of apoptosis, growth arrest and dendritic branching on cortical neurons (Bredt and Snyder, 1994; Peunova and Enikolopov, 1995; Palluy and Rigaud, 1996). 4.4. NADPH-DIAPHORASE/NITRIC OXIDE SYNTHASE DISTRIBUTION PATTERN AND NITRIC OXIDE FUNCTIONAL IMPLICATIONS Nitric oxide in the brain acts in different ways. Firstly, nitric oxide functions as retrograde messenger (see Good, 1996). In a model of brain activity such a retrograde messenger is involved in the mechanism of inducing and/or maintaining long-term memory (O'Dell et al., 1991; Chapman et al., 1992; Izumi et al., 1992). A second role for nitric oxide in the brain is more likely that of a normal neurotransmitter in that it acts upon nerve cells other than the presynaptic nerve cell although direct proximity is not a prerequisite. It also seems probable that nitric oxide in the brain plays a role in the cerebral blood supply (Raszkiewicz et al., 1992; Rosenblum, 1992). The regulatory function of nitric oxide in transmitter release seems to be correlated to the different NOS isoforms in different neuronal subsets. Knock-out mice for neuronal NOS show a substantial reduction of NMDA-mediated glutamate release, whereas in the knock-out for endothelial NOS there is a considerable reduction of GABArelease (Kano et al., 1998). Therefore, the activity of each isoform seems to be in parallel to the regulation of excitatory or inhibitory neurotransmission, and thus, the expression of distinct NOS isoforms in particular neuronal subsets could lead to distinct regulatory mechanisms in transmitter release. It has been proposed that nitric oxide regulates neurotransmitter releasing through cGMP-dependent protein phosphorylation (O'Dell et al., 1991; Hirsch et al., 1993; Meffert et al., 1994; Schuman and Madison, 1994; Garthwaite and Boulton, 1995; Kuriyama and 92
Comparative and developmental neuroanatomical aspects of the NO system
Ch. III
Ohkuma, 1995; Nei et al., 1996; Bogdanov and Wtirtman, 1997). Nitric oxide has been proved to be directly involved in the releasing of corticotropin-releasing factor and histamine in the hypothalamus (Karanth et al., 1993; Prast et al., 1997), and acetylcholine in the striatum (Prast et al., 1994). Some transmitters are released after stimulation of NMDA glutamate receptors, and NOS inhibitors block the transmitter release in synaptosomes obtained from cerebral cortex and striatum (Hirsch et al., 1993; Montague et al., 1994). Other experiments using nitric oxide donors have also demonstrated the involvement of this molecule in the regulation of the releasing of luteinizing hormone, oxytocin and luteinizing hormone-releasing hormone (Aguan et al., 1996; Okere et al., 1996; Luckman et al., 1997; Rettori et al., 1997), thus acting at the neuroendocrine control level. Even, the releasing of glutamate, the transmitter that indirectly activates neuronal NOS, is also regulated through a nitric oxide- and cGMP-dependent pathway (Sistiaga et al., 1997). This mechanism may have implications in the nitric oxide-mediated neurotoxicity. The presence of NOS isoforms with specific distribution and regulated expression makes the analysis of these functional processes difficult. In this sense, neuronal NOS and endothelial NOS are present in different elements of the hippocampus (Wendland et al., 1994; Gonz~ilezHern~ndez et al., [996; Vaid et al., 1996). The presence of distinct NOS isoforms in neurons acting as pre- and post-synaptic elements can be related to the specific function of nitric oxide in each of these elements (Iadecola, 1997), given their distinct regulatory mechanisms. In addition, the stimulation and tissue manipulation carried out in these experiments may induce the expression of different NOS isoforms, that would respond in different ways to inhibitors (see Iadecola, 1997). In conclusion, establishing a functional effect for nitric oxide based upon data from the distribution pattern of nitric oxide synthesizing cells is more complex than it has usually been for other transmitter systems. This is due to the alternative pathways for nitric oxide production that can be misinterpreted by the detection system and the difficulties to localize target elements. We have described the characteristics of the NADPH-d labeling in all major groups of vertebrates and during the rat brain development. Whereas consistent patterns are usually found between different animals under the same normal conditions, the NADPH-d/NOS staining is drastically altered after experiments or diseases. It has been suggested that the overproduction of nitric oxide could be responsible for brain damage and certain neurodegenerative conditions, and it seems to be involved in the neurotoxicity of Alzheimer's disease, Huntington's disease, and cerebral ischemia (Hoffman, 1991), alcohol-induced brain damage (Lancaster et al., 1992), cerebral stroke (Nowicki et al., 1991) and in the neuropathology associated with AIDS dementia complex (Morgan et al., 1992). We have reviewed those changes in the hippocampal formation (Alonso et al., 2000), one of the brain regions where the effects of a higher variety of conditions on the NADPH-d/NOS staining have been explored. Alterations in the NADPH-d staining pattern include NADPH-d-positive staining of previously negative neuronal types after mechanical damage (Divac et al., 1993; Regidor et al., 1993) or associated with epilepsy (Talavera et al., 1997). In other cases, a reduction on the number of NADPH-d-stained elements is observed. In epilepsy such activity loss has been described as transient (Stringer and Erden, 1995) or permanent (Miettinen et al., 1995; Kotti et al., 1997), but it seems to be a long-lasting alteration in schizophrenia (Akbarian et al., 1993), ischemic damage (Hong et al., 1993), or treatments with DSP-4 neurotoxin (Zhang and Yu, 1995). Other changes in the NADPH-d/NOS staining pattern in the hippocampus include the relative sparing of NADPH-d-positive cells in comparison with NADPH-d-negative neurons after neurotoxicity induced by glutamate agonists (Wolf et al., 1993) and in Alzheimer's disease (Hyman et al., 1992), or changes in NOS activity or NOS mRNA production without affecting 93
Ch. III
J.R. Alonso et al.
the number of NOS-containing neurons as reported in aging (Yamada and Nabeshima, 1998) and chronic ethanol exposure (Kimura and Brien, 1998). Changes in the NADPH-d staining pattern have been also reported in the fiber staining. There is an increase in the density of NADPH-d fiber staining as a result of aging (Sobreviela and Mufson, 1995) and a reduction in the density of NADPH-d fiber staining in Alzheimer's disease (Rebeck et al., 1993). Furthermore, NADPH-d staining can be found in previously negative glial cells following ischemia (Endoh et al., 1993, 1994b; Kato et al., 1994), in epilepsy (Lerner-Natoli et al., 1994), after mechanical or photothrombic damage (Regidor et al., 1993; Wallace and Bisland, 1994; Bidmon et al., 1998; Stojkovic et al., 1998) or intense neuronal activity (Wallace and Bisland, 1994). These changes have very different time courses (from minutes to months) and they do not affect all brain regions or neuronal populations to the same extent. This capacity for plasticity is therefore another aspect that has to be considered when the distribution pattern of NADPH-d/NOS is evaluated. What contributes to the selective vulnerability of certain subsets of NADPH-d/NOS-positive neurons will be one of the most important subjects for future investigation.
5. ABBREVIATIONS
A Ac Ad AD ADT Aid Alh Am Amb Amc Ame AMH AMT APH Apl Apm AV AVT B bci BCI BL BM BST CA1 CA2 CA3 CA 94
nucleus anterior thalami nucleus accumbens nucleus tegmentalis anterodorsalis area dorsalis amygdalae nucleus anterodorsalis thalami archistriatum intermedium, pars dorsalis area lateralis hypothalami amygdala nucleus ambiguus nucleus centralis amygdalae nucleus externus amygdalae nucleus anteromedialis hypothalami nucleus anteromedialis thalami area parahippocampalis amygdala, pars lateralis amygdala, pars medialis area ventralis amygdalae area ventralis tegmenti nucleus basalis Meynert bracchium colliculi inferioris nucleus bracchii colliculi inferioris nucleus basolateralis amygdalae nucleus basomedialis amygdalae bed nucleus of the stria terminalis hippocampus, area CA1 hippocampus, area CA2 hippocampus, area CA3 commissura anterior
Comparative and developmental neuroanatomical aspects of the NO system CAA Cans Cb CC CCb CCI CD Cgus CH CHa ci CI C1 CLI CM cmsp CO CoPL CoPM CP Cpop CPu CS Ct CTc Cu CV Cven Cx Cxd Cxla Cxmp D DB DBH DBV Dc Dd D1 DLA DLI Dlm Dlp Dm DM DMH DMTg Dp
Ch. III
nucleus corticalis anterioris amygdalae commissura ansulata cerebellum corpus callosum corpus cerebelli nucleus centralis colliculi inferioris nucleus cochlearis dorsalis commissura nuclei gustatorii secundarii commissura horizontalis commissura habenularum capsula interna colliculus inferior claustrum nucleus centralis lobi inferioris hypothalami corpus mammillare columna motoria spinalis chiasma opticum nucleus corticalis posterolateralis amygdalae nucleus corticalis posteromedialis amygdalae commissura posterior commissura postoptica = commissura supraoptica caudatus putamen colliculus superior nucleus centralis thalami commissura tecti nucleus cuneatus nucleus cochlearis ventralis commissura ventralis rhombencephali cortex cortex dorsalis cortex lateralis anterior cortex medialis, pars parvocellularis dorsal field of the spinal cord nucleus of the diagonal band of Broca horizontal limb of the diagonal band of Broca vertical limb of the diagonal band of Broca area dorsalis telencephali, zona centralis area dorsalis telencephali, zona dorsalis area dorsalis telencephali, zona lateralis nucleus dorsolateralis anterior thalami nucleus diffusus lobi inferioris hypothalami nucleus dorsolateralis thalami, pars magnocellularis nucleus dorsolateralis thalami, pars parvocellularis area dorsalis telencephali, zona medialis nucleus dorsomedialis thalami nucleus dorsomedialis hypothalami nucleus tegmentalis dorsomedialis area dorsalis telencephali, zona posterior 95
Ch. III
DPT DPTg dso dsum DV DVR E EG En EW f Fi fll tim fit fmt fr FRM FStr G GC GD Gi GLD GLV GM GP GPt Gr GS HA Hab HbL HbM Hp HV IA
icj ICo IG Inf IP Is Ism Isp La LC LCa 96
J.R. Alonso et al.
nucleus dorsalis posterior thalami nucleus tegmentalis dorsalis pericentralis decussatio supraoptica decussatio supramammillaris radix descendens nervi trigemini dorsal ventricular ridge ectostriatum eminentia granularis nucleus endopiriformis nucleus Edinger-Westphal fornix fimbria hippocampi fasciculus longitudinalis lateralis fasciculus longitudinalis medialis fasciculus lateralis telencephali fasciculus medialis telencephali fasciculus retroflexus formatio reticularis mesencephali fundus striati glomerus olfactorius griseum centrale gyrus dentatus nucleus gigantocellularis reticuli nucleus geniculatus laterodorsalis nucleus geniculatus lateroventralis nucleus geniculatus medialis globus pallidus griseum praetectale nucleus gracilis nucleus gustatorius secundarius hyperstriatum accessorium habenula nucleus habenularis lateralis nucleus habenularis medialis hippocampus hyperstriatum ventrale colliculus superior, stratum album intermedium insula Callejae nucleus intercollicularis colliculus superior, stratum griseum intermedium superior colliculus superior, stratum inferius nucleus interpeduncularis nucleus isthmi nucleus isthmi, pars magnocellularis nucleus isthmi, pars parvocellularis nucleus lateralis thalami, pars anterior locus coeruleus lobus caudalis cerebelli
Comparative and developmental neuroanatomical aspects of the NO system LD LDTg 11 LLi LM lm Lm LP LRt LVII LX MC Mdd Mdv ME Me ML MLd MM MnV Mp mt N NCP NCPa NDBC NDV ne Nflm nIII NIII NIV nIV NIX-X NIX NLV NOB NPM NPT Nsa Nsd Nsi Nsl Nsol NT NTA NVI NVII
Ch. III
nucleus laterodorsalis thalami nucleus tegmentalis laterodorsalis lemniscus lateralis nucleus ventralis lemnisci lateralis lateral motor field of spinal cord lemniscus medialis nucleus lentiformis mesencephali nucleus lateroposterioris thalami nucleus reticularis lateralis lobus facialis lobus vagus nucleus mediocentralis thalami nucleus medullaris reticularis, pars dorsalis nucleus medullaris reticularis, pars ventralis eminentia mediana nucleus medialis amygdalae nucleus mammillaris lateralis nucleus mesencephalicus lateralis, pars dorsalis nucleus mammillaris medialis nucleus motorius nervi trigemini nucleus medialis posterior tractus mammillaris thalami neostriatum nucleus commissurae posterioris nucleus commissurae pallii nucleus decussationis bracchiorum conjunctivorum nucleus descendens nervi trigemini neuroepithelium nucleus fasciculi longitudinalis medialis nervus oculomotorius nucleus nervi oculomotorii nucleus nervi trochlearis nervus trochlearis nucleus nervi glossopharyngei et motorius nervi vagi nucleus nervi glossopharyngei nucleus lateralis valvulae nucleus opticus basalis nucleus profundus mesencephali nucleusposterior thalami nucleus septalis anterior nucleus septalis dorsalis nucleus septalis impar nucleus septalis lateralis nucleus fasciculi solitarii nucleus taeniae nucleus tuberis anterior nucleus nervi abducentis nucleus nervi facialis 97
Ch. III
NVIIId NVIIIv NVme nX NX NXII 0 OAd OA1 OAm OAv OI Ols OM OMa OS P Pa PA PB PC pc Pd PG PG1 PGm PHc PHd PHv pir Pir PL P1 PLs PM Pm PMD PMn PMV PnC PnO PnV PO POa POL POM Pp PP 98
J.R. Alonso et al.
nucleus octavus dorsalis nucleus octavus ventralis nucleus mesencephalicus nervi trigemini nervus vagus nucleus nervi vagi nucleus nervi hypoglossi colliculus superior, stratum opticum nucleus olfactorius, pars dorsalis anterior nucleus olfactorius, pars lateralis anterior nucleus olfactorius, pars medialis anterior nucleus olfactorius, pars ventralis anterior oliva inferior nucleus olivae superioris nucleus octavolateralis medialis nucleus octavus magnocellularis populatio octavia secundaria nucleus pontinus nucleus paraventricularis hypothalami paleostriatum augmentatum nucleus parabracchialis nucleus paracentralis thalami pedunculus cerebelli pallium dorsale area praeglomerulosa nucleus praeglomerulosus lateralis nucleus praeglomerulosus medialis nucleus periventricularis hypothalami, zona caudalis nucleus periventricularis hypothalami, zona dorsalis nucleus periventricularis hypothalami, zona ventralis tractus piramidalis cortex piriformis nucleus pontis lateralis pallium laterale nucleus perilemniscalis nucleus praeopticus magnocellularis pallium mediale nucleus praemammillaris dorsalis nucleus raphe paramedianus nucleus praemammillaris ventralis nucleus pontino-centralis reticuli nucleus pontino-oralis reticuli nucleus pontino-ventralis reticuli area praeoptica area praeoptica anterior nucleus praeopticus lateralis nucleus praeopticus medialis area praeoptica periventricularis paleostriatum primitivum
Comparative and developmental neuroanatomical aspects of the NO system PPo PPp PPTg pr PrG Prv PrXII PT Pta PTA Pth PTp PV Pv PVN PVT R
Rad Rai Ram Ras Re Ri Rm ROb ROT RPa Rpgl rs
Rti Rtp Rts Ru S SC SCd sg SGC SGFS sgl sgr SHp SI SLD SLI SLV sm SM
Ch. III
nucleus praetectalis posterior nucleus praeopticus parvocellularis, pars posterior nucleus pedunculopontinus tegmenti area fibrillaris periventricularis thalami colliculus superior, stratum griseum profundum nucleus praetectalis ventralis nucleus praepositus hypoglossi nucleus parataenialis thalami nucleus praetectalis accessorius nucleus praetectalis anterior pallial thickening nucleus periventricularis tuberculi posterioris nucleus paraventricularis posterioris thalami pallium ventrale nucleus paraventricularis paleostriatum ventrale nucleus raphe nucleus raphe dorsalis nucleus raphe inferior nucleus raphe medianus nucleus raphe superior nucleus renius thalami nucleus reticularis inferior nucleus reticularis medialis nucleus raphe obscurus nucleus rotundus nucleus reticularis paramedianus nucleus reticularis paragigantocellularis lateralis tractus rubrospinalis area reticularis intermedia area reticularis parvocellularis area reticularis superior nucleus ruber subiculum nucleus suprachiasmaticus nucleus subcoeruleus dorsalis stratum glomerulare stratum griseum centrale stratum griseum et fibrosum superficiale bulbus olfactorius accessorius, stratum glomerulare stratum granulare nucleus septohippocampalis substantia innominata septum laterale, pars dorsalis septum laterale, pars intermedia septum laterale, pars ventralis stria medullaris septum mediale 99
Ch. III
smi SN SO sol spe SPFPT spV ss
SStr st
STh Str SubB SuG SUM SV SY T tbs TD TeB Tg tgs Th TL TLa tmca Tmg TO TOL tol tpm TPO Tr.op TR TS TSc TSco TS1 TT ttb ttbc Tu tvs
V VC1 VCm Vd 100
J.R. Alonso et al.
stratum mitrale substantia nigra nucleus supraopticus tractus solitarius stratum plexiforme extemum nucleus subparafascicularis parvocellularis thalami tractus spinalis trigeminalis stratum subependimarium area substriatalis stria terminalis thalami nucleus subthalamicus striatum nucleus subbrachialis colliculus superior, stratum griseum superficiale nucleus supramammillaris nucleus spinalis trigemini sulcus ypsiloniformis nucleus tangentialis tractus bulbospinalis nucleus tegmentalis dorsalis telencephalon basalis tegmentum tractus gustatorius secundarius thalamus torus longitudinalis torus lateralis tractus mesencephalo-cerebellaris anterior torus semicircularis, nucleus magnocellularis tectum opticum nucleus tractus olfactorii lateralis tractus olfactorius lateralis tractus praectecto-mammillaris area temporo-parieto-occipitalis tractus opticus nucleus tegmentalis rostralis torus semicircularis torus semicircularis, nucleus centralis torus semicircularis, nucleus commissuralis torus semicircularis, nucleus laminaris taenia tecta tractus tectobulbaris tractus tectobulbaris cruciatus tuberculum olfactorium tractus vestibulospinalis ventriculum valvula cerebelli, pars lateralis valvula cerebelli, pars medialis area ventralis telencephali, nucleus dorsalis
C o m p a r a t i v e a n d d e v e l o p m e n t a l n e u r o a n a t o m i c a l a s p e c t s o f the N O s y s t e m Ve
area vestibularis
Vedl
n u c l e u s vestibularis d o r s o l a t e r a l i s
Vem
n u c l e u s vestibularis m e d i a l i s
Vesp
n u c l e u s vestibularis spinalis
Vev
n u c l e u s vestibularis ventralis
Vl
area ventralis t e l e n c e p h a l i , n u c l e u s lateralis
Vm
nucleus ventromedialis thalami
VMH
nucleus ventromedialis hypothalami
VT
n u c l e u s ventralis t h a l a m i
Vv
area ventralis t e l e n c e p h a l i , n u c l e u s ventralis z o n a incerta
ZI
Ch. III
6. REFERENCES Afework M, Tomlinson A, Belai A, Burnstock G (1992): Colocalization of nitric oxide synthase and NADPHdiaphorase in rat adrenal gland. Neuroreport 3:893-896. Aguan K, Mahesh VB, Ping L, Bhat G, Brann DW t1996): Evidence for a physiological role for nitric oxide in the regulation of the LH surge: effect of central administration of antisense oligonucleotides to nitric oxide synthase. Neuroendocrinology 64:449-455. Akbarian S, Bunney WE, Pot'kin SG, Wigal SB, Hagman JO, Sandman CA. Jones EG (1993): Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Arch Gen Psvchiatlw 50:169-177. Alonso JR, S~inchez F, Ar6valo R, Carretero J, Vfizquez R, Aij6n J (1992a): Partial coexistence of NADPHdiaphorase and somatostatin in the rat hypothalamic paraventricular nucleus. Neurosci Lett 148:101-104. Alonso JR, SS.nchez F, Ar6valo R, Carretero J, Aij6n J. V~zquez R (1992b): Calbindin D-28k and NADPHdiaphorase coexistence in the magnocellular neurosecretory nuclei. Neuroreport 3:249-252. Alonso JR, Ar~valo R, Porteros A, Brifi6n JG. Lara J. Aij6n J (1993): Calbindin D-28k and NADPH-diaphorase activity are localized in different populations of periglomerular cells in the rat olfactory bulb. J Chem Neuroanat 6: l-6. Alonso JR, Ar6valo R, Brifi6n JG, Garcfa-Ojeda E, Porteros A, Aij6n J. (1995a): NADPH-diaphorase staining in the central nervous system. Neurosci Protoc 050-04:1-11. Alonso JR, Ar6valo R, Garcfa-Ojeda E, Porteros A, Brifi6n JG. Aij6n J (1995b): NADPH-diaphorase active and calbindin D-28k-immunoreactive neurons and fibers in the olfactory bulb of the hedgehog (Erinaceus europaeus). J Comp Neurol 351:307-327. Alonso JR, Porteros A, Crespo C, Ar6valo R, Brifi6n JG. Weruaga E. Aij6n J (1998): Chemical anatomy of the macaque monkey olfactory bulb: NADPH-diaphorase/nitric oxide synthase activity. J Comp Neurol 402:419434. Alonso JR, Pitkanen A, Amaral DG (2000): NADPH-diaphorase active neurons and fibers in the Macaca fascicularis monkey hippocampal formation. Submitted. Anken RH, Rahmann H (1996): An atlas of the distribution of NADPH-diaphorase in the brain of the highly derived swordtail fish Xiphopkorus helleri (Atherinoformes: Teleostei). J Brain Res 37:421-449. Ar6valo R, S~.nchez F, Alonso JR, Carretero J, V:~zquez R, Aij6n J (1992): NADPH-diaphorase activity in the hypothalamic magnocellular neurosecretory nuclei of the rat. Brain Res Bull 28:599-603. Ar6valo R, S~inchez F, Alonso JR, Rubio M, Aij6n J. V,~zquez R (1993): Infrequent cellular coexistence of NADPH-diaphorase and calretinin in the neurosecretory nuclei and adjacent areas of the rat hypothalamus. J Chem Neuroanat 6:335-341. Ar6valo R, Alonso JR, Garcfa-Ojeda E, Brifi6n JG, Crespo C. Aij6n J (1995): NADPH-diaphorase in the central nervous system of the tench (Tinca tinca L., 1758). J Comp Neurol 352:398-420. Bell TD, Pereda AE, Faber DS (1997): Nitric oxide synthase distribution in the goldfish Mauthner cell. Neurosci Lett 226:187-190. Bertini G, Bentivoglio M (1997): Nitric oxide synthase in the adult and developing thalamus: histochemical and immunohistochemical study in the rat. J Comp Neurol 388:89-105. Bidmon HJ, Wu J, Buchkremer-Ratzmann I, Mayer B. Witte OW, Zilles K (1998): Transient changes in the 101
Ch. III
J.R. A l o n s o et al.
presence of nitric oxide synthases and nitrotyrosine immunoreactivity after focal cortical lesions. Neuroscience 82:377-395. Black SM, Bedolli MA, Martfnez S, Bristow JD. Ferriero DM, Soifer SJ (1995): Expression of neuronal nitric oxide synthase corresponds to regions of selective vulnerability to hypoxia-ischaemia in the developing rat brain. Neurobiol Dis 2:145-155. Bogdanov MB, WiJrtman RJ (1997): Possible involvement of nitric oxide in NMDA-induced glutamate release in the rat striatum: an in vivo microdialysis study. Neurosci Lett 221:197-201. Bories PN, Bories C (1995): Nitrate determination in biological fluids by an enzymatic one-step assay with nitrate reductase. Clin Chem 41:904-907. Bredt DS, Snyder SH (1990): Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 87:682-685. Bredt DS, Snyder SH (1994): Transient nitric oxide synthase neurons in embryonic cerebral cortical plate, sensory ganglia, and olfactory epithelium. Neuron 13:301-313. Bredt DS, Glatt CE, Hwang PM, Fotuhi M, Dawson TM, Snyder SH (1991a): Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPHdiaphorase. Neuron 7:615-624. Bredt DS, Hwang PH, Glatt C, L6wenstein C, Reed RR, Snyder SH (1991b): Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 351:714-718. Brifi6n JG, Crespo C, Weruaga E, Alonso J. Sobreviela T, Aij6n J, Alonso JR (1998): NADPH-diaphorase/nitric oxide synthase-positive elements in the human olfactory bulb. Neuroreport 9:3141-3146. BriJning G (1993): Localization of NADPH-diaphorase in the brain of the chicken. J Comp Neurol 334:192-208. BriJning G, Mayer B (1996): Localization of nitric oxide synthase in the brain of the frog, Xenopus laevis. Brain Res 741:331-343. BriJning G, Funk U, Mayer B (1994a): Immunocytochemical localization of nitric oxide synthase in the brain of the chicken. Neuroreport 5:2425-2428. BriJning G, Wiese S, Mayer B ( 1994b): Nitric oxide synthase in the brain of the turtle Pseudemvs scripta elegans. J Comp Neurol 348:183-206. Brianing G, Katzbach R, Mayer B (1995): Histochemical and immunocytochemical localization of nitric oxide synthase in the central nervous system of the goldfish, Carassius auratus. J Comp Neurol 358:353-382. Burazin TC, Gundlach AL (1995): Localization of NO synthase in rat brain by [3H]t.-NG-nitro-arginine autoradiography. Neuroreport 6:1842-1844. Buwalda B, Nyakas C, Gast J, Luiten PGM. Schmidt HHHW (1995): Aldehyde fixation differentially affects distribution of diaphorase activity but not of nitric oxide synthase immunoreactivity in rat brain. Brain Res Bull 38:467-473. Carboni AA, Lavelle WG, Barnes CL, Cipolloni PB (1990): Neurons of the lateral entorhinal cortex of the rhesus monkey: a Golgi, histochemical, and immunocytochemical characterization. J Comp Neurol 291:583-608. Chapman PF, Atkins CM, Allen MT, Haley JE. Steinmetz JE (1992): Inhibition of nitric oxide synthesis impairs two different forms of learning. Neuroreport 3:567-570. Cline HT, Constantine-Paton M (1989): NMDA receptor antagonists disrupt the retinotectal topographic map. Neuron 3:413-426. Cline HT, Constantine-Paton M (1990): NMDA receptor agonist and antagonists alter retinal ganglion cell arbor structure in the developing frog retinotectal projection. J Neurosci 10:1197-1216. Cozzi B, Massa R, Panzica GC (1997): The NADPH-diaphorase-containing system in the brain of the budgerigar (Melopsittacus undulatus). Cell Tissue Res 287:101-112. Cramer KS, Angelucci A, Hahm JO, Bogdanov MB. Sur M (1996): A role for nitric oxide in the development of the ferret retinogeniculate projection. J Neurosci 16:7995-8004. Crespo C, Ar6valo A, Brifi6n JG, Porteros A, Aij6n J, Alonso JR (1998a): Co-localization of calretinin and parvalbumin with nicotinamide adenine dinucleotide phosphate-diaphorase in tench Mauthner cells. Neurosci Lett 250:107-110. Crespo C, S~inchez F, Alonso JR, Ar6valo R, Carretero J, Aij6n J. V~izquez R (1998b): Partial co-existence of NADPH-diaphorase and acetylcholinesterase in the hypothalamic magnocellular secretory nuclei of the rat. J Chem Neuroanat 14:71-78. Crow JP, Beckman JS (1995): Reactions between nitric oxide, superoxide, and peroxynitrite: footprints of peroxynitrite in vivo. In: Ignarro L, Murad F (Eds), Nitric Oxide. Biochemistry; Molecular Biology and Therapeutic Implications Vo134. San Diego. CA: Academic Press, pp 17-43. Darius S, Wolf G, Huang PL, Fishman MC (1995): Localization of NADPH-diaphorase/nitric oxide synthase in the rat retina: an electron microscopic study. Brain Res 690:231-235. 102
C o m p a r a t i v e a n d d e v e l o p m e n t a l n e u r o a n a t o m i c a l a s p e c t s o f the N O s y s t e m
Ch. / / /
D~ivila JC, Megfas M, Andreu MJ, Real MA, Guirado S (1995): NADPH diaphorase-positive neurons in the lizard hippocampus: a distinct subpopulation of GABAergic interneurons. Hippocarnpus 5:60-70. Davis BJ (1991): NADPH-diaphorase activity in the olfactory system of the hamster and rat. J Comp Neurol 314:493-511. Dawson TM, Bredt DS, Fotuhi M, Hwang PM, Snyder SH (1991): Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues. Proc Natl Acad Sci USA 88:7797-7801. Derer P, Derer M (1993): Ontogenesis of NADPH-diaphorase neurons in the mouse forebrain. Neurosci Lett 152:21-24. Desvignes C, Robert F, Vachette C, Chouvet G, Cespuglio R, Renaud B, Lamb~is-Sefias L (1997): Monitoring nitric oxide (NO) in rat locus coeruleus: differential effects of NO synthase inhibitors. Neuroreport 8:1321-1325. Dinerman JL, Dawson TM, Schell MJ, Snowman A, Snyder SH (1994): Endothelial nitric oxide synthase localized to hippocampal pyramidal cells: implications for synaptic plasticity. Proc Natl Acad Sci USA 91:4214-4218. Divac I, Ramfrez-Gonzfilez JA, Ronn LC, Jahnsen H, Regidor J (1993): NADPH-diaphorase (NOS) is induced in pyramidal neurones of hippocampal slices. Neuroreport 5:325-328. Doyle CA, Slater P (1997): Localization of neuronal and endothelial nitric oxide synthase isoforms in human hippocampus. Neuroscience 76:387-395. Egberongbe YI, Gentleman SM, Falkai P, Bogerts B, Polak JM, Roberts GW (1994): The distribution of nitric oxide synthase immunoreactivity in the human brain. Neuroscience 59:561-578. Ellison DW, Kowall NW, Martin JB (1987): Subset of neurons characterized by the presence of NADPH-diaphorase in human substantia innominata. J Comp Neurol 260:233-245. Endoh M, Maiese K, Pulsinelli WA, Wagner JA (1993): Reactive astrocytes express NADPH diaphorase in vivo after transient ischemia. Neurosci Lett 154:125-128. Endoh M, Maiese K, Wagner JA (1994a): Expression of the neural form of nitric oxide synthase by CA1 hippocampal neurons and other central nervous system neurons. Neuroscience 63:679-689. Endoh M, Maiese K, Wagner JA (1994b): Expression of the inducible form of nitric oxide synthase by reactive astrocytes after transient global ischemia. Brain Res 651:92-100. Gabbott PL, Bacon SJ (1996): Localisation of NADPH-diaphorase activity and NOS immunoreactivity in astroglia in normal adult rat brain. Brain Res 714:135-144. Gaily JA, Montague PR, Reeke GN, Edelman GM (1990): The NO hypothesis: possible effects of a short-lived, rapidly diffusible signal in the development and function of the nervous system. Proc Natl Acad Sci USA 87:3547-3551. Garcfa-Ojeda E, Alonso JR, Arrvalo R, Weruaga E, Brifi6n JG, Aij6n J (1994): Nicotinamide-adenine-dinucleotidephosphate diaphorase-positive neurons and fibers in the nucleus olfactorius anterior of the rat. Arch Ital Biol 132:13-24. Garcfa-Ojeda E, Alonso JR, Crespo C, Weruaga E, Brifi6n JG, Arrvalo R, Aij6n J (1997): Transient expression of NADPH-diaphorase/nitric oxide synthase in the paratenial nucleus of the rat thalamus. Dev Brain Res 101:177186. Garthwaite J, Boulton CL (1995): Nitric oxide signaling in the central nervous system. Annu Rev Phvsiol 57:683706. Geula C, Schatz CR, Mesulam MM (1993): Differential localization of NADPH-diaphorase and calbindin-D28k within the cholinergic neurons of the basal forebrain, striatum and brainstem in the rat, monkey, baboon and human. Neuroscience 54:461-476. Giuili G, Luzi A, Poyard M, Guellai~n G (1994): Expression of mouse brain soluble guanylyl cyclase and NO synthase during ontogeny. Dev Brain Res 81:269-283. Gonz~ilez A, Mufioz A, Mufioz M, Marfn O, Arrvalo R, Porteros A, Alonso JR (1996): Nitric oxide synthase in the brain of a urodele amphibian (Pleurodeles waltl) and its relation to catecholaminergic neuronal structures. Brain Res 727:49-64. Gonz~ilez MF, Sharp FR, Sagar SM (1987): Axotomy increases NADPH-diaphorase staining in rat vagal motor neurons. Brain Res Bull 18:417-427. Gonzfilez-Hermindez T, Conde-Sendfn M, Gonzfilez-Gonzfilez B, Mantol~in-Sarmiento B, Prrez-Gonz~ilez H, Meyer G (1993): Postnatal development of NADPH-diaphorase activity in the superior colliculus and the ventral lateral geniculate nucleus of the rat. Dev Brain Res 76:141-145. Gonz~,lez-Hern~indez T, Prrez-de la Cruz MA, Mantol~in-Sarmiento B (1996): Histochemical and immunohistochemical detection of neurons that produce nitric oxide: effect of different fixative parameters and immunoreactivity against non-neuronal NOS antisera. J Histochem Cvtochem 44:1399-1413. Good M (1996): Targeted deletion of neuronal nitric oxide: a step closer to understanding its functional significance?. Trends Neurosci 19:83-84. 103
Ch.
III
J.R. A l o n s o et al.
Gorbatyuk O, Landry M, Emson E Akmayev I, H6kfelt T I1997): Developmental expression of nitric oxide synthase in the rat diencephalon with special reference to the thalamic paratenial nucleus, htt J Dev Neurosci 15:931-938. Green LC, Wagner DA, Glodowsky J, Skipper PL, Wishnok JS, Tannenbaum SR (1982): Analysis of nitrate, nitrite, and [JSN]nitrate in biological fluids. Anal Biochem 126:13 !-138. Hirsch DB, Steiner JR Dawson TM, Mammen A. Hayek E, Snyder SH (1993): Neurotransmitter release regulated by nitric oxide in PC-12 cells and brain synaptosomes. Curr Biol 3:749-754. Hoffman M (1991): A new role for gases: neurotransmission. Science 252:1788. Holmqvist BI, Ostholm T, Aim E EkstrOm P t 1994): Nitric oxide synthase in the brain of a teleost. Neurosci Lett 171:205-208. Hong SC, Lanzino G. Collins J. Kassell NF, Lee KS I1993): Selective loss of NADPH-diaphorase-containing neurons in the dentate gyrus following transient ischemia. Neltrorepot7 5:84-86. Hope BT, Vincent SR (1989): Histochemical characterization of neuronal NADPH-diaphorase. J Histochem Cvtochem 37:653-661. Hope BT, Michael GJ, Knigge KM. Vincent SR 11991): Neuronal NADPH-diaphorase is a nitric oxide synthase. Proc Natl Acad Sci USA 88:2811-2814. Hopkins DA, Steinbusch HWM, Markerink-Van Ittersum M, De Vente J (1996): Nitric oxide synthase, cGME and NO mediated cGMP production in the olfactory bulb of the rat. J Comp Neurol 375:641-658. Huang PL, Dawson TM, Bredt DS, Snyder SH, Fishman MC I1993): Targeted disruption of the neuronal nitric oxide synthase gene. Cell 75:1273-1286. Hyman BT, Marzloff K, Wenninger JJ, Dawson TM, Bredt DS, Snyder SH ( 1992): Relative sparing of nitric oxide synthase-containing neurons in the hippocampal Iormation in Alzheimer's disease. Ann Neurol 32:818-820. Iadecola C (1997): Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci 20:132-139. Iwase K, Iyama K, Akagi K, Yano S, Fukunaga K. Miyamoto E, Mori M. Takiguchi M {1998a): Precise distribution of neuronal nitric oxide synthase mRNA in the rat brain revealed by non-radioisotopic in situ hybridization. Mol Brain Res 53:1-12. Iwase K, Takemura M, Shimada T, Wakisaka S, Nokubi T, Shigenaga Y (1998b): Ontogeny of NADPH-diaphorase in rat forebrain and midbrain. Am~t Embn'ol 197:229-247. Izumi Y, Benz AM, Clifford DB, Zorumski CF (1992): Nitric oxide inhibitors attenuate N-methyl-D-aspartate excitotoxicity in rat hippocampal slices. Neurosci Lett 135:227-230. Jiang P-J, Terashima S (1996): Distribution of NADPH-diaphorase in the central nervous system of an infrared-sensitive snake, Trimeresurus flavoviridis. Brain Res 713:168-177. Johnson MD, Ma PM (1993): Localization of NADPH-diaphorase activity in monoaminergic neurons of the rat brain. J Comp Neurol 332:391-406. Kano T, Shimizu-Sasamata M, Huang PL. Moskowitz MA, Lo EH 11998): Effects of nitric oxide synthase gene knockout on neurotransmitter release in vivo. Net~roscience 86:695-699. Kantor DB, Lanzrein M, Stary SJ, Sandoval GM. Smith WB, Sullivan BM, Davidson N, Schuman EM (1996): A role for endothelial NO synthase in LTP revealed by adenovirus-mediated inhibition and rescue. Science 274:1744-1748. Karanth S, Lyson K, McCann SM (1993): Role of nitric oxide in interleukin-2-induced corticotropin-releasing factor release from incubated hypothalami. Proc Natl Acad Sci USA 15:3383-3387. Kato H, Kogure K, Liu Y, Araki T, ltoyama Y I1994): Induction of NADPH-diaphorase activity in the hippocampus in a rat model of cerebral ischemia and ischemic tolerance. Brain Res 652:71-75. Kharazia VN, Schmidt HHHW, Weinberg RJ (1994): Type I nitric oxide synthase fully accounts for NADPHdiaphorase in rat striatum, but not cortex. Neuroscience 62:983-987. Kimura KA, Brien JF (1998): Hippocampal nitric oxide synthase in the fetal guinea pig: effects of chronic prenatal ethanol exposure. Dev Brain Res 106:39-46. Kinjo N, Skinner RD, Powell EW (1989): A study of NADPH-diaphorase positive septohippocampal neurons in rat. Neurosci Res 7:154-158. Kishimoto J, Keverne EB, Hardwick J. Emson PC (19931: Localization of nitric oxide synthase in the mouse olfactory and vomeronasal system: a histochemical, immunological and in situ hybridization study. Eur J Neulvsci 5:1684-1694. Kitchener PD, Diamond J (1993): Distribution and colocalization of choline acetyltransferase immunoreactivity and NADPH diaphorase reactivity in neurons within the medial septum and diagonal band of Broca in the rat basal forebrain. J Comp Neurol 335:1-15. Knowles RG, Moncada S (1994): Nitric oxide synthases in mammals. Biochem J 298:249-258. Kotti T, Halonen T, Sirvio J, Riekkinen P. Miettinen R (1997): Comparison of NADPH diaphorase histochemistry, 104
Comparative and developmental neuroanatomical aspects of the NO system
Ch. III
somatostatin immunohistochemistry, and silver impregnation in detecting structural and functional impairment in experimental status epilepticus. Neuroscience 80:105-117. Kowall NW, Beal ME Ferrante RJ, Martin JB (1985): Topography of nicotinamide adenine dinucleotide phosphatediaphorase staining neurons in rat striatum. Neurosci Lett 59:61-66. Kubrina LN, Caldwell WS, Mordvintcev PI, Malenkova IV. Vanin AF (1992): EPR evidence for nitric oxide production from guanidino nitrogens of L-arginine in animal tissues in vivo. Biochim Biophys Acta 1099:233237. Kugler P, Drenckhahn D (1996): Astrocytes and Bergmann glia as an important site of nitric oxide synthase I. Glia 16:165-173. Kulkarni AE Getchell TV, Getchell ML (1994): Neuronal nitric oxide synthase is localized in extrinsic nerves regulating perireceptor processes in the chemosensory nasal mucosae of rats and humans. J Comp Neurol 345:125-138. Kuonen DR, Kemp MC, Roberts PJ (1988): Demonstration and biochemical characterization of rat brain NADPHdependent diaphorase. J Neurochem 50:1017-1025. Kuriyama K, Ohkuma S (1995): Role of nitric oxide in central synaptic transmission: effects on neurotransmitter release. Jpn J Pharmacol 69:1-8. Lancaster JR, Langrehr JM, Bergonia HA, Murase N, Simmons RL, Hoffman RA (1992): EPR detection of heine and nonheme iron-containing protein nitrosylation by nitric oxide during rejection of rat heart allograft. J Biol Chem 26 7:10994-10998. Lerner-Natoli M, De Bock F, Bockaert J, Rondouin G (1994): NADPH diaphorase-positive cells in the brain after status epilepticus. Neuroreport 5:2633-2637. Li J, Chert S, Lin RC, Smith SS (1997): Cerebellar nitric oxide synthase is expressed within granule cell patches innervated by specific mossy fiber terminals: a developmental profile. Dev Neurosci 19:274-282. Li ZS, Burness JB, Young HM, Campbell G (1992): Nitric oxide synthase immunoreactivity and NADPH diaphorase enzyme activity in neurons of the gastrointestinal tract of the toad, Bufo marinus. Arch Histol Cvtol 55:333-350. L6wenstein CJ, Snyder SH (1992): Nitric oxide, a novel biologic messenger. Cell 70:705-707. Luckman SM, Huckett L, Bicknell RJ, Voisin DL, Herbison AE (1997): Up-regulation of nitric oxide synthase messenger RNA in an integrated forebrain circuit involved in oxytocin secretion. Neuroscience 77:37-48. Luebke JL, Weider JM, McCarley RW, Greene RW (1992): Distribution of NADPH-diaphorase positive somata in the brainstem of the monitor lizard Varanus exanthematicus. Neurosci Lett 148:129-132. Marfn O, Gonz~ilez A, Smeets WJAJ (1995): Evidence tot a mesolimbic pathway in anuran amphibians: a combined tract-tracing/immunohistochemical study. Neurosci Lett 190:183-186. Matsumoto T, Nakane M, Pollock JS, Kuk JE, F/3rstermann U (1993): A correlation between soluble brain nitric oxide synthase and NADPH-diaphorase activity is only seen after exposure of the tissue to fixative. Neurosci Lett 155:61-64. Meek J (1994): Catecholamines in the brains of Osteichthyes (bony fishes). In: Smeets WJAJ, Reiner A (Eds), Phylogeny and Development of Catecholamine Systems in the CNS ~( Vertebrates. Cambridge: Cambridge University Press, pp 49-76. Meffert MK, Haley JE, Schuman EM, Schulman H, Madison DV (1994): Inhibition of hippocampal heme oxygenase, nitric oxide synthase, and long-term potentiation by metalloporphyrins. Neutvn 13:1225-1233. Miettinen R, Kotti T, Halonen T, Riekkinen P (1995): NADPH diaphorase-containing nonpyramidal cells in the rat hippocampus exhibit differential sensitivity to kainic acid. Eur J Nemvsci 7:1822-1825. Minc-Golomb D, Yadid G, Tsarfaty I, Resau JH, Schwartz JP (1996): In vivo expression of inducible nitric oxide synthase in cerebellar neurons. J Neurochem 66:1504-1509. Mizukawa K, McGeer PL, Vincent ST, McGeer EG (1988): Ultrastructure of reduced nicotinamide adenine dinucleotide phosphate (NADPH) diaphorase-positive neurons in the cat cerebral cortex, amygdala and caudate nucleus. Brain Res 452:286-292. Mizukawa K, Vincent SR, McGeer PL, McGeer EG (1989): Distribution of reduced nicotine-adenine-dinucleotidephosphate-diaphorase-positive cells and fibers in the cat central nervous system. J Comp Neutvl 279:281311. Montague PR, Gancayco CD, Winn MJ, Marchase RB, Friedlander MJ (1994): Role of NO production in NMDA receptor-mediated neurotransmitter release in cerebral cortex. Science 263:973-977. Morgan MJ, Kimes AS, London ED (1992): Possible roles for nitric oxide in AIDS and associated pathology. Med Hypoth 38:189-193. Mufson EJ, Brady DR, Carey RG (1990): Reduced nicotinamide adenine dinucleotide phosphate-diaphorase 105
Ch. I I I
J.R. A l o n s o et al.
(NADPH-d) histochemistry in the hippocampal formation of the New World monkey (Saimilq sciureus). Brain Res 516:237-247. Mufioz M, Mufioz A, Marfn O, Alonso JR, Ar6valo R, Porteros A, Gonz~lez A (1996): Topographical distribution of NADPH-diaphorase activity in the central nervous system of the frog, Rana perezi. J Comp Neuro136 7:54-69. Nakamura S, Kawamata T, Kimura T, Akiguchi I, Kameyama M. Nakamura N, Wakata Y, Kimura H (1988): Reduced nicotinamide adenine dinucleotide phosphate-diaphorase histochemistry in the pontomesencephalic region of the human brainstem. Brain Res 455:144-147. Nei K, Matsuyama S, Shuntoh H, Tanaka C (1996): NMDA receptor activation induces glutamate release through nitric oxide synthesis in guinea pig dentate gyrus. Brain Res 728:105-110. Nowicki JP, Duval D, Poignet H, Scatton B (1991): Nitric oxide mediates neuronal death after focal cerebral ischemia in the mouse. Eur J Pharmacol 204:339-340. O'Dell TJ, Hawkins RD, Kandel ER, Arancio O (1991): Tests of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger. Proc Natl Acad Sci USA 88:11285-11289. Okere CO, Higuchi T, Kaba H, Russell JA, Okutani F, Takahashi S, Murata T (1996): Nitric oxide prolongs parturition and inhibits maternal behavior in rats. Neuroreport 7:1695-1699. Ostholm T, Holmqvist BI, Alto P, Ekstr6m P (1994): Nitric oxide synthase in the CNS of the Atlantic salmon. Neurosci Lett 168:233-237. Palkovits M, Brownstein MJ (1988): Maps and Guide to Microdissection of the Rat Brain. New York, NY: Elsevier. Palluy O, Rigaud M (1996): Nitric oxide induces cultured cortical neurons apoptosis. Neutvsci Lett 208:1-4. Panzica GC, Ar6valo R, S~inchez E Alonso JR. Aste N, Viglietti-Panzica C, Aij6n J, V~izquez R (1994): Topographical distribution of reduced nicotinamide adenine dinucleotide phosphate-diaphorase in the brain of the Japanese quail. J Comp Neuro1342:97-114. Panzica GC, Garzino A, Ojeda EG (1996): Coexistence of NADPH-diaphorase and tyrosine hydroxylase in the mesencephalic catecholaminergic system of the Japanese quail. J Chem Neuroanat 11:37-47. Peunova N, Enikolopov G (1995): Nitric oxide triggers a switch to growth arrest during differentiation of neuron cells. Nature 375:68-73. P6rez SE, Adrio F, Rodrfguez MA, Rodrfguez-Moldes I. Anad6n R (1996): NADPH-diaphorase histochemistry reveals oligodendrocytes in the rainbow trout (teleosts). Neulvsci Lett 205:83-86. Pierre J, Rio JE Mahouche M, Rep6rant J (1994): Catecholamine systems in the brain of cyclostomes, the lamprey, Lampetra fluviatilis. In: Smeets WJAJ, Reiner A (Eds). Phylogeny and Development of Catecholamine Systems in the CNS of Vertebrates. Cambridge: Cambridge University Press, pp 7-19. Porteros A, Alonso JR, Ar6valo R, Garcfa-Ojeda E, Crespo C, Aij6n J (1994): Histochemical localization of NADPH-diaphorase in the rat accessory olfactory bulb. Chem Senses 19:413-424. Porteros A, Ar6valo R, Crespo C, Brifi6n JG, Weruaga E, Aij6n J, Alonso JR (1996): Nitric oxide synthase activity in the olfactory bulb of anuran and urodele amphibians. Brain Res 724:67-72. Prasada-Rao PD, Sato T, Ueck M (1997): Distribution of NADPH-diaphorase activity in the hypothalamohypophysial system of the frog, Rana esculenta. Nelovsci Lett 235:61-64. Prast H, Fischer HE Prast M, Philippu A (1994): In vivo modulation of histamine release by autoreceptors and muscarinic acetylcholine receptors in the rat anterior hypothalamus. Naunvn Schmiedebergs Arch Pharmacol 350:599-604. Prast H, Lamberti C, Fischer H, Philippu A (1997): Modulation of histamine release in the hypothalamus by nitric oxide. Inflamm Res 46:$41-$42. Pullen AH, Humphreys P, Baxter RG (1997): Comparative analysis of nitric oxide synthase immunoreactivity in the sacral spinal cord of the cat, macaque and human. J Anat 191:161-175. Raszkiewicz JL, Linville DG, Kerwin JF, Wagenaar F, Arneric SP (1992): Nitric oxide synthase is critical in mediating basal forebrain regulation of cortical cerebral circulation. J Neurosci Res 33:129-135. Rebeck GW, Marzloff K, Hyman BT (1993): The pattern of NADPH-diaphorase staining, a marker of nitric oxide synthase activity, is altered in the perforant pathway terminal zone in Alzheimer's disease. Neurosci Lett 152:165-168. Regidor J, Montesdeoca J, Ramfrez-Gonz~ilez JA, Hern~indez-Urqufa CM, Divac I (1993): Bilateral induction of NADPH-diaphorase activity in neocortical and hippocampal neurons by unilateral injury. Brain Res 631:171174. Rettori V, Canteros G, Renoso R, Gimeno M, McCann SM (1997): Oxytocin stimulates the release of luteinizing hormone-releasing hormone from medial basal hypothalamic explants by releasing nitric oxide. Proc Natl Acad Sci USA 94:2741-2744. Rodrigo J, Springall DR, Uttenthal O, Bentura ML, Abadfa-Molina F, Riveros-Moreno V, Martfnez-Murillo R, 106
Comparative and developmental neuroanatomical aspects of the NO system
Ch.H/
Polak JM, Moncada S (1994): Localization of nitric oxide synthase in the adult rat brain. Philos Trans R Soc Lond B 345:175-221. Rosenblum WI (1992): Endothelium-derived relaxing factor in brain blood vessels is not nitric oxide. Stroke 23:1527-1532. Roskams AJ, Bredt DS, Dawson TM, Ronnet GV (1994): Nitric oxide mediates the formation of synaptic connections in developing and regenerating olfactory receptor neurons. NeuJvn 13:289-299. S~inchez F, Alonso JR, Ar6valo R, Blanco E, Aij6n J, Vzizquez R (1994): Coexistence of NADPH-diaphorase with vasopressin and oxytocin in the hypothalamic magnocellular neurosecretory nuclei of the rat. Cell Tissue Res 276:31-34. S~inchez F, Alonso JR, Ar6valo R, BriJning G. Panzica GC (1996): Absence of coexistence between NADPHdiaphorase and antiduretic hormone in the hypothalamus of two galliforms: Japanese quail (Coturnix japonica) and chicken (Gallus domesticus). Neurosci Lett 216:155-158. Sandell JH, Graybiel AM, Chesselet MF (1986): A new enzyme marker for striatal compartmentalization: NADPH diaphorase activity in the caudate nucleus and putamen of the cat. J Comp Neurol 243:326-334. Sato T (1990a): Immunohistochemical demonstration of NADPH-diaphorase activity in the pineal organ of the frog (Rana esculenta), but not in the pineal organ of the rat. Arch Histol Cvtol 53:141-146. Sato T (1990b): A method for the demonstration of NADPH-diaphorase activity in anuran species using unfixed retina wholemounts. Arch Histol Cvtol 54:207-211. Schober A, Malz CR, Meyer DL (1993): Enzyme histochemical demonstration of nitric oxide synthase in the diencephalon of the rainbow trout (Oncorhynchus mykiss). Neurosci Lett 151:67-70. Schober A, Malz CR, Schober W, Meyer DL (1994): NADPH-diaphorase in the central nervous system of the larval lamprey (Lampetra planeri). J Comp Neurol 345:94-104. Schuman EM, Madison DV ( 1994): Nitric oxide and synaptic function. Atmu Rev Neulwsci 17:153-185. Sestan N, Kostovi6 I (1994): Histochemical localization of nitric oxide synthase in the CNS. Trends Neurosci 17:105-106. Simon DK, Prusky GT, O'Leary DDM, Constantine-Paton M (1992): N-methyl-D-aspartate receptor antagonists disrupt the formation of a mammalian neural map. Proc Natl Acad Sci USA 89:10593-10597. Sims KS, Williams RS (1990): The human amygdaloid complex: a cytologic and histochemical atlas using Nissl, myelin, acetylcholinesterase and nicotinamide adenine dinucleotide phosphate diaphorase staining. Neuroscience 36:449-472. Sistiaga A, Miras-Portugal MT, S~inchez-Prieto J (1997): Modulation of glutamate release by a nitric oxide/cyclic GMP-dependent pathway. Eur J Pharmacol 321:247-257. Skinner RD, Conrad C, Henderson V, Gilmore SA. Garcfa-Rill E (1989): Development of NADPH-diaphorase-positive pedunculopontine nucleus neurons. Exp Neurol 104:15-21. Smeets WJAJ, Reiner A (1994): Catecholamine in the CNS of vertebrates: current concepts of evolution and functional significance. In: Smeets WJAJ, Reiner A (Eds), Phylo,~eny and Development of Catecholamine S~'stems in the CNS of Vertebrates. Cambridge: Cambridge University Press, pp 463-481. Smeets WJAJ, Alonso JR, Gonz~ilez A (1997): Distribution of NADPH-diaphorase and nitric oxide synthase in relation to catecholaminergic neuronal structures in the brain of the lizard Gekko gecko. J Comp Neurol 377:121-141. Sobreviela T, Mufson EJ (1995): Reduced nicotinamide adenine dinucleotide phosphate-diaphorase/nitric oxide synthase profiles in the human hippocampal formation and perirhinal cortex. J Comp Neurol 358:440-464. Spessert R, Claassen M (1998): Histochemical differentiation between nitric oxide synthase-related and -unrelated diaphorase activity in the rat olfactory bulb. Histochem J 30:41-50. Spessert R, Layers E (1994): Fixation conditions affect the intensity but not the pattern of NADPH-diaphorase staining as a marker for neuronal nitric oxide synthase in rat olfactory bulb. J Histochem Cvtochem 42:13091315. Stojkovic T, Colin C, Le Saux F, Jacque C (1998): Specific pattern of nitric oxide synthase expression in glial cells after hippocampal injury. Glia 22:329-337. Stringer JL, Erden F (1995): In the hippocampus in vivo, nitric oxide does not appear to function as an endogenous antiepileptic agent. Exp Brain Res 105:391-401. Takemura M, Wakisaka S, Iwase K, Yabuta NH. Nakagawa S, Chen K, Bae YC, Yoshida A, Shigenaga Y (1996): NADPH-diaphorase in the developing rat: lower brainstem and cervical spinal cord, with special reference to the trigemino-solitary complex. J Comp Neu~vl 365:511-525. Talavera E, Martfnez-Lorenzana G, Corkidi G, Le6n-Olea M. Condes-Lara M (1997): NADPH-diaphorase-stained neurons after experimental epilepsy in rats. Nitric" Oxide 1:484-493. 107
Ch. III
J.R. A l o n s o et al.
Ta~kiran D, Kutay FZ, Sozmen E, P6~a/in S (1997)" Sex differences in nitrite/nitrate levels and antioxidant defense in rat brain. Neuroreport 8:881-884. Thomas E, Pearse AGE (1961): The fine localization of dehydrogenases in the nervous system. Histochemie 2:266-282. Thomas E, Pearse AGE (1964)" The solitary active cells. Histochemical demonstration of damage-resistant nerve cells with a TPN-diaphorase reaction. Acta Neuropathol (Berlin) 3:238-249. Tracey WR, Nakane M, Pollock JS, F6rstermann U (1993)" Nitric oxide synthases in neural cells, macrophages and endothelium are NADPH diaphorases, but represent only a traction of total cellular NADPH diaphorase activity. Biochem Biophys Res Commun 195:1035-1040. Turner RW, Moroz LL (1995): Localization of nicotinamide adenine dinucleotide phosphate-diaphorase activity in electrosensory and electromotor systems of a gymnotiform teleost. Apteronotus leptorhynchus. J Comp Neurol 356:261-274. Vaid RR, Yee BK, Rawlins JN, Totterdell S (1996) NADPH-diaphorase reactive pyramidal neurons in Ammon's horn and the subiculum of the rat hippocampal formation. Brain Res 733:31-40. Valtschanoff JG, Weinberg RJ, Rustioni A (1992): NADPH-diaphorase in the spinal cord of rats. J Comp Neurol 321:209-222. Valtschanoff JG, Weinberg RJ, Kharazia VN. Nakane M, Schmidt HHHW (1993)' Neurons in rat hippocampus that synthesize nitric oxide. J Comp Neurol 331:11 I-121. Villani L, Guarnieri T (1995): Localization of NADPH-diaphorase in the goldfish brain. Brain Res 679:261-266. Vincent SR (1994): Nitric oxide: a radical neurotransmitter in the central nervous system. P~vg Neurobiol 42:129160. Vincent SR, Kimura H (1992): Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience 46:755-784. Vincent SR, Satoh K, Armstrong DM, Panula E Vale W. Fibiger HC (1986): Neuropeptides and NADPH-diaphorase activity in the ascending cholinergic reticular system of the rat. Nemvscience 17:167-182. Vizzard MA, Erdman SL, De Groat WC (1995): Increased expression of neuronal nitric oxide synthase in dorsal root ganglion neurons after systemic capsaicin administration. Netttvscience 67:1-5. Von Bartheld CS, Schober A (1997): Nitric oxide synthase in learning-relevant nuclei of the chick brain" morphology, distribution, and relation to transmitter phenotypes. J Comp Nemvl 383:135-152. Wallace MN, Bisland SK (1994): NADPH-diaphorase activity in activated astrocytes represents inducible nitric oxide synthase. Neuroscience 59:905-919. Wallace MN, Fredens K (1989)" Relationship of afferent inputs to the lattice of high NADPH-diaphorase activity in the mouse superior colliculus. Exp Brain Res 78:435-445. Wallace MN, Fredens K (1992): Activated astrocytes of the mouse hippocampus contain high levels of NADPHdiaphorase. Neuroreport 3:953-956. Wallh~iusser-Franke E, Collins CE, De Voogd TJ (1995): Developmental changes in the distribution of NADPHdiaphorase-containing neurons in telencephalic nuclei of the zebra finch song system. J Comp Neurol 356:345354. Wendland B, Schweizer FE, Ryan TA. Nakane M. Murad E Scheller RH, Tsien RW (1994): Existence of nitric oxide synthase in rat hippocampal pyramidal cells. P~vc Natl Acad Sci USA 91:2151-2155. Weruaga E, Crespo C, Porteros A. Brifi6n JG. Ar6valo R. Aij6n J, Alonso JR (1998): NADPH-diaphorase histochemistry reveals heterogeneity in the distribution of nitric oxide synthase-expressing interneurons between olfactory glomeruli in two mouse strains. J Neurosci Res 53:239-250. Williams CV, Nordquist D, McLoon SC (1994): Correlation of nitric oxide synthase expression with changing patterns of axonal projections in the developing visual system. J Neurosci 14:1746-1755. Wolf G, Wtirdig S, Schtinzel G (1992)" Nitric oxide synthase in rat brain is predominantly located at neuronal endoplasmatic reticulum: an electron microscopic demonstration of NADPH-diaphorase activity. Neurosci Lett 147:63-66. Wolf G, Henschke G, Wtirdig S (1993): Glutamate agonist-induced hippocampal lesion and nitric oxide synthase/NADPH-diaphorase" a light and electron microscopical study in the rat. Neurosci Lett 161:49-52. Wolf G, Schmidt W, Calka J, Henschke G, Wtirdig S (1995): Brain lesion and nitric oxide synthase/NADPH-diaphorase: a light and electron microscopical study. In: Weissman BA, Allon N, Shapira S (Eds), Biochemical, Pharmacological and Clinical Aspects of Nitric Oxide. New York, NY: Plenum Press, pp 213-220. Wtirl J, Wiesand M, Mayer B, Gresk6tter K-R, Neuhuber WL (1994): Neuronal and endothelial nitric oxide synthase immunoreactivity and NADPH-diaphorase staining in rat and human pancreas: influence of fixation. Histochemistla" 102"353-364. 108
Comparative and d e v e l o p m e n t a l neuroanatomical aspects o f the N O system
Ch. III
Wu HH, Williams CV, McLoon SC (1994): Involvement of nitric oxide in the elimination of a transient retinotectal projection in development. Science 265:1593-1596. Xia Y, Zweier JL (1997): Direct measurement of nitric oxide generation from nitric oxide synthase. Proc Natl Acad
Sci USA 94:12705-12710. Yamada K, Nabeshima T (1997): Simultaneous measurement of nitrite and nitrate levels as indices of nitric oxide release in the cerebellum of conscious rats. J Neurochem 68:1234-1243. Yamada K, Nabeshima T (1998): Changes in NMDA receptor/nitric oxide signaling pathway in the brain with aging. Microsc Res Tech 43:68-74. Zhang X, Yu PH (1995): Depletion of NOS activity in the rat dentate gyrus neurons by DSP-4 and protection by deprenyl. Brain Res Bull 38:307-311. Zielinski BS, Osahan JK, Hara TJ, Hosseini M, Wong E (1996): Nitric oxide synthase in the olfactory mucosa of the larval sea lamprey (Petromizon marinus). J Comp Neurol 365:18-26.
109
This Page Intentionally Left Blank
CHAPTER IV
Nitric oxide in the retina W.D. ELDRED
1. I N T R O D U C T I O N In the past few years, there has been an explosion of interest in the role of nitric oxide (NO) in neural function, development and pathology. Although numerous studies have focused on the brain, many of the most detailed studies have examined the retina. In many ways, the retina is an ideal model system to study NO. The anatomy and physiology of many retinal neurons have been well characterized in a wide variety of species, and numerous detailed comparisons of the same cell types in different species have been made. This comparative approach has an advantage over many studies in brains that have analyzed many diverse neuronal systems in a limited number of mammalian species. Detailed cross-species comparisons will establish which functions of NO are universal cellular mechanisms and which are more species-specific. The retina also has the advantage that, within certain limits, all regions of a retina have similar anatomical connections and use the same physiological mechanisms for visual processing. Finally, some of the best characterized retinal model systems, such as salamanders or turtles, have large cells that are ideal for electrophysiology and have very well-developed NO signal transduction pathways. Thus, the retina provides a perfect blend of well-characterized anatomical and physiological complexity to examine the roles of NO in neural function. NO represents a new class of neurotransmitters that serve a variety of synaptic and non-synaptic functions that are not characteristic of traditional neurotransmitters. It is not like a classic neurotransmitter in that it is made on demand and not stored for vesicular release. Its action is not restricted to specific morphologically specialized sites and it can rapidly diffuse to trigger cGMP synthesis in cells that are not connected synaptically. The cGMP that is produced can in turn activate ion channels, protein kinase G or phosphodiesterases (PDEs). NO can also have direct effect on target proteins like NMDA receptors or ADP-ribosyl transferase. This review is not intended to be an exhaustive of NO in the entire visual system, but it will summarize many aspects of NO in the retina and suggest new areas for future research. For recent reviews of the role of NO in a more general ocular function and its role in retinal and ocular pathology, please see Goldstein et al. (1996) or Becquet et al. (1997).
2. L O C A L I Z A T I O N OF NITRIC OXIDE SYNTHASE IN THE RETINA Historically, the first localizations of nitric oxide synthase (NOS) in the retina were done before it was discovered. This is because NADPH-diaphorase histochemistry was first used over 40 years ago (Wislocki and Sidman, 1954) to selectively stain retinal neurons. Only Handbook of Chemical Neuroanatom3; Vol. 17: Functional Neuroanatonly o.f the :Vitric Oxide System H.W.M. Steinbusch, J. De Vente and S.R. Vincent, editors (~) 2000 Elsevier Science B.V. All rights reserved.
111
Ch. IV
W.D. Eldred
much later (Vincent and Hope, 1992), did the NADPH-diaphorase activity become associated with NOS. The precise localization of NOS at the cellular and subcellular levels is critical to provide insight into mechanisms by which NO is functionally involved in the signal transduction in the retina. Although sites of NO synthesis do not necessarily correlate with the sites of action, they must be in close proximity given the short half-life of NO (Vincent, 1994). 2.1. METHODOLOGICAL CONSIDERATIONS
2.1.1. NADPH-diaphorase histochemistry Since the enzymatic activity of NOS requires a cofactor NADPH, histochemistry has been used extensively to localize NOS through the reduction of tetrazolium salts to an insoluble formazan reaction product. NADPH-diaphorase is still widely used to localize NOS in the retina because of its effectiveness and simplicity. More recently, immunocytochemistry using antibodies directed against specific isoforms of NOS has also gained wide acceptance. Both NADPH-diaphorase histochemistry and NOS immunocytochemistry each have their own advantages and disadvantages, which can lead to difficulties in the interpretations of the anatomical localizations. Although NADPH-diaphorase histochemistry is very easy and inexpensive, there are some difficulties with this method. First, there are at least six other enzymes dependent on NADPH (Schonfelder et al., 1993), such as cytochrome P450 reductase that has a 58% sequence homology with NOS. However, paraformaldehyde fixation is reported to destroy 100% of particulate diaphorase and retain 40-60% of the cytosolic fixation-resistant diaphorase that is thought to be real NOS (Matsumoto et al., 1993; Tracey et al., 1993). Another possible cross-reaction with the NADPH-diaphorase-dependent enzyme, DT-diaphorase, is shown to be inhibited by 10-100 ~M dicumarol (Riley and Workman, 1992). Such potential difficulties in correlating NOS with NADPH-diaphorase are given strong support by a comprehensive study that compares the localizations of NADPH-diaphorase staining to the immunocytochemical localizations of nNOS, eNOS, iNOS and cytochrome P450 reductase in a wide range of tissues (Young et al., 1997). These authors find that cells that are immunoreactive for any of these four NADPH-dependent enzymes also have NADPH-diaphorase in formaldehyde-fixed tissue, but that in some tissues there is NADPH-diaphorase staining when none of these enzymes can be localized immunocytochemically. There are also two variations of the NADPH-diaphorase reaction: the direct method which adds NADPH to the reaction mix, and the indirect method that depends on activity of other enzymes in the tissue itself, like glucose-6-phosphate dehydrogenase enzyme or malic enzyme to make NADPH from NADP (Sandell, 1985). Detailed examination of the literature indicates that although the direct method is easier and is reported to produce more intense staining, there is more variation in the results of different investigators using the same method, than between the indirect and direct methods. They both can produce excellent results if done well. One remaining source of ambiguity is that NADPH-diaphorase histochemistry cannot distinguish between different isoforms of NOS (Young et al., 1997), some of which may remain to be discovered. This is particularly relevant when one is trying to establish the function of NOS, in that all NOS isoforms possibly have NADPH-diaphorase activity, but they may have very distinct regulatory mechanisms and functions. There is also the question of the ultrastructural localization of NADPH-diaphorase. To localize NADPH-diaphorase at the electron microscopic level, one must use a special 112
Nitric oxide in the retina
Ch. IV
tetrazolium salt, to form an osmiophilic formazan deposit. At the ultrastructural level in the retina, the subsequent BSPT reaction product is localized on the endoplasmic reticulum, the nuclear membrane, mitochondria and the Golgi apparatus (Darius et al., 1995; Villani and Guarnieri, 1996). These seemingly metabolic subcellular localizations are difficult to reconcile with the known synaptic localizations of NOS using immunocytochemical methods (Haverkamp and Eldred, 1998b). However, the BSPT reaction product is not present in NOS-knockout mice (Darius et al., 1995), which argues for the involvement of NOS. It is possible that the BSPT might be localizing an alternate novel isoform of NOS, and further studies will be necessary to resolve this issue.
2.1.2. NOS immunocytochemistry In recent years, many excellent commercial antibodies against several NOS isoforms have become available. In some cases these antibodies produce the same labeling in the retina as seen with NADPH-diaphorase histochemistry (Roufail et al., 1995), while in other cases there are some differences (Perez et al., 1995; Blute et al., 1997). In many cases, species differences may prevent good labeling with NOS immunocytochemistry. Another consideration is that these antibodies are ideally directed against a single isoform of NOS, which prevents the detection of other isoforms of NOS. These methods do have the advantage that the same NOS antibodies can also be used for Western blots to more precisely biochemically characterize the antigens being labeled (Goureau et al., 1997). Two studies use immunocytochemical methods at the electron microscopic level to localize NOS in the retina (Roufail et al., 1995; Haverkamp and Eldred, 1998b), and the results of these studies will be described in detail later. 2.2. ISOFORMS OF NOS IN THE RETINA As discussed above, the NADPH-diaphorase histochemistry does not allow the specification of the NOS isoform involved. In some cases, even pharmacological studies cannot clarify the isoform involved because the high concentrations of isoform-specific NOS inhibitors needed in vivo or in vitro eliminate their isoform specificity (Wellard et al., 1995). This leaves only isoform-specific antibodies to distinguish the presence of certain NOS isoforms. The majority of retinal research focuses on the neuronal NOS (nNOS) isoform, while relatively few studies examine the presence of endothelial NOS (eNOS) or inducible NOS (iNOS). The existence of retinal nNOS is clearly established as described in the subsequent portions of this review. The presence of eNOS in the retina remains somewhat unresolved in that although Haberecht et al. (1998) report that there is no eNOS in the rabbit retina, Goureau et al. (1997) find a 135 kDa protein corresponding to eNOS in membrane fractions using Western blots and find eNOS-like immunoreactivity (-LI) in the inner nuclear layer (INL), in Mtiller cells at inner and outer limiting membranes, in the ganglion cell layer (GCL) and in the outer plexiform layer (OPL) in the chick retina. It is possible that these differences reflect species specificity in the presence of eNOS, or more likely, a difference in the recognition of an eNOS isoform by the antibodies used. However, detailed studies of eNOS in the brain indicate it is absent from neurons (Stanarius et al., 1997). The presence of the iNOS isoform is more clearly established in both normal and pathological retinas. Park et al. (1994) use primers of a conserved cofactor region of nNOS and iNOS for RT-PCR in human retina and find that the amino acid sequence of retinal nNOS has only several amino acid differences from brain NOS, and that retinal iNOS has 113
Ch. IV
W.D. Eldred
only one amino acid difference from human chondrocyte iNOS. Both of these differences are only in the non-cofactor binding sites and indicate more than 99% homology. Their Northern blot analyses show a message for iNOS but not nNOS. L6pez-Costa et al. (1997) immunocytochemically localize iNOS in normal rat retina in labeled Mtiller cell somas in the INL and in Mtiller cell processes in OPL and IPL, in photoreceptor inner segments, in the OPL, and maybe in some horizontal cells, ganglion cells or displaced amacrine cells. Fujii et al. (1998) use in situ hybridization in chick to detect the expression of iNOS mRNA in the outer part of the photoreceptor layer and in the inner and outer parts of retinal pigment epithelium and choroid. Interestingly, Fujii et al. (1998) find that form deprivation reduces iNOS and nNOS mRNA, while only iNOS protein is reduced. This suggests that there is an ocular-specific regulation of the iNOS gene under non-pathological conditions. There is evidence that only specific pathological conditions may change iNOS expression in the retina. Patel et al. (1997) find iNOS in scattered cells in the INL and GCL, and in the IPL in normal rat retina. They report that optic tract lesions that cause severe ganglion cell loss do not increase levels of iNOS or nNOS, and they conclude that neither iNOS or nNOS have a role in cell death or degeneration. In contrast, Goureau et al. (1994a) report that stimulation with lipopolysaccharide, interferon-), and tumor necrosis factor-~ increases NO synthesis by human pigment epithelial cells, and that this effect can be blocked by selective iNOS inhibitors, cyclohexamide or transforming growth factor-J3. Stimulation with lipopolysaccharide, interferon-), and tumor necrosis factor-~ also increases NO synthesis by Mtiller cells (Goureau et al., 1994b), although each alone has no effect. In the case of Mtiller cells, they also find macrophage iNOS mRNA and the effect is again blocked by selective iNOS inhibitor, cyclohexamide and transforming growth factor-j3. These results indicate that in both human pigment epithelial cells and Mtiller cells, the expression of iNOS is transcriptionally regulated and that iNOS may be important in inflammation and uveitis in the eye. 2.3. ANATOMICAL LOCALIZATIONS OF NOS As discussed above, many of the localizations of NOS in the retina have been done using NADPH-diaphorase histochemistry which can simultaneously localize more than one isoform of NOS. This often gives a much broader localization than is seen using immunocytochemical methods. Thus, it is prudent to analyze the localization of NOS using both NADPH-diaphorase histochemistry and a combination of antibodies directed against several distinct epitopes of different NOS isozymes. In spite of these differences, there is a strong similarity in the localization of NOS in a variety of species. 2.3.1. Mammals Rats. Although the majority of localizations of NOS in the retina have been done in the rat,
there are considerable differences reported in the literature. The first detailed study done by Sandell (1985) finds NADPH-diaphorase only in sparse somas of presumptive amacrine cells in the INL, but provides little anatomical detail about the cells involved. Subsequent studies indicate that there might be two classes of amacrine cells with NADPH-diaphorase, one that is larger and heavily stained and a second population that is smaller and more weakly stained (L6pez-Costa et al., 1997). Later studies find that these amacrine cells contain GABA (Young and Vaney, 1989) and that there are three bands of NOS-LI in the IPL at strata 1 (S1), $2-$3 and at $5 (Yamamoto et al., 1993). 114
Nitric oxide in the retina
Ch. IV
Other labeled cells are described in the INL, some of which are classified as horizontal cells (Yamamoto et al., 1993; Huxlin, 1995; Sheng and Ignarro, 1996), Mtiller cells (Huxlin, 1995), or as bipolar or interplexiform cells (Yamamoto et al., 1993; Perez et al., 1995). The existence of NOS-LI or NADPH-diaphorase in rat photoreceptors is under debate. Although in some cases no labeled photoreceptors are described (NADPH-diaphorase - - Sandell, 1985; NOS i m m u n o c y t o c h e m i s t r y - Yamamoto et al., 1993; Perez et al., 1995; Sheng and Ignarro, 1996), in other cases labeled photoreceptors are reported (NADPH-diaphorase - - Yamamoto et al., 1993; Huxlin, 1995; Perez et al., 1995; Roufail et al., 1995; Sheng and Ignarro, 1996; NOS i m m u n o c y t o c h e m i s t r y - Roufail et al., 1995; Lrpez-Costa et al., 1997). A recent study using a combination of light and electron immunocytochemistry (Haverkamp and Eldred, 1998b) confirms the localization of nNOS-LI in photoreceptors, bipolar cells and horizontal cells in rat. Following the initial studies showing NADPH-diaphorase in amacrine cells, it is suggested that some of these amacrine cells are also displaced to the GCL (Huxlin, 1995; Perez et al., 1995; Sheng and Ignarro, 1996). A study combining retrograde labeling and ganglion cell degeneration (Huxlin and Bennett, 1995), proves that some of the diaphorase cells in the GCL are ganglion cells and that the rest are displaced amacrine cells. A number of studies (Mitrofanis, 1989; Huxlin, 1995; Perez et al., 1995; Roufail et al., 1995) indicate the presence of NADPH-diaphorase, but not nNOS-LI (Perez et al., 1995; Roufail et al., 1995; Sheng and Ignarro, 1996) in the rat retinal vasculature. This suggests that the NADPH-diaphorase in the vasculature is eNOS, as would be expected. Additionally, in both rats and humans, cell bodies and processes of both NADPH-diaphoraseand NOS-positive neurons are associated closely with the vasculature. The dendrites of these amacrine cells go into IPL and then project back to INL to form a pericapillary network. It is suggested that NO released from these amacrine cells may induce changes in the vascular diameter and modulate retinal blood flow (Roufail et al., 1995). To date, only one study has done electron immunocytochemistry to localize NOS in the rat retina. Haverkamp and Eldred (1998b) examine the localization of NOS in the OPL and find NOS in some rod bipolar and B-type horizontal cell axon terminals at rod ribbon synapses. The fact that not all rod bipolar and B-type horizontal cell axon terminals have NOS may indicate that there is more than one physiologically distinct cell type of each. It is also significant that the NOS-LI in these bipolar and horizontal cells is primarily confined to the processes of these cells in the photoreceptor terminal, with little cytoplasmic NOS in the rest of the cell body. These results indicate that NOS-LI can be selectively localized at synapses in potentially every nerve cell type involved in the OPL. Rabbits. The localization of NOS in the rabbit retina has been carefully examined and there is considerable agreement between the various reports. The initial NADPH-diaphorase studies done by Sandell (1985) find sparse well-labeled somas in the inner INL with poorly labeled processes that are assumed to be amacrine cells. A number of subsequent studies (Sagar, 1986, 1990; Vaney and Young, 1988; Osborne et al., 1993; Perez et al., 1995; Haberecht et al., 1998) clarify that there are two distinct classes of NADPH-diaphorase-positive afnacrine cells, the ND1 and ND2, that constitute about 1 in 1000 of the total number of amacrine cells. Both the ND 1 and ND2 cells contain GABA(Vaney and Young, 1988). There are ---.4000 NDI cells that are darkly stained and have well-defined dendrites up to 5 mm long (Sagar, 1990). The ND2 cells are more numerous ('~24,000 cells), but their dendrites are weakly stained and less than 100-200 Ixm long. These amacrine cells have their dendritic arborizations primarily in $3, with many varicose dendrites in other strata in the IPL (Vaney and Young, 1988). NOS immunocytochemistry (Perez et al., 1995; Haberecht et al., 1998) confirms the localization of 115
Ch. IV
W.D. Eldred
nNOS-LI in the NDI and ND2 amacrine cells, although a small number of cells in the GCL and amacrine cell layer only have NADPH-diaphorase (Perez et al., 1995). In addition to the amacrine cells, NADPH-diaphorase is localized in the vascular endothelium, as diffuse staining in the OPL and IPL, in displaced amacrine cells, in weakly labeled large cell bodies in GCL and in photoreceptor inner segments and cone outer segments (Perez et al., 1995; Haberecht et al., 1998). The results of NOS immunocytochemistry are not as consistent. Koch et al. (1994) find NOS-LI primarily in photoreceptor ellipsoids, with some NOS-LI in photoreceptor inner segments and in cone outer segments but not rod outer segments. Although both Perez et al. (1995) and Haberecht et al. (1998) agree that NOS-LI is in ganglion cells, Haberecht et al. (1998) find NOS-LI in rod and cone inner segments and cone outer segments, while Perez et al. (1995) find no NOS-LI in photoreceptor inner segments, the OPL or in horizontal cells, but do describe its presence in bipolar and/or interplexiform cells. These divergent results may be the result of using different nNOS antibodies that differentially recognize distinct isoforms of nNOS. Cat. Several studies localize NADPH-diaphorase in the cat retina. Following the initial localization of NADPH-diaphorase in amacrine cells (Sandell, 1985) in the INL and in some cells in the GCL, subsequent studies provide more details on the specific cells involved. Studies of W~issle et al. (1987) establish that although some ganglion cells have weak NADPH-diaphorase, the more strongly labeled cells in the GCL are a heterogeneous population of displaced amacrine cells with dendritic arborizations in the lower IPL where the rod bipolar cells terminate. There are only one quarter as many labeled amacrine cells in the INL as in the GCL. In addition to the displaced amacrine cells, there are also both normally placed amacrine cells and interstitial amacrine cells with somas in the IPL. The interstitial amacrine cells arborize in the central IPL and there is a third band of labeled dendrites in the outer IPL. Double-labeling studies indicate that one out of six NADPH-diaphorase cells can accumulate the indoleamine 5,6-dihydroxytryptamine and are likely to be serotonergic, while later studies established that the NADPH-diaphorase amacrines contain GABA (Mtiller et al., 1988). Vaccaro et al. (1991) later reported that NADPH-diaphorase is in cone pedicles, the photoreceptor layer and vasculature, and confirmed that 75% of the total of 40,000 amacrine cells are located in the GCL. Monkey. The presence of NADPH-diaphorase in amacrine cells and in some cells in the GCL is first described in owl monkey, squirrel monkey and rhesus macaque by Sandell (1985), and later NOS immunocytochemistry (Haberecht et al., 1998) confirms these localizations in macaque. Roufail and Rees (1997) describe one class of diaphorase cells in Macaca fascicularis that is similar in appearance to ND2 cells in human (Provis and Mitrofanis, 1990), with somas that are predominantly in the INL although some are in the GCL. In addition, both NADPH-diaphorase (Roufail and Rees, 1997; Chen et al., 1998) and NOS-LI are localized in cone and rod inner segments (Haberecht et al., 1998). Human. Following the initial general description of NADPH-diaphorase-positive amacrine cells (Sandell, 1985), subsequent studies (Provis and Mitrofanis, 1990; Roufail et al., 1995) clearly characterize three distinct amacrine cell types in humans. The ND1 have large oval/triangular somas that are located in the INL or GCL, with strongly labeled dendrites in the middle or outer IPL. The ND2 amacrine cells have smaller, more rounded somas that are also located in the INL and give rise to stout primary dendrites in the middle of the IPL and more delicate beaded processes in the middle or outer IPL or GCL. The ND3 amacrine cells are not always seen, but they have small round somas that are predominantly in the GCL and sometimes in the INL, with poorly labeled dendrites. In a given human retina, there can be a total of 118,000 NADPH-diaphorase-positive cells, 90% of which are located in the 116
Nitric oxide in the retina
Ch. IV
INL (Provis and Mitrofanis, 1990). Subsequent NOS immunocytochemistry finds NOS-LI in all of these three amacrine cell types (Roufail et al., 1995). The human ND2 cells resemble the rabbit ND2 amacrine cells in morphology and density, the human ND1 cells resemble the ND1 cells in rabbit and the NDa cells in guinea pig, while the human ND3 cells appear to be a distinct new class. In addition to these amacrine cells, NADPH-diaphorase is also localized in the outer (Provis and Mitrofanis, 1990) or inner (Chen et al., 1998) segments of photoreceptors and in the retinal vasculature (Roufail et al., 1995). The NO released from these amacrine cells is postulated to cause pericytes to change the vascular diameter and modulate blood flow (Roufail et al., 1995), because the retinal arterioles and capillaries do not receive autonomic innervation (Ye et al., 1990). Hamster. Lau et al. (1994) did the only study localizing NADPH-diaphorase in the hamster retina. They find 8033 ND(g) cells in the GCL with 2-4 sparse dendrites up to 700 ~m long and 5051 ND(i) cells in the INL with weakly labeled dendrites. The arborizations of these cells are in S 1, $3 and $5 of the IPL. Following optic nerve transection there is no change in any cell numbers, and there is also no diaphorase in any retrogradely labeled ganglion cells, both of which indicate that all of the NADPH-diaphorase-positive neurons are amacrine cells. The ND(g) cells have large somas and sparse dendrites like the ND1 cells in rabbit, while the ND(i) cells resemble the ND2 cells in rabbit. Guinea pig. In the guinea pig there are two NADPH-diaphorase-positive cell types. Cobcroft et al. (1989) find 3450 NDa cells with darkly labeled somas, primarily in the INL (and a few in the GCL), that give rise to dendrites which spread several hundred microns in the middle of the IPL. They also find 4389 NDb cells with much more lightly labeled somas in the GCL that give rise to poorly defined dendrites. These investigators conclude that both cell types are amacrine cells because there is no diaphorase in ganglion cell axons, and that the ND1 cells in rabbit are like the NDa cells, but that the ND2 cells in rabbit are different than the NDb cells. Tree shrew. The results of the study by Petry and Murphy (1995) of tree shrews resemble those in other mammals in that they find NADPH-diaphorase in some amacrine cells, displaced amacrine cells, Mtiller cells and in the ellipsoids of all cone photoreceptors. However, they also make the unique finding that NADPH-diaphorase is selectively present in the myoids in the inner segments, and surrounding the nucleus in short-wavelength-sensitive blue cones and all rods. This suggests that the short-wavelength-sensitive cones have different biochemical machinery than other cones, and may more closely resemble rods. Another correlation between short-wavelength light responses and NOS is present in fish retina (Furukawa et al., 1997), and is described later in this review. 2.3.2. Lower vertebrates Birds. In the pigeon, Sato (1990), localizes NADPH-diaphorase activity in three amacrine cell types that can be distinguished on the basis of their soma size and staining intensity. The type I cells have large intensely stained somas in the inner INL that give rise to processes that ramify for up to 150 Ilm in the IPL near the IPL and INL border, or in S1 of the IPL. Type II and type III cells also have somas in the INL, but their processes are only weakly labeled and difficult to follow, although some of the processes of type III cells run toward $3 of the IPL. In addition to amacrine cells, there is NADPH-diaphorase in faintly labeled somata in the GCL and strong labeling in the inner segments of photoreceptors. Morgan et al. (1994) use NADPH-diaphorase histochemistry and find that diaphorase activity is present in the horizontal cell layer, in the OPL and in the outer segments of the
117
Ch. IV
W..D. Eldred
photoreceptors in the chicken retina, but they provide little detail on the specifics of the cells involved. Although subsequent studies also localize NADPH-diaphorase or NOS-LI in the bird retina, the focus of these studies is primarily developmental or biochemical, so little additional detailed information is added about the specific cell types involved. However, these later studies do localize NADPH-diaphorase in subsets of amacrine and ganglion cells (De Carvalho et al., 1996), in the OPL, IPL and GCL, and in cell processes (Goureau et al., 1997). Goureau et al. (1997) do immunocytochemistry that localizes nNOS-LI in the GCL and in the outer limiting membrane near the tips of the Mtiller cells, and they localize eNOS-LI in the OPL, the inner INL, and especially in the GCL and ganglion cell axons. Turtles. Several studies localize nNOS in the turtle retina using a combination of NOS immunocytochemistry and NADPH-diaphorase histochemistry. Blute et al. (1997) find both NADPH-diaphorase and NOS-LI in the ellipsoids and inner segments of photoreceptors, efferents from the brain to the retina, at least three amacrine cell types and in many processes in the IPL. In optimized double-labeled preparations, all cells with NADPH-diaphorase activity also have nNOS-LI, although some somas in the ganglion cell layer only have nNOS-LI. The ND 1 amacrine cells are relatively common, and in retinal cross-sections they have large vertically oriented darkly staining pyriform-shaped somas with relatively symmetric dendritic arborizations about 300 ~tm in diameter. In small numbers of ND1 cells, in addition to these relatively conventional dendritic fields, some cells also have at least one dendrite that leaves the primary dendritic field and runs for at least 600 ~tm through the retina. A distinguishing characteristic of ND 1 amacrine cells is that the primary dendrites run for some distance in the outer IPL, before branching and arborizing deeper in the middle of the IPL and more diffusely in the inner IPL. The dendrites in the deeper portions of the IPL are studded with boutons. The ND2 amacrine cells are the most common of the three NADPH-diaphorase amacrine cell types in the turtle retina. These cells have smallish, moderately stained, rounded somas that give rise to several delicate processes, which run a short distance in the outer IPL, before branching extensively in the central IPL and giving rise to terminal processes deep in the IPL or among the somas in the GCL. The ND3 amacrine cells have large, faintly stained, flattened, oval somas that often give rise to two thick, faintly labeled primary processes that arborize in the outer IPL. The ND1 and ND2 amacrine cell types in turtle are very similar to the ND1 and ND2 (Vaney and Young, 1988) or type 1 and type 2 (Sagar, 1990) NADPH-diaphorase-positive amacrine cell types in the rabbit, and to the NDa and NDb NADPH-diaphorase-positive amacrine cell types in the guinea pig (Cobcroft et al., 1989). In addition to amacrine cells, both NADPH-diaphorase and NOS-LI are present in 7-10 well-labeled efferent fibers that exit the optic nerve head into the retina and give rise to several branches before reversing direction and then running back toward the optic nerve head. Although the efferent fibers initially run in the IPL near the GCL, the more terminal portions run in the outer third of the IPL. More detail is provided about these efferents in a subsequent section. In addition to these light microscopic studies, NOS-LI has been ultrastructurally localized in the OPL in turtle (Haverkamp and Eldred, 1998b). These workers find nNOS-LI at both the central and lateral positions at photoreceptor ribbon synapses which indicates that nNOS-LI is in both invaginating bipolar and horizontal cell processes at photoreceptor terminals. In addition, Haverkamp and Eldred (1998b) also report processes from presumptive OFF-bipolar cells with nNOS-LI that make basal synaptic contacts with photoreceptors. Thus, NO is produced by all of the major nerve cell types in the outer retina at specific synaptic contacts 118
Nitric oxide in the retina
Ch. IV
(Blute et al., 2000). The selective subcellular localization of strong nNOS-LI at synaptic contacts, made by cells with low or undetectable levels of nNOS-LI at the light microscopic level, suggests that NO may be utilized at many more synaptic contacts than previously realized. A similar selective localization of NOS is also seen in the IPL of the turtle retina, where some amacrine cells have NOS-LI only at presynaptic specializations and not in their general cytoplasm, while other amacrine cells have NOS-LI throughout their cytoplasm (W.D. Eldred, pers. commun., 2000). Fish. The localization of both NADPH-diaphorase and NOS-LI is examined in several species of fish. The first study of NADPH-diaphorase in the carp retina (Weiler and Kewitz, 1993) finds diaphorase in putative amacrine and ganglion cells, in one type of ON-bipolar cell and in H 1 horizontal cells. Although there is NADPH-diaphorase in cone outer segments, there is none in rod outer segments, in H2, H3 and H4 horizontal cells or in horizontal cell axon terminals. The H1 horizontal cells with NADPH-diaphorase also contain GABA. A subsequent study of carp retina (Djamgoz et al., 1996), confirms the staining seen in amacrine, ganglion and bipolar cells, and in addition finds NADPH-diaphorase in the ellipsoids of rod and cone photoreceptors, Mtiller cells and more than one type of horizontal cell. However, no staining is seen in photoreceptor outer segments. Two studies make comparative localizations of both NADPH-diaphorase and NOS-LI in the goldfish retina (Liepe et al., 1994; Villani and Guarnieri, 1996). In both studies, NOS-LI is in amacrine cells and in somas in the GCL. However, Liepe et al. (1994) also find NOS-LI in Mtiller cells, the outer limiting membrane and terminals of ON-bipolar cells, while Villani and Guarnieri (1996) find strong NOS-LI in the OPL. In both studies, the localization of NADPH-diaphorase is more extensive than NOS-LI. In addition to the localizations above, NADPH-diaphorase is also in photoreceptor ellipsoids or outer segments, H1, H2 and H3 horizontal cells and in two bands in the IPL. Liepe et al. (1994) also find both NADPH-diaphorase and NOS-LI in amacrine cells, Mtiller cells and photoreceptor ellipsoids in catfish retina as well. Amphibians. Three studies do detailed localizations of both NADPH-diaphorase and NOS-LI in the salamander retina and find similar results. The initial study by Liepe et al. (1994) finds NOS-LI around photoreceptor nuclei and in rod and cone ellipsoids, in occasional amacrine cells, somas in the GCL, and in the IPL and OPL. They also find NADPH-diaphorase in amacrine cells, in photoreceptor ellipsoids and around photoreceptor somas, in horizontal and Miiller cells, and near the inner and outer limiting membranes. Subsequent studies by Kurenni et al. (1994, 1995) confirm and extend these initial results. They find intense NADPH-diaphorase in the rod and cone photoreceptor ellipsoids, and fainter labeling in the myoid regions of photoreceptors, but no significant labeling in the outer segments, synaptic terminals or perinuclear cytoplasm of the photoreceptors. Some bipolar cell somas in the INL and their Landolt clubs are labeled, and there is variable Mtiller cell staining that is strong in distal and proximal Miiller cell processes and is weaker, fiber-like staining in the Mtiller cell somas and trunks. Finally, there is NADPH-diaphorase in dark puncta in the OPL and IPL and some labeling in ganglion cells and in the optic nerve. The corresponding NOS immunocytochemistry by Kurenni et al. (1994, 1995) confirmed the localization of nNOS in the outer segments, ellipsoids and myoids of photoreceptors, in MUller cells, and in select amacrine, horizontal and bipolar cells. Unlike many previous studies, Straznicky and Gabriel (1991) find that they could only get NADPH-diaphorase staining in the toad (Bufo) retina by using unfixed tissue. They find labeling in the inner segments of photoreceptors, some somas in the GCL, and in many bipolar cells with intensely stained Landolt clubs. They also find three types of labeled amacrine cells 119
Ch. IV
W.D. Eldred
that, like the bipolar cells, primarily arborize in the outer portion of the IPL. One labeled amacrine cell is a narrow-field amacrine cell, the second has an oval-shaped soma with two main dendrites, while the last amacrine cell type is characterized by having a grossly eccentric dendritic tree. In the frog retina, Sato (1990) describes two populations of amacrine cells with NADPHdiaphorase activity. As is the case for other species, one population of cells is darkly stained with clearly labeled processes, while the second population is weakly labeled with poorly stained processes. The processes of the darkly labeled amacrine cells often run to $5 of the IPL or to the GCL. In addition to amacrine cells, NADPH-diaphorase is also seen in the inner segments of photoreceptors in frog. In summary, the comparative localization of nNOS in different species can indicate what is universal and what is species-specific. Although there are some differences between species, in many cases these differences are not as great as the variation between different studies of the same species. For this reason, it is likely that there are similar localizations of nNOS in all species, and that many of the reported differences are methodological. Therefore, in considering these results as a whole, there is evidence for the presence of nNOS in all cell types in the retina, but not in every cell of a given type. For example, nNOS does seem to be restricted to certain cells of a given type, i.e. some amacrine cells. Photoreceptors in particular, have potentially a very complex localization of nNOS in their outer segments, inner segments and synaptic terminals. The localization of NOS in all retinal cell types is strongly supported by the physiological and biochemical studies described later. One nearly universal observation is that, in most species, there are some amacrine cells with darkly stained somas and processes, while often larger numbers of amacrine cells have more weakly stained somas and poorly labeled processes. It is tempting to speculate that these weakly labeled amacrine cells give rise to the many synapses with NOS-LI that are found in the IPL in processes with little cytoplasmic NOS-LI. In several species, the cells with strong cytoplasmic NOS-LI or NADPH-diaphorase have large dendritic arborizations, while the more lightly labeled cells have smaller arborizations. This raises the possibility that the cells with large dendritic arbors and strong cytoplasmic NOS may release NO more diffusely, to influence large numbers of neurons, as might take place during light and dark adaptation. In contrast, the other lightly labeled cells may employ NOS only at synapses involved in specific synaptic circuits. 2.4. REGIONAL DISTRIBUTION OF NOS The precise retinal distribution of cells with NOS or NADPH-diaphorase has only been examined in a limited number of species. In the rat retina (Huxlin, 1995), there are four times more NADPH-diaphorase-positive cells in the GCL than in the INL. The ganglion cells and displaced amacrine cells in the GCL (Huxlin and Bennett, 1995) form a heterogeneous population that are relatively evenly and randomly distributed. In contrast, the amacrine cells containing NADPH-diaphorase in the INL are more regularly distributed and the somas in the GCL physically overlap with somas in the INL. The distribution of cells with NADPH-diaphorase in the rabbit retina shows a strong central to periphera] gradient, with the highest density of cells in the visual streak (Vaney and Young, 1988). There are also significant regional distributions in the specific amacrine cell types with NADPH-diaphorase. In the visual streak there are six times more ND2 cells than ND1 cells, and in the periphery there are nine times more ND2 cells than ND1 cells (Vaney and Young, 1988). Interestingly, the dendritic arborizations of most ND1 amacrine cells in the visual 120
Nitric oxide in the retina
Ch. IV
streak are oriented parallel to the visual streak, while those amacrine cells in the inferior periphery of the retina have dendritic arborizations oriented orthogonally to the visual streak (Mitrofanis et al., 1992). In humans (Provis and Mitrofanis, 1990), amacrine cell types with NADPH-diaphorase have relatively uniform topographical distributions with no real peak at the fovea, although the cells have a minimal density near the retinal edges and there are none in the foveola. The outer segments of cone and rod photoreceptors also show a weaker NADPH-diaphorase staining near the foveola. Lau et al. (1994) show that the cells with NADPH-diaphorase in hamster have a different distribution in the INL and GCL. The ND(g) cells in GCL are not evenly distributed, in that there are more cells in the inferior than in the superior retina, and they have a peak density 1 mm below the optic disk. In contrast, the ND(i) cells in the INL are evenly distributed with no obvious density gradient, although there is a somewhat higher density of labeled cells 1 mm superior to the optic disk. In guinea pig, there are equal numbers of two NADPH-diaphorase-positive cells types (Cobcroft et al., 1989), each with a unique retinal distribution. The somas of the NDa cells are primarily located in the INL, although a few are in the GCL. However, in both cases these NDa cells are relatively uniformly distributed in both the superior and inferior retina, although there is a decrease in density toward the retinal edge. The NDb cells are much more lightly labeled cells and have their somas in the GCL. In contrast, the NDb cells are only above the optic disk and not below, with a higher concentration of cells in an elongated area just above the optic disk near the visual streak. The distribution of NADPH-diaphorase-positive cells in the cat retina is first analyzed by W~issle et al. (1987). These workers analyze the density of labeled displaced amacrine cells using a vertical intersect through the central retina. They find an even distribution of cells with no indication of a peak in the central retina, although the lower retina has cell densities twice those in the upper retina. The distribution of NADPH-diaphorase-positive cells is later examined in more detail by mapping the distribution of labeled cells throughout the retina (Vaccaro et al., 1991). These studies largely confirmed the results of W~issle et al. (1987), in that there is a relatively uniform distribution of cells in most of the retina. However, they did find an area with the highest cell density located slightly inferior to the area centralis. In lower vertebrates, Straznicky and Gabriel (1991) find in the toad (Bufo) that the distribution of bipolar cells follows the overall cell density, with a peak in density in the retinal center and decreased density in the dorsal and ventral regions. In contrast, the amacrine cells in Bufo have the lowest density in the central retina, and the highest density in the periphery near the ciliary margin where more cells are generated throughout life. In birds, Sato (1990) analyzes the distribution of NADPH-diaphorase-positive cells in pigeon retina. He reports that there can be 5180 labeled cells located throughout the retina, and that there is only a very shallow density gradient from the central to the peripheral area of the retina. The regional distributions of NOS-containing cells have not been examined in detail in other lower vertebrates, although there are no obvious regional specializations in the distribution of any NOS-containing cells in turtle retina (Blute et al., 1997). In summary, there is considerable variation in the distribution of retinal cells with NADPH-diaphorase in various species. The ND(i) cells in the INL of hamsters and the NDa cells in the INL of guinea pigs, and most cells in rats, humans and turtles, are relatively evenly distributed throughout the majority of the retina. In contrast, there are more cells and a slight peak in labeled cell density in the inferior retina for all cells in cats, and for the ND(g) cells located in the GCL in hamster retinas. Other variations are the peaks in cell density of 121
Ch. IV
W.D. Eldred
NADPH-diaphorase-positive amacrine cells in the visual streak in rabbits, the slight peak in amacrine cell density toward the central retina of pigeon, and the peak in labeled bipolar cells seen in the central retina in Bufo. Finally, still other variations are seen in the distributions of amacrine cells, in that the NDb cells in the GCL in guinea pigs are only above the optic disk, and that the amacrine cells with NADPH-diaphorase in Bufo reach their peak density toward the ciliary margin. Given the diversity of these distributions in different species, it is difficult to correlate these distributions with potential functions. Some of these regional differences may represent differences in the enzymes which give rise to the NADPH-diaphorase activity in certain species. The development of more selective probes for specific NOS isoforms may clarify some of these regional differences. 2.5. EFFERENTS Two studies indicate that NOS is in efferents that project from the brain to the retina. In birds, the efferents to the retina originate from the isthmo-optic nucleus and Morgan et al. (1994) report that these projections are NADPH-diaphorase-positive. They confirm that these are efferents by doing lesions of the isthmo-optic nucleus in the brain. In the bird retina, the isthmo-optic terminals are of the restricted type and they are in 2-4 cell layers in the INL, primarily in the inferior retina close to the optic nerve head and pectin. The existence of NOS-LI and NADPH-diaphorase in retinal efferents is also demonstrated in turtle (Blute et al., 1997; Haverkamp and Eldred, 1998a). Blute et al. (1997) use a combination of NOS immunocytochemistry and NADPH-diaphorase histochemistry to label 7-10 efferent fibers that exit the optic nerve head and travel in the ganglion cell axon layer before entering the IPL. Although the efferent fibers initially run in the IPL near the GCL, the more terminal portions also run in the outer third of the IPL. In tangential sections, these darkly stained processes have numerous, large boutons and in several cases these efferents run for some distance in the retina, and then arch back toward the optic nerve head. Haverkamp and Eldred (1998a) use cholera toxin B as a retrograde tracer to locate the somas in the turtle brain that give rise to these efferents. Colocalization studies of this retrograde tracer with NADPH-diaphorase histochemistry indicate that 30% of the cells with cholera toxin B-LI are also positive for NADPH-diaphorase. The location of these double-labeled cells around the locus coeruleus corresponds to the NADPH-diaphorase-positive efferent cells in the avian isthmo-optic field. In summary, the localization of NADPH-diaphorase in these efferents in birds and turtles indicates that retinal efferents may use NO to modulate the retinal function and that these efferents arise from similar regions of the brain.
3. DEVELOPMENT OF NOS IN THE RETINA AND CENTRAL VISUAL TARGETS The development of NOS has been examined using both anatomical and biochemical techniques in the retina and in several central visual targets. In all cases, there is a close correlation between NOS and synaptic development. The development of both NADPH-diaphorase and NOS-LI has been examined in the rat retina. Mitrofanis (1989) first detected NADPHdiaphorase by postnatal day 3 (P3). By P5, NADPH-diaphorase is present in the INL, and by P11 there are labeled cells with extensive processes in the IPL. This time corresponds to the time when there is the first appearance of amacrine and bipolar synapses and the beginning of electrical activity. At P25, there is a reduction in labeling of processes in the IPL, and a decrease in the diameter of labeled somas, similar to that seen in adults. Mitrofanis 122
Nitric oxide in the retina
Ch. IV
(1989) speculates that the staining seen at P3-P7 in the OPL may relate to the formation of horizontal cell synapses in the OPL. He further speculates that the relatively uniform distribution of NADPH-diaphorase-positive cells in the adult rat retina, is the result of a higher initial concentration of cells in the periphery, coupled with a greater subsequent expansion in the periphery. These results are confirmed and extended by Patel et al. (1997) who use a combination of nNOS and iNOS immunocytochemistry in rat retina. They find that weak nNOS-LI is present in cells in the INL at P10, that by P14 nNOS-LI is strong in the IPL and in cells in the INL, and that by P21 and P30 the number and intensity of cells with nNOS-LI is decreased, iNOS has a similar developmental time course, in that it appears by P10, rises to a maximum near P14 and declines by P16-P30. Patel et al. (1997) conclude that because NOS is detected after the peak of retinal ganglion cell death during the first postnatal week, and because axotomy did not increase either iNOS or nNOS, NOS does not play a role in cell death or degeneration. However, they do conclude that NOS may play a role in development, because it appears during the second postnatal week, which coincides with synaptogenesis in the inner retina and maturation of the vasculature. A similar developmental situation also occurs in rabbit and cat retina. In the rabbit (Mitrofanis et al., 1992), NADPH-diaphorase cells are first seen at post-conception day 28 (28PCD) in the central part of the visual streak. Only during 28-42PCD is NADPH-diaphorase present in the OPL, and by 51PCD NADPH-diaphorase is gone from the OPL and is only present in the IPL. Again, the presence of NADPH-diaphorase corresponds with the timing of the main amacrine cell synaptogenesis between 40PCD and 51PCD. Mitrofanis et al. (1992) speculate that these cells may play a developmental role, because they appear before there are light responses, and that the NADPH-diaphorase-positive cells appear so early that they must be preprogrammed and are not environmentally determined. In the cat retina, there are two times as many cells with NADPH-diaphorase at birth as in the adult (Vaccaro et al., 1991). By P10, there are many NADPH-diaphorase-positive cells with growth cones and spines and an intense continuous band of labeling in the OPL, but there is a strong reduction in NADPH-diaphorase by P25. Vaccaro et al. (1991) conclude that the most intense NADPH-diaphorase occurs during the appearance of bipolar cell synapses from late gestation to early postnatal periods, and that there is a reduction following the IPL synaptogenesis that occurs from P11 to P 15. In birds, NADPH-diaphorase is in subsets of amacrine and ganglion cells. De Carvalho et al. (1996) detect NADPH-diaphorase beginning in the 7-day-old embryo (E7), and by El2 it is present in photoreceptors, and in somas in the INL and GCL. After hatching, the NADPH-diaphorase is in photoreceptor inner segments and in somas in the INL and GCL, but not in photoreceptor outer segments. Goureau et al. (1997) expand on these earlier studies to include both eNOS and nNOS immunocytochemistry and Western blots, in addition to NADPH-diaphorase staining. When examined using both immunocytochemistry and Western blots, both nNOS and eNOS appear by E8 and by E 12-E14 both are in photoreceptors, the ONL, INL and GCL. By El8, eNOS levels peak in photoreceptors, the OPL, IPL and GCL, and levels of nNOS peak in the IPL and amacrine cells. Levels of both eNOS and nNOS decrease by 8 days after hatching, but some remains, primarily in ganglion cells. The timing of higher levels of both nNOS and eNOS closely correlates with the time of much of the active synaptic development in chick retina (Hering and Kr6ger, 1996). The role of NOS has also been examined in a number of central targets. Williams et al. (1994) are interested in the activity-dependent presynaptic mechanisms and NMDA receptor-mediated postsynaptic mechanisms that determine the connections of the retina 123
Ch. IV
W.D. Eldred
to central visual targets like the optic tectum in chick. They find NADPH-diaphorase NOS-positive cells in the chick optic tectum at E5-E7, and that the peak staining occurs in radially oriented bipolar and stellate cells at EI2-E15. However, in eyeless animals the number and intensity of labeled bipolar cells are reduced and no stellate cells are labeled in the tectum. They also find that the expression of NADPH-diaphorase activity in the tectum coincides with the time of innervation by ganglion cell axons and that the NADPH-diaphorase activity peaks at the time of refinement of the initial pattern of connections. Williams et al. (1994) conclude that NOS expression is dependent on the presence of the ganglion cell retinal axons, and that it is likely that the developing ganglion cell axons are exposed to NO. The NO may then provide a retrograde communication to the ganglion cell axons to facilitate the development and refinement of their tectal connections. This idea is supported by the fact that NOS expression begins to decline at the end of this period of refinement. A similar increase and decline in NADPH-diaphorase are also seen in cells in the developing rat superior colliculus. Tenrrio et al. (1996) find that NADPH-diaphorase activity starts in five cell types by the end of the first postnatal week and reaches a maximum by postnatal day 15. Following this time, the NADPH-diaphorase activity decreases in three of these cell types. These authors conclude that these NADPH-diaphorase-positive neurons may play a role in the refinement of the retino-collicular or cortico-collicular projections. This is because the developmental timing of the NADPH-diaphorase activity correlates with the functional development of the retino-collicular pathway that begins at the end of the first postnatal week and occurs primarily during the second week after birth. A role for NOS in retinogeniculate development is provided by the studies of Cramer et al. (1995) which indicate that there are high levels of NADPH-diaphorase in the lateral geniculate nucleus during the period of the ON/OFF sublamination phase of retinogeniculate development. A subsequent study (Cramer et al., 1996) finds that treatment with a NOS inhibitor during the third and fourth postnatal weeks reduces the formation of these ON/OFF sublaminae in the geniculate. They conclude that NOS acts together with postsynaptic NMDA receptors in the activity-dependent refinement of the size, position and synaptic connectivity of the presynaptic ganglion cell arbors. They suggest that NO may work through guanylate cyclase and cGMP-gated channels to increase intracellular calcium and axonal structure, and/or through adenosine diphosphate ribosyl transferase to act on growth-associated protein 43 (GAP-43) in remodeling these synaptic connections. They speculate that NO may inhibit growth cone elongation or that it may regulate local blood flow and growth factors. The idea that NO can influence growth cone elongation during development receives strong support from studies by Renterfa and Constantine-Paton (1996). These workers find that NO donors induce the collapse of ganglion cell axonal growth cones that are extending from explants of tadpole retina in culture. They conclude that this effect is not mediated by cGMP and that it is not due to the production of NO within the growth cones, because neither cGMP or NOS inhibitors induce collapse. They suggest that perhaps NO may cause ADP-ribosylation of G-actin or that there may be NO-dependent modifications of growth cone proteins such as GAP-43 or synaptic associated protein 25 (SNAP-25). Finally, they suggest that the NO produced by the activated target dendrites could alter the growth patterns of axons by causing a local collapse of growth cones. This collapse may then increase arborizations within a target of glutamate-sensitive dendrites to help establish new synapses on the depolarized dendrite targets. In summary, in various species, NO seems to play several roles in synaptic development of the visual system. In the case of the retina, optic tectum, superior colliculus and lateral geniculate there is a close temporal correlation in the developmental appearance of NOS, and 124
Nitric oxide in the retina
Ch. IV
the development and refinement of synaptic connections. Furthermore, at least in the case of the optic tectum and lateral geniculate, NO is required for the correct establishment of these connections. It is particularly intriguing that NO may be involved in the maturation of synapses at all levels of the visual system from within the retina itself, to its central projections.
4. BIOCHEMISTRY AND MOLECULAR BIOLOGY OF NOS IN THE RETINA 4.1. NOS A number of detailed studies have been made on NOS in the retina, many of which extend the knowledge obtained in the brain, and indicate that the roles of different NOS isotbrms may be much more complicated than previously realized. It is generally accepted that both nNOS and eNOS are calcium-dependent while iNOS is calcium-independent, and that more than 85% of the NOS in brain and macrophages is soluble, while 95% of eNOS is membrane-bound (Schmidt et al., 1993). However, several studies indicate that subcellular localization and calcium dependence of NOS in the retina may be more complicated. At least two studies use molecular methods to analyze NOS in the retina. As described above, Park et al. (1994) use primers of a conserved cofactor region of nNOS and iNOS for RT-PCR and find that both retinal nNOS and retinal iNOS have very close sequence homologies to brain NOS and human chondrocyte iNOS, respectively. The cDNA was subsequently cloned using RT-PCR and human retinal mRNA (Park et al., 1996), and the sequence shows a possible genetic polymorphism in comparison to brain NOS that is due to single-base substitutions and not due to frame shift by addition or deletions of bases. Northern blot analysis indicates that although the retinal nNOS mRNA is identical in size to brain and muscle types, there are lower levels of nNOS mRNA expression in the retina than in either human brain or skeletal muscle. These data could suggest that nNOS protein has a high level of stability in the retina. Other studies examine the regulation of NOS activity in the retina. Sheng and Ignarro (1996) measure NOS activity by citrulline formation in the rat retina and find that 70% of the activity is soluble in the supernatant, with the remaining being particulate. Inclusion of the calmodulin inhibitor, calmidazolium, reduces soluble NOS activity by only 75%, while 40% of the soluble NOS activity is retained under calcium-free conditions. This is in contrast to the total loss of activity in soluble cerebellar NOS activity under these same conditions. Although these authors find a soluble 160 kDa protein that cross-reacts to specific antibody to nNOS, they conclude that the retina contains more that one type of NOS. They speculate that some of the particulate NOS may be eNOS, but that the calcium-insensitive NOS is probably not iNOS in healthy eyes and may represent a new isoform of constitutively expressed NOS with tightly bound calcium and calmodulin. The idea that there may be a calcium-independent NOS present in retina is also supported by studies in both bird and bovine retina. De Carvalho et al. (1996) use a quantitative NADPH-diaphorase assay as a measure of NOS enzyme activity in the chick retina. They find that arginine-analogue NOS inhibitors inhibit the diaphorase activity by 65% in embryonic retinas and by 50% in post-hatch retinas, which may indicate the presence of other NADPH-dependent metabolic enzymes. Their developmental studies indicate that, during early embryonic development, NADPH-diaphorase is stimulated 50% by calcium, and that this stimulation decreases during development and is gone in post-hatched retinas. They 125
Ch. IV
W.D. Eldred
conclude that there are two populations of NOS, a calcium-dependent diaphorase that is predominant in early embryonic development and is inhibited by low concentrations of NOS inhibitor, and a calcium-independent NOS that predominates in mature retinas and is only inhibited by high concentrations of NOS inhibitor. Although these studies also argue for the presence of calcium-independent NOS in retina, the interpretation of these results is hampered by the potential influence of other NADPH-dependent metabolic enzymes. A recent study uses the conversion of [3H]arginine to [3H]citrulline to study the regulation of retinal NOS activity by calcium (Margulis et al., 1998). They find that the total NOS activity is higher in synaptosomal fractions made from the inner retina than in synaptosomal fractions made from photoreceptors. In addition, 20-25% of the NOS activity in synaptosomal fractions is soluble and in all cases it is calcium-dependent, while 75-80% of NOS activity in synaptosomal fractions is membrane-bound and 50-60% is calcium-dependent. These investigators conclude that the calcium-independent NOS may be iNOS, which is consistent with the previous retinal localizations of iNOS by Park et al. (1994), L6pez-Costa et al. (1997) and Fujii et al. (1998). Margulis et al. (1998) calculate that synaptosomal fractions from the inner retina can produce 4 nM/s of NO under optimal conditions, which suggests that NO may reach the concentration of 250 nM NO needed for the half-maximal activation of soluble guanylate cyclase (sGC) (Stone and Marietta, 1995). Finally, Wellard et al. (1995) investigate the effects of NOS inhibitors on arginine uptake by examining the conversion of [3H]arginine to [3H]citrulline in intact chicken retinas. They find that several NOS inhibitors, like the arginine analogues L-NMMA, L-NIO, L-NA and L-NAME, all have IC50s in the micromolar range for retinal homogenates. In contrast, these same inhibitors have 20-3000 times higher ICsos in intact retina. These inhibitors also produce the following varying effects on arginine uptake in intact retina: L-NA causes a 31% reduction in arginine uptake, L-NMMA and L-NIO reduce arginine uptake by about 75%, and L-NAME has no obvious effect on arginine uptake. The authors conclude that because many NOS inhibitors may block arginine uptake, these inhibitors cannot distinguish arginine uptake from the effects of NOS inhibition, and thus citrulline production cannot be used as an accurate measure of NOS activity. Another implication of their results is that it will be very difficult to use isoform-selective NOS inhibitors to examine the function of specific NOS isoforms in intact retina. This is because most of these inhibitors show only a relative specificity for a certain isoform, and that any isoform selectivity may be obscured by the high dosages needed to inhibit NOS in intact tissue. 4.2. PHOTORECEPTORS cGMP plays a crucial role in phototransduction, and photoreceptors have many biochemical pathways to regulate cGMP levels, some of which involve NO. As discussed in one of the following sections, NO also plays distinct roles in modulating synaptic release from the terminals of photoreceptors. The majority of studies of the particulate guanylate cyclases (pGCs) in photoreceptor outer segments have concentrated on the two pGCs, retGC (Dizhoor et al., 1994) and retGC2 (Lowe et al., 1995), which are modulated by intracellular calcium and a soluble factor (Koch, 1992). However, one early study also indicates a potential role for NO in modulating cGMP in bovine photoreceptor outer segments. Horio and Murad (1991) examine a pGC that is solubilized from bovine outer segment membranes and find that it is activated by low calcium and inhibited by higher calcium. They state that they carefully washed their samples to eliminate potential sGC contamination and that antibodies against sGC did not recognize this pGC. Interestingly, they find that the NO donor sodium nitroprusside (SNP), 126
Nitric oxide in the retina
Ch. IV
and NO gas also activate this pGC up to 20 fold, although higher concentrations of NO inhibit this pGC. The potential source of NO in activating this outer segment GC is examined by Venturini et al. (1991). These workers use a crude preparation of rod and cone outer segments and find NOS activity that is similar to nNOS, in that it is NADPH- and calcium-dependent and that it is blocked by NOS inhibitor. They suggest that this NOS may provide the NO to activate the NO-sensitive pGC described by Horio and Murad ( 1991 ). The activation of guanylate cyclase (GC) in photoreceptor outer segments by NO has also been investigated by Margulis et al. (1992). In contrast to the results of Horio and Murad (1991), Margulis et al. (1992) find that although NO can produce a 1300-1400% activation of the sGC in photoreceptor outer segments, they find no NO activation of the pGC that they isolated from outer segments. They could not explain the difference between their results and those of Horio and Murad (1991). Margulis et al. (1992) conclude that the high levels of free Ca 2+ in dark-adapted outer segments can activate NOS to make NO and subsequently activate sGC. The characterization of NOS in photoreceptors and its interactions with GC are also examined by Koch et al. (1994). They report the existence of a calcium/calmodulin-regulated NOS in biochemical fractions made from outer segments and the adjacent portions of the photoreceptor inner segments from bovine retina. The biochemical properties of photoreceptor NOS resemble that of mammalian brain nNOS in terms of its cofactor requirements and its 160 kDa molecular weight on Western blots using antibodies against nNOS. They conclude that photoreceptor inner segments, but not the outer segments, contain a NOS that is functionally coupled to sGC, and that the pGC in the outer segments is not sensitive to NO. They suggest that the NOS in the outer segments is involved in the ADP-ribosylation of outer segment proteins to modulate phototransduction, as described below (Pozdnyakov et al., 1993). In contrast, the recent studies of Yoshida et al. (1995) report the existence of NOS in bovine rod outer segments. They find that both cytosolic and membrane fractions of rod outer segments have NOS activity. Adding calcium increases the activity of both the membrane and cytosolic NOS. However, in the absence of calcium and calmodulin, the cytosolic NOS is inactive, while the membrane NOS still retains basal activity. They speculate that the calcium-free basal activity of rod outer segment membrane NOS may be due to a tightly bound calmodulin like that found in iNOS, and that the non-calcium-dependent NOS could influence the rate of recovery of the light response when calcium is low. Again, they speculate that the NO may relate to ADP-ribosylation of G proteins in rod outer segments (Pozdnyakov et al., 1993). One mechanism of action of NO is the ADP-ribosylation of proteins (Bredt and Snyder, 1994), and the studies of Pozdnyakov et al. (1993) indicate that this occurs in retina as well. Pozdnyakov et al. (1993) find that both the membrane and cytosolic fraction of rod outer segments contain ADP-ribosyl transferases that can be regulated by NO. A NO donor or endogenously produced NO inhibits ribosylation of 116 kDa, 66 kDa and 46 kDa membrane proteins, while NO increases the ribosylation of 38 kDa cytosolic and 39 kDa membrane proteins. The 39 kDa protein is the ~ subunit of the G protein transducin and thus NO may modulate visual transduction through ADP-ribosylation. They conclude that rod outer segments may have at least two membrane ribosyl transferases, one that is inhibited by NO while the other is stimulated, and that both membrane and cytosolic NOS each have their own associated ADP-ribosyl transferases. In summary, the biochemical results indicate the presence of several distinct isoforms of NOS. There is good evidence for both soluble and particulate NOS in the retina, with more 127
Ch. IV
W.D. Eldred
NOS activity being concentrated in the inner retina than in the outer retina. The most recent studies indicate that, in the retina as a whole, all of the soluble NOS is calcium-dependent, while only ~60% of the particulate NOS is calcium-dependent. In light of both biochemical and immunocytochemical studies, it is possible that at least some of the calcium-independent NOS is iNOS, although the possibility of other NOS isoforms cannot be eliminated. A similar situation occurs in photoreceptors where all of the soluble NOS is calcium-dependent, while the particulate NOS retains some basal activity in calcium-free solutions. Finally, there is good evidence that although NO can activate sGC or ADP-ribosyl transferases in photoreceptor outer segments, it probably has no effect on the pGCs in outer segments.
5. FUNCTION OF NO IN SPECIFIC RETINAL CELL TYPES 5.1. PHOTORECEPTORS In comparison to other retinal cell types, the role of NO in photoreceptors has been the most thoroughly investigated and has proven to be complex. In their investigation of tiger salamander rods, Kurenni et al. (1994) find that NO increases the Ica current in barium-conducting calcium channels by 183%. They postulate that an activation of ADP-ribosyl transferase or direct nitrosylation of cellular protein thiols is responsible for the shift in the activation curve of these channels, because cGMP analogs have no effect on this current. The effects of NO are specific for these channels, in that the nonselective cation current Ih and the non-inactivating IK~ currents remain unaffected. The activation of these calcium channels by NO could modulate the photoreceptor output, because the postsynaptic response in the horizontal cells is a third-power relation of the calcium influx at the photoreceptor synapse (Attwell et al., 1987). Kurenni et al. (1994) postulate that calcium influx through cGMP-gated channels in the outer segment, or through voltage-gated calcium channels in the inner segment, activates the NOS in the ellipsoids to produce NO that depolarizes the rod. This NO may then diffuse to neighboring photoreceptors to make a smooth gradient of channel modulation that spreads light adaptation through the photoreceptor mosaic. Rieke and Schwartz (1994) also examine effects of NO donors on synaptic exocytosis in salamander cones. They conclude that the cone soma and synaptic processes contain a sGC that can modulate the cGMP-gated current, Ca 2+ entry and thus, exocytosis. Interestingly, they find that this mechanism continues when the cones are hyperpolarized to more than - 4 0 mV, and thus serves to extend the voltage range of exocytosis in the cones. In contrast, the rods are driven primarily by voltage-gated Ca 2+ channels and their exocytosis is terminated by such hyperpolarizations. These results indicate that NO can serve to extend the range of the light response in cone photoreceptors. N611 et al. (1994) also speculate that the same mechanisms involved in the recovery of photoreceptor responses are involved in light adaptation and that NO is implicated in these processes. They find that, while recording from photoreceptors using whole-cell patch clamp electrodes, there is a reduction in the flash response due to a spontaneous hyperpolarization caused by the loss of intracellular cGMP. They find that addition of a NO donor in the electrode prevents this hyperpolarization and accelerates the speed of flash recovery, presumably by increasing both the concentration and turnover of cGMP. Lowering of intracellular calcium with EGTA blocks the effects of the NO donor, and inhibition of NOS produces the same retardation of the recovery of the light response. They suggest that the 128
Nitric oxide in the retina
Ch. IV
sGC is regulated by calcium, and that calcium and NO form two different feedback loops that regulate each other to modulate the light response. In a related study, Tsuyama et al. (1993) also examine the relationship between NO, the dark voltage and the recovery of light responses in isolated frog rods. They too find that during whole-cell patch recording there appears to be a loss of components that sustain the normal dark voltage, and that the cell hyperpolarizes. This hyperpolarization is slowed by including either GTP or L-arginine in the pipette, while including NADPH in the pipette depolarizes the rod photoreceptors and accelerates the repolarization of the light responses. They came to a similar conclusion as N611 et al. (1994), in that increases in NO activate sGC to increase cGMP which could depolarize the cells and accelerate repolarization to counterbalance the increased PDE activity in the light. The results of all these studies strongly support a role for NO in light adaptation in photoreceptors. The role of NO and cGMP-gated channels in photoreceptor synaptic exocytosis is also investigated by Savchenko et al. (1997). They do whole-cell patch clamp recordings of lizard cones that lack outer segments and find that the cGMP, analog pCPT-cGMP, produces an inward current in the synaptic terminals that is distinct from the voltage-gated calcium current. They show that this current is through channels directly activated by cGMP and not through protein kinase G (PKG). Interestingly, they find that only 31% of the patches made on these terminals have channels, but when present they have a high density of 13-34 channels in comparison to outer segment patches that have only 9-19 channels. This indicates that the cGMP-gated channels are clustered on the cone terminals. These workers also find that NOS inhibitors depress the feedback inhibition onto cone terminals by the horizontal cells, and conclude that the endogenous production of NO modulates communication between cones and horizontal cells. Finally, using pairs of horizontal cells and cone terminals, they find that NO, by working through cGMP to open cGMP-gated channels, increases glutamate release onto the horizontal cells. From this they conclude that the cGMP-gated channels clustered on the photoreceptor terminals may be tonically activated to allow calcium influx at hyperpolarized potentials and thus extend the photoresponse during light stimulus. Finally, Greenstreet and Djamgoz (1994) investigate the role of NO in light adaptation and retinomotor movements in cyprinid fish retinas. They find that NO donors produce two significant aspects of light adaptation in fish. Treatment of isolated dark-adapted cyprinid retinas with NO donors causes the inner segments of cone photoreceptors to contract, and the dendrites of horizontal cells to form finger-like projections called spinules that invaginate into cone pedicles. These authors speculate that these effects could originate directly in the photoreceptors and horizontal cells, because NADPH-diaphorase staining is demonstrated in both cell types (Weiler and Kewitz, 1993). These results indicate that NO may be a signal regulating light adaptation in photoreceptors. 5.2. HORIZONTAL CELLS A number of studies have also focused on the role of NO in horizontal cells. One of the first of these studies examines the effects of NO on the gap junction coupling between horizontal cells. De Vries and Schwartz (1988) find that when cGMP is introduced directly into solitary pairs of catfish horizontal cells in culture, there is a 40% decrease in the junctional conductance between the cells. They also obtain similar uncoupling by perfusing the cultures with the NO donor SNP. They conclude that horizontal cells can be uncoupled by concentrations of cGMP which can be produced by NO activation of the endogenous GC present in the horizontal cells. 129
Ch. IV
W.D. Eldred
Miyachi et al. (1990) confirm these earlier results by finding that injection of either cGMP or L-arginine into H1 luminosity-type horizontal cells in turtle retina reduces their light responses. They also find a dramatic increase in the cells' input resistance, and that there is a decrease in the horizontal cells' response to a surround and an increase in their response to stimulation of their receptive field center. They conclude that L-arginine is blocking the gap junctions between horizontal cells, and because a NOS inhibitor blocks the effects of L-arginine, they conclude that the arginine effect is not a direct effect and works through NOS. These physiological results support the presence of a NOS pathway in these horizontal cells. The immunocytochemical studies of Haverkamp and Eldred (1998b) confirm the existence of NOS-LI in turtle horizontal cells. Taken with the results by De Vries and Schwartz (1988), it is apparent that the entire N O S / N O / s G C / c G M P signal transduction system is present in horizontal cells. As mentioned above, Greenstreet and Djamgoz (1994) find that NO donors stimulate the formation of spinules by fish horizontal cells. A study by Pottek et al. (1997) also addresses the formation of spinules and several other effects of NO on fish horizontal cells. They find that the NO donor SNP increases the full-field light response of HI, H2 and H3 cone horizontal cell types. Stimulation with cGMP produces similar increases in H1 cell responses, which suggests that NO is working through cGMP. Moreover, because SNP decreases the 455-nm response in H3 horizontal cells, but increases its depolarization to green and red stimuli, they suggest that red and green cones are involved but not blue cones. SNP also blocks spread of Lucifer Yellow to one-half of the adjacent H1 cells, although dopamine uncouples them all. Finally, in contrast to the results of Greenstreet and Djamgoz (1994), Pottek et al. (1997) find that the NOS inhibitor, nitroarginine, has no effect in vivo on spinules. They attribute the difference in spinule formation to the loss of efferents to the retina in vitro. These results indicate that NO can influence the physiology of multiple horizontal cell types, both in terms of their chromatic responses and their network coupling. A second study of fish horizontal cells also supports a role for NO in chromatic processing. Furukawa et al. (1997) report that H1 cells in carp have different postsynaptic mechanisms in response to short- and long-wavelength stimulation, and that short-wavelength stimulation is only active during the light-adapted state. They find that the spectral balance in H1 horizontal cells is modulated by NO and that NOS inhibitor eliminates the light-adapted changes. In contrast, a NO donor produces the same effect as light adaptation. They conclude that the short-wavelength transmission to H1 horizontal cells uses an APB-sensitive glutamate receptor coupled through NO as a light-adaptive messenger, much like the photoreceptors and ON-bipolar cells. Finally, McMahon and Ponomareva (1996) investigate the modulation of glutamate receptors on fish horizontal cells by NO. Fish horizontal cells mainly have AMPA receptors and dopamine/cAMP/protein kinase A (PKA) increases the sensitivity of these AMPA receptors. These workers report that NO donors reduce the response of these glutamate receptors to kainate by -~54%. These effects of NO are reported to work through cGMP/PKG because cGMP also reduces the kainate response by 34%, and intracellular injection of the PKG inhibitor peptide, RKRARKE, also blocks the NO effects. Bath application of L-arginine also decreases the kainate responses like cGMP and NO in H1 cells, and thus it is likely that the H1 cells can serve as their own source and target of NO. These authors conclude that the glutamate receptors on horizontal cells can be positively modulated by dopamine or cAMP to increase the gain at photoreceptor-horizontal cell synapses, or they can be negatively modulated by NO to decrease this gain. Although this decrease in gain is too slow to play a role in visual processing, it may protect the horizontal cells from the high rates of release 130
Nitric oxide in the retina
Ch. IV
of glutamate from photoreceptors during darkness or from excitotoxicity (McMahon and Ponomareva, 1996). As shown by Djamgoz et al. ( 1996) above. there are a number of possible sources of NO in the outer retina of the fish. 5.3. BIPOLAR CELLS The light response in ON-bipolar cells is produced by the decrease in glutamate release from photoreceptors in the light. This decreased transmitter release reduces the activation of an APB-sensitive glutamate receptor on the ON-bipolar cells, which is in turn linked through a G protein to PDE. The decrease in receptor activation, decreases the activity of the G protein and the PDE, which allows an increase in cGMP levels to open cGMP-gated channels and depolarize the bipolar cell (Shiells and Falk, 1990). Shiells and Falk (1992) have investigated the effects of NO on the light responses of these ON-bipolar cells by doing whole-cell voltage clamp recordings using a pipette filled with the NO donor SNP. They find that, as the NO donor diffuses into the bipolar cell, it produces an inward current accompanied by a rise in dim and bright flash response amplitudes and an increase in membrane conductance. Inclusion of sGC inhibitors in the pipette causes outward currents, and a suppression of the light responses and membrane conductances. They conclude that there is a NO-sensitive GC in bipolar cells and that the G protein probably acts by activation of a phosphodiesterase. Interestingly, by measuring the light response in the presence of different intracellular levels of cGMP, they conclude that small cGMP levels increase the light response until saturation, but that higher levels then decrease the light response. The results of Haverkamp and Eldred (1998b) indicate that nNOS-LI is present in ON-bipolar cells and may provide a cell autonomous endogenous source of NO in ON-bipolar cells. 5.4. AMACRINE CELLS In the mammalian retina, rod signals are integrated into cone pathways through A11 amacrine cells that are in turn connected through gap junctions to other A11 amacrines and cone bipolar cells. Just as NO modulates the coupling between horizontal cells (De Vries and Schwartz, 1988; Miyachi et al., 1990). Mills and Massey (1995) show that NO donors can also selectively modulate gap junction coupling between the A11 amacrine cells and cone bipolar cells. By using specialized biotin tracers, Mills and Massey (1995) show that dopamine and CAMP decrease the gap junction coupling between adjacent A11 amacrine cells, but not between the A11 amacrine cells and the cone bipolar cells. In contrast, although NO, the PDE inhibitor Zaprinast and cGMP all decrease the coupling between the A11 amacrine cells and the cone bipolar cells, they do not decrease the gap junction coupling between adjacent A11 amacrine cells. They conclude that by working through cGMP, the NO released by light stimulation (Koistinaho et al., 1993) decreases the rod input and increases the cone input during light adaptation by uncoupling the A11 amacrine cells from the cone bipolars. As described above, NO modulates glutamate receptors on fish horizontal cells (Mc'Mahon and Ponomareva, 1996). Recently, Wexler et al. (1998) extended this result by demonstrating that NO can depress the GABAAreceptor function on arnacrine cells. They tind that both a NO donor or cGMP decrease GABA responses by 34-4 1 %. In contrast. inhibiting sGC enhances the GABA response and blocks 45% of the NO-stimulated depression of the GABA current. Inhibition of PKG prevents the depression of GABA currents in the basal condition. but not when stimulated with cGMP, which suggests that cGMP may have other targets in addition to PKG. Because activation of the cGMP-activated CAMP-specific type 11 PDE also depresses
Ch. IV
W..D. Eldred
GABA currents, the authors believe that the amacrine cells contain a PDE that depresses GABA currents. Wexler et al. (1998) conclude that NO stimulates sGC to increase cGMP levels which then increase phosphorylation by PKG. The increased cGMP also stimulates the cGMP-activated PDE to decrease cAMP levels and PKA phosphorylation. Thus, activators of adenylate cyclase, like dopamine, enhance GABAA currents, while activators of guanylate cyclase, like NO, do the opposite, and therefore cAMP and NO/cGMP function in a push-pull mechanism in GABAergic transmission. 5.5. GANGLION CELLS One of the clearest examples of the function of cGMP in the inner retina is the modulation of cGMP-gated channels. Ahmad et al. (1994) use in situ hybridization to localize rat rod photoreceptor cGMP-gated cation channels in the inner segments of rod photoreceptors, throughout the INL and in a subpopulation of cells in the GCL. They find that patch electrodes filled with cGMP are able to activate these nonspecific cation channels on ganglion cells and that stimulation with the NO donor SNP also activates these channels after a short delay. Ahmad et al. (1994) conclude that the cGMP-gated channels are regulated by a NO-sensitive sGC in these ganglion cells. In summary, NO plays a role in the physiology of every nerve cell type in the retina. In photoreceptors, NO can modulate transmitter release and may serve to spread this modulation to adjacent photoreceptors. NO also signals light adaptation and both speeds and extends the range of the light response in photoreceptors, and modulates the communication between photoreceptors and horizontal cells. The entire signal transduction cascade from NOS through NO and sGC to cGMP has been demonstrated in horizontal cells. In addition to NOs reducing the response of their glutamate receptors, NO and cGMP can influence both the chromatic responses and network coupling in horizontal cells. In bipolar cells, there is a NO-sensitive sGC that can increase cGMP levels and the gain of the light response. In amacrine cells, in addition to depressing responses of GABAA receptors, NO can also influence the network coupling of All amacrine cells from rods to cones during light adaptation. Finally, ganglion cells have been shown to have cGMP-gated channels that are regulated by a NO-sensitive sGC.
6. RELEASE OF NO IN THE RETINA
To date, only the study of Neal et al. (1998) has directly examined the release of NO in the retina. The difficulty in directly measuring NO release is that it is quickly broken down into its stable breakdown products nitrite and nitrate before it can be reliably measured. To overcome this limitation, Neal et al. (1998) cleverly took advantage of this fact and converted all of the nitrate to nitrite using nitrate reductase and then converted all of the resultant nitrite to NO by using KI/HzSO4. Thus, they could use nitrate-nitrite formation to measure NO release from the retina. They find that there is a spontaneous release of NO from unstimulated dark-adapted retinas of 1.2 nmol/min and that treatment with arginine doubles this resting release. Note that this is substantially below the 4 nM/s of NO that Margulis et al. (1998) calculate that synaptosomal fractions from the inner retina can produce under optimal conditions. Stimulations with flickering or continuous light increases the NO release and NOS inhibitor blocks the light-stimulated release of NO. They find that the photoreceptors are not releasing NO, because the blocking of the ON-bipolar cells with APB also blocks the light-stimulated release. In contrast, the blocking of glutamate receptors with the nonselective 132
Nitric oxide in the retina
Ch. IV
glutamate receptor antagonist PDA, blocks the NO release stimulated by continuous light, but has no effect on the release stimulated by flickering light. From these results, Neal et al. (1998) conclude that because PDA blocks all glutamate synapses except from the photoreceptors to the ON-bipolar cells, the NO release stimulated by flickering light must be from ON-bipolars or Mtiller cells. In contrast, because both APB and PDA block the NO release stimulated by continuous light, it must be from amacrine cells. They speculate that in most cases there is a diffuse release of NO in the IPL that may be related to the reduction of the coupling from cone bipolars to AII amacrines during light adaptation, or to regulation of the gain in ON-bipolar cells. In contrast, flickering light causes NO release from specific ON-bipolar cells.
7. MODULATION OF TRANSMITTER RELEASE BY NO NO has also been shown to increase and decrease release of specific neurotransmitters. Ientile et al. (1996) find that stimulation with NMDA releases GABA, glutamine and glutamate in chick embryo retina, and that this effect is blocked by the NOS inhibitor, nitro-t-arginine. Stimulation with the NO donors, SNP or (+)-S-nitroso-N-acetylpenicillamine (SNAP), also increases the release of GABA and glutamine, but stimulation with cGMP has no effect. These results indicate that NO can stimulate transmitter release through a mechanism that does not involve cGMP. A direct.role for NO in stimulating synaptic release is provided by the studies of Meffert et al. (1994), that report that NO directly stimulates synaptic vesicle release in a calcium-independent manner, and by the studies of Meffert et al. (1996), that indicate that NO can directly interact with proteins involved in synaptic vesicle docking fusion reactions. In addition to increasing transmitter release, Bugnon et al. (1994) report that NO exerts a negative feedback effect on the basal and potassium-induced release of dopamine in bovine retina. They find that the NO donor, hydroxylamine, decreases release similar to the effects of potassium stimulation under calcium-free conditions, and that the NOS inhibitor, t-nitroarginine, increases basal dopamine release with no effect on potassium-stimulated release. They conclude that NO does not work through cGMP because cGMP itself has no effect on basal or potassium-stimulated release, and they suggest that possibly NO reduces release by decreasing intracellular calcium levels. The inhibition of dopamine release by NO is also demonstrated in rabbit retina by Djamgoz et al. (1995), who report that the NO donors SNP and SNAP also cause a dramatic decrease in potassium-stimulated dopamine release in rabbit retina. Their results indicate that GABAA receptors are not involved, and suggest that NO could be activating calcium-dependent potassium channels as in smooth muscle. Further experiments will be required to determine the mechanism of action of NO, and whether NO modulates the release of other transmitters as well.
8. THE cGMP SIGNAL TRANSDUCTION PATHWAY IN RETINA AND ITS MODULATION BY NO Since perhaps the best established function of NO is the activation of sGC to increase levels of cGMP, a discussion of retinal cGMP is necessary to put the role of NO in a functional perspective. Many aspects of the NOS/NO/cGMP signal transduction pathways are summarized in Fig. 1. Clearly, there are many interrelated systems regulating the cGMP levels in the retina. Several earlier studies carefully biochemically quantify and localize cGMP in the retina (Berger et al., 1980; review by Ferrendelli and De Vries, 1983). These 133
Ch. IV
134
W.D. Eldred Fia. 1. This tieurc illustrates some o f the hiochcmical pathways involved in the nitric oxidc/cyclic GMP s i m a l transduction bystem, inany of' which have hccn demonstrated in retina. It is designed to he a diagrammatic summary of the results From numerous studies and is not intended to indicate the precise cellular location or coIocitli/:iltion of specitic hiochernical pathways in a known cell type.
Nitric oxide in the retina
Ch. IV
studies report that cGMP levels in the retina are 10-100 times higher than in any other part of the nervous system, ~5 gM in whole mouse retina. The concentration of cGMP in the photoreceptors is 10-20 times higher than in the inner retina, with the photoreceptor outer segments having 2-3 times the cGMP found in the inner segments. In contrast, the levels of cGMP in the inner portions of control retinas are the same as in the brain. Cyclic GMP is synthesized by either pGC or sGC and there are several isoforms of each type of GC (Fig. 1; Wong and Garbers, 1992: Murad et al., 1993). Microdissection studies find high levels of GC in photoreceptor outer segments, where they are 30-40 times higher than in the brain and 10-50 times higher than in other retinal layers (Berger et al., 1980; review by Ferrendelli and De Vries, 1983). Outside of the photoreceptors, the IPL and OPL have the highest levels of GC. Soluble GC mRNA is expressed at high levels in the INL of rat retina, while pGC mRNA is primarily localized in the outer retina (Ahmad and Barnstable, 1993). However, Ahmad and Barnstable (1993) report that both sGC and pGC mRNA are in all layers of the retina and that 25% of the pGC is in the inner retina. In the rabbit retina, sGC has been localized immunocytochemically in many photoreceptor somas in the distal layer of the ONL, and in amacrine, ganglion and bipolar cells (Haberecht et al., 1998). Soluble GC has also been functionally localized in many amacrine, bipolar and ganglion cells in turtle retina (Blute et al., 1998). There are several forms of pGC in the retina. In photoreceptors, there are two pGCs, retGC (Dizhoor et al., 1994) and retGC2 (Lowe et al., 1995), which are both modulated by intracellular calcium (Koch, 1992). In addition to the retGCs, there is biochemical or molecular evidence in the retina for (1) A-type particulate GC (pGC-A) that can be activated by atrial natriuretic factor (ANF) or brain natriuretic factor (BNF) (Kutty et al., 1992), (2) B-type particulate GC (pGC-B), which is activated by C-type natriuretic factor (CNF) (Chrisman et al., 1992), and (3) C-type particulate GC (pGC-C) (Duda et al., 1993) that can be activated by heat-stable enterotoxin or guanylin (Chrisman et al., 1992). The ligand for pGC-A, ANF, has been detected in retina using biochemical techniques (Stone and Glembotski, 1986), and it is found diffusely in both the IPL and OPL of rat and rabbit retinas using immunocytochemistry (Palm et al., 1989). ANF receptors are found biochemically in rat and human retinas (Fernandez-Durango et al., 1989; Pardhasaradhi et al., 1994). mRNAs encoding pGC-A and pGC-B, as well as mRNAs encoding BNF and CNF are found in rat retina (Fernandez-Durango et al., 1995). Two other pGCs, E-type (pGC-E) and F-type (pGC-F), are in the eye, but their cellular location and precise function are unclear. It is thought that pGC-E and pGC-F, along with D-type particulate GC (pGC-D) in olfactory epithelia, represent a subfamily of pGCs restricted to sensory systems (Yang et al., 1995). With few exceptions, although molecular or biochemical studies indicate their presence in retina, the precise cellular location of specific pGCs and their activating ligands, and their function in regulating retinal cGMP, is not known. In addition to their biochemical studies of retinal NOS described above, Margulis et al. (1998) also examine retinal sGC in bovine eyes. They find that conventional synaptosomes from the inner retina have a 4-5 fold higher sGC activity than the sGC in the cytosol or in photoreceptor synaptosomes, and that 80% of the sGC activity is in the synaptosomes from inner retina. None of this sGC activity is influenced by calcium. They use their data to calculate that the measured sGC activity in inner retina could produce 2.3 nM of cGMP per second, and that, when stimulated with NO, the inner synaptic layers could produce 76-934 nM of cGMP per second. Given the fact that the volume of the band with increased cGMP in response to NO stimulation (Koistinaho et al., 1993) represents only about 10-15% of the IPL or 3% of the total retinal volume, they conclude that cGMP production could reach 135
Ch. IV
W.D. Eldred
0.6-7.2 ~M/s in synaptic terminals. This value for the stimulated cGMP level fits well with the fact that 10-40 laM cGMP produces half saturation of cGMP-gated channels in rod outer segments (Fesenko et al., 1985; Koutalos et al., 1995). Such cGMP concentrations also fit well with the immunocytochemical demonstrations of NO-stimulated increases in cGMP in specific retinal neurons described below (Koistinaho et al., 1993; Blute et al., 1998). Extensive studies of the sensitivity of the cGMP antibody employed by Koistinaho et al. (1993) and Blute et al. (1998) indicate that it is able to detect as little as 10-5 M cGMP (De Vente et al., 1987, 1989). The early biochemical studies (Berger et al., 1980; review by Ferrendelli and De Vries, 1983) find a very high PDE activity in photoreceptor outer segments that is 15-300 times the activity in other retinal layers and 40 times that in the brain. Outside of the photoreceptors, the PDE activity is slightly higher in the plexiform layers. In both bipolar and ganglion cells, PDEs reduce the levels of cGMP, in that PDE inhibitors raise intracellular levels of cGMP and open cGMP-gated channels (Nawy and Jahr, 1991; Abroad et al., 1994). Another well-established function of cGMP is the activation of PKG, and the PKG activity in retina is three times that in whole rabbit brain (Berger et al., 1980; review by Ferrendelli and De Vries, 1983). These studies report that there is little PKG in the photoreceptor outer segments and in the inner retina, but that the levels of PKG activity peak in the photoreceptor inner segments and in the OPL. PKG phosphorylates several proteins in photoreceptor outer segments that are dephosphorylated by light. These PKGs are regulated by changes in cGMP concentration that are in the same range as those found in rod outer segments. Other studies use an antibody against cGMP itself to investigate the modulation of cGMP in specific cell types. Using this method, Berkelmans et al. (1989) find some cGMP-LI in photoreceptors and ganglion cells in control rat retinas. However, they find that stimulation with SNP increases cGMP-LI in the OPL and IPL, in cell bodies in the INL, and in photoreceptors and ganglion cells. They conclude that sGC is present in the INL and OPL, in amacrine cells and in fibrous structures in the IPL. Koistinaho et al. (1993) use the same cGMP antibody (De Vente et al., 1987, 1989) to examine control rabbit retinas and find cGMP-LI in photoreceptor outer segments and in some faint neurons in the GCL. Like Berkelmans et al. (1989), Koistinaho et al. (1993) report that stimulation with a NO donor increases cGMP-LI in photoreceptor inner segments and sparse ganglion cells. However, in rabbit the increased cGMP-LI is most apparent in two populations of bipolar cells, the majority being ON cone bipolars and the minority being OFF-midget bipolar cells. None of these bipolar cells with increased cGMP have protein kinase C and therefore rod bipolar cells are not involved (Greferath et al., 1990). Koistinaho et al. (1993) postulate that the amacrine cells with NOS could regulate their synaptic input. They speculate that flashing light could stimulate glutamate release from ON-bipolars that could cause the type I NADPH-diaphorase-positive amacrine cells to release NO, and in turn this NO could increase the cGMP levels in these same ON-cone bipolar cells and enhance their light response and transmitter release. Some of the most detailed studies of the activation of sGC by NO are in the turtle retina. Blute et al. (1998) functionally localize sGC within cells by using cGMP immunocytochemistry to detect the cell autonomous increases in cGMP-LI in response to the activation of sGC by NO. In turtle, NO-stimulated increases in cGMP-LI occur in at least eight different amacrine cell types, three bipolar cell types, some somas in the GCL and in discrete bands of processes in the IPL. These results are consistent with the high levels of sGC mRNA expressed in the inner retina (Ahmad and Barnstable, 1993). ELISA measurements indicate that stimulation with NO increases total retinal levels of cGMP by ~1500%. The control baseline levels of cGMP primarily represent the cGMP in approximately one hundred million 136
Nitric oxide in the retina
Ch. 1V
photoreceptors (Ferrendelli and De Vries, 1983). Thus, the magnitude of this increase in cGMP in less than one hundred thousand amacrine, bipolar and ganglion cells suggests that the NO-stimulated levels of cGMP are remarkably high in these neurons. The broad neuronal distribution of NO-stimulated cGMP-LI suggests that the NO/sGC/cGMP signal transduction cascade is involved at several levels of visual processing in the inner retina. The study by Blute et al. (1998) indicates that exogenous NO activates sGC in specific neurons in turtle retina. A subsequent study by B lute et al. (1999), shows that activation of either kainate or NMDA-sensitive glutamate receptors also produces sufficient increases in endogenous NO to activate sGC and increase levels of cGMP. In these studies (Blute et al., 1999), stimulation with NMDA or kainate increases cGMP in overlapping subsets of the previously demonstrated sGC containing neurons, including 4-5 amacrine cell types, some bipolar cells and some somas in the GCL. These increases in cGMP are blocked by NOS inhibitors, which confirms the involvement of NOS and NO. ELISA measurements indicate that stimulation with either NMDA or kainate approximately doubles the total retinal levels of cGMP, which is consistent with the number of cells seen with increased cGMP-LI, in comparison to the number seen with NO stimulation. These results also indicate that by working through NO, activation of glutamate receptors can increase levels of cGMP in cells that may or may not even have glutamate receptors. A recent study by Gotzes et al. (1998) also examines NO stimulated increases in cGMP, but goes on to suggest that there are interrelationships of NO and cGMP between the inner and outer retina. They find that, in control bovine retinas treated with IBMX, there is some immunocytochemically detectable cGMP in mostly OFF- and a few ON-bipolar cells, and that there is weak cGMP in rod photoreceptor spherules, somas and inner segments, but not in photoreceptor outer segments. If these retinas are treated with NOS inhibitors, there is a total loss of cGMP-LI in the inner retina and an increase in cGMP-LI in the rod photoreceptor somas, inner segments and spherules. Treatment with SNP decreases the cGMP-LI in the outer retina, and increases cGMP-LI in both OFF- and ON-bipolar cells, in the nerve fiber layer and in amacrine and ganglion cells. They suggest that the endogenous NO released from the inner retina may inhibit cGMP synthesis in the outer retina. They conclude that the NO is probably released from amacrine cells, and that this NO may inhibit cGMP synthesis or enhance the degradation of cGMP in the outer retina. Finally, they propose that all of this relates to light and dark adaptation; just as dopamine is released during the light from amacrine cells and influences photoreceptor responses, NO is released in the light and increases levels of cGMP in the inner retina. Given that NO can influence dopamine release (Djamgoz et al., 1995), they speculate that NO and dopamine might interact to regulate light and dark adaptation in the retina. As mentioned above, Wexler et al. (1998) also propose that dopamine and NO/cGMP may function in a push-pull mechanism in GABAergic transmission. In summary, many aspects of the cGMP signal transduction system are extremely well developed in the retina. The retina has very high overall levels of cGME particularly in photoreceptors. This cGMP is produced by many different GCs, including the sGC found in high concentrations in inner retina, and by the multiple types of pGC, some of which are localized in specific cell types like photoreceptors. There are also clearly established roles for both PKG and PDEs in the retina, although few details are available. NO can activate sGC in large numbers of retinal neurons, and functionally active levels of NO are produced endogenously by the activation of glutamate receptors. Finally, there is a complex interactive regulation of NO and cGMP between the inner and outer retina. Clearly, NO and cGMP are important for many diverse aspects of retinal function, but many critical details remain to be clarified. 137
Ch. IV
W.D. Eldred
9. F U T U R E AREAS OF INVESTIGATION It should be apparent from this review that NO plays many important roles in the function of the retina. The last ten years have provided many interesting details, but many questions remain. The existence and subcellular localizations of all the potential isoforms of NOS give rise to many questions. Although the existence of nNOS seems a certainty, recent studies describe more than one isoform of nNOS. Eliasson et al. (1997) report the existence of nNOS(x, nNOS[3 and nNOSu in brain, of which both nNOS6 and nNOSu are cytoplasmic because they are missing the postsynaptic density 95 (PSD-95) binding domain that could anchor them to membranes. It will be important to determine if these isoforms also exist in retina, and if the nNOS6 and nNOSy are responsible for the NOS-LI seen in the cytoplasm of the strongly stained amacrine cells. It is possible that nNOS(x is the isoform found at synapses while nNOSI3 or nNOSy are found in the cytoplasm, and nothing is known about the differential regulation of these enzymes. The details concerning the existence of both soluble and membrane-bound NOS, some of which is calcium-sensitive and some of which is not, also calls for further investigation. The application of new methods for the direct imaging of NO (Blute et al., 2000) will greatly facilitate the exploration of the activation of NOS isoforms and the release of NO from specific cell types. For instance, in many ganglion cells there is NOS in the soma but not in the processes of these cells. Is NO released from these somas, or does it just represent NOS that may be transported to the axon terminals of these ganglion cells? The existence, localization and function of both eNOS and iNOS need to be clarified. There is evidence both for and against the existence of eNOS in the retina, while the presence of iNOS in the retina is more conclusive. The existence of iNOS and the continuous basal levels of NO that it might produce raise the possibility that in the retina, NO may not just function as a neurotransmitter/neuromodulator. Physiologically, the retina is an extremely complex tissue with a very high rate of metabolism. It is entirely possible, that in some cases, the NO is regulating metabolism and not functioning in synaptic processing. This has already been suggested by the studies that localize nNOS in cells with a close relationship to the retinal vasculature. Such a metabolic function is also supported by McKee et al. (1994), who report that NO can modulate the activity of Na+/K+-ATPase, and by Clementi et al. (1998), who describe interactions of NO with mitochondrial metabolism. It is also very likely that NO will modulate levels of intracellular calcium, as has been clearly demonstrated in the brain (Clementi and Meldolesi. 1997). The regulation of calcium by NO will be extremely interesting in that both eNOS and nNOS are activated by calcium, which raises the possibility for some complex biochemical feedback relationships. Many studies of NO in retina have focused on the function of NO in specific cell types or transmitter systems, such as NO modulation of dopamine release or NO regulation of the junctional coupling between horizontal cells. However, in retina, gap junction coupling has been demonstrated between large numbers of diverse cell types (Vaney, 1994), which raises the possibility that NO may modulate coupling between many different cells in the retina. A similar enlargement of the role of NO may occur in the relationship of NO to neurotransmitter release. In brain, NO increases or decreases the release of many neuropeptides or neurotransmitters (Zhu and Luo, 1992; Bugnon et al., 1994; Garry et al., 1994; Jones et al., 1995), NO inhibits glutamate or dopamine (Pogun and Kuhar, 1994) transport into synaptosomes, and NO can evoke GABA release through either calcium-dependent release or through reversal of the calcium-independent and Na+-dependent transporter-mediated GABA uptake system (Ohkuma et al., 1996). Similar mechanisms may occur in the retina, where all 138
Nitric oxide in the retina
Ch. IV
of these transmitter systems are well developed. Therefore, it will be important to determine if the functions of NO that have been demonstrated in specific retinal cell types occur in other retinal cell types, and which of the diverse functions of NO in the brain also occur in retina. In summary, although other second-messenger pathways, such as the dopamine/cAMP system, have been shown to function in select cells in the retina, it is becoming clear that the NO/cGMP signal transduction system may play some role in every cell type in the retina. Although the biochemistry and pharmacology of these NO/cGMP pathways is extremely complicated by the numerous interrelated control mechanisms, it will be vital for future studies to characterize these pathways in order to truly understand retinal function.
10. ABBREVIATIONS
ADP ANF BNF BSPT cAMP cGMP CNF ELISA eNOS GABA GC GCL IBMX INL iNOS IPL kDa LI mRNA NADPH NMDA NO NOS OPL PDE pGC PKA PKG RT-PCR S sGC SNAP SNP
adenine dinucleotide phosphate atrial natriuretic factor brain natriuretic factor 2-(2'-benzothiazolyl)-5-styryl-3(4'-phthalhydrazidyl)-tetrazolium chloride cyclic adenosine monophosphate cyclic guanosine monophosphate C-type natriuretic factor enzyme linked immunos0rbant assay endothelial nitric oxide synthase gamma amino butyric acid guanylate cyclase ganglion cell layer isobutyl methyl xanthine inner nuclear layer inducible nitric oxide synthase inner plexiform layer kilodalton like immunoreactivity messenger ribonucleic acid nicotinamide adenine dinucleotide phosphate N-methyl-D-aspartic acid nitric oxide nitric oxide synthase outer plexiform layer phosphodiesterase particulate guanylate cyclase protein kinase A protein kinase G reverse transcriptase polymerase chain reaction strata soluble guanylate cyclase (+)-S-nitroso-N-acetylpenicillamine sodium nitroprusside 139
Ch. I V
11.
W.D. E l d r e d
ACKNOWLEDGEMENTS
I w i s h to t h a n k Dr. T o d d A. B l u t e a n d M i c h a e l L e e for c r i t i c a l r e a d i n g o f the m a n u s c r i p t , a n d I e s p e c i a l l y t h a n k Dr. B l u t e for m a n y useful d i s c u s s i o n s .
12. REFERENCES Ahmad I, Barnstable CJ (1993): Differential laminar expression of particulate and soluble guanylate cyclase genes in rat retina. Exp Eve Res 56:51-62. Ahmad I, Leinders-Zufall T, Kocsis JD, Shepard GM. Zufall F, Barnstable CJ ( 1994): Retinal ganglion cells express a cGMP-gated cation conductance activated by nitric oxide donors. Neupvn 12:155-165. Attwell D, Borges S, Wu SM. Wilson M (1987): Signal clipping by the rod output synapse. Nature 328:522-524. Becquet F, Courtois Y, Goureau O (1997): Nitric oxide in the eye: multifaceted roles and diverse outcomes. Supa' Ophthalmol 42:71-82. Berger SJ, De Vries GW, Carter JG. Schulz DW, Passonneau PN, Lowry OH. Ferrendelli JA (1980): The distribution of the components of the cyclic GMP cycle in retina. J Biol Chem 255:3128-3133. Berkelmans HS, Schipper J, Hudson L, Steinbusch HWM, De Vente J (1989): cGMP immunocytochemistry in aorta, kidney, retina and brain tissues of the rat after perfusion with nitroprusside. Histochemistrv 93:143-148. Blute TA, Mayer B, Eldred WD (1997): Immunocytochemical and histochemical localization of nitric oxide synthase in the turtle retina. Vis Netuvsci 14:717-729. Blute TA, Velasco E Eldred WD (1998): Functional localization of soluble guanylate cyclase in turtle retina: modulation of cGMP by nitric oxide. Vis Neupvsci 15:485-498. Blute TA, De Grenier J, Eldred WD (1999): Activation of NMDA or kainate receptors modulates cGMP-like immunoreactivity in the turtle retina: involvement of nitric oxide synthase. J Comp Neurol 404:75-85. Blute TA, Lee MR, Eldred WD (2000): Direct imaging of NMDA-stimulated nitric oxide production in the retina. Vis Neurosci, in press. Bredt DS, Snyder SH (1994): Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem 63:175-195. Bugnon O, Schaad NC, Schorderet M (1994): Nitric oxide modulates endogenous dopamine release in bovine retina. Neuroreport 5:401-404. Chert Z, Gu Q, Kaufman PL, Cynader MS (1998): Histochemical mapping of NADPH-diaphorase in monkey and human eyes. Curr Eve Res 17:370-379. Chrisman TD, Schulz S, Garbers DL (1992): Guanylyl cyclases: ligands and functions. CoM Spring Harbor Syrup Quant Biol 57:155-161. Clementi E, Meldolesi J (1997): The cross-talk between nitric oxide and Ca2-'-: a story with a complex past and a promising future. Trends Phannacol Sci 18:266-269. Clementi E, Brown GC, Feelisch M, Moncada S (1998): Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione. Proc Natl Acad Sci USA 95:7631-7636. Cobcroft M, Vaccaro T, Mitrofanis J (1989): Distinct patterns of distribution among NADPH-diaphorase neurones of the guinea pig retina. Neurosci Len 103:1-7. Cramer KS, Moore CI, Sur M (1995): Transient expression of NADPH-diaphorase in the lateral geniculate nucleus of the ferret during early postnatal development. J Comp Neurol 353:306-316. Cramer KS, Angelucci A, Hahm JO, Bogdanov MB, Sur M (1996): A role for nitric oxide in the development of the ferret retinogeniculate projection. J Neurosci 16:7995-8004. Darius S, Wolf G, Huang PL, Fishman MC (1995): Localization of NADPH-diaphorase/nitric oxide synthase in the rat retina: an electron microscopic study. Brain Res 690:231-235. De Carvalho RE De Faria MH, Do Nascimento JLM, Hokoq JN (1996): Development of NADPH-diaphorase in the avian retina: regulation by calcium ions and relation to nitric oxide synthase. J Neluvchem 67:1063-1071. De Vente J, Steinbusch HWM, Schipper J (1987): A new approach to immunocytochemistry of 3',5'-cyclic guanosine monophosphate: preparation specificity and initial application of a new antiserum against formaldehyde-fixed 3',5'-cyclic guanosine monophosphate. Neuroscience 22:361-373. De Vente J, Schipper J, Steinbusch HWM (1989): Formaldehyde fixation of cGMP in distinct cellular pools and their recognition by different cGMP-antisera: an immunocytochemical study in the problem of serum specificity. Histochemistrv 91:401-412. 140
N i t r i c o x i d e in t h e r e t i n a
Ch. I V
De Vries SH, Schwartz EA (1988): Modulation of an electrical synapse between solitary pairs of catfish horizontal cells by dopamine and second messengers. J Phvsiol Land 414:351-375. Dizhoor AM, Lowe DG, Olshevskaya EV, Laura RE Hurley JB (1994): The human photoreceptor membrane guanylyl cyclase retGC is present in outer segments and is regulated by calcium and a soluble activator. Neuron 12:1345-1352. Djamgoz MBA, Cunningham JR, Davenport SL. Neal MJ (1995): Nitric oxide inhibits depolarization-induced release of endogenous dopamine in the rabbit retina. Neulvsci Lett 198:33-36. Djamgoz MBA, Aguilo R, Greenstreet EH, Reynolds R, Wilkin GP {1996): Histochemistry of NADPH-diaphorase a marker for neuronal nitric oxide synthase - - in the carp retina. Neurochem lnt 28:283-291. Duda T, Goraczniak RM, Sitaramayya A. Sharma RK (1993): Cloning and expression of an ATP-regulated human retina C-type natriuretic factor receptor guanylate cyclase. BiochemistpT 32:1391-1395. Eliasson MJL, Blackshaw S, Schell MJ. Snyder SH (1997): Neuronal nitric oxide synthase alternatively spliced forms: prominent functional localizations in the brain. Proc Natl Acad Sci USA 94:3396-3401. Fernandez-Durango R, Sanchez D, Gutkowska J. Carrier F, Fernandez-Cruz A (1989): Identification of atrial natriuretic factor receptors in the rat retina. Life Sci 44:1837-1846. Fernandez-Durango R, Nunez DJR, Brown MJ (1995) Messenger RNAs encoding the natriuretic peptides and their receptors are expressed in the eye. Exp Eve Res 61"723-729. Ferrendelli JA, De Vries GW (1983): Cyclic GMP systems in the retina. Fed Ppvc 42:3103-3106. Fesenko EE, Kolesnikov SS, Lyubarsky AL (1985): Induction of cyclic GMP of cationic conductance in plasma membrane of retinal rod outer segments. Nature 313:310-313. Fujii S, Honda S, Sekiya Y, Yamasaki M, Yamamoto M, Saijoh K (1998): Differential expression of nitric oxide synthase isoforms in form-deprived chick eyes. Curr Eve Res 17:586-593. Furukawa T, Yamada M, Petruv R, Djamgoz MBA, Yasui S {1997): Nitric oxide 2-amino-4-phosphonobutyric acid and light/dark adaptation modulate short-wavelength-sensitive synaptic transmission to retinal horizontal cells. Neurosci Res 27:65-74. Garry MG, Richardson JD, Hargreaves KM (1994): Sodium nitroprusside evokes the release of immunoreactive calcitonin gene-related peptide and substance P from dorsal horn slices via nitric oxide-dependent and nitric oxide- independent mechanisms. J Neurosci 14:4329-4337. Goldstein IM, Ostwald P, Roth S (1996): Nitric oxide: a review of its role in retinal function and disease. Vision Res 36:2979-2994. Gotzes S, De Vente J, Mtiiler F (1998): Nitric oxide modulates cGMP levels in neurons in the inner and outer retina in opposite ways. Vis Neurosci 15:945-955. Goureau O, Hicks D, Courtois Y (1994a): Human retinal pigmented epithelial cells produce nitric oxide in response to cytokines. Biochem Biophys Res Commun 198:120-126. Goureau O, Hicks D, Courtois Y, De Kozak Y (1994b): Induction and regulation of nitric oxide synthase in retinal Mtiller glial cells. J Neurochem 63:310-317. Goureau O, R6gnier-Ricard E Jonet L, Jeanny JC, Courtois Y, Chany-Fournier F (1997): Developmental expression of nitric oxide synthase isoform I and III in chick retina. J Neurosci Res 50:104-113. Greenstreet EH, Djamgoz MBA (1994): Nitric oxide induces light-adaptive morphological changes in retinal neurones. Neuroreport 6:109-112. Greferath U, Grtinert U, W~issle H (1990): Rod bipolar cells in the mammalian retina show protein kinase C-like immunoreactivity. J Comp Neurol 301:433-442. Haberecht MF, Schmidt HHHW, Mills S, Massey SC, Nakane M, Redburn-Johnson DA (1998): Localization of nitric oxide synthase NADPH diaphorase and soluble guanylyl cyclase in adult rabbit retina. Vis Neurosci 15:881-890. Haverkamp SH, Eldred WD (1998a): Localization of the origin of retinal efferents in the turtle brain and the involvement of nitric oxide synthase. J Comp Neurol 393:185-195. Haverkamp SH, Eldred WD (1998b): Localization of nNOS in photoreceptor bipolar and horizontal cells in turtle and rat retinas. Neuroreport 10:2231-2235. Hering H, Kr6ger S (1996): Formation of synaptic specializations in the inner plexiform layer of the developing chick retina. J Comp Neurol 375:393-405. Horio Y, Murad F (1991): Solubilization of guanylyl cyclase from bovine rod outer segments and effects of lowering Ca 2+ and nitro compounds. J Biol Chem 266:3411-3415. Huxlin KR (1995): NADPH-diaphorase expression in neurons and glia of the normal adult rat retina. Brain Res 692:195-206. Huxlin KR, Bennett MR (1995): NADPH diaphorase expression in the rat retina after axotomy ~ a supportive role for nitric oxide. Eur J Neurosci 7:2226-2239. 141
Ch. I V
W.D. E l d r e d
Ientile R, Picciurro V, Pedale S, Nucci C, Malecka B, Nistic6 G. Macaione S (1996): Nitric oxide enhances amino acid release from immature chick embryo retina. Neurosci Lett 219:79-82. Jones NM, Loiacono RE, Beart PM (1995): Roles for nitric oxide as an intra- and interneuronal messenger at NMDA release-regulating receptors: evidence from studies of the NMDA-evoked release of [3H]noradrenaline and O-[3H]aspartate from rat hippocampal slices. J Neutw'hem 64:2057-2063. Koch KW (1992): Biochemical mechanism of light adaptation in vertebrate photoreceptors. Trends Biochem 17:307-311. Koch KW, Lambrecht HG, Haberecht M, Redburn D. Schmidt HHHW (1994): Functional coupling of a CaZ+/calmodulin-dependent nitric oxide synthase and a soluble guanylyl cyclase in vertebrate photoreceptor cells. EMBO J 13:3312-3320. Koistinaho J, Swanson RA, De Vente J, Sagar SM I1993): NADPH-diaphorase (nitric oxide synthase)-reactive amacrine cells of rabbit retina: putative target cells and stimulation by light. Neuroscience 57:587-597. Koutalos Y, Nakatani K, Tamura T, Yau KW (1995): Characterization of guanylate cyclase activity in single retinal rod outer segments. J Gen Phvsiol 106:863-890. Kurenni DE, Moroz LL, Turner RW, Sharkey KA, Barnes S (1994): Modulation of ion channels in rod photoreceptots by nitric oxide. Neuron 13:315-324. Kurenni DE, Thurlow GA, Turner RW, Moroz LL, Sharkey KA, Barnes S (1995): Nitric oxide synthase in tiger salamander retina. J Comp Neurol 361:525-526. Kutty RK, Fletcher RT, Chader GJ, Krishna G (1992): Expression of guanylate cyclase-A mRNA in the rat retina: detection using polymerase chain reaction. Biochem Biophys Res Commun 182:851-857. Lau KC, So KF, Tay D, Leung MCP (1994): NADPH-diaphorase neurons in the retina of the hamster. J Comp Neurol 350:550-558. Liepe BA, Stone C, Koistinaho J, Copenhagen DR (1994): Nitric oxide synthase in Mtiller cells and neurons of salamander and fish retina. J Neurosci 14:7641-7654. L6pez-Costa JJ, Goldstein J, Saavedra JP (1997): Neuronal and macrophagic nitric oxide synthase isoforms distribution in normal rat retina. Neurosci Lett 232:155-158. Lowe DG, Dizhoor AM, Liu K, Gu Q, Spencer M, Laura R, Lu L, Hurley JB (1995): Cloning and expression of a second photoreceptor-specific membrane retina guanylyl cyclase (RetGC) RetGC-2. Proc Natl Acad Sci USA 92:5535-5539. Margulis A, Sharma RK, Sitaramayya A (1992): Nitroprusside-sensitive and insensitive guanylate cyclases in retinal rod outer segments. Biochem Biophys Res Commun 185:909-914. Margulis A, Pozdnyakov N, Dang L, Sitaramayya A (1998): Soluble guanylate cyclase and nitric oxide synthase in synaptosomal fractions of bovine retina. Vis Neurosci 15:867-873. Matsumoto T, Nakane M, Pollock JS, Kuk JE. F6rstermann U (1993): A correlation between soluble brain nitric oxide synthase and NADPH-diaphorase activity is only seen after exposure of the tissue to fixative. Neurosci Lett 155:61-64. McKee M, Scavone C, Nathanson JA (1994): Nitric oxide cGMP and hormone regulation of active sodium transport. Proc Natl Acad Sci USA 91:12056-12060. McMahon DG, Ponomareva LV (1996): Nitric oxide and cGMP modulate retinal glutamate receptors. J Neutvphysiol 76:2307-2315. Meffert MK, Premack BA, Schulman H (1994): Nitric oxide stimulates Ca2+-independent synaptic vesicle release. Neuron 12:1235-1244. Meffert MK, Calakos NC, Scheller RH, Schulman H (1996): Nitric oxide modulates synaptic vesicle docking fusion reactions. Neuron 16:1229-1236. Mills SL, Massey SC (1995): Differential properties of two gap junctional pathways made by All amacrine cells. Nature 377:734-737. Mitrofanis J (1989): Development of NADPH-diaphorase cells in the rat's retina. Neurosci Lett 102:165-172. Mitrofanis J, Robinson SR, Ashwell K (1992): Development of catecholaminergic indoleamine-accumulating and NADPH-diaphorase amacrine cells in rabbit retinae. J Comp Neurol 319:560-585. Miyachi E, Murakami M, Nakaki T (1990): Arginine blocks gap junctions between retinal horizontal cells. Neuroreport 1:107-110. Morgan IG, Miethke R Li ZK (1994): Is nitric oxide a transmitter of the centrifugal projection to the avian retina. Neurosci Lett 168:5-7. Mtiller FH, Wiissle H, Brecha NC (1988): NADPH-diaphorase positive amacrine cells show GABA-Iike immunoreactivity in cat retina. EurJ Neurosci [Suppl] 1:153. Murad F, Fostermann U, Nakane M, Pollock J, Tracey R, Matsumoto T, Buechler W (1993): The nitric oxide142
N i t r i c o x i d e in the r e t i n a
Ch. I V
cyclic GMP signal transduction system for intracellular and intercellular communication. Adv Second Messenger Phosphoprotein Res 28:101 - 109. Nawy S, Jahr CE (1991): cGMP-gated conductance in retinal bipolar cells is suppressed by the photoreceptor transmitter. Neuron 7:677-683. Neal M, Cunningham J, Matthews K (1998): Selective release of nitric oxide from retinal amacrine cells and bipolar cells, bwest Ophthalmol Vis Sci 39:850-853. N611 GN, Billek M, Pietruck C, Schmidt KF (1994): Inhibition of nitric oxide synthase alters light responses and dark voltage of amphibian photoreceptors. Neuropharmacology 33:1407-1412. Ohkuma S, Katsura M, Chen DZ, Naihara H, Kuriyama K (1996): Nitric oxide-evoked [3H]y-aminobutyric acid release is mediated by two distinct release mechanisms. Brain Res Mol Brain Res 36:137-144. Osborne NN, Barnett NL, Herrera AJ (1993): NADPH diaphorase localization and nitric oxide synthetase activity in the retina and anterior uvea of the rabbit eye. Brain Res 610:194-198. Palm DE, Keil LC, Sassani JW, Severs WB (1989): Immunoreactive atrial natriuretic peptide in the retina of rats and rabbits. Brain Res 504:142-144. Pardhasaradhi K, Kutty RK, Gentleman S. Krishna G (1994): Expression of mRNA for atrial natriuretic peptide receptor guanylate cyclase (ANPRA) in human retina. Cell Mol Neurobiol 14:1-7. Park CS, Pardhasaradhi K, Gianotti C, Villegas E, Krishna G (1994): Human retina expresses both constitutive and inducible isoforms of nitric oxide synthase mRNA. Biochem Biophys Res Commun 205:85-91. Park CS, Gianotti C, Park R, Krishna G (1996): Neuronal isoform of nitric oxide synthase is expressed at low levels in human retina. Cell Mol Neurobiol 16:499-515. Patel JI, Gentleman SM, Jen LS, Garey LJ (1997): Nitric oxide synthase in developing retinas and after optic tract section. Brain Res 761:156-160. Perez MTR, Larsson B, Alto E Andersson KE, Ehinger B (1995): Localisation of neuronal nitric oxide synthaseimmunoreactivity in rat and rabbit retinas. Exp Brain Res 104:207-217. Petry HM, Murphy HA (1995): Differentiation of short-wavelength-sensitive cones by NADPH diaphorase histochemistry. Proc Natl Acad Sci USA 92:5121-5123. Pogun S, Kuhar MJ (1994): Regulation of neurotransmitter reuptake by nitric oxide. Amt NY Acad Sci 738:305315. Pottek M, Schultz K, Weiler R (1997): Effects of nitric oxide on the horizontal cell network and dopamine release in the carp retina. Vision Res 37:1091 - 1102. Pozdnyakov N, Lloyd A, Reddy VN, Sitaramayya A (1993): Nitric oxide-regulated endogenous ADP-ribosylation of rod outer segment proteins. Biochem Biophys Res Commun 192:610-615. Provis JM, Mitrofanis J (1990): NADPH-diaphorase neurones of human retinae have a uniform topographical distribution. Vis Neurosci 4:619-623. Renter/a RC, Constantine-Paton M (1996): Exogenous nitric oxide causes collapse of retinal ganglion cell axonal growth cones in vitro. J Neurobiol 29:415-428. Rieke F, Schwartz EA (1994): A cGMP-gated current can control exocytosis at cone synapses. Neuron 13:863-873. Riley RJ, Workman P (1992): DT-diaphorase and cancer chemotherapy. Biochem Pharmaco143:1657-1669. Roufail E, Rees S (1997): Ageing has a differential effect on nitric oxide synthase-containing and catecholaminergic amacrine cells in the human and rat retina. J Comp Neurol 389:329-347. Roufail E, Stringer M, Rees S (1995): Nitric oxide synthase immunoreactivity and NADPH diaphorase staining are co-localised in neurons closely associated with the vasculature in rat and human retina. Brain Res 684:36-46. Sagar S (1990): NADPH-diaphorase reactive neurons of the rabbit retina: differential sensitivity to excitotoxins and unusual morphological features. J Comp Neurol 300:309-319. Sagar SM (1986): NADPH diaphorase histochemistry in the rabbit retina. Brain Res 373:153-158. Sandell JH (1985): NADPH diaphorase cells in the mammalian inner retina. J Comp Neurol 238:466-472. Sato T (1990): NADPH-diaphorase positive amacrine cells in the retinae of the frog (Rana esculenta) and pigeon (Columbia livia). Arch Histol Cvtoi 53:63-69. Savchenko A, Barnes S, Kramer RH (1997): Cyclic-nucleotide-gated channels mediate synaptic feedback by nitric oxide. Nature 390:694-698. Schmidt HHHW, Lohmann SM, Walter U (1993): The nitric oxide and cGMP signal transduction system: regulation and mechanism of action. Biochim Biophys Acta 1178:153-175. Schonfelder G, Matejevic D, Vernerova Z (1993): Histochemical reduction of TNBT by NADPH-diaphorase in association with additives used for nitric oxide synthase detection. Histochem J 25:891. Sheng H, Ignarro LJ (1996): Biochemical and immunohistochemical characterization of nitric oxide synthase in the rat retina. Pharmacol Res 33:29-33. 143
Ch. I V
W.D. E l d r e d
Shiells RA, Falk G (1990): Glutamate receptors of rod bipolar cells are liked to a cyclic GMP cascade via a G-protein. Proc R Soc Lond 242:91-94. Shiells RA, Falk G (1992): Retinal on-bipolar cells contain a nitric oxide-sensitive guanylate cyclase. Neuroreport 3:845-848. Stanarius A, T6pel I, Schulz S, Noack H, Wolf G (1997): Immunocytochemistry of endothelial nitric oxide synthase in the rat brain: a light and electron microscopical study using the tyramide signal amplification technique. Acta Histochem 99:411-429. Stone JR, Marletta MA (1995): Heme stoichiometry of heterodimeric soluble guanylate cyclase. Biochemistry 34:14668-14674. Stone RA, Glembotski CC (1986): Immunoactive atrial natriuretic peptide in the rat eye: molecular torms in anterior uvea and retina. Biochem Biophys Res Commtm 134:1022-1029. Straznicky C, Gabriel R (1991): NADPH-diaphorase positive neurons in the retina of Bufo marinus: selective staining of bipolar and amacrine cells. Arch Histol Cvtol 54:213-220. Ten6rio F, Giraldi-Guimaraes A, Mendez-Otero R 11996): Morphology of NADPH-diaphorase-positive cells in the retinoceptive layers of the developing rat superior colliculus, lnt J Dev Neurosci 14:1-10. Tracey WR, Nakane M, Pollock JS, FOrstermann U (1993): Nitric oxide synthases in neuronal cells macrophages and endothelium are NADPH diaphorases but represent only a fraction of total cellular NADPH diaphorase activity. Biochem Biophys Res Commtm 195:1035-1040. Tsuyama 1", N611 GN, Schmidt KF (1993): L-Arginine and nicotinamide adenine dinucleotide phosphate alter dark voltage and accelerate light response recovery in isolated retinal rods of the lYog (Rana temporaria). Neurosci Lett 149:95-98. Vaccaro TM, Cobcroft MD, Provis JM, Mitrofanis J (1991): NADPH-diaphorase reactivity in adult and developing cat retina. Cell Tissue Res 265:371-379. Vaney DI (1994): Patterns of neuronal coupling in the retina. Pro~ Retin Eve Res 13:302-355. Vaney DI, Young HM (1988): GABA-Iike immunoreactivitv in NADPH-diaphorase amacrine cells of the rabbit retina. Brain Res 474:380-385. Venturini CM, Knowles RG, Palmer RMJ. Moncada S (1991): Synthesis of nitric oxide in the bovine retina. Biochem Biophys Res Commun 180:920-925. Villani L, Guarnieri T (1996): Localization of nitric oxide synthase in the goldfish retina. Brain Res 743:353-356. Vincent SR (1994): Nitric oxide: a radical neurotransmitter in the central nervous svstem. Prog Neutvbiol 42:129160. Vincent SR, Hope BT (1992): Neurons that say NO. Tremts Neurosci 15:108-113. W~issle H, Hoon Chun M, Mtiller F (1987)" Amacrine cells in the ganglion cell layer of the cat retina. J Comp Neurol 265:391-408. Weiler R, Kewitz B (1993): The marker for nitric oxide synthase NADPH-diaphorase colocalizes with GABA in horizontal cells and cells of the inner retina in the carp retina. Neu~vsci Lett 158:151-154. Wellard JW, Miethke R Morgan IG (1995): Neural barriers affect the action of nitric oxide synthase inhibitors in the intact chicken retina. Neurosci Lett 201:17-20. Wexler EM, Stanton PK, Nawy S (1998): Nitric oxide depresses GABA,x receptor function via coactivation of cGMP-dependent kinase and phosphodiesterase. J Neurosci 18:2342-2349. Williams CV, Nordquist D, McLoon SC (1994): Correlation of nitric oxide synthase expression with changing patterns of axonal projections in the developing visual system. J Neurosci 14:1746-1755. Wislocki GB, Sidman RL (1954): The chemical morphology of the retina. J Contp Neurol 101:53-91. Wong SKF, Garbers DL (1992): Receptor guanylyl cyclases. J Clin hn'est 90:299-305. Yamamoto R, Bredt DS, Snyder SH, Stone RA I1993): The localization of nitric oxide synthase in the rat eye and related cranial structures. Neutvscience 54:189-200. Yang RB, Foster DC, Garbers DL, Ftille HJ (1995): Two membrane forms of guanylyl cyclase found in the eye. Ppvc Natl Acad Sci USA 92:602-606. Ye X, Laties AM, Stone RA (1990): Peptidergic innervation of the retinal vasculature and optic nerve head. hn'est Ophthalmol Vis Sci 31:1731-1737. Yoshida A, Pozdnyakov N, Dang L, Orselli SM, Reddy VN, Sitaramayya A (1995): Nitric oxide synthesis in retinal photoreceptor cells. Vis Neurosci 12:493-500. Young HM, Vaney DI (1989): GABA-Iike immunoreactivity in NADPH-diaphorase amacrine cells of rabbit and rat retinae. Neurosci Lett [Suppl] 27:S114. Young HM, O'Brien AJ, Furness JB, Ciampoli D, Hardwick JR McCabe TJ, Narayanasami R, Masters BSS, Tracey WR (1997): Relationships between NADPH diaphorase staining and neuronal endothelial and inducible nitric 144
Nitric oxide in the retina
Ch. I V
oxide synthase and cytochrome P450 reductase immunoreactivities in guinea-pig tissues. Histochem Cell Biol 107:19-29. Zhu XZ, Luo LG (1992)" Effects of nitroprusside (nitric oxide) on endogenous dopamine release from rat striatal slices. J Neurochem 59:932-935.
145
This Page Intentionally Left Blank
CHAPTER V
Nitric oxide signaling in the hypothalamus B. WOODSIDE AND S. AMIR
1. INTRODUCTION The mammalian hypothalamus plays an important role in the control of autonomic and neuroendocrine functions such as cardiovascular activity and secretion of stress hormones; it is also implicated in diverse physiological and behavioral processes such as temperature regulation, energy balance, circadian rhythmicity, and reproductive behavior. Comprised of a network of anatomically discrete nuclei, the hypothalamus serves an integrative function by altering metabolic, endocrine, and autonomic activities in anticipation of, or in response to, specific organismic or environmental challenges. It is now well recognized that an important mechanism underlying the functional integrity of the hypothalamic surveillance system is neurochemical diversity. Transduction of signals to and from various hypothalamic regulatory systems involves disparate classes of excitatory and inhibitory transmitters, hormones, peptides, and second messengers. An important new addition to this neurochemical diversity is nitric oxide (NO). NO is a highly reactive free radical gas which, in neurons, is produced from L-arginine by a calcium- and calmodulin-dependent and NADPH-requiring neuronal form of the enzyme, nitric oxide synthase (NOS) (Garthwaite, 1991; Bredt and Snyder, 1992). Neuronal NOS is a constitutive protein that can rapidly and transiently synthesize and release small amounts of NO in response to stimuli that increase intracellular calcium concentration (Bredt and Snyder, 1990; Alagarsamy et al., 1994). Once released, NO can interact with various target proteins within the generating cell or in adjacent cells to influence ion channels, transmitter receptors, enzymes, and second-messenger systems (Bredt and Snyder, 1989; Knowles et al., 1989; Schmidt et al., 1993; Schuman and Madison, 1994; Vincent, 1994; Bhat et al., 1996). In this chapter studies of NO as a messenger molecule within the hypothalamus are reviewed. The focus of this chapter is the involvement of this messenger in the regulation of hypothalamic systems involved in neuroendocrine and autonomic control.
2. NOS IN THE HYPOTHALAMUS
Studies of the distribution of NOS mRNA and neuronal NOS protein within the mammalian central nervous system have been conducted using in situ hybridization as well as immunohistochemical and NADPH-diaphorase (NADPH-d) histochemical methods (Bredt et al:, 1990, 1991; Dawson et al., 1991; Hope et al., 1991). These studies have revealed the presence of a large number of NOS-containing neurons in the magnocellular and parvocellular subdivisions of the hypothalamic paraventricular nucleus (PVN), supraoptic nucleus (SON), nucleus circularis, and lateral hypothalamus. Additional groups of hypothalamic neurons that express Handbook o f Chemical Neun~anatom ~; Vol. 17: Functional Neunmnatom v o f the Nit ric Oxide Svstem
H.W.M. Steinbusch, J. De Vente and S.R. Vincent, editors @ 2000 Elsevier Science B.V. All rights reserved.
147
Ch. V
B. Woodside and S. Amir
•
..
TU
ME
148
•
--:.
Nitric oxide signaling in the hypothalamus
Ch. V
NOS have been demonstrated in the preoptic nucleus, periventricular nucleus and portions of the ventromedial nucleus (VMH), lateral anterior nucleus, bed nucleus of the stria terminalis, magnocellular neurons in the horizontal limb of the diagonal band, supraoptic decussation, tuber cinereum, the medial and lateral tuberal nuclei, the organ vasculosum of the lamina terminalis (OVLT) (Vincent and Kimura, 1992: Vincent, 1994) and the suprachiasmatic nucleus (SCN) (Decker and Reuss, 1994; Lupi et al., 1996; Wang and Morris, 1996b: Chen et al., 1997). NO-producing neurons within the PVN project to the posterior pituitary and the brain stem and nerve endings containing NOS have been demonstrated in the internal portion of the median eminence (ME) (Arevalo et al., 1992: Vincent and Kimura, 1992; Vanhatalo and Soinila, 1995; Kawakami et al., 1998). As well as being a source of NO neurons the hypothalamus is also the recipient of NOS-positive inputs. For example, a nitrergic input from the amygdala to the hypothalamus has been identified (Tanaka et al., 1997). Illustrations of major NOS-containing hypothalamic nuclei as revealed by NADPH-d histochemistry are shown in Figs. 1-7.
3. CO-LOCALIZATION Hypothalamic NOS has .been co-localized with several neuropeptides, classical neurotransmitters, and receptor-types. Within the PVN, NOS-containing cells have been shown to contain corticotropin-releasing hormone (CRH) (Siaud et al., 1994), vasopressin (AVP) (Calka and Block, 1993b; Sanchez et al., 1996), oxytocin (OT) (Miyagawa et al., 1994), angiotensin (Calka and Block, 1993a), pituitary adenylate cyclase-activating polypeptide (PACAP) (Okamura et al., 1994a), calbindin (Alonso et al., 1992a), and enkephalin (Yamada et al., 1996). Similar patterns of co-localization have been observed in the SON where cholecystokinin (CCK) immunoreactivity as well as galanin message-associated peptide-like immunoreactivity have also been observed in some NOS-stained neurons (Yamada et al., 1996). In both the medial preoptic area (MPOA) and the VMH, NOS has been co-localized with substance P-like (Yamada et al., 1996) and with estrogen-receptor immunoreactivity (Okamura et al., 1994b,c). Some NOS-stained cells in the VMH also show enkephalin- and somatostatin-like immunoreactivity (Yamada et al., 1996). Within the SCN, NOS neurons have been shown to stain for vasoactive-intestinal polypeptide (VIP) (Reuss et al., 1995). In the dorsomedial nucleus enkephalin-, galanin message-associated peptide- and substance P-like immunoreactivity have all been shown to co-localize with NOS, and enkephalin-like immunoreactivity has also been found in NOS-containing neurons in the arcuate nucleus (Yamada et al., 1996). Finally, CCK, substance P, and enkephalin-like immunoreactivity have all been co-localized with NOS in the mammillary region (Yamada et al., 1996). With respect to the classical neurotransmitter systems, co-localization of NOS and acetylcholine has been reported in the PVN, SON, and nucleus circularis and co-localization of NOS and tyrosine hydroxylase has been observed in some neurons in the SON (Johnson and Ma, 1993; Blanco et al., 1997; Crespo et al., 1998). Consistent with the close association
,+
Fig. 1. Examples of NADPH-d staining in three anterior-posterior levels of the PVN. Line illustrations (derived from Swanson, 1992) on the right side of the figure indicate the approximate level of the PVN, and the area within the black box the location of the photomicrographs. 149
Ch. V
B. Woodside and S. Amir
.... ~
9
:.-
~:,~
50- ~ m l ~ i~ ~i~-~::-- ~
150
~
~
Nitric oxide signaling in the hypothalamus
Ch. V
between NMDA receptor activation and the induction of NO, the mRNA for NMDA-R1 receptors has been shown in NOS-containing neurons in the OVLT, MPOA, VMH, PVN, and SON (Bhat et al., 1995).
4. REGULATION Levels of NOS as reflected in the density of staining for NADPH-d, NOS immunoreactivity or mRNA hybridization signal within specific nuclei of the hypothalamus are modulated both by naturally occurring changes in the state of the organism and by a variety of exogenous stimuli. One potent class of stimuli associated with endogenous changes in state are the gonadal hormones. In male rats, castration has been shown to decrease levels of NOS in the MPOA (Hull et al., 1997; Shi et al., 1998; Du and Hull, 1999) and ovariectomized females show lower levels of NOS in both the MPOA (Okamura et al., 1994b) and the VMH (Ceccatelli et al., 1996" Rachman et al., 1998) than intact animals. In ovariectomized females levels of the enzyme in these areas increases following estrogen administration when this hormone is given acutely so that it mimics changes that occur across the estrous cycle (Okamura et al., 1994b; Ceccatelli et al., 1996; Rachman et al., 1998). The co-localization of NOS with estrogen-receptor immunoreactivity in the VMH and MPOA suggests that this is a direct effect of estrogen. NOS levels in the PVN and SON are also modulated by reproductive state and are increased during late pregnancy and lactation (Ceccatelli and Eriksson, 1993; Woodside and Amir, 1996; Xu et al., 1996; Popeski et al., 1999) as is the mRNA for NOS in the OVLT, and lamina terminalis (Luckman et al., 1997). NOS staining in the PVN and SON is not affected by administration of estrogen alone but does increase in response to a exogenous hormone administration that mimics the changes in ovarian hormone levels seen in late pregnancy (Popeski et al., 1999). In contrast, 4 days of estrogen treatment alone may be sufficient to increase NADPH-d staining in the pituitary (Wang and Morris, 1999). Together these data demonstrate the importance of gonadal hormones in the regulation of NOS and emphasize the fact that their effects are both site-specific and dependent on the pattern of hormone exposure. It is interesting to note that in contrast to the powerful effects of gonadal steroids on NOS levels, adrenal steroids do not seem to play a major role in regulating NOS levels in the hypothalamus. Bilateral adrenalectomy, for example, produces only a small and non-significant increase in NADPH-d staining in magnocellular neurons of the PVN (Sanchez et al., 1996). Thyroid hormone status does have a marked effect on mRNA for NOS, however. Hypothyroidism induced by propylthiouracil administration reduces mRNA for NOS and this effect can be reversed by adding T3 to the food (Ueta et al., 1995a). Finally, there are diurnal influences on NOS. Neuronal NOS immunoreactivity in the MPOA increases in the afternoon in female rats and increases in MPOA cGMP efftux in the afternoon, which are assumed to be NO-dependent, have also been observed in both male and female rats (Pu et al., 1998a,b). NOS levels in the SCN also fluctuate with the light/dark cycle with high levels being associated with the dark phase of the cycle. These fluctuations
<_.___
Fig. 2. Examples of NADPH-d staining in the posterior PVN. The line illustration (derived from Swanson, 1992) indicates the approximate level of the PVN, and the area within the black box the location of the photomicrographs. The bottom panel represents the same area at a higher magnification. 151
Ch. V
B. Woodside and S. Amir
q~
,L 41
,~
&
:'~ "
"....
.
o
v
.'." %:i..,
""...""
F-:'sc.-
...
~ " .....-..-.-.'."."
~tA"
" .... " .
,~.
50 ~ Fig. 3. E x a m p l e s of N A D P H - d staining in the S O N and the lateral hypothalamic area dorsal to the S O N as s h o w n in the line illustration (derived from S w a n s o n . 1992). The top right and bottom left panels show the same areas at higher magnification.
a
disappear when the animal is placed in constant darkness (Ferreyra et al., 1998). Further, it has been shown that the pineal hormone melatonin, the release of which is restricted to the dark phase of the cycle inhibits NOS activity in the hypothalamus in rats (Bettahi et al., 1996). NO has also been implicated as a mediator of melatonin's effects on the suppression of norepinephrine-induced prostaglandin E2 and cAMP production (Bettahi et al., 1998). Diverse types of manipulations that activate the stress axis have been shown to upregulate NOS levels in the PVN and/or SON. These include challenges to the immune system such as injection of lipopolysaccharide (Lee et al., 1995" Jacobs et al., 1997; Harada et al., 1999) or interleukin-1 (Brunetti et al., 1996) as well as psychogenic stressors such as forced swim 152
Nitric oxide signaling in the h3pothalamus
Ch. V °.
[01) ~ m
•
.
.
..
° °.
°'o,
• " " ,
°
° °
°°°
,
• •
•
,~1
.o, :°
°
•
.
°
°
°°°
•o o"
°
°
"°
. . . . . .
° ,°
•
°°
~
,
~.....
i-
f 50 lam
Fig. 4. An example of NADPH-d staining in the periventricular region of the hypothalamus as shown in the line illustration in the top right. The bottom panel shows the same region at higher magnification.
and restraint (Calza et al., 1993" Kishimoto et al., 1996 • Sanchez et al., 1999). In addition, a variety of homeostatic stressors such as salt loading (Pow, 1994: Villar et al., 1994b), water deprivation (Calka et al., 1994" Ueta et al., 1995c" O'Shea and Gundlach, 1996) and 153
Ch. V
B. Woodside and S. Amir
° °
•°
..oo
~:).
i~~i
~
~ T~ ¸ L
¸
Fig. 5. An example of NADPH-d staining in the nucleus circularis as shown in the line illustration in the top right. The bottom panel shows the same region at higher magnification.
hypovolemia induction following propylene glycol administration increase NOS levels in these structures (Ueta et al., 1998). Conversely, food deprivation decreases NOS staining in the PVN (Ueta et al., 1995b; O'Shea and Gundlach, 1996). Decreased levels of NOS have also been observed in cholestatic rats (Swain et al., 1997). The sensitivity of this system to homeostatic challenge raises the issue of how it is changed in mutant strains that show 154
Nitric oxide signaling in the hypothalamus
Ch. V
'o
.
".r. •
~ .
. o
.
,..;f~ •
f /
No-
i
- .'~
z
?,
'4
:? q :,,L:-
t ~~t~ ~'~~~-~'~~ ~ : ~ ' ~~: ii~ .... ~
llm Fig. 6. An example of NADPH-d staining in the VMH as shown in the line illustration in the top right. The bottom panel shows the same region at higher magnification.
disturbances of homeostatic systems. Studies of ob/ob mutant mice have found increased levels of mRNA for NOS whereas Zucker fa/fa rats show a decrease in mRNA for NOS in the hypothalamus (Morley et al., 1995; Morley and Mattammal, 1996). 155
Ch. V
B. Woodside and S. Amir
100 l~m II
..
.
.%..'."
.,.:.i-i;
..................... I
,,
. ~.~H.
..~.".... ,,
•
tx .°
-
,
°"
.
,o
o. •
•
.
•
.
o o
o
J
20 ~ m
Fig. 7. An example of NADPH-d staining in the ME as shown in the line illustration in the top right. The bottom panel shows the same region at higher magnification.
Diabetes either inherited or induced by streptozotocin administration is associated with an increase in NOS in the PVN and SON (Wang and Morris, 1996a" Yamamoto et al., 1997; Serino et al., 1998) as is hypertension (Alaghband-Zadeh et al., 1996; Plochocka-Zulinska 156
Nitric oxide signaling in the hypothalamus
Ch. V
and Krukoff, 1997; Takeda et al., 1997). On the other hand, decreases in levels of NOS in PVN have been observed after experimentally induced heart failure (Patel et al., 1996; Zhang et al., 1998). In humans, reduced levels of NOS have also been observed in the PVN of schizophrenic patients (Bernstein et al., 1998). In addition to changes in endogenous state a number of external stimuli have been shown to modulate NOS levels in the PVN and SON. Consistent with the upregulation of NOS following water deprivation and salt loading, the administration of oxytocin (Melis et al., 1997b; Popeski et al., 1999) or angiotensin II (Dawson et al., 1998), both of which are implicated in the control of drinking and water balance, increases NOS levels in the PVN and/or SON. In addition, a series of studies have demonstrated that NO is increased in the PVN in response to administration of dopamine and of the glutamate receptor agonist N-methyl-D-aspartate (NMDA) (Melis et al., 1996, 1997a). As in other systems axonal damage induced by pituitary stalk transection also increases NOS levels in neurosecretory cells of the PVN and SON (Wu and Scott, 1993: Villar et al., 1994a; Lumme et al., 1997). Finally, recent evidence suggests that treatment with NO donors decreases NOS pointing to a possible negative feedback effect of NO on its own production (Canteros et al., 1996).
5. FUNCTIONAL CONSIDERATIONS 5.1. STRESS AXIS The synthesis and release of glucocorticoids from the adrenal cortex is regulated by the anterior pituitary hormone adrenocorticotropin (ACTH), whose secretion is controlled by the hypothalamic corticotropin-releasing hormone (CRH) neurosecretory system. Cell bodies containing CRH as well as other ACTH-releasing factors such as vasopressin are located in the parvocellular subdivision of the PVN: these cells project axons to the portal capillary plexus in the external zone of the median eminence. A number of findings prompted investigation of the role of NO in the modulation of the hypothalamic-pituitary-adrenal (HPA) axis. These include: (a)co-localization of NOS and CRH in neurons of the PVN (Siaud et al., 1994): (b) upregulation of NOS following both psychogenic and immune stress (Calza et al., 1993; Lee et al., 1995: Kishimoto et al., 1996; Harada et al., 1999; Sanchez et al., 1999): and (c) induction of immediate early gene expression in NOS-containing neurons following a variety of stressors including restraint, glucoprivation, hypotension, and morphine withdrawal (Petrov et al., 1995; Hatakeyama et al., 1996; Jhamandas et al., 1996; Amir et al., 1997; Krukoff and Khalili, 1997; Dawson et al., 1998; Briski and Sylvester, 1999; Yang et al., 1999). The results of the research on this topic have pointed to a complex relationship between NO and the stress axis. Studies using the hypothalamic slice preparation have shown that treatment with either the NO precursor L-arginine, or the NO donors molsidomine and sodium nitroprusside, did not affect basal release of CRH but did block the stimulated release of CRH induced by KC1 or interleukin-1. The inhibitory effect of L-arginine could be reversed by treatment with the competitive NOS blocker NG-monomethyl-L-arginine (L-NMMA) and the inhibitory effect of the NO donors on CRH release was blocked by treatment with hemoglobin, a scavenger of NO. On the basis of these findings it has been suggested that NO exerts an inhibitory effect on stimulated CRH release by hypothalamic neurons (Costa et al., 1993). Contrary to these findings, evidence has been reported suggesting that NO exerts a permissive or facilitatory 157
Ch. V
B. Woodside and S. Amir
effect on CRH release (Karanth et al., 1993). In these experiments, prolonged treatment with L-arginine enhanced both the basal release of CRH as well as interleukin-2-induced stimulation of CRH release from hypothalamic slices. Treatment with the NOS blocker L-NMMA completely suppressed the interleukin-2-induced release of CRH but had no effect on norepinephrine-induced CRH release. Additional data supporting a permissive role of NO on CRH release has been reported (Brunetti et al., 1993). These experiments showed that treatment with the competitive NOS blocker NG-nitro-L-arginine (L-NOArg) inhibits interleukin-l-induced release of CRH and ACTH from cultured hypothalamic neurons in vitro. Similarly, Sandi et al. (1995) using a rat hypothalamus perifusion system showed that pre- and co-incubation with a NOS inhibitor or a NO scavenger produced a strong attenuation of interleukin-1-stimulated CRH secretion. More recently, NO has been identified as a mediator of IL-10 stimulation of CRF release from median eminence fragments (Stefano et al., 1998). Both inhibitory and permissive effects of NO have also been reported from in vivo studies. The effects of manipulating NO on the stress axis depend on the type of stimulus administered and the parameters measured. In general, NO appears to inhibit the HPA response to immune stressors but facilitate that to psychogenic stressors. Using the c-fos gene product Fos as a marker of neuronal activation, it was found that immobilization stress activates PVN cells that express the NOS histochemical marker, NADPH-diaphorase (Hatakeyama et al., 1996; Amir et al., 1997). Further, systemic treatment with NOS blockers, either NG-nitro-L-arginine methyl ester (L-NAME) or 7-nitro indazole, significantly attenuates immobilization stress-induced Fos expression in the PVN (Amir et al., 1997) and the release of adrenal corticosterone in rats (Rackover et al., 1994). Pretreatment with D-NAME, an inactive isomer of L-NAME had no effect. Interestingly, a low dose of L-NAME that was sufficient to block the immobilization-induced release of corticosterone did not reduce the stress-induced expression of Fos in the NOS-containing PVN neurons although a higher dose attenuated both the corticosterone and Fos response to restraint stress. Although NO has been implicated in basal steroidogenesis (Adams et al., 1992) as well as in the control of basal adrenal vascular tone in the rat isolated adrenal gland preparation, it was found not to be involved in either the vascular or steroidogenic response to ACTH stimulation (Cameron and Hinson, 1993). These data provide further support for the conclusion that the inhibitory effect of L-NAME on stress-induced corticosterone release is mediated centrally and may not involve peripheral actions at the level of the adrenal gland. Contrary to the finding suggesting that NO has a permissive role in the control of stress-induced corticosterone release, other authors have obtained data suggesting an inhibitory effect of NO on acute inflammation-, interleukin-1-, vasopressin-, and oxytocin-induced ACTH release in vivo (Rivier and Shen, 1994; Turnbull and Rivier, 1996). Specifically, Rivier and Shen (1994) found that peripheral administration of the NOS blocker L-NAME enhances the stimulatory effect of peripherally administered interleukin-1, vasopressin and oxytocin on ACTH release, whereas treatment with L-arginine blunts the effect of interleukin-1 on ACTH release. Furthermore, systemic treatment with L-NAME enhanced lipopolysaccharide-induced ACTH and corticosterone release. Interestingly, systemic L-NAME had no effect on centrally administered interleukin-1-induced release of ACTH, suggesting that the facilitatory effects of L-NAME on ACTH and corticosterone release following systemic treatment with the different secretagogues was mediated downstream from the hypothalamus (Rivier and Shen, 1994). Additional evidence in support of the latter view is that although administration of NOS blockers reduced NGFlt3 expression in the PVN following footshock it had no effect on that seen following IL-1 administration (Lee and Rivier, 1998). 158
Nitric oxide signaling in the hypothalamus
Ch. V